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Cognitive impairment in amyotrophic lateral sclerosis (ALS) is characterized by deficits on 
tests of executive functions however the contribution of processing speed is unknown. By 
contrast, multiple sclerosis (MS) is a disorder in which slowed processing speed is regarded 
as the core deficit, however, methodology is often confounded by tasks which depend on 
motor speed. MRI studies have revealed multi-system cerebral involvement in ALS, with 
evidence of reduced white matter volume and integrity in predominantly frontotemporal 
regions. The current study had two aims. Firstly, to investigate whether cognitive 
impairments in ALS and MS are due to executive dysfunction or slowed processing speed, 
independent of motor dysfunction. Secondly, to investigate the relationship between specific 
cognitive impairments and the integrity of distinct white matter tracts in ALS. Twenty-nine 
ALS patients, twenty-five MS patients, and matched healthy control groups were 
administered a dual task paradigm and processing speed tasks in which stimulus 
presentation times were manipulated. In addition background measures of executive 
functioning, working memory, verbal memory, and language were administered. White 
matter integrity was investigated using region-of-interest (ROI) and tract based spatial 
statistics (TBSS) analyses of diffusion MRI data. ALS patients did not show impairments in 
tests of processing speed, but deficits were revealed in the dual task, as well as background 
tests of executive functioning, working memory, and verbal memory. MS patients also 
exhibited deficits in the dual task as well as background tests of executive functioning, 
working memory, and verbal memory. However, in contrast to ALS patients, a processing 
speed deficit was also observed in MS.  ROI analyses revealed significant differences in 
fractional anisotropy (FA) and mean diffusivity (D) between ALS patients and healthy 
controls. Reduced integrity was observed in the corticospinal tracts and prefrontal and 
temporal white matter tracts including uncinate fasciculus, inferior longitudinal fasciculus, 
 
 
and regions of the cingulum. Significant differences also emerged in the white matter 
underlying the superior, medial and inferior frontal gyri, and the temporal gyri. Similar 
group differences were found in the TBSS analyses; ALS patients displayed prominent 
changes in the corticospinal tract and corpus callosum as well as extensive changes in 
prefrontal and temporal tracts and association fibres. Correlations between task performance 
and ROI parameters revealed that dual task performance was associated with FA in the 
middle frontal gyrus white matter while letter fluency indices correlated with FA in the 
corpus callosum and corticospinal tracts. Furthermore, verbal memory performance 
correlated with FA in the inferior longitudinal fasciculus and working memory performance 
correlated with D in uncinate fasciculus and hippocampal portion of the cingulum. 
Correlations with TBSS revealed significant associations between letter fluency indices and 
FA in the corticospinal tracts and anterior corpus callosum. The current study demonstrates 
that cognitive impairment in ALS is not due to slowed processing speed. Moreover dual task 
deficits are related to distinct prefrontal tract involvement in ALS, whilst fluency deficits 
may reflect decreasing callosal integrity. Deficits in working memory and verbal memory 
are related to white matter changes in fibre bundles connecting prefrontal, temporal, and 





Prior to the completion of the current thesis, two publications related to this body of work 
have been submitted to peer-reviewed journals. The first is an imaging methods paper 
concerning the sensitivity of a novel tractography protocol for detecting white matter 
abnormalities in ALS: 
 
Bastin, M. E., Pettit, L. D., Bak, T. H., Gillingwater, T. H., Smith, C., & Abrahams, S. 
(2013). Quantitative tractography and tract shape modeling in amyotrophic lateral sclerosis. 
Journal of Magnetic Resonance Imaging. Article first published online: 28 Feb 2013. 
doi: 10.1002/jmri.24073 
 
The second concerns the white matter region-of-interest analysis and correlations with 
cognitive performance described in Chapter 6. The ALS group investigated for the purpose 
of this publication included an additional patient who met the criteria for ALS-FTD and thus 
the data, although similar, are not identical to that described in the current thesis. 
 
Pettit, L. D., Bastin, M. E.,
 
Smith, C., Bak, T. H., Gillingwater, T. H., & Abrahams, S. 
(2013). Executive deficits, not processing speed relates to abnormalities in distinct 
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Chapter 1. Literature review 
1.1 Disease description 
Amyotrophic lateral sclerosis (ALS) is the most common form of a group of 
neurodegenerative disorders which encompasses primary lateral sclerosis and progressive 
muscular atrophy, and which collectively fall under the bracket of motor neuron disease. 
Originally described by Charcot (1869; 1874), ALS is a fatal disorder of the human motor 
system which causes progressive degeneration of pyramidal motor neurons in the brain 
(upper motor neurons), and anterior horn cells in the spinal cord (lower motor neurons). The 
resultant disruption of the motor system causes progressive muscle weakness and wastage 
as well as spasticity and fasciculations, eventually leading to death usually through 
respiratory failure (Anderson et al., 2007).  
 
The physiological mechanisms underlying neurodegeneration in ALS are not fully 
understood, although are likely to be multifactorial in nature and include factors such as 
glutamate excitoxicity, the formation of protein aggregates, DNA/RNA processing, 
mitochondrial dysfunction, and disruption to axonal transport processes (Keirnan et al., 
2011). There is still debate as to whether the disease begins in the upper motor neurons or 
lower motor neurons. The “dying-forward” hypothesis (Eisen, Kim & Pant, 1992) proposes 
that pathology begins in the pyramidal motor neurons and spreads to the anterior horn cells 
via glutamate excitoxicity, whereas the “dying-back” hypothesis proposes that pathology 
begins in the neuromuscular junction where depleted levels of neurotrophic hormone result 
in disruption to functioning of the upstream neuronal cell (Chou & Norris, 1992 Fischer et 
al., 2004). However, the possibility remains that upper and lower motor neuron pathology 
develops independently as physiological and pathological studies have predominantly 
2 
 
reported a lack of association between degeneration in the respective anatomical areas 
(Kiernan & Hudson, 1991; Attarian, Vedel, Pouget & Schmied, 2008). 
 
1.2 Diagnosis and progression 
The diagnosis of ALS presents a challenge as there is no definitive diagnostic test for the 
disease. Instead clinicians must rely on observations, nerve conduction analyses 
(electromyography), neuroimaging, and biopsies to identify a combination of upper and 
lower motor neuron pathology, as well as evidence of disease spread from one body region 
to another. Diagnosis is usually made based on the revised El Escorial criteria (Miller, 
Munsat, Swash & Brooks, 1999) which provides different levels of diagnostic certainty 
based on the extent and distribution of observed pathology, and the presence or absence of 
genetic components.  
 
Further complexity arises in the variation of clinical phenotypes. Disease onset is focal in 
ALS and reflects the involvement of upper and lower motor neuron regions which subserve 
the same anatomical area. Typically, patients may present with limb-onset (approx 70%), 
bulbar onset (approx 25%), or trunk or respiratory involvement (approx 5%) which are focal 
in nature before spreading to other areas of the body (Vucic, Burke & Kiernan, 2007). 
Atypical forms of onset include, weight loss, emotional lability and cognitive dysfunction 
(Ferguson & Elman, 2007). Disease spread in ALS is thought to be predominantly 
contiguous, with degeneration spreading to adjacent areas in both the upper and lower motor 
neuron anatomy (Brooks, 1991; Ravits, Paul & Jorg, 2007). However, in the lower motor 
neurons spread may move in a rostral to caudal direction, whereas in the upper motor 
neurons spread is medial to lateral in nature (Ravits & La Spada, 2009). This process, 
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coupled with rapid disease progression and the fact that the relative involvement of upper 
and lower motor neuron pathology is highly heterogeneous, may explain why there is such 
variation in clinical phenotype from one patient to another. Progression in ALS is relentless 
and survival statistics are harrowing with approximately 50% of patients dying within 30 
months of symptom onset, and only 20% surviving to between 5 and 10 years after 
symptom onset. Poor survival is predicted by older onset age, early respiratory dysfunction, 
and bulbar-onset whereas younger age at onset, diagnostic delay and limb-onset are 
predictors of longer survival (Talbot, 2009).  
 
1.3 Intervention and management 
Currently, drug intervention in ALS is restricted to Riluzole, a glutamate release inhibitor, 
which has been shown in randomised control trials to increase survival by 3 – 6 months 
(Miller, Mitchell, Lyon & Moore, 2007). In the absence of effective disease modifying 
drugs, management of ALS and its progression becomes paramount. Optimal care is 
provided by multidisciplinary teams encompassing physiotherapists, occupational therapists, 
speech therapists, respiratory physicians, gastroenterologists and social workers; support of 
this kind not only benefits the patient in terms of well being and alleviation of symptoms, 
but can also improve survival significantly (Van den Berg et al., 2005).  
 
Respiratory and nutrition management are the most vital components of palliative care as 
both are significant predictors of prognosis and survival (Miller et al., 2009). Respiratory 
weakness can be present from the onset of symptoms, and as the disease progresses ALS 
patients can suffer from nocturnal hypoxia as well as inspiratory and diaphragmatic 
weakness. Intervention comes in the form of non-invasive ventilation (NIV) which can 
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prolong survival and also improve quality of life by alleviating the associated 
symptomology of respiratory dysfunction (Bourke, Tomlinson, Williams, Bullock, Shaw & 
Gibson, 2006). Invasive ventilation is also an option and does significantly improve 
survival, but the reality of drastically reduced quality of life and financial costs mean that 
this strategy is rarely implemented. Malnutrition in ALS can be a result of weakened 
swallow and choking (dysphagia), or due to an increase in metabolic rate that affects 
approximately 50% of patients (Bouteloup et al., 2009). The associated weight loss can be 
mediated by the implementation of a feeding tube, either by percutaneous endoscopic 
gastrostomy (PEG) or radiologically inserted gastrostomy (RIG) depending on the patient’s 
symptoms. However as ALS progresses, palliative care is the main requirement as patients 
require careful monitoring of physical symptoms and emotional distress to make the end 
stage of the disease as easy as is possible. 
 
1.4 Epidemiology and genetics 
Although ALS has been reported throughout the world, precise global incidence is as yet 
unknown. However, population based studies in Europe have indicated a relatively stable 
incidence rate of 2.16 per 100,000 person-years (Logroscino et al., 2009), with men having 
a slightly higher incidence (3.0 per 100,000 person-years) than women (2.4 per 100,000 
person-years).  Risk of disease onset increases with age; peak incidence in the sporadic form 
is between 58 – 63 years old although it is considerably lower in familial forms (47 – 52 
years old).   
 
Although ALS appears to be a predominantly sporadic disease, approximately 10% are 
familial and follow a Mendelian pattern of inheritance (Kiernan et al., 2011). Currently, 
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fourteen genetic loci have been identified in familial forms of ALS with advancements in 
genomic techniques allowing new discoveries in recent years. Indeed, the proportion of 
ALS cases with a genetic component may be larger than is currently estimated as new 
discoveries continue to be made. Although the proportion of familial cases in ALS is 
relatively small, genetic studies remain a crucial line of investigation as the familial and 
sporadic phenotypes are virtually indistinguishable suggesting that there may be common 
pathways underpinning the observed pathology (Ravits & La Spada, 2009).  
 
Until recently, the most common known genetic mutation was SOD1 which accounts for 
20% of familial ALS and up to 5% of cases thought to be sporadic. SOD1 encodes for 
copper-zinc superoxide dismutase and is responsible for toxic gain of function (Rosen et al., 
1993). Other important genetic markers discovered in recent years are TDP-43 (or TARDBP 
which encodes TAR DNA binding protein) and FUS (which encodes fusion in sarcoma). 
Both of these genes are multifunctional but play an important role in RNA processing 
suggesting that this may be a key feature of ALS molecular pathology (Sreedharan et al., 
2008; Vance et al., 2009).  
 
In addition to the Mendelian inheritance of familial forms of ALS itself, epidemiological 
studies in relatives of ALS sufferers have revealed above average incidences of other 
neurodegenerative diseases (Fallis & Hardiman, 2009), suggesting that there may be 
susceptibility genes which increase overall risk of neurodegeneration. Indeed, pathology 
studies have revealed that TDP-43 pathology is present in almost all ALS cases and more 
than 50% of frontotemporal dementia (FTD) cases providing strong evidence for a link 
between the two disorders (Neumann et al., 2006). Moreover, the most recent and 
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potentially significant genetic mutation, the hexanucleotide repeat expansions in C9orf72, 
has been shown to account for up to 41% of familial ALS cases, and is also present is a 
significant proportion of FTD patients (Byrne et al., 2012; Snowden et al., 2012).  
 
1.5 Overlap with FTD 
Frontotemporal dementia (FTD) is a progressive neurodegenerative disease which causes 
focal atrophy of the frontal or anterior temporal lobes, or both, depending on the variant. 
Incidence and prevalence rates are variable, but the highest rates are in people of 60 – 69 
years old (prevalence 9.4 per 100,000; Knopman, Petersen, Edland, Cha & Rocca, 2004, 
incidence 8.9 per 100,000 person-years; Rosso & Kaat, 2003) and it is the second most 
common form of dementia in people under 65 years old (Ratnavalli et al., 2002). Three 
variants of FTD are recognised; behavioural variant (bvFTD), semantic dementia (SD) and 
progressive non-fluent aphasia (PNFA), and each have a different cognitive and behavioural 
profile.   
 
BvFTD is the most common variant and is characterised by profound behavioural and 
personality disturbances including disinhibition, impulsivity, emotional blunting, 
stereotyped behaviour, changes in appetite, lack of insight, and apathy (Neary et al., 1998). 
Cognitive changes may also be present at onset, or may develop as the disease progresses, 
with impairments observed in tests of executive functioning (goal-directed behaviours such 
as planning, strategy formation, mental flexibility, and inhibition), but relative sparing of 
episodic memory and visuospatial abilities (Rascovsky et al., 2011). Presentation in bvFTD 
is relatively heterogeneous, but typical pattern of atrophy associated with the syndrome is 
primarily of orbitofrontal and medial frontal cortex, with involvement of more dorsolateral 
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prefrontal areas as the disease spreads in an anterior – posterior direction (Weder, Aziz, 
Wilkins & Tampi, 2007). SD is characterised by a profound loss of semantic knowledge 
resulting in word finding difficulties (anomia), as well as poor conceptual knowledge and 
recognition of words, objects, and faces. As semantic networks are lost, speech becomes 
increasingly empty with a paucity of nouns although grammatical structure is preserved 
(Weder et al., 2007). Behavioural changes may also be present in SD, but compared to 
bvFTD, patients with SD are less likely to be apathetic and more likely to be compulsive 
(Boxer & Miller, 2005). As in bvFTD, episodic memory and visuospatial skills are typically 
spared, however, in contrast to bvFTD problem solving ability and executive functioning 
tends to remain intact, at least in the earlier stages of the disease (Lillo & Hodges 2009). 
Atrophy associated with SD is consistently within the anterior and inferior temporal lobes, 
and often asymmetrical with a left hemispheric bias (Hodges & Patterson, 2007). PNFA 
predominantly affects the language abilities, but in contrast to SD, impairments are present 
in grammar and phonology (speech sounds) resulting in speech which non-fluent, poorly 
articulated and agrammatical (Wender et al., 2007). Like SD, patients with PNFA may also 
present with word finding difficulties, however they can be differentiated from SD patients 
by the presence of intact comprehension and recognition of words and objects (Knibb, 
Kipps & Hodges, 2006). Unlike either bvFTD or SD, behavioural changes do not occur in 
PNFA until later into disease progression, and the associated atrophy is observed in insular 
and inferior frontal regions (Nestor et al., 2003).  
 
The association between ALS and cognitive and psychiatric symptoms has been 
documented in some of the earliest descriptions of the disorder; Marie (1892) stated that 
psychic disturbances were relatively common in ALS, and subsequent clinicians noted 
patients with personality and behavioural changes, failure of memory, and intellectual 
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impairment (Westphal, 1925; Meyer, 1929; Ziegler, 1930). Further investigations revealed 
that ALS was associated with a higher incidence of frontotemporal lobar dementia than in 
the normal population (e.g. Brion et al., 1981, and see Hudson, 1981 for a review), and 
seminal work by Neary et al. (1990) described patients with cognitive, behavioural, and 
cerebral hallmarks of FTD with co-occurring ALS. In spite of this, the traditional view of 
FTD assumed that the syndrome was clinically and pathologically separate from other 
neurodegenerative disorders (Lillo & Hodges, 2009). Likewise the prevailing view adopted 
by neurologists and scientist alike was that ALS was purely a motor disorder.  However, 
with the discovery of shared FUS and TDP-43 pathology in both disorders as mentioned 
above, a plausible biological link between ALS and FTD was tentatively established. 
Further evidence was provided by families in which members developed ALS or FTD, or 
both, with linkage identified on chromosome 9 (Vance et al., 2009; Pearson et al., 
2011).The recent discovery of the mutation in C9orf72 has consolidated this relationship 
(Renton et al., 2011), and the overlap between the FTD and ALS is now well recognised. In 
FTD populations, there is now consistent evidence that a significant minority of patients 
also have ALS with some studies suggesting that co-incidence is as high as 15% (Lomen-
Hoerth, Anderson & Miller, 2002; Hodges et al., 2003). Incidences of ALS patients 
developing or presenting with FTD (ALS-FTD) have been subject to more investigation; the 
percentage of patients meeting FTD criteria in small scale studies have ranged from 22% to 
52% (Murphy, Henry, Langmore, Kramer, Miller & Lomen-Hoerth, 2007; Lillo, Savage, 
Mioshi, Kiernan, & Hodges, 2012; Lomen-Hoerth, Murphy, Langmore, Kramer, Olney & 
Miller, 2003). However, larger clinic-based studies have shown that the true overlap is 
likely to be smaller; the largest study to date of 279 consecutive ALS patients found that 
15% also met criteria for FTD (Ringholz et al 2005), whilst a more recent population-based 
study of 186 ALS patients reported that 14% met criteria for FTD (Phukan et al., 2012). 
ALS-FTD patients predominantly present with the behavioural variant of the disease, 
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although cases of ALS-SD or ALS-PNFA have been reported (Lomen-Hoerth et al., 2003). 
Patients exhibit the same behavioural and cognitive sequelae that characterise the pure FTD 
syndromes. For example, patients with ALS-FTD have been shown to exhibit behavioural 
abnormalities such as aggression, impulsivity, and apathy (Neary et al., 1990), as well as 
showing more formalised changes on the Frontal Systems Behaviour Scale (Woolley, 
Moore & Katz, 2010). Executive deficits have been reported in letter and category fluency 
tests (Lepow et al., 2010), and on the Stroop Interference Test (Lomen-Hoerth et al., 2003), 
and linguistic impairment have been reported in confrontation naming (Lomen-Hoerth et al., 
2003). Moreover, investigation of ALS-FTD patients by structural magnetic resonance 
imaging (MRI) has revealed atrophy in corresponding frontotemporal regions, although to a 
lesser extent than patients with FTD in isolation (Lillo, Mioshi, Burrell, Kiernan, Hodges, & 
Hornberger, 2012).  
 
The clinical and pathological overlap between ALS and FTD discussed above had led to the 
suggestion that the two syndromes exist on a single continuum (Murphy et al., 2007). 
Neuroimaging studies have shown that although ALS, ALS-FTD and FTD have discrete and 
dissociable structural changes, there is overlapping structural pathology in frontotemporal 
grey and white matter structures between all the disorders (Chang et al., 2005; Lillo et al., 
2012). Further support for this idea is provided by the growing evidence base of studies 
which have demonstrated cognitive and behavioural impairments in ALS patients who do 
not meet FTD criteria, implying that a proportion of patients lie somewhere on the spectrum 
between pure ALS and ALS-FTD (see Goldstein & Abrahams, 2013 for a review).  Large 
scale studies have shown that detailed neuropsychological testing can detect cognitive 
impairments in a high proportion of patients, with estimates between 35% and 50% 
(Massman, Sims, Cooke, Haverkamp & Appel, 1996; Ringholz et al., 2005). Recently, a 
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consensus criteria was proposed in which characteristics of cognitive impairment (ALSci) 
and behavioural impairment (ALSbi) were defined (Strong et al., 2009). ALSci patients are 
defined as those performing below the 5
th
 percentile on two or more tests that are sensitive 
to executive functioning, and several large population-based studies have reported that 
significant proportion of patients (21 – 25%) meet this criteria (Phukan et al., 2012; Taylor 
et al., 2012; Elamin et al., 2013). Indeed, the most consistently reported cognitive 
impairments in non-demented ALS patients are in the domain of executive functioning 
(Massman et al., 1996; Frank, Haas, Heinze, Stark & Münte, 1997; Ringholz et al., 2005; 
Gordon et al., 2010). However, some have argued that language deficits are equally 
prevalent (Taylor et al., 2012), and memory impairment is also an increasingly recognised 
feature of this disorder (Ringholz et al., 2005; Christidi, Zalonis, Smyrnis & Evdokimidis, 
2012). These impairments will be discussed in more detail in the following sections.  
 
1.6 Cognition in non-demented ALS 
1.6.1 Executive functions 
Executive functions can be defined as high-level cognitive processes that facilitate new 
ways of behaving, and optimise one’s approach to unfamiliar circumstances (Gilbert & 
Burgess, 2008). Executive functions can be based upon internally or externally driven goal-
directed behaviours, and are highly involved in self-enhancing behaviours and social 
interaction (Anderson, Jacobs, & Anderson, 2008). The precise nature, and number of 
discrete cognitive functions that fall under the bracket of “executive functions” is highly 
debated (Jurado & Roselli, 2007), however most models agree that they play a crucial role 
in adaptive behaviour by facilitating processes such as: selective attention, planning, 
problem solving, initiation of action, mental flexibility, monitoring and inhibition, and 
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working memory (the ability to temporarily hold and manipulate information “in mind”).  In 
Chapter 3 a detailed discussion of models of executive functions are given in order to 
provide a foundation for the methodological design of the current thesis. The literature 
investigating executive functions in ALS has not typically been related to specific models of 
executive processes but rather has been described in relation to specific tests, most 
commonly standard assessments used in clinical neuropsychology, the results of which are 
summarised in Table 1.  
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Table 1. Studies investigating executive functions in ALS 
Study Group/Case 
analyses 
Impaired performance Normal performance  
Gallassi et al., 
1985 
 
Group: 22 ALS Letter fluency, visual attention (Barrage test) 
 
Working memory (verbal and spatial memory spans) 
 
David et al., 
1986 
Group: 14 ALS Concept formation (WCST) 
 
Working memory (digit span) 
Ludolph et al., 
1992 
Group: 18 ALS Verbal fluency  Concept formation (WCST), cognitive inhibition 
(Stroop), working memory (digit span), visual 




Group: 24 ALS Attention (Digit symbol substitution test), 




Kew et al., 
1993 
Group: 16 sporadic 
ALS 
 





Group: 12 sporadic 
ALS 
 
Letter fluency impaired subgroup (n = 6); letter 
fluency fi (written + spoken) WCST (trials to 
first criterion), random joystick movement 
 
WCST (no. of categories, errors, perseverations) 
 
 
Massman et al., 
1996 
Case: 146 sporadic 
ALS 
Letter fluency (spoken), attention (VSAT, 
SDMT), concept formation (WCST) 
 
NOTE: 35.6% showed cognitive impairment (2 tests). 
Dysarthric patients more impairment (48.5%) than 




Group: 52 ALS; 
bulbar subgroup (n = 
24) 
All ALS patients: Letter fluency fi (written), 
planning + working memory (computerised 
Tower of Hanoi), concept formation (WCST), 
Inhibition (Stroop errors and reaction time) 
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inhibition (Stroop negative priming – trend). 
Bulbar patients only; random movement 
joystick test  
 
Frank et al., 
1997 
Group: 74 sporadic 
ALS 
Letter fluency, inhibition (Stroop) – both 
correlated with age. Visual attention (D2 test), 








Group: 18 ALS Verbal fluency (letter and category), working 
memory (reverse digit span) 
Working memory (digit span) 
Strong et al., 
1999 
Group: 13 ALS; 8 
longitudinal 
Letter fluency (spoken +written) 
BULBAR only: Concept formation (WCST), 
working memory (consonant trigrams test).  
 
Concept formation (WCST), working memory 




Group: 22 sporadic 
ALS 
Fluency fi (written letter, category, design), 
Working memory (letter strings) 
 
Letter fluency fi (spoken) 
Newsom-Davis 
et al., 2001 
Group: 19 ALS; 
hypoventilation 
subgroup (n = 9) 
 
Hypoventilation patients only: Letter fluency fi 
(written). NOTE: All improved after nocturnal 
ventilation. 
Working memory (digit span) 
Hanagasi et al., 
2002 
Group: 20 sporadic 
ALS 
Verbal fluency (letter + category), attention 
(continuous performance test), working memory 
(reverse digit span, SDLT, delayed recognition 
test), inhibition (Stroop), processing 
speed/switching (TMT A, TMT B, TMT B-A) 
 
Working memory (digit span) 
Moretti et al., 
2002 
Group: 14 ALS Verbal fluency, concept formation (WCST), 
cognitive inhibition (Stroop), attention 
(PASAT) 
Working memory (digit span) 
 
 
Lomen-Hoerth Case: 100 ALS; full Verbal fluency screen (31% impaired). Full NOTE: 50% bulbar patients had VF impairment vs 
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et al., 2003 assessment subgroup 
(n = 44)  
neuropsych; Inhibition (Stroop interference), 
concept formation (WCST + California card 
sort) most sensitive  
25% limb 
Of 44; 17 had VF deficit, 12/17 met FTLD criteria. 
Of 44; 27 had no VF deficit, 6/27 met FTLD criteria 
 
Abrahams et al. 
2004 
 
Group: 28 Sporadic 
ALS 
Letter fluency fi (written + spoken), working 
memory (letter span) 
 
Category fluency fi, design fluency fi, concept 
formation (WCST) 
Kilani et al., 
2004 
Group: 18 ALS; 
longitudinal 
Switching (TMT B-A) 
NOTE: no change over 12 months 
 




Group: 23 sporadic 
ALS; fluency 
impaired subgroup (n 
= 11) 
 
Subgroup only: Fluency fi (written letter and 
category), working memory (letter span) 
Fluency fi (design), concept formation (WCST) 
Ringholz et al., 
2005 
Case: 279 sporadic 
ALS 
 
 Cluster analysis 32% mild impairment, 13% 
moderate impairment, 15% FTD. Sensitive 
tests: Attention (VSAT), letter fluency 
 
Cluster analysis: 49% patients cognitively intact 
Abrahams et 
al., 2005 
Group: 20 ALS; 
longitudinal 
Letter fluency fi (written and spoken), 
computerised sentence-completion task (at time 
point 2). 
 
Fluency fi (category and design), attention (PASAT), 
working memory (letter span), concept formation 
(WCST). 
 
Schreiber et al., 
2005 
Group: 52 sporadic 
ALS; longitudinal 
Fluency (letter and design), concept formation 
(WCST), interference (colour word interference 
test – bulbar only), attention (phasic and tonic 
alertness RTs), divided attention (dual task RTs) 
 
NOTE: only bulbar patients showed some evidence of 
longitudinal deterioration (interference, design 
fluency, recognition memory) 
Robinson et al., 
2006 
Case: 19 sporadic 
ALS; longitudinal 
Z scores: (37%) had abnormalities at 6 month 









Group and case: 16 
sporadic ALS 
ALS vs controls: Attention/processing speed, 
(SDMT). Z scores: 50% of patients were ALSi; 
2SD below normative data on 2 tests.  
 
ALS vs controls: Working memory (Brown-Peterson 
interference test), letter fluency, interference (stroop)  
Kim et al., 
2007 
Group: 16 ALS; low 
FVC subgroup (n = 8) 
Low FVC vs High FVC: letter fluency fi 
(spoken) 
NOTE: no healthy control group 
 
Low FVC vs High FVC: letter fluency fi (written), 
category fluency fi 
 
Lule et al., 
2007 
Group: 13 sporadic 
ALS 
Verbal fluency (letter and alternating) Fluency (design),  concept formation (WCST-
computerised), attention/processing speed (SDMT) 
 
Pinkhardt et al., 
2008 
Group: 20 sporadic 
ALS 
Fluency (letter and design), selective attention 
(incompatibility task) 
 
Fluency (category), inhibition (Stroop). 
Bartels et al., 
2008 
Case: 22 ALS Z-scores; most sensitive tests = verbal fluency 
(57%), working memory (digit span – 40%), 




Wicks et al., 
2009 
Group: 58 ALS; 41 
sporadic, 7 SOD1 
familial, 10 non-
SOD1 familial 
Non-SOD1 familial ALS patient: written letter 
fluency fi, inhibition (Hayling test - trend) 
 
Sporadic and SOD1 ALS patients were unimpaired in 
all tests of executive functioning: letter fluency fi, 
category fluency, concept formation (WCST), 




Group: 22 ALS Letter fluency fi, switching (trail making task 
B), ecological executive planning task 
(Medication scheduling task). 
 
Fluency fi (category, switching), inhibition (Stroop), 
planning and working memory (Tower of London) 
 
Gordon et al., 
2010 
Case: 50 ALS; 
longitudinal  
 28% ALSi. Most sensitive tests were: fluency 
(letter and category), concept formation 
(WCST). 
 
NOTE: only category fluency performance decreased 
over time. ALSi patients had shorter survival times. 
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Witgert et al., 
2010 
Case: 141 sporadic 
ALS; longitudinal 
Cluster analysis: 43% with mild cognitive 
impairment and 17% with moderate to severe 
cognitive impairment. Most sensitive tests; 
letter fluency, attention (VSAT), processing 
speed/switching (TMT A, TMT B)  
 
Least sensitive test; delayed verbal recall (Logical 
Memory II) 
Meier et al., 
2010 
Group and case: 18 
ALS 
ALS vs Controls; fluency fi (letter and 
category), planning (One-touch Stockings of 
Cambridge – similar to tower of London). Z 
scores; 28% impaired letter fluency, 39% 
impaired category fluency, 22% impaired 
stockings of Cambridge. 
 
 
Sterling et al., 
2010 
Group: 355 sporadic 
ALS; 31% bulbar 
94/175 dysarthric 
NOTE: no controls 
Dysarthric patients performed worse on 
inhibition (Stroop), attention (VSAT) and 
switching (TMT A + B), only Stroop remained 
significant after motor control condition. 
 
Bulbar patients performed worse than limb onset 
patients on inhibition (Stroop) and attention (VSAT) 
but not after motor control. 
 
Lepow et al., 
2010 
Group: 49 ALS; 13 
ALSu, 17 ALSi, 7 
ALS-FTD 
All ALS patients vs controls: verbal fluency 
(letter and semantic) 
ALSu vs ALSi vs ALS-FTD: group differences 
in the number of switches made in the letter 




Hammer et al., 
2011 
Group and case: 20 
ALS patients  
 
ALS vs controls: fluency (letter, figural) 
Z scores: letter fluency (35%), digit span (25%) 
ALS vs controls: working memory (digit span, 
reading span), concept formation (WCST), attention 
(tone alertness), inhibition (go/no-go) 
 
Sarro et al., 
2011 
Case: 16 sporadic 
ALS 
Z scores: processing speed (TMT A, 6%), 
inhibition (Stroop, 19%), concept formation 
(WCST, 19%), letter fluency (12%), category 






Libon et al., 
2012 
Case: 41 ALS Cluster analysis: 20% impaired, 45% average, 
and 34% above average on concept formation; 
DKEFS card sort performance (free recall and 
recognition). DKEFS scores were related to 
letter fluency scores 
 
DKEFS card sort performance was not related to 
performance in working memory and switching (oral 
trail making task)  
Phukan et al., 
2012 
Case and group: 160 
ALS; cognitive 
subgroups 
ALS vs controls: ALS higher incidence of 
executive impairment. ALSi vs ALSu: category 
fluency and inhibition (Stroop). Z-scores: 14% 
ALS-FTD, 21% ALSci. Letter fluency fi most 
sensitive (94%) 
 
NOTE: 14% non executive impairment (language, 
memory, visuospatial), 47% intact. ALS vs Controls: 
no group difference in incidence of memory, language 
or visuospatial impairment.   
 
Jelsone-Swain 
et al., 2012 
Group and case: 22 
ALS 
ALS vs Controls: Verbal fluency (letter and 
category). Z scores: 36% executive dysfunction 
(Strong criteria).  
ALS vs controls: Switching (oral trail making test), 
working memory (digit span forward and backward). 
NOTE: depression not associated with cognitive 
impairment but physical decline. 
 
Taylor et al., 
2012 
Group and case: 51 
ALS 
ALS vs controls: concept formation (DKEFS), 
letter fluency fi, rule detection (Brixton errors). 
Z scores: 31% executive impairment (25% 
ALSci).  
 
ALS vs controls: inhibition (Hayling test), category 
fluency. 
 
Zalonis et al., 
2012 
Group: 48 sporadic 
ALS; bulbar subgroup 
(n = 18) 
Attention/switching (TMT B-A), inhibition 
(Stroop), perseveration (WCST).  
Concept formation (WCST).  
NOTE: no differences on executive measures between 
spinal and bulbar onset patients. 
 
Lillo et al., 
2012 
Group: 20 ALS ALS vs controls; Working memory (reverse 
digit span), inhibition (Hayling test). NOTE: 
25% were ALS-FTD 
Decision making (Iowa gambling task). NOTE: rasch 





Elamin et al., 
2013 
Case: 186 ALS; 
longitudinal 
Z scores: at baseline 12% ALS-FTD, 25% 
ALSci 
NOTE: 12% ALS with non-executive 
impairment. 
 
NOTE: baseline cognitive dysfunction associated 
with ALS severity, death, and development of further 
impairment.  
 
Mioshi et al., 
2013 




ALS vs controls: verbal fluency (letter and 
category). Z scores: 32% ALSci  
ALS vs controls: inhibition (Hayling test errors), 
switching (TMT B-A). 
FVC = forced vital capacity. WCST=Wisconsin card-sorting test. VSAT=verbal series attention test. PASAT=paced auditory serial addition test. TMT = trail 
making test, parts A TMT B = trail making test, part B, TMT B-A = trail making test, part B minus part A. SDLT = serial digit learning test. SDMT = symbol-digit 
modality test.  DKEFS = Delis-Kaplan executive function system. FrSBe = Frontal systems behaviour scale. ALSi = patients with cognitive impairment. ALSu = 
patients without cognitive impairment. ALSci = patients meeting consensus criteria (Strong et al., 2009) for cognitive impairment. FTD = frontotemporal 




The most striking deficits in ALS are in tests of verbal fluency, and in particular letter 
(phonemic) fluency (e.g. Gallassi et al., 1985; Abrahams et al., 1996; Rakowicz & Hodges, 
1998; Abrahams, Leigh & Goldstein, 2005; Lepow et al., 2010; Phukan et al., 2012). Letter 
fluency tasks require participants to generate as many words as possible beginning with a 
specified letter, and within a time limit. Intrinsic generation is required for these tasks as 
participants cannot rely heavily on external or environmental cues. Lesion studies have 
suggested that category fluency tasks are more sensitive to temporal lobe damage whereas 
letter fluency is more sensitive to frontal lobe lesions (Baldo, Shimamura, Delis, Kramer & 
Kaplan, 2001; Baldo, Schwartz, Wilkins & Dronkers, 2006), although parietal regions have 
been implicated in both types of task. The specificity of fluency tests has been brought into 
question by studies demonstrating that patients with non-frontal lesions can perform as 
badly as those with frontal lesions (Perret, 1974). However, other studies have shown that 
letter fluency tasks are particularly sensitive to left dorsolateral and inferior frontal lesions 
(Stuss et al., 1998; Robinson, Shallice, Bozzali & Cipolotti, 2012), which supports the 
results of functional imaging studies reporting higher activation in dorsolateral and inferior 
frontal gyri of the left hemisphere during letter fluency tasks (Frith et al., 1995; Phelps, 
Hyder, Blamire & Shulman, 1997; Warkentin & Passant, 1997; Abrahams et al., 2004).  
 
A recent meta-analysis of cognitive impairments in ALS reported that letter fluency tests 
were the most common deficit reported in the literature and produced medium effect sizes 
(Raaphorst et al., 2010). This is reflected by the fact that virtually every study in which 
letter fluency has been investigated have reported impairments, either at the group level, or 
in a significant proportion of cases (see Table 1).  However, letter fluency tasks have an 
inherent motor component as responses must be spoken or written which presents an 
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obvious confound when testing populations with compromised motor functioning. This 
problem has been overcome by the introduction of a motor control condition in which 
participants simply repeat or copy the words that they produced during the fluency test. This 
information can then be used to work out a Fluency Index (Fi – Abrahams et al., 1996); a 
measure of the average time to think of a word which is independent of motor slowing. Not 
all studies investigating fluency performance in ALS have employed motor control 
measures (Frank et al., 1997; Ringholz et al., 2005; Witgert et al., 2010; Jelsone-Swain et 
al., 2012), casting some doubt over the validity of the findings. However, studies in which 
fluency indices were employed have invariably found deficits in letter fluency (Abrahams et 
al., 2000; Abrahams, Leigh & Goldstein, 2005; Kim et al., 2007; Meier, Charleston & 
Tippett, 2010; Phukan et al., 2012), and the necessity for controlling for motor dysfunction 
when assessing cognition in ALS is now well recognised (Raaphorst et al., 2010; Goldstein 
& Abrahams, 2013). Of note, letter fluency tests are repeatedly reported as the most 
sensitive tests in studies investigating the prevalence of cognitive impairments in ALS 
populations, with one study reporting that 94% of patients had impaired letter fluency 
(Gordon et al., 2010, Witgert et al., 2010; Taylor et al., 2012; Phukan et al. 2012).   
 
Thus, letter fluency tests appear to be particularly sensitive to cognitive dysfunction in ALS 
even when motor dysfunction is controlled for. However, the underlying reasons for this 
sensitivity are not fully resolved.  It has been suggested that fluency performance can be 
divided into dissociable components of clustering and switching (Troyer, Moscovitch & 
Winocur, 1997), with clustering being more sensitive to temporal lobe damage affecting 
semantic retrieval, and switching more sensitive to frontal lobe damage and executive 
dysfunction (Troyer, Moscovitch, Winocur, Alexander & Stuss, 1998). Lepow and 
colleagues (2010) investigated clustering and switching performance in a heterogeneous 
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group of ALS patients, some of which had mild cognitive impairment and some which had 
ALS-FTD. The authors reported that all ALS patients performed worse than controls in both 
measures of clustering and switching. Moreover, patients with cognitive impairment and 
ALS-FTD were worse again than cognitively intact patients in both measures, suggesting 
progressive involvement of both frontal and temporal regions in the ALS continuum.  In 
addition, letter fluency performance has been found to be correlated with picture naming 
and verbal memory performance (Robinson et al., 2012). Thus, although letter fluency tasks 
are assumed to be measures of executive functioning, they may also rely on an efficient 
lexical network implicating basic linguistic processes such as simple word retrieval and 
subvocal rehearsal.  
 
Attempts have been made to elucidate the underlying processes that contribute towards 
fluency deficits in ALS by investigating performance in terms of the multiple component 
model of working memory (Baddeley & Hitch, 1974; Baddeley, 2000 – see Chapter 3, 
Section 3.3.1 for a review). Abrahams et al. (2000) investigated fluency performance in a 
number of domains including letter, category and design (non-verbal fluency).  
Phonological loop and store components of working memory were assessed by testing for 
the word length effect and phonological similarity effect; reliable cognitive phenomena in 
which longer words are more difficult to remember than shorter words, and phonologically 
similar words are harder to recall than phonologically dissimilar ones (Baddeley & Wilson, 
1988). In addition, basic word retrieval was assessed through confrontation naming and 
sentence completion tasks. Impairments were found in fluency tasks, including letter 
fluency, in the absence of basic linguistic deficits. Moreover, the investigation of word 
length and phonological similarity effects revealed that word span was significantly lower in 
ALS patients compared to controls, although normal word length and phonological 
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similarity effects were observed. Taken together, the results indicated that executive 
dysfunction and reduced short-term memory capacity are more likely to contribute towards 
poor verbal fluency performance in ALS than basic linguistic and verbal abilities.  
 
Fluency tasks are thought to recruit several discrete executive processes including; 
initiation, strategy formation, sustained attention, set-shifting, working memory and 
inhibition (Troyer, Moscovitch & Winocur, 1997; Azuma, 2004; Abrahams et al., 2000; 
Rende, Ramsberger & Miyake, 2002). Robinson and others (2012) have postulated that 
letter fluency tasks impose a particular demand on selective attention as there is a high 
degree of competition amongst potential responses for any given letter. Selective attention 
has been argued to be a key function of the left inferior frontal gyrus (Thompson-Schill, 
D’Esposito, Aguirre & Farah, 1997; Robinson, Shallice, Bozzali & Cipolotti, 2010), and is 
thought to be particularly relevant to letter fluency tasks as these tasks impose fewer 
constraints than semantic fluency tasks therefore inducing higher response competition. 
Divided attention may also play an important role in fluency tasks as it has been 
demonstrated in healthy populations that fluency performance is reduced when concurrent 
tasks are employed – especially those requiring set-shifting (Rende, Ramsberger & Miyake, 
2002). However, these processes have not been sufficiently investigated in ALS. It has also 
been suggested that processing speed plays an important role in fluency tasks. Performance 
in measures such as the Digit Symbol Substitution Test and Letter Comparison task have 
been found to be strong predictors of fluency performance in populations with traumatic 
brain injury (Bittner and Crowe, 2007) and Parkinson’s disease (McDowd et al., 2011), as 
well as in normal ageing (Bryan, Luszcz & Crawford, 1997). Indeed, ALS patients have 
also been shown to be impaired on the Symbol Digit Modalities Test (Mezzapesa et al., 
2007) which was adapted to control for motor impairment.  Thus, the diversity of processes 
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required by letter fluency tasks may be the key to their sensitivity in ALS as disruption to 
any of the above processes could potentially lead to impaired performance. 
 
1.6.1.2 Working memory 
Working memory can be defined as a system responsible for the active maintenance of 
information in the face of ongoing processing and/or distraction (Conway et al., 2005). 
Working memory is an integral component of many tasks that purportedly assess executive 
functioning as information must be held in mind in order to form a strategy or monitor, 
inhibit, or update responses (Miyake et al., 2000, 2002; Engle, 2002). Although executive 
functioning is the most commonly reported deficit in ALS, only a few tasks have been 
employed in the study of cognition in ALS that purportedly isolate working memory 
capacity, the most common of which are digit span and reverse digit span. There is some 
debate as to whether digit span tasks are true measures of working memory capacity as they 
only require the storage and maintenance of information in absence of any additional 
processing (Baddeley, 1997; Conway et al., 2005). As such digit span may be a better 
representation of short-term memory capacity (Engle, Tuholski, Laughlin & Conway, 
1999), or even attention (Lezak, 1995; Sattler, 2001). By contrast, reverse digit span tasks 
do require additional processing as digits must be transformed from their original sequence 
into the reverse order – indeed reverse digit span tasks have been shown to correlate highly 
with well validated measures of working memory capacity such as reading/sentence span 
(Oberauer, Süß, Wilhelm & Wittmann, 2003). Studies investigating digit span in ALS 
cohorts have predominantly reported that ALS patients perform normally in this measure 
(see Table 1), although two studies have reported deficits (Bartels et al., 2008; Hammer et 
al., 2011), with both studies reporting that impairments were exhibited by a significant 
proportion of patients (40% and 25% respectively). Moreover, Abrahams and colleagues 
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(2000) reported that ALS patients exhibited impaired short-term memory span for letters 
and words. Although fewer studies have investigated reverse digit span, the majority of 
studies have reported deficits in ALS patients (Rackowicz & Hodges, 1998; Hanagasi et al., 
2002; Lillo et al., 2012). However, Mezzapesa at al., (2007) employed the Brown-Peterson 
task which utilizes distracter tasks such as backward counting during 10 or 30 second delay 
periods between the presentation and recall of verbal trigrams. The authors reported no 
performance difference between patients and controls, suggesting that ALS patients in this 
cohort at least, exhibited normal performance in a working memory tasks which required 
considerable additional processing.  
  
Further evidence for working memory impairments in ALS patients is derived from studies 
which have investigated cognition by combining neuropsychological and event-related 
potentials (ERP) methodologies. Volpato and collaborators (2010) reported that ALS 
patients had deficits on several working memory tasks including digit span and spatial span 
(Corsi blocks). Moreover, the study replicated the results of an earlier investigation (Paulus 
et al., 2002) by showing that performance in these tests correlated with abnormal ERP 
characteristics in an auditory “odd-ball” paradigm in which target tones must be detected 
within a presentation consisting primarily of distracter tones. The authors concluded that the 
data suggested that an attentional impairment was influencing poor working memory 
performance. A more direct investigation of working memory performance was carried out 
by Hammer et al. (2011) who collected ERP data during an n-back working memory tasks 
for figural and spatial stimuli. N-back tasks require participants to decide whether each 
stimulus in a sequence matches the one that appeared n items ago, and have been shown to 
be a valid test of working memory capacity (Kane, Conway, Miura & Colflesh, 2007) as 
they require the continuous monitoring and updating of information (Conway et al., 2005). 
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A significant proportion of the patients were unable to complete the n-back paradigms, and 
those who did were impaired relative to controls in the spatial version of the task. ALS 
patients also exhibited abnormally exaggerated ERP response to targets in the n-back 
working memory. Of note, there were no group differences between patient and controls in 
digit span leading the authors to suggest that n-back paradigms are more sensitive to 
working memory impairment than span tasks. Despite the somewhat inconsistent results 
between different studies described above, there is evidence to suggest that at least a 
proportion of ALS patients present with impairments in short-term memory capacity with 
more convincing evidence of impairments in working memory capacity. Thus, potential 
deficits in working memory should be considered in the interpretation of deficits in tests of 
executive functioning described subsequently.  
 
1.6.1.3 Concept formation and planning 
Another component of executive functioning that has come under investigation in the ALS 
literature is concept formation by way of tests such as the Wisconsin Card Sort Test 
(WCST) and Delis-Kaplan Executive Functions System (D-KEFS) sorting test. The WCST 
requires participants to sort cards based upon simple visuoperceptual rules of colour, shape, 
or number. However, the sorting rule changes regularly requiring participants to update their 
responses accordingly. The D-KEFS sorting test (formally known as the California Card 
Sort Test) shares similarities with the WCST as it requires participants to find different 
ways to sort a set of cards based on visuoperceptual and verbal cues. Such tasks require 
multiple executive processes as participants must first have the ability to generate sorting 
strategies, as well as switch strategy (i.e. set-shifting) in response to rule changes or 
generate alternative sorting strategies, and inhibit previous responses (Nyhus & Barceló, 
2009; Fine et al., 2010). Both tests have the advantage of providing untimed measures of 
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executive functioning. However the D-KEFS sorting test has the added advantage of 
explicitly testing abstract reasoning as participants are required to provide a description of 
each sort they make, allowing easier differentiations to be made between conceptual and 
perseverative errors (Delis et al., 2001).  
 
Historically, the WCST has been reported to be sensitive to frontal lobe damage and in 
particular to lesions in dorsolateral prefrontal cortex (Milner, 1963), and functional imaging 
studies have largely supported the involvement of this area as part of a larger network of 
brain regions involved in WCST  outside performance (Nyhus & Barceló, 2009). However, 
more recent studies have questioned the specificity of the WCST by demonstrating that 
performance is also affected by lesions to different sites in the prefrontal cortex (e.g. medial 
prefrontal cortex; Drewe, 1974; Stuss et al., 2000), and even lesions in regions outside of 
prefrontal cortex such as hippocampus (Igarashi et al., 2002), and other non-frontal lesions 
(Mukhopadhyay et al., 2008). The D-KEFS sorting test is a relatively recent addition to 
neuropsychological assessment and so has received less scrutiny. Nevertheless, deficits in 
the sorting test have been associated with focal frontal lesions (Dimitrov et al., 1999), 
Parkinson’s disease (Beatty & Monson, 1990), and Multiple Sclerosis (Parmenter et al., 
2007). A recent study employing volumetric structural imaging showed a correlation 
between left frontal lobe volume and performance in the D-KEFS sorting test (Fine et al., 
2010). However, in the same study, performance on the D-KEFS sorting test was unable to 
differentiate between patients with Alzheimer’s disease (AD), FTD, SD, or PNFA, once 
again casting doubt as to whether deficits on tests of this nature are specific to frontal lobe 
pathology. That said, involvement of dorsolateral prefrontal cortex pathology is not always 
observed in these disorders (Weder et al., 2007) which may explain the lack of sensitivity in 




In ALS, deficits have been shown in both the WCST (e.g. David & Gillham 1986; Massman 
et al., 1996; Schreiber et al., 2005) and the D-KEFS sorting test (Libon et al., 2012; Taylor 
et al., 2012), although almost as many studies have reported intact performance in the 
WCST (e.g. Kew et al., 1993; Abrahams et al., 2005; Lule et al., 2007; Wicks et al., 2009). 
The inconsistent findings in the WCST may be explained to some extent by heterogeneity in 
the ALS cohorts between the different studies. For example, Lomen-Hoerth and colleagues 
(2003) reported that WCST was one of the most sensitive tests for detecting cognitive 
impairment in a study in which 18/44 of ALS patients met criteria for FTD. By contrast, 
Wicks and others (2009) did not find a deficit in a cohort of patients, a proportion of which 
were SOD1 familial cases which are reported to have very low incidences of cognitive 
impairment (Battistini et al., 2005), and none of whom met FTD criteria. Despite the 
inconsistencies, the WCST has proved useful in detecting cognitive impairments, with some 
investigators reporting that it was the most sensitive test (Robinson , 2006; Gordon et al., 
2010), and others reporting deficits in 19% of patients (Sarro et al., 2011). Similar results 
have been reported for the D-KEFS sorting test, with reports of high sensitivity and 
impairment in 27% of ALS cases (Taylor et al., 2012). Another aspect of D-KEFS sorting 
test performance was investigated by Libon and colleagues (2012) who used cluster analysis 
to differentiate an ALS cohort into patients with impaired, average, and above average 
performance on the test – see Table 1. The authors reported that a significant proportion of 
patients showed impaired performance in the sorting test, the scores of which correlated 
with letter fluency performance. By contrast D-KEFS sorting test scores were not related to 
performance on an oral trail making test leading the authors to suggest that performance was 




Planning ability has also been investigated in ALS, albeit to a lesser extent than other 
processes. Some studies have employed tasks based upon the Tower of London paradigm 
(Shallice, 1982) which typically require participants to arrange a set of coloured balls spread 
across three wells into a specified configuration in the minimum number of moves possible. 
These tasks impose high demands on problem solving and spatial planning and 
manipulation, and have been shown to be sensitive to frontal lesions (Unterrainer & Owen, 
2006) and disorders of fronto-striatal dysfunction such as Parkinson’s disease (Owen et al., 
1992). Moreover, functional imaging studies have implicated right dorsolateral and 
rostrolateral prefrontal activation (Van den Heuvel et al., 2003; Wagner, Koch, 
Reichenbach, Sauer & Schlosser, 2006) in Tower of London tasks. The employment of 
Tower of London paradigms in ALS cohorts is problematic due not only to the motor 
requirements of the task itself, but also because the performance measures are typically 
time-based meaning that the results are difficult to interpret. However, investigators have 
employed computerized versions which minimize the motor component of the tasks 
(Abrahams et al., 1997; Meier et al., 2010), with the former study also employing a motor 
control condition. Abrahams and colleagues (1997) reported that ALS patients were 
impaired relative to controls, whilst Meier and others (2010) reported impairment in 22% of 
ALS patients. A recent study employed a motor independent naturalistic test of planning 
which required patients to plan a hypothetical medication schedule based on different rules 
that ranged in complexity (Stukovnik, Zidar, Podnar & Repovs, 2010). ALS patients 
performed poorly in the Medication Scheduling task whilst performance in motor 
independent measures of Tower of London was normal. The authors suggested that the 
naturalistic properties of the Medication Scheduling task provide a more sensitive test of 
self-initiated planning and online manipulation of information than standard 
neuropsychological tests, and may be a better reflection of everyday cognitive problems in 
ALS. However, unlike other ecological tests of executive functioning such as the Multiple 
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Errands Task (Shallice & Burgess, 1991), the Medication Scheduling task has yet to be 
validated and standardised. Another test assessing spatial planning and inductive reasoning 
is the Brixton Spatial Anticipation Test (Burgess & Shallice, 1996a) which has been shown 
to be particularly sensitive to lesions in lateral regions of left prefrontal cortex (Reverberi, 
Lavaroni, Gigli, Skrap & Shallice, 2005). The test requires participants to predict the spatial 
position of a target based on patterns derived from its previous position; patterns change 
regularly requiring participants to learn the new pattern quickly and adapt their predictions 
accordingly. The Brixton test also has the advantage of allowing responses to be made 
manually or verbally and providing an untimed measure of performance, making it 
particularly useful for the assessment of ALS patients. Despite this, only one study has 
investigated Brixton test performance in ALS patients (Taylor et al., 2012); the authors 
reported that there was a significant difference between the patient and control group in 
terms of the number of errors made on the test, with 25% of patients exhibiting impaired 
performance suggesting that the test is sensitive to executive deficits in ALS. 
 
1.6.1.4 Attention and processing speed 
Attention can be defined as a top-down, effortful set of processes which control non-routine 
behaviours or functions (Stuss, Shallice, Alexander & Picton, 1995). Control of attention is 
postulated to be a crucial aspect of executive functioning as cognitive resources must be 
allocated to the appropriate operations in order to complete a task effectively (Stuss et al., 
1995; Baddeley, 1996; Shallice, Burgess & Robinson, 1996). Processing speed can be 
defined as the maximum rate at which elementary cognitive operations can be executed 
(Salthouse, 1985, 1992), and will impact upon performance in executive tasks as elementary 
operations must be completed within certain temporal limits to facilitate the processing of 
more complex operations. Models of attention and processing speed are discussed in more 
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detail in Chapter 3 (Sections 3.3.2 and 3.1 respectively). As can be seen in Table 1, attention 
has been evaluated in ALS by way of a variety of tasks over the past 25 years, although the 
distinction with processing speed is not always clear. An early investigation into cognition 
in ALS reported deficits in visual attention assessed by a digit cancellation task (Gallassi et 
al., 1985). However, a subsequent study by Ludolph and others (1992) failed to show 
impairment in a similar test of character cancellation. ALS patients have also exhibited 
impairment in a computerised visual search task assessing focussed attention (Chari, Shaw 
& Sahgal, 1996). However, tests of this nature may be a better reflection of basic 
visuoperceptual speed (i.e. simple processing speed; Chiaravalloti, Christodoulou, Heath & 
Deluca, 2003; Bates & Lemay, 2004) than high order attention. 
 
Mixed results have also been reported in other purported tests of attention such as the 
Symbol Digit Modalities (SDMT) test in which impairments were reported by Massman et 
al. (1996) and Mezzapesa et al. (2007), but not by Lule and colleagues (2007). The SDMT 
measures the time and accuracy with which participants can match abstract symbols with 
specific numbers, and is particularly sensitive to cognitive impairment in Multiple sclerosis 
(Huijbregts, Kalkers, Sonneville, De Groot, Reuling, & Polman, 2004) and mild traumatic 
brain injury (DeMonte, Geffen, May & MacFarland, 2009). Although commonly employed 
as a test of sustained attention, the SDMT also has an inherent visuomotor component and is 
highly correlated with processing speed measures (Crowe et al., 1999). Thus, although 
efforts were made to control for motor slowing in the SDMT by using an oral version of the 
test (Mezzapesa et al., 2007) or only recording response accuracy (Lule et al., 2007), the 
findings are still likely to be affected by processing speed.  The Paced Auditory Serial 
Addition Test (PASAT) has also been employed to assess sustained attention, with one 
study reporting impairment in ALS patients relative to controls (Moretti et al., 2002), whilst 
31 
 
a subsequent study found no group differences (Abrahams et al., 2005). The PASAT 
requires participants to keep track of a sequence of numbers presented at a constant rate so 
that the last two numbers can be summed. Once again, interpretation of results is ambiguous 
as factor analysis studies have associated the PASAT with various cognitive constructs 
including attention (Bate, Mathias & Crawford, 2001), working memory (Robertson et al., 
1996), and processing speed (Larrabee & Curtiss, 1995), and performance in the test is now 
widely regarded as multifactorial (Madigan et al., 2000).  
 
The verbal series attention test (VSAT) has been employed by several large scale studies to 
measure attention in ALS and all reported that a significant proportion of patients were 
impaired either in terms of the time taken to complete the test (Massman et al., 1996; 
Witgert et al., 2010), or the number of errors made (Ringholz et al., 2005; Witgert et al., 
2010). In the largest study, Ringholz and collaborators (2005) concluded that the VSAT was 
the most sensitive test and stated that the majority of ALS patients in a cohort of 279 
exhibited impairments. The VSAT is comprised of several subtests such as reciting the 
alphabet and months of the year backwards, alternatively saying letters and numbers in 
ascending order, and counting backwards from 100 by threes. Massman and colleagues 
(1996) reported that bulbar patients were significantly more impaired in the VSAT than 
those with limb-onset which is likely to be a reflection of the high demands placed on 
speech production by this particular test. Indeed, another study comparing dysarthric to non-
dysarthric patients found that impairments in the VSAT were mediated when a motor 
control condition was taken into account (Sterling et al., 2010). Moreover, as has been 
acknowledged by some investigators (Ringholz et al., 2005), the VSAT is another example 
of a test of attention that is multifactorial in nature and has been shown to be particularly 




Another task which shares similarities with those discussed above is the Trail Making Test 
(TMT). This task is typically administered as a paper and pencil test, although oral versions 
have also been developed, and comprises two sections; TMT A requires participants to draw 
a continuous line (i.e. trail) linking numbers from 1 to 25 which are randomly arranged on 
the page. TMT B increases the complexity by adding letters into the arrangement and 
participants must link numbers and letters in alternate and ascending order, e.g. 1-A, 2-B, 3-
C etc. Performance is typically measured in terms of time to completion for TMT A and 
TMT B, and a derived measure comprising of the time for Part B minus Part A which is 
meant to control for motor speed (Lezak, 1995). A recent study investigating the construct 
validity has shown that TMT A is related to visuomotor speed, TMT B to working memory 
and switching, and TMT B-A isolates the switching component (Sanchez-Cubillo et al., 
2009). Some studies utilising the TMT in ALS have reported intact performance (Palmieri 
et al., 2009) or impairment in TMT A only (Sarro et al., 2011). Others have found 
impairments in TMT A and TMT B (Witgert et al., 2010), as well as TMT B-A (Hartikainen 
& Soininen, 1993; Hanagasi et al., 2002). However, the most convincing evidence of an 
attention deficit comes from investigators that have found an isolated deficit in TMT B-A 
indicative of a specific problem with attentional switching (Kilani et al., 2004; Zalonis et al., 
2012), although others have failed to replicate this finding (Mioshi et al., 2013).    
 
Some studies have employed tasks in which the putative process is more defined. Pinkhardt 
and collaborators (2008) utilised the incompatibility subtest of the Test battery for 
Attentional Performance (TAP; Zimmermann & Fimm, 2002); this stimulus- response 
paradigm required participants to respond to compatible visual stimuli and inhibit responses 
to incompatible stimuli. The authors reported that ALS patients had slower reaction times 
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than controls in this test, suggesting that this result reflected a deficit in selective attention. 
Moreover, ERP recording during a dichotic listening task showed that patients had 
attenuated responses to target and increased responses to irrelevant stimuli, providing more 
evidence for an attentional impairment.  
 
A different approach to the investigation of attentional control can be seen in studies which 
employ dual tasks to assess divided attention. Dual task ability has been postulated to be a 
key process in complex human behaviour (Baddeley, Della Sala, Papagno & Spinnler, 1997, 
Engle, 2002), and has been shown to be sensitive to executive dysfunction in FTD (Perry & 
Hodges, 2000; Sebastian & Hernandez-Gill, 2010), and in particular Alzheimer’s disease 
(Logie, Cocchini, Della Sala & Baddeley, 2004). Functional imaging studies have suggested 
that a network of areas are activated during dual tasking (Erickson et al., 2005), with 
particular importance placed on dorsolateral and inferior prefrontal regions (MacDonald, 
Cohen, Stenger & Carter, 2000; Wager & Smith, 2003). The only study to investigate dual 
tasking in ALS employed the divided attention subtest from the TAP in which participants 
are required to react to sequences of simultaneously presented visual and auditory cues. The 
authors reported that ALS patients had impaired reaction times in comparison to normative 
data (Schreiber et al., 2005) indicative of a deficit in divided attention. However, the true 
extent of the deficits in selective and divided attention reported by the above studies is 
difficult to evaluate as reaction times in ALS cohorts are likely to be affected by motor 
dysfunction. 
 
Inhibition is a process which refers to the ability to suppress or reject a prepotent or learned 
response in an inappropriate situation and has been postulated to be a crucial component of 
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theories of executive and attentional control alike (Miyake et al., 2000; Stuss, Shallice, 
Alexander & Picton, 1995). The Stroop colour-word interference test (Stroop, 1935) is one 
of the most commonly used tests of selective attention and inhibition (MacLeod, 1991). It 
has been shown to be sensitive, if not specific, to lesions in lateral and medial prefrontal 
cortex, and functional imaging studies have highlighted the involvement of distributed 
networks in Stroop performance with particular emphasis placed on anterior cinglulate 
cortex (Alvarez & Emory, 2006). The Stroop test requires participants to name the colour of 
ink in which colour-words are presented in and induces increased response times for 
incongruent trials (i.e. when the word “RED” is presented in blue ink) compared to when 
congruent trials (i.e. when the word “GREEN” is presented in green ink). Although the 
Stroop test is a timed measure, the interference condition remains relatively independent of 
motor slowing as it is derived from the time taken to complete the congruent subtracted 
from the time taken to complete the incongruent condition. Studies investigating the Stroop 
test in ALS patients have found relatively inconsistent results – see Table 1. Early 
investigations (e.g. Kew et al., 1993) reported intact Stroop performance, although a 
subsequent study showed a trend towards impairment in the Negative Priming condition 
(Abrahams et al., 1997). More recent studies have reported deficits in the interference 
condition (e.g. Lomen-Hoerth et al., 2003) while others have shown impairments in a 
significant proportion of patients (e.g. Sarro et al., 2011). However some investigations, 
including one large scale study, did not report impairment in the Stroop test (Ringholz et al., 
2005; Pinkhardt et al., 2008; Stukovnik et al., 2010). Inconsistencies between studies may 
reflect the heterogeneity of ALS impairment in different cohorts; for example two of the 
studies in which Stroop impairment was reported included a proportion of FTD patients 
(Moretti et al., 2002; Lomen-Hoerth et al., 2003) which may have exaggerated group 
effects. The Hayling Sentence Completion Test (Burgess & Shallice, 1997) is another 
purported test of cognitive inhibition which is dissociable from other tests of executive 
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functioning and has been shown to distinguish patents with frontal lesions from those with 
posterior lesions (Burgess & Shallice, 1994; Burgess & Shallice, 1996). The Hayling test 
requires participants to inhibit stereotypical and context-dependent responses when 
completing simple sentences.  With regards to ALS, a relatively small number of studies 
have employed the Hayling test, and once again results have been inconsistent; some studies 
have reported that ALS patients exhibit normal performance (Taylor et al., 2012; Mioshi et 
al., 2013), whereas another reported that ALS patients were impaired (Lillo et al., 2012) 
although 25% of the ALS cohort met criteria for FTD.  Moreover, Wicks et al. (2009) 
reported that only patients with bulbar disease onset were impaired in the Hayling test. 
Thus, it would appear that the Stroop test may be more sensitive to impairments in 
inhibitory control, although results from this test are by no means clear-cut. Of note, a key 
difference between the Hayling and Stroop tests is in the sensory domain that is under 
investigation; the Stroop test requires inhibition of perceptual prepotent responses, whereas 
the Hayling test requires inhibition of auditory/semantic responses. Whether this a 
determining factor in the sensitivity of either test for detecting impairments in ALS remains 
to be seen.     
 
1.6.1.5 Executive functioning in ALS summary 
The last 20 years has seen a considerable rise in the number of studies including cognitive 
assessment as part of their investigations into ALS, with the main focus on executive 
functions. Deficits in letter fluency remain the most consistently reported executive 
impairment, with several recent population-based studies confirming that it is one of the 
most sensitive tests in ALS. Attempts have been made to investigate the underlying cause of 
dysfunction in this complicated test, and it would seem that basic linguistic processes are 
not responsible, placing emphasis back on high-order executive processes. Further 
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impairments have been commonly although not consistently found in tasks of concept 
formation, planning, and working memory suggesting that executive dysfunction in ALS is 
not restricted to letter fluency. Inconsistencies within the literature may in part be explained 
by the heterogeneous nature of cognitive impairment in ALS. Cognitive impairments are 
typically present in 30 – 50% of patients, with a smaller proportion presenting with ALS-
FTD and the relative number of impaired patients is likely to differ between studies and 
affect group comparisons. Studies investigating attention have also reported deficits in a 
range of attentional processes including selective attention, divided attention, and inhibition. 
However, inconsistencies among results are common in this domain, and may reflect the 
nature of the tasks used to assess them which are often confounded by involvement of 
additional processes such as working memory, processing speed and motor ability; indeed, a 
commonality between many purported neuropsychological tests of attention is that they are 
also employed as measures of processing speed. Thus the challenge remains to explicitly 
delineate the constructs of executive functioning, attention, and processing speed, as well as 
develop tests which can assess these functions independently while controlling for motor 
dysfunction. 
 
1.6.2 Language  
Historically, reports of language dysfunction in ALS have been documented, although these 
were typically restricted to clinical observations and case studies (Bak, 2010). More 
recently, language dysfunction has been reported in ALS patients who present with co-
morbid primary progressive aphasia syndromes associated with frontotemporal lobar 
degeneration; patients have been described with language deficits that appear consistent 
with progressive non-fluent aphasia and semantic dementia, lending support to the proposed 
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continuum between ALS and FTD (Casselli et al., 1993; Doran, Xeureb & Hodges, 1995; 
Bak, O’Donovan, Xuereb, Boniface & Hodges, 2001; Catani et al., 2003).  
 
However, language deficits have also been found in non-demented ALS patients. 
Confrontation naming has been the most widely employed method of assessing language 
ability in ALS; measures such as the Graded Naming Test (GNT) or Boston Naming Test 
(BNT) which require participants to name pictures of objects of increasing difficulty (i.e. 
decreasing frequency) have been used by numerous studies with relatively inconsistent 
findings. For example, some relatively early investigations reported intact confrontation 
naming (Ludolph et al., 1992; Kew et al., 1993), whereas others reported impairments 
(Hartikainen & Soinenen, 1993; Rakowicz & Hodges, 1998). More recent investigations 
have predominantly reported deficits in confrontation naming (e.g. Kilani et al., 2004; 
Wicks et al., 2008; Gordon et al., 2010), but see Abrahams et al. (2000, 2005a), and a recent 
meta-analysis has suggested that language dysfunction (primarily assessed by confrontation 
naming) is present in non-demented ALS patients although the authors warn of a publication 
bias in this domain (Raaphorst et al., 2010). The same authors suggested that inconsistencies 
in confrontation naming findings may be a reflection of small heterogeneous samples 
typically recruited in most cross-sectional studies. Indeed population based studies reporting 
case incidences as opposed to group findings have shown that a significant proportion of 
ALS patients (between 11% and 23%) exhibit deficits in confrontation naming tests 
(Ringholz et al., 2005; Phukan et al., 2012) suggesting that these measures are reasonably 




Assessing language functioning in ALS is complicated by speech disruption that affects 
patients with bulbar symptoms and makes distinguishing dysarthria from dysphasia 
particularly problematic (Bak & Hodges, 2004; Abrahams, 2012). Indeed, the relationship 
between language impairment and these symptoms is not fully understood (Bak & 
Chandran, 2012), although some have suggested that dysarthric patients are more likely to 
exhibit cognitive dysfunction (Sterling et al., 2010). As such, in depth investigations of 
linguistic functioning have been relatively rare, but some investigators have demonstrated 
deficits in simple naming and word-picture matching as well as non-verbal semantic 
knowledge and syntactic comprehension in individual ALS cases (Rakowicz & Hodges, 
1998). In a longitudinal study, Strong and colleagues (1999) reported that several ALS 
patients exhibited impairments in single-word vocabulary comprehension, as well as deficits 
in confrontation naming – moreover, when naming errors and were analysed, they revealed 
verbal paraphasias (e.g. “yell” when correct response was “funnel”) and semantic 
paraphasias (e.g. “nut” instead of “acorn”) although impairments did not decrease over time. 
However, another longitudinal study reported that ALS patients’ ability to complete simple 
sentences became poorer over time, independent of motor slowing (Abrahams et al., 2005a) 
which may reflect progressive slowing of word retrieval processes. Moreover, an Italian 
study (Moretti et al., 2002) which employed the Bilingual Aphasia Test reported that non-
demented ALS patients showed increasing numbers of paraphasias, morpheme substitutions, 
and semantically deviant sentences longitudinally, with bulbar patients exhibiting additional 
impairment in complex command execution and syntactic comprehension. Concordantly, a 
study of Japanese patients revealed writing errors in ALS with predominance for “kana” 
errors which are used primarily for syntactic meaning; although half of the patients met 
criteria for ALS-FTD, significant kana errors were also exhibited by non-demented patients 
(Ichikawa et al., 2010). A subsequent study by the same group demonstrated that writing 
errors correlated with frontal lobar atrophy on longitudinal brain imaging data which 
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suggested that writing errors may predict cognitive decline and ALS dementia (Ichikawa, 
Ohno, Murakami, Ohnaka & Kawamura, 2011).   
 
Following on from findings reported in ALS-FTD/aphasia studies (Bak et al., 2001; Bak & 
Hodges, 2004) which demonstrated selective impairments for verbs over nouns, Grossman 
et al. (2008) investigated action knowledge in a cohort of 34 ALS patients some of which 
showed signs of cognitive impairment and FTLD. The authors reported that patients were 
impaired relative to controls in tests requiring knowledge of actions as opposed to 
knowledge of objects, and that those with cognitive impairment performed worse than those 
without impairment. Moreover action object and object knowledge were both correlated 
with syntactic performance indicating that the deficits in action knowledge were not caused 
by grammatical problems. The authors concluded that ALS patients exhibited a specific 
impairment in action knowledge which may reflect the neuronal degeneration of associative 
motor areas. However, performance in action knowledge was correlated with tests of 
executive functioning (category fluency and reverse digit span), making it difficult to 
determine whether the reported language deficits were a primary aphasic syndrome or a 
secondary symptom of executive dysfunction. Some investigators have proposed that the 
relationship between ALS patients with cognitive impairment or co-occurring FTLD 
syndromes and specific linguistic impairments in action and verb knowledge reflects the 
underlying neurodegenerative process. Bak and Chandran (2012) have suggested that 
impairments in verb and action processing reflect the degeneration of a wider network of 
motor and prefrontal areas responsible for movement control, speech production, and action 




Some studies have attempted to delineate language impairment from executive dysfunction. 
In a functional imaging study, Abrahams et al. (2004) showed that ALS patients exhibited 
reduced activation in a network of areas during a confrontation naming task as well as a 
fluency task suggesting that functional abnormalities were not specific to executive tasks. A 
recent clinic-based study of 51 non-demented patients carried out a detailed investigation 
into language and executive functioning (Taylor et al., 2012).  Tests of vocabulary, 
confrontation naming, syntactic and semantic comprehension, verb and noun naming, 
synonym judgement, and spelling, as well as standardised measures of executive 
functioning were employed to derive composite scores for language and executive 
functioning; the authors reported that relative to controls, 31% of patients were impaired in 
the executive composite whilst 43% were impaired in the language composite score. 
Moreover, although, there was a strong correlation between the two composite scores, a 
regression revealed that executive functioning performance only accounted for 44% of the 
variance in language scores suggesting that a large proportion of language deficits were 
independent of executive dysfunction. This is an important finding as it indicates that a) 
language impairment may not only be more common than previous reports, it may be the 
most common cognitive impairment in ALS and should be investigated more thoroughly by 
subsequent investigations, and b) language impairment may occur independently of 
executive dysfunction. The findings of Taylor et al. (2012) may also go some way to 
explaining the sensitivity of verbal fluency to cognitive deficits in ALS, as although 
predominantly tests of executive functioning, fluency measures undoubtedly require 
linguistic processing as well (Abrahams, 2012). Moreover, the pattern of higher prevalence 
of language impairment than executive impairment may indicate a departure from the 
purported continuum between ALS and FTD where executive and behavioural abnormalities 
are much more common than language dysfunction, although this needs to be replicated by 




1.6.3 Memory  
In comparison to the reports of executive dysfunction and more recently language 
impairment in ALS, investigations into memory have proved less consistent. Various 
memory paradigms have been employed and almost all have provided mixed results. For 
example, episodic memory has been investigated by story recall paradigms such as the 
Logical Memory subtest from the Wechsler Memory Scale. These paradigms require 
participants to listen to a short passage of prose, and then recall as much of the story as 
possible, either immediately, or after a delay (typically 20 – 30 minutes). Some investigators 
have reported intact immediate and delayed recall of stories (Newsom-Davis, Lyall, Leigh, 
Moxham & Goldstein, 2001) whereas others have reported impairments in both conditions 
(Mantovan et al., 2003; Christidi et al., 2012), and there have also been reports of impaired 
immediate recall but preserved delayed recall of prose passages (Hartikainen & Soinenen, 
1993).  
 
Other studies have employed so called Paired Associates paradigms in which participants 
are presented with a list of word pairs such as TRUCK-ARROW. At recall, participants are 
presented with one word from the pair (i.e. TRUCK) and are required to recall its match (i.e. 
ARROW), thus the task assesses cued verbal recall. Mixed findings have also been reported 
in this test with some investigators reporting impaired performance in ALS cohorts (David 
& Gillham, 1986; Abrahams et al., 1996) whilst other studies have reported a trend towards 
impairment (Abrahams et al., 2004) or impairments only in those patients with executive 
dysfunction (Abrahams et al., 2005b). However, other studies by the same group have failed 
to show impairments in Paired Associates paradigms (Kew et al., 1993, Abrahams et al., 
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1997; Abrahams et al., 2005a), suggesting that verbal memory deficits may not be a core 
feature of cognitive impairment in ALS.   
 
Other paradigms based on list learning have been employed in ALS investigations including 
the California Verbal Learning Test (CVLT) and the Rey Auditory Verbal Learning Test 
(RAVLT). These tests share similarities in that both require participants to learn lists of 
words over a number of trials to assess encoding efficiency as well as employing a delayed 
recall condition. The CVLT also assess the use of encoding organisation strategies as words 
in the list are split into semantically related chunks e.g. “fruits”, “spices” etc. In addition, 
both tests can be used to assess interference by presenting another list of distracter words 
before recall or recognition of the original list. Deficits in these tasks have been 
predominantly reported in immediate recall conditions (Massman et al., 1996; Robinson et 
al., 2006; Hammer et al., 2011), although the reverse pattern of intact immediate recall and 
impaired delayed recall in the CVLT was reported by Hanagasi et al. (2002). However, as 
with Paired Associates paradigms, some studies have reported that ALS patients exhibit 
normal performance in these list learning measures (Strong et al., 1999; Lomen-Hoerth et 
al., 2003; Strutt et al., 2012).    
 
Recognition memory for verbal and non-verbal stimuli has also been investigated in ALS 
patients, primarily through the use of the Warrington Recognition Memory Test (RMT). 
This test involves the presentation of 50 words or faces on individual cards at a rate of 1 
every three seconds; subsequently participants are presented with word pairs or face pairs 
and asked to decide which word came from the original target list. Once again ALS 
performance in this test has been variable – impairments have been reported by some studies 
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(Abrahams et al., 1997; Strong et al., 1999) but others have failed to find deficits (Kew et 
al., 1993; Abrahams et al., 1996, 2004, 2005a), although it should be noted that the latter 
two studies only investigated recognition memory for words. Interestingly, Strong et al. 
(1999) reported no deficits on the RMT at initial testing but showed that deficits appeared in 
the RMT for faces longitudinally, although this was not replicated in another longitudinal 
study by Abrahams et al. (2005a). By contrast, Abrahams et al. (1997) reported impairment 
in the recognition of words, but not faces. Non-verbal memory has received less attention 
than verbal memory in ALS investigations, but some studies have employed paradigms such 
as the Kendrick Object Learning Test (KOLT) which assesses immediate non-verbal 
memory by presenting participants with pictures of common household objects and asking 
them to recall as many as possible. ALS performance in this test is also characterised by 
inconsistent findings; impairments have been reported by some studies (Kew et al., 1993; 
Abrahams et al., 1996; Newsom-Davis et al., 2001), although it should be noted that the 
latter study was in patients with poor respiratory functioning. Conversely, others have found 
intact performance in the KOLT (Abrahams et al., 1997, 2004, 2005a), suggesting that, like 
verbal memory, non-verbal memory impairment may not be a consistent feature of the ALS 
cognitive profile.  
 
However, a recent meta-analysis of by Raaphorst et al. (2010) reported significant effects 
for immediate verbal memory and visual memory, and borderline significance for delayed 
verbal memory. Moreover, the effect sizes for immediate and delayed verbal memory were 
as large as those for fluency (d = 0.5), and the effect size for visual memory was only 
slightly smaller (d = 0.4) suggesting that memory impairment may in fact be a crucial 
component in ALS. Inconsistent memory findings may be explained by the inherent 
heterogeneity of cognitive impairment in ALS patients which can lead to different 
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proportions of impaired patients from one study to the next. This may be exacerbated in 
studies with small sample sizes which employ group analyses, particularly if impairments in 
the given domain are relatively rare. This point is highlighted by large-scale studies 
investigating the prevalence of cognitive impairment in ALS which have reported that a 
significant proportion of ALS patients exhibit memory impairment, but invariably less so 
than exhibit executive dysfunction (Massman et al., 1996; Ringholz et al., 2005; Phukan et 
al., 2012). Indeed, Massman et al. (1996) reported that 20% of patients were impaired in the 
CVLT and 22% in the continuous recognition memory test. More recent studies have 
employed a wider range of memory tests to produce a composite memory, for example 
Taylor et al. (2012) reported that 14% of ALS patients were impaired in a score which 
encompassed performance in story recall, the RMT and the KOLT, whereas the large 
population-based study by Phukan et al. (2012) reported memory impairment in 11% of 
patients as assessed by Logical Memory, Paired Associates, CVLT, and the Rey-Osterrieth 
complex figure test.          
 
Although the evidence discussed above indicates that memory impairment is present in a 
proportion of ALS patients, the nature of these deficits may reflect executive dysfunction 
rather than memory impairment per se. Memory is a complicated process requiring 
processes of encoding, consolidation and retrieval, and moreover, the content and strength 
of memory can be affected by attention (Chun & Turk-Browne, 2007). Indeed, the 
predominant finding of impairments in immediate memory as opposed to delayed memory 
support the notion that executive dysfunction may be the underlying cause of memory 
impairments, as in general, immediate memory deficits are thought to reflect damage to 
prefrontal structures whereas delayed memory deficits are thought to reflect disruption to 




Several studies have provided further evidence of executive involvement in memory 
impairment in ALS. For example Hartikainen and Soinenen (1993) reported that, in a list 
learning test, ALS patients made more false-positive recognition errors suggesting that they 
may have impaired inhibitory control. Moreover, an ERP investigation (Munte et al., 1998) 
revealed that ALS patients had a dramatically attenuated ERP signature for recognising 
previously presented items after a 1 hour delay; a result which the authors proposed was due 
to the failure to lay down a strong memory trace during the initial encoding condition. A 
different approach was adopted by Mantovan et al. (2003) who investigated serial 
positioning recall in word lists and found that although ALS patients displayed a normal 
recency effect (better retention of items presented near the end of the list), unlike controls, 
they did not display a primacy effect (better retention of items at the start of the list) 
indicative of a long term memory deficit. A cued post-encoding condition in which 
participants were told which type of item to recall improved primacy recall in controls but 
not in patients, suggesting that the ALS patients may not be able to make effective use of 
strategies to enhance retrieval. Furthermore, ALS patients were impaired in logical memory, 
the scores of which correlated with verbal fluency performance which suggested that 
memory impairments may reflect executive dysfunction. A recent study by Christidi et al. 
(2012) applied an item specific deficit approach to a RAVLT list learning task which 
produces indices for encoding, consolidation and retrieval based on the type of omissions 
made during recall. The authors reported that ALS patients were impaired in both immediate 
and delayed condition of the RAVLT, and moreover, exhibited deficits in the encoding and 
consolidation indices but not the retrieval indices. In addition, the authors demonstrated that 
ALS patients were impaired in selective attention as measured by the Stroop test, and 
reported that performance in this test explained the largest amount of variance in RAVLT 
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performance (approx. 40%). This finding suggested that an executive impairment in 
selective attention affected encoding and consolidation processes in ALS and was 
responsible for poor memory performance in the RAVLT.   
 
1.7 Social cognition, emotional processing and behaviour in ALS 
In addition to executive dysfunction and language impairment discussed in previous 
sections, behavioural variant FTD patients can exhibit profound changes in behaviour and 
social cognition including theory of mind, emotional recognition, and affective decision 
making (Snowden et al., 2003; Lough et al., 2006; Torralva et al., 2007). Moreover, changes 
of this nature often occur before deficits are evident on standard neuropsychological test of 
executive functioning (Lough, Gregory & Hodges, 2001). In recent years increasing 
recognition of the link between ALS and FTD, and particularly bvFTD, has encouraged the 
growth of research into ALS which focuses on the cognitive and behavioural changes 
sensitive to bvFTD.  
 
One of the first studies to investigate social cognition in non-demented ALS reported that 
patients failed to show the normal effect of enhanced recall for emotional words as opposed 
to neutral words, suggesting that changes may be present in limbic pathways affecting 
emotional memory (Papps, Abrahams, Wicks, Leigh & Goldstein, 2005). However, the 
same study showed that patients were unimpaired on tests of facial expression recognition 
as well as judging approachability and trustworthiness. By contrast, a subsequent study 
demonstrated that ALS patients with bulbar symptoms were impaired in the recognition of 
facial emotions, but could recognise embedded emotional tone in prosody (Zimmerman, 
Eslinger, Simmons & Barrett, 2007). Although some patients in this study showed signs of 
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dementia and depression, 50% of those exhibiting impaired facial expression recognition 
were otherwise intact. Furthermore, others have shown that ALS patients judged 
emotionally salient (ranging from unpleasant to pleasant) and arousing pictures (calm to 
exciting) differently to controls, with a follow up study associating this behaviour with 
reductions in brain activity in anterior insular regions, again suggesting that the processing 
of emotional stimuli is altered in ALS (Lulé et al., 2005, 2007). Further support for 
abnormal emotional processing has been provided by a study which demonstrated reduced 
right prefrontal activity during the selection of negative emotional words, and subsequent 
poor performance in the recognition of the negative words compared to controls (Palmieri et 
al., 2010). A recent study investigating emotional processing and recognition reported that 
ALS patients had attenuated responses to negative emotional words, and replicated the 
finding that patients fail to show enhanced recall of emotionally salient words (Cuddy, 
Papps, Thambisetty, Leigh & Goldstein, 2012). This relationship was only present in a 
subset of patients suggesting heterogeneity of performance in this type of test, and 
moreover, the subgroup performed poorly on immediate and delayed memory as measured 
by the CVLT, suggesting that general memory impairment may have influenced the 
observed pattern of results.   
 
A study by Gibbons et al. (2007) investigated theory of mind, the ability to understand the 
thoughts and intentions of others, by assessing the interpretation of humorous cartoons and 
stories. Although group differences between ALS patients and controls were not evident, a 
subgroup of patients with bulbar signs did show abnormalities in ascribing mental states and 
errors were qualitatively similar to those produced by FTD patients. However, the findings 
of the study were difficult to interpret as a pure theory of mind deficit as performance on the 
tasks correlated with performance in the WCST and verbal fluency suggesting that an 
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underlying executive dysfunction may have been the root cause of the observed 
abnormalities. Cavallo et al. (2011) also employed a cartoon paradigm which distinguished 
between social contexts and non-social contexts in which participants had to choose an 
event to complete each cartoon. The authors reported that ALS patients were only impaired 
in the cartoon scenarios in which there was a social context suggesting that patients had 
particular difficulty interpreting social situations. Further investigations into theory of mind 
have been carried out using “faux pas” tests in which participants must identify socially 
inappropriate events within stories or scenarios. Meier et al. (2010) showed that ALS 
patients performed worse than controls at identifying faux pas events, even though they 
performed comparably in comprehension of the stories indicative of a specific deficit in 
theory of mind. In contrast the findings of Zimmerman et al. (2007), the same authors 
reported that ALS patients were impaired in the identification of emotional expression from 
prosody, and performance on this task correlated with faux pas task performance.  
 
In an effort to control for the possible confounds of executive functioning, a very simplistic 
theory of mind task was employed by Girardi, MacPherson and Abrahams (2011) in which 
participants simply had to infer which of four objects a cartoon face liked best by following 
its eye-gaze. ALS patients made more errors than controls in this test suggesting that they 
had difficulty following the simple social cue of eye-gaze, and moreover, group differences 
were also evident in facial expression recognition and Reading the Mind in the Eyes tests 
(trend). Furthermore, approximately 50% of patients who performed abnormally in the eye-
gaze task were not impaired in tests of executive functioning suggesting that deficits in 
theory of mind can occur independently. In addition to social cognition, tasks, Girardi et al. 
(2011) also investigated affective decision making with a version of the Iowa Gambling 
Task which assesses participants’ ability to make rational reward-based decisions. 
49 
 
Participants are presented with four decks of cards which vary in their probability of 
producing a monetary reward and participants must try to accumulate as much money as 
possible through-out the task.  ALS patients performed poorly in this task and exhibited 
poor decision making by choosing more disadvantageous decks than controls. However, 
ALS participants did not exhibit more risky strategies evidenced by patients with FTD and 
poor performance may have reflected difficulty in learning task rules as opposed to 
irrational decision making. Of note, an earlier study reported that ALS patients performed 
comparably to controls in a similar task of probabilistic reversal learning (Meier et al., 
2010).  
 
Despite some inconsitencies, tests of social cognition and emotional processing have 
demonstrated sensitivity to cognitive change in ALS, with some studies reporting that 
deficits in social cognition are more common than executive dysfunction in non-demented 
patients (Girardi et al., 2011). Results of this nature have implicated orbitofrontal 
involvement in ALS as social cognition tests are sensitive to damage to these regions 
(Eslinger & Damasio, 1985; Gregory et al., 2002). Moreover ALS patients have shown 
classical dissociations between deficits in social cognition and impairment in executive tests 
assumed to be more dependent on dorsolateral prefrontal regions (Meier et al., 2010). As 
such, the reported deficits in emotion and social cognition clearly support the postulated link 
between ALS and FTD, with further support derived from studies investigating behavioural 
change in ALS.  
 
Profound behavioural abnormalities characterise patients with bvFTD and those patients 
with co-occurring ALS-FTD (Neary et al., 1990; Lillo et al., 2003) with associated atrophy 
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of the orbitomedial prefrontal cortex (Rosen et al., 2002). Recent investigations have shown 
that behavioural changes are also evident in non-demented ALS patients. Investigations 
employing standardised measures such as the Frontal Systems Behaviour Scale (FrSBe) and 
Frontal Behavioural Inventory have revealed self-reported and spouse/carer-reported 
increases in disinhibited, dysexecutive, and apathetic behaviour after disease onset, with 
apathy representing the most common behavioural change (Grossman, Wooley-Levine, 
Bradley & Miller, 2007; Witgert et al., 2010; Woolley, Moore & Katz, 2010; Lillo, Mioshi, 
Zoing, Kiernan & Hodges, 2011). Morever, apathy scores in the FrSBe have been correlated 
with reduced white matter integrity in anterior cingulum (Woolley, Zhang, Schuff, Weiner 
& Katz, 2011). However, a study employing an informant-based semi-structured interview 
concluded that self-centeredness and irritability were more common behavioural changes 
than apathy and loss of affect (Gibbons, Richardson, Neary & Snowden, 2008). In contrast 
to ALS-FTD patients, non-demented ALS patients are less likely to exhibit lack of insight 
into behavioural changes (Wooley et al., 2010).  
 
Some criticism regarding the use of standard behavioural questionnaires for measuring 
apathy has been raised as these measures to do not take into account motor symptoms in 
ALS which inevitably effect patients’ ability to participate in activities, and thus may 
confound apathy scores (Masellis, Zinman & Black, 2010) . Support for this notion has been 
provided by a large study which reported that a specifically developed behavioural 
questionnaire for ALS detected lower prevalence of apathy and other behavioural 
disturbances than did the FrSBe or Frontal Behaviour Inventory suggesting that these 
measures may indeed exaggerate behavioural dysfunction (Raaphorst et al., 2012). Another 
potential confound in the assessment of behaviour is ALS is the presence of co-occurring 
mood disorders which may reflect a psychological reaction to the diagnosis rather than a 
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disease specific state (Goldstein & Abrahams, 2013). However, the majority of studies 
investigating behaviour in ALS have reported that although levels of depression may be 
elevated in ALS patients (Lillo et al., 2011, cf. Jelsone-Swain et al., 2012), depression is not 
associated with apathy (Grossman et al., 2007; Woolley et al., 2011; Lillo, et al., 2011) or 
cognitive dysfunction (Jelsone-Swain et al., 2012).                
 
The prevalence of behavioural dysfunction in ALS populations has been investigated by 
several large-scale studies in recent years. In a cohort of 225 ALS patients, Witgert et al. 
(2010) reported that 40% of patients had impairment in at least one of the FrSBe scores of 
apathy, executive dysfunction, or disinhibition (apathy most common at 31%). In a subset of 
patients (n = 141), the authors also demonstrated that although half of those with 
behavioural impairment had cognitive deficits, a significant proportion (16%) of cognitively 
intact patients also presented with behavioural dysfunction, suggesting that although 
associated, cognitive and behavioural impairments can occur independently. Similar results 
were reported by Lillo et al. (2011) who reported that 41% of ALS patients had moderate to 
severe apathy as assessed by the Cambridge Behavioural Inventory, with 20% also 
displaying evidence of further abnormal and stereotypic behaviours, although it should be 
noted that 11% of the cohort met criteria for ALS-FTD. Raaphorst et al. (2012) reported a 
lower prevalence of behavioural impairment in non-demented ALS; 33% had behavioural 
disturbances as measured by the FrSBe and Frontal Behaviour Inventory, whereas only 18% 
had behavioural impairments as assessed by the ALS-FTD-Q, a specifically designed 
behavioural screen for ALS patients. Some studies have also investigated the presence of 
neuropsychiatric symptoms in ALS (Lillo et al., 2011, 2012), although prevalence was 




The studies investigating social cognition and behaviour discussed above lend support to the 
existence of a spectrum between ALS and FTD. Indeed, Witgert et al. (2010) showed that 
cluster analysis could differentiate between ALS patients with mild, moderate, or severe 
cognitive and behavioural impairments, but that all three groups were similar qualitatively. 
This relationship was replicated is a smaller study by Lillo et al. (2012) who showed that 
ALS, ALS-FTD, and bvFTD patients have overlapping cognitive, behavioural, and 
neuropsychiatric syndromes. Finally, these studies also serve to highlight the heterogeneity 
of presentations in this disorder as patients may exhibit impairments in neuropsychological 
assessment, social cognition, or behaviour, either in isolation or as a constellation of 
deficits.  
 
1.8 Neuroimaging and cognition in non-demented ALS 
Neuroimaging has been used in the investigation of ALS pathology for the last 30 years 
(Turner, 2011); staring out with CT images revealing hyperintensities in the corticospinal 
tract (Goodin, Rowley & Olney, 1988), advances in radioisotopes facilitated the 
measurement of cerebral blood flow and glucose metabolism. With improvements in 
magnetic resonance imaging (MRI) and computer processing power, non-invasive and more 
spatially refined techniques have been developed and applied to ALS research. These 
techniques have not only increased our understanding of pathology in the motor system, but 
have contributed significantly to the recognition of extra-motor abnormalities that are now a 
recognised component of the ALS syndrome (Turner, 2011). Moreover, neuroimaging 
techniques have been employed to investigate the relationship between cognitive 
impairment in ALS and cerebral functioning, either directly (via activation paradigms) or 
indirectly (via correlations with structural abnormalities). Studies investigating the 
relationship between cognition and cerebral change are summarised in Table 2.    
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Table 2. Neuroimaging correlates of cognition in ALS 
Study ALS Cohort Method/Technique Findings 
Ludolph et al., 
1992 
18 ALS PET resting state Verbal fluency scores correlated with reduced glucose uptake in frontal cortex 
and thalamus 
 
Kew et al., 1993 10 sporadic ALS  




Stereotyped vs. free 
joystick movements 
All ALS patients showed reduced rCBF in anterior cingulate at rest. During 
freely selected joystick task ALSu showed reduced activation in left medial 
prefrontal cortex.  
ALSi showed reduced activation in the medial prefrontal cortex, right anterior 
cingulate cortex, right parahippocampal gyrus and the anterior thalamic nuclear 
complex. 
 ALSi showed reduced activation in comparison with ALSu in the right 
parahippocampal gyrus, the anterior thalamic nuclear complex and the rostral 
anterior cingulate cortex. Fluency score correlated with right parahippocampal 
activation and anterior thalamic complex, picture recall correlated with anterior 
thalamic complex. 
 
Abrahams et al., 
1995 
12 sporadic ALS 
(6 ALSi, 6 
ALSu; verbal 
fluency) 
PET activation. Verbal 
fluency; generation vs.  
repetition conditions 
ALSi patients showed bilateral reduced activation in the prefrontal cortex 
(dorsolateral, lateral and medial), the premotor areas, insula, and the anterior 
thalamus.  
ALSu showed reduced activation in the right DLPFC and the left middle and 
superior temporal gyrus. 
 
Yamauchi et al., 
1995 
25 sporadic ALS 
(5 ALSi; MMSE, 
verbal memory) 
SPECT + Structural 
MRI; corpus callosum 
ROI ratios 
ALSi showed reduced SPECT uptake in prefrontal regions (dorsolateral, medial 
and inferior). Corpus callosum ratio reduced, predominantly anterior quarter. 
ALSu showed reduced corpus callosum ratio in anterior half.  
Corpus callosum ratio correlated with cognitive impairment. 
 
Abrahams et al., 
1996 
12 sporadic ALS 
(6 ALSi, 6 
PET activation; Verbal 
fluency. 
ALSi group showed reduced activation in the DLPFC, lateral premotor cortex, 







thalamic nuclear complex. ALSu showed minor reduction of activation in 
DLPFC and bilateral inferior parietal lobule. Executive and memory dysfunction 
in the ALSi group only.  
 
Frank et al., 
1997 
74 sporadic ALS Structural MRI; cluster 
analysis with cognition 
ALS patients had lower parenchymal and higher ventricular volume compared to 
controls. Cluster analysis indicated a subgroup (n = 45) with ALSi in short-term 
memory, attention and WAIS. The subgroup did not differ from ALSu (n = 15) 
in clinical characteristics but did have greater ventricular enlargement. 
   
Strong et al., 
1999 





Bulbar patients (more cognitively impaired) showed neuronal loss in anterior 
cingulate and motor strip at initial testing. Limb onset patients showed no 
changes at initial testing but showed neuronal loss in both areas at follow-up (6 
months). 
 
Abrahams et al. 
2004 
 
28 Sporadic ALS fMRI; Letter fluency, 
confrontation naming. 
Neuropsych testing 
ALS patients showed reduced activation in the middle and inferior frontal gyri 
and anterior cingulate gyrus, in addition to regions of the parietal and temporal 
lobes during the letter fluency task. Reduced activation in the inferior frontal 
gyrus and regions of the temporal, parietal and occipital lobes during the 
confrontation naming task.  Neuropsych assessment consistent with executive 
and short-term memory dysfunction. 
 
Abrahams et al., 
2005 
23 sporadic ALS; 
(11 ALSi, 12 
ALSu; verbal 
fluency) 
Structural MRI; VBM. 
Correlations with 
neuropsych testing. 
ALSi patients had reduced white matter volume in extensive prefrontal regions, 
including superior, medial, and anterior cingulate association fibres as well in 
regions through which run the occipitofrontal fasciculus, cingulum, and superior 
longitudinal fasciculus, inferior longitudinal fasciculus, and anterior commisure. 
These patients demonstrated a corresponding cognitive profile of executive and 
memory dysfunction. ALSu patients had less extensive white matter reductions 
corresponding to corpus callosum, anterior and posterior cingulum, 
occipitofrontal fasciculus, and precuneus. White matter volumes correlated with 
performance on memory tests (letter span and VPAL). No significant reductions 




Mezzapesa et al., 
2007 
16 sporadic ALS Structural MRI; Whole 
brain and VBM 
ALS patients had lower brain parenchymal fraction than controls. VBM revealed 
reduced grey matter density in right superior, middle, and parahippocampal 
temporal gyri as well as inferior and superior frontal gyri. Left hemispheric 
changes were found in middle temporal gyri as well as inferior frontal gyrus and 
insula. No white matter changes. 8/16 patients were ALSi; 2SD below normative 
data on 2 tests. 
 
Lule et al., 2007 13 sporadic ALS fMRI; response to 
picture with emotional 
valence 
ALS had similar BOLD response characteristics to controls. However ALS 
patients had a different base response to emotional stimuli with increase 
activation in right surpramarginal/inferior parietal lobe and inferior frontal 
operculum as well as left cerebellum and primary visual areas. Lower BOLD 
response in higher visual areas. At 6 month follow up, further reduced activation 
was found in parahippocampal, lingual and precentral gyri as well as anterior 
insula.  
 
Murphy et al., 
2007 






From 22: 5 met FTLD criteria, 2 had executive impairment and 4 had 
behavioural impairment (neuropsychiatric inventory). Patients with FTLD or 
evidence of cognitive or behavioural impairment had reduced volumes in right 
frontal, parietal and limbic areas compared to ALSu patients.  
 
Bartels et al., 
2008 
13 ALS Structural MRI; DTI of 
corpus callosum. 
Neuropsych testing. 
No FA differences between patients and controls in frontal, corticospinal or 
occipital portions of the corpus callosum. However, ALS patients did show 
within group differences with reduced FA in corticospinal corpus callosum 
relative to frontal and occipital portions. No correlations with neuropsychological 
tests. 
 
Wicks et al., 
2008 
12 ALS PET binding; 
correlations with 
neuropsych testing 
Higher fluency indices (worse performance) correlated with reduced flumazenil 
binding in right inferior frontal gyrus, superior temporal gyrus and anterior 
insula. Poorer scores in confrontation naming (GNT) correlated with reduced 
binding in left inferior and middle frontal gyri as well as left cuneus.  
 
Grossman et al., 34 ALS (14 of Structural MRI; VBM More patients were impaired in action knowledge (73%); performance correlated 
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2008 cohort ALSi or 
ALS-FTD) 
correlated with action 
and object knowledge. 
with reduced volumes in premotor areas as well as bilateral dorsolateral 
prefrontal cortex and inferior frontal cortex. Performance in object knowledge 
only correlated with dorsolateral prefrontal and inferior frontal cortex. Action 
knowledge correlated with executive functioning (verbal fluency and reverse 
digit span). 
 
Rusina et al., 
2010 
42 ALS SPECT and neuropsych 
testing 
Neuropsych battery included; trail making test (A+B), Stroop test, Wisconsin 
card sort test, tower of London, digit and letter span. 17/42 patients were ALSi 
(below 1.5SD in at least 2 tests). However, there were no correlations with 
SPECT imaging and any cognitive measure.  
 
Palmieri et al., 
2010 




ALS patients exhibited abnormal lateralisation of the emotional processing and 
recognition, predominantly of negative words, with increased BOLD activation 
in left inferior frontal gyrus and reduced activation in right parietal and precentral 
areas. Control participants displayed the typical pattern of right lateralised 
activation. 
 
Goldstein et al., 
2011 
14 sporadic ALS fMRI; Stroop inhibition 
and negative priming 
No difference in Stroop effect or negative priming effect between ALS and 
controls (behavioural data).  However, ALS group showed increased activation 
during Stroop effect of several left hemisphere areas; middle and superior 
temporal gyri, anterior cingulate gyrus, as well as hippocampus, caudate, insula 
and cerebellum. In addition, ALS group showed reduced activation during the 
negative priming effect in left hemispheric areas; cingulate gyrus, precentral 
gyrus, and medial frontal gyrus. 
 
Sarro et al., 2011 16 sporadic ALS Structural MRI; DTI 
tractography and 
neuropsych testing 
69% of ALS patients were impaired in one cognitive test, and 13% were ALSci 
(impaired on at least 2 tests). ALS had reduced white matter integrity in bilateral 
corticospinal tracts, corpus callosum, superior longitudinal fasciculus, uncinate 
fasciculus, as well right cingulum. ALS patients without cognitive deficits only 
had reduced integrity in corticospinal tract and left uncinate fasciculus. 
Correlations between white matter parameters and cognitive tests revealed 
relationships between with Trail Making Task (corpus callosum, corticospinal 
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tract, inferior fronto-occipital fasciculus, inferior longitudinal fasciculus, 
bilaterally, and right uncinate fasciculus), letter fluency (left cingulum), verbal 
memory (fornix) and visuospatial abilities (unicinate). Only trail making test 
correlations remained significant after multiple comparisons correction. 
 
Tsujimoto et al., 
2011 
21 sporadic ALS Structural MRI; DTI 
and VBM. Behavioural 
testing; Frontal systems 
behaviour scale (FrSBe) 
Patients were impaired relative to controls on MMSE and Frontal Assessment 
Battery. In addition, apathy scores increased from pre to post ALS diagnosis. 
ALS group had volumetric reductions in occipital, limbic, insula, and frontal 
lobes as well as midbrain.  DTI abnormalities were present in bilateral 
corticospinal tracts as well as subcortical frontal white matter. Reduced FrSBe 
apathy scores correlated with reduced grey matter volume in bilateral 
orbitofrontal cortex and frontal pole as well as right dorsolateral prefrontal 
cortex. Apathy scores also correlated with white matter integrity in right medial 
frontal gyrus (FA) and left superior frontal gyrus D. 
 
Libon et al., 
2012 





Cortical thickness was reduced in ALS patients in frontal (anterior, dorsolateral, 
inferior, ventral), motor and premotor, as well as anterior temporal and parietal 
regions. D-KEFS card sort (free recall) was not associated with any cortical 
region. However, D-KEFS card sort (recognition) scores were associated with 
cortical thinning in left dorsolateral prefrontal cortex and left parietal cortex. 
 
Yabe et al., 2012 10 sporadic ALS PET; binding. 
Neuropsych testing 
Writing errors correlated with PET binding potential in frontotemporal areas but 
were most strongly associated with reduced binding potential in bilateral anterior 
cingulate 
 
Agosta et al., 
2013 
16 sporadic ALS fMRI; resting state 
networks. Neuropsych 
testing 
Relative to controls, resting state networks in ALS patients showed altered 
connectivity in the default mode network, the right frontoparietal network, and 
the left frontoparietal network. No group differences in salience or executive 
resting state networks. 7 patients were ALSi, (below 5
th
 percentile on 1 executive 
test); performance in the WCST was negatively correlated with connectivity 
between left precuneus and angular gyrus in the default mode network, and right 




Mioshi et al., 
2013 





Structural MRI; VBM. 
Neuropsych testing 
ALS patients (whole group) showed volume reductions in motor areas as well as 
frontal and temporal regions. 14 ALSu patients vs 8 ALSi patients(either 
cognitive or behavioural according to Strong 2009 criteria); ALSi patients had 
more atrophy across motor and somatosensory regions as well as superior frontal 
gyrus, superior parietal gyrus, and left planum temporal.  ALS-FTD vs ALSi; 
more atrophy in orbitofrontal cortex, frontal pole, temporal pole and cingulate 
gyrus. 
 
CT = computed tomography. PET = positron emission tomography. MRI = magnetic resonance imaging. fMRI = functional magnetic resonance imaging. rCBF = 
regional cerebral blood flow. BOLD = blood-oxygen level dependent. SPECT = single photon emission computed tomography. ERP = event related potential. 
VBM = voxel based morphometry. DTI = diffusion tensor magnetic resonance imaging. FA = fractional anisotrophy. D = mean diffusivity. ROI = regions of 
interest. ALSi = ALS with cognitive impairment. ALSu = ALS without cognitive impairment. FTD = frontotemporal dementia. 
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1.8.1 Resting state and ligand studies  
Some of the earliest studies employing neuroimaging techniques to investigate cerebral 
changes in ALS used single positron emission computed tomography (SPECT). Several 
studies have employed the SPECT tracer hexamethylpropylene amine oxime (HMPAO) to 
indirectly measure brain glucose uptake and regional cerebral blood flow (rCBF) during 
rest. An initial study by Neary et al. (1990) demonstrated that 4 ALS patients with dementia 
had reduced tracer uptake in the frontal lobes and exhibited cognitive and behavioural 
impairments. A subsequent study in ALS patients without dementia revealed reduced uptake 
relative to controls in bilateral orbitofrontal cortex, anterior and medial prefrontal cortex, as 
well as bilateral anterior temporal regions (Talbot et al., 1995). In addition, the authors 
reported that these ALS patients showed deficits in picture sequencing and trends toward 
impairment in executive measures providing tentative evidence that prefrontal and anterior 
temporal abnormalities may underpin cognitive dysfunction.  
 
Following on from these findings, Abe et al. (1997) demonstrated that low tracer uptake in 
frontal regions was associated with a subgroup of ALS patients who performed poorly in 
verbal fluency, digit span and the WCST. Concordantly, case analyses by Yamauchi et al. 
(1995) revealed reduced tracer uptake in prefrontal regions (see Table 2) in ALS patients 
with cognitive and psychiatric symptoms who also exhibited atrophy of anterior portions of 
the corpus callosum. Moreover, SPECT abnormalities indicative of reduced rCBF in frontal, 
temporal, and limbic regions have been associated with cognitive impairment in tests 
including verbal fluency, confrontation naming, and logical memory (Mantovan et al., 
2003). A more recent study employing SPECT in combination with three-dimensional 
statistical imaging has demonstrated that prefrontal hypoperfusion can be detected in non-
demented ALS patients, albeit to a lesser extent than ALS-FTD cases, suggesting that this 
60 
 
methodology can be applied to improve the resolution and objectivity of SPECT data 
(Ishikawa et al., 2007). However, Rusina et al. (2010) reported that although approximately 
40% of a cohort of 42 ALS patients exhibited cognitive impairment in tests of attention and 
executive functioning (see Table 2), regional glucose uptake in prefrontal, anterior temporal, 
and parietal regions were not associated with performance in any cognitive measure. 
 
Resting state characteristics in ALS have also been investigated using positron emission 
tomography (PET) which provides higher spatial resolution than SPECT imaging – 
furthermore, the availability of a variety of binding ligands enables the investigation of 
different cerebral properties (Turner & Leigh, 2000). Several early PET studies employed 
the ligand 2-[
18
F]-2-deoxy-D-glucose (FDG) to investigate regional cerebral metabolic rates 
for glucose, and reported reduced glucose uptake in the multiple cerebral areas including the 
brainstem and basal ganglia (Dalakas, Hatazawa, Brooks & Di Chiro, 1987), sensorimotor 
cortex and putamen (Hatazawa, Brooks, Dalakas, Mansi & Di Chiro, 1988), as well as the 
entire cortex (Dalakas et al., 1987; Ludolph et al., 1992), suggesting the presence of 
widespread functional abnormalities in ALS patients. Moreover, the latter study also 
reported that a proportion of the cohort of 18 patients exhibited impairments in tests of 
verbal and non-verbal fluency which correlated with reduced glucose utilisation in the 
cortex, thalamus, and caudate nucleus. A series of studies by Kew and colleagues (1993a, 
1993b) investigated resting state rCBF in ALS; the first reported reduced uptake of the 
water-binding PET tracer (H₂O¹⁵) in motor, parietal, and insular areas, whilst a subsequent 
study employing a carbon-dioxide-binding tracer (C¹⁵O₂) demonstrated reduced perfusion in 
anterior cingulate, and further rCBF reductions in inferior and superior parietal areas as well 





Other PET investigations have employed Flumazenil, a ligand which binds to cerebral 
GABA receptors, which may be more representative of neuronal loss and degeneration than 
indirect measures such as glucose uptake and rCBF. Lloyd et al. (2000) reported reduced 
flumazenil uptake in multiple prefrontal regions including Brocas’s area, left dorsolateral 
and ventral areas, as well as posterior reductions in parietal and visual association areas. 
Although this study did not include neuropsychological assessment, a later study by Wicks 
et al. (2008) reported that reduced flumanzenil binding in right frontotemporal regions (see 
Table 2) at rest correlated with poor ALS performance in written verbal fluency indices. 
Moreover, poor patient performance in confrontation naming was associated with reduced 
uptake in left middle frontal gyrus (Broca’s area) and left cuneus suggesting that different 
functional networks underpinned poor performance in these tasks.  Further associations 
between flumanzenil binding reductions and cognition have been reported by Yabe et al. 
(2012) who reported that writing errors in ALS patients correlated with reduced uptake in 
bilateral anterior cingulate gyri. Serotonin receptor-binding ligands have also been used in 
ALS investigations with reports of reduced uptake over the entire cortex with pronounced 
reductions in cingulate and frontotemporal regions, especially in patients with bulbar 
symptoms (Turner et al., 2005). Neuropsychological assessment was not performed in this 
study, however, similar results have been reported in FTD patients (Lanctôt et al., 2007) 
suggesting that serotonin binding tracer reductions may be particularly sensitive to cognitive 
impairment.  
 
A recent development in neuroimaging research has been the implementation of functional 
connectivity analyses, a functional MRI technique which allows the extraction of data 
describing connections between disparate brain areas to visualise various purported 
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functional networks (Van den Heuvel, Mandl, Kahn, Pol & Hilleke, 2009). Various resting 
state networks have been investigated in ALS cohorts. Mohammadi et al. (2009) reported 
significant differences in activation between patients and controls in the so called “default 
mode network” in anterior and posterior cingulate as well as bilateral inferior parietal 
cortex. Further reduced activation was exhibited in the sensorimotor network although in 
anterior premotor regions as opposed to primary motor and somatosensory areas. By 
contrast, others have reported intact functional motor networks in ALS (Verstaete et al., 
2010), whilst another study has reported increased functional connectivity in a network 
comprising of sensorimotor, premotor, prefrontal, and thalamic areas (Douand, Filippini, 
Knight, Talbot & Turner, 2011) suggesting the neural changes underpinning functional 
connectivity analyses are not yet fully understood. A recent study by Agosta and others 
(2013) reported “alteration” of functional connectivity in ALS patients; decreased 
connectivity was observed in right orbitofrontal cortex in the default network, and left 
inferior frontal cortex of the fronto-parietal network, together with increased connectivity in 
left parietal cortex in the fronto-parietal network.  Moreover, enhanced parietal connectivity 
correlated with poor performance in the WCST which the authors theorized may reflect 
compensatory attentive processing in response to diminished frontotemporal functioning. 
 
1.8.2 Activation studies  
A more direct approach to the relationship between cognitive performance and the 
associated neural correlates can be made with activation studies in which cortical responses 
to “on-line” cognitive tasks can be elucidated. Activation studies were initially achieved by 
way of PET employing the water-binding (H₂O¹⁵) and carbon dioxide-binding (C¹⁵O₂) 
tracers to provide an index of rCBF. Kew and colleagues (1993a, 1993b) investigated rCBF 
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during a joy-stick moving task which had two conditions; a stereotyped condition in which 
movements were predefined, and a random condition requiring intrinsic generation and 
monitoring to produce novel sequences. During the executively demanding random 
condition, relative to controls ALS patients exhibited rCBF reductions in medial prefrontal 
and parahippocampal gyri compared to controls. A follow up study revealed that patients 
with verbal fluency deficits had additional rCBF reductions in anterior cingulate and the 
anterior thalamic complex during the same task (Kew et al., 1993b), supporting the earlier 
findings of Ludolph et al. (1992) who reported an association between verbal fluency 
performance and reduced glucose uptake in cortico-thalamic pathways.  
 
Using a similar approach to that of Kew et al. (1993b), a series of studies (Abrahams et al., 
1995, 1996) investigated online spoken letter fluency performance in ALS patients who 
were divided into impaired or normal groups based on performance in a written letter 
fluency task. Changes in rCBF were investigated in two conditions; a generation condition 
in which participants produced as many words as possible, and a repetition condition in 
which participants read out their previously generated responses. A contrast between the 
generation and repetition conditions thus revealed areas of rCBF (i.e. activation) associated 
with the executively demanding intrinsic generation component of the task. Compared to 
controls, ALS patients with impaired written fluency exhibited reduced activation in 
bilateral prefrontal, motor, temporal, and thalamic regions (see Table 2). By contrast, ALS 
patients who performed normally in the written fluency task also exhibited relatively normal 
activation in the scanning task, with only small areas of reduced activation observed. The 
findings suggested that verbal fluency deficits in ALS patients reflected cerebral 
dysfunction in predominantly prefrontal and thalamic networks. Moreover, (Abrahams et 
al., 1996) demonstrated that patients with verbal fluency deficits were also impaired in other 
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tests of executive functioning and memory (WCST, Random movement generation, Paired 
Associates, and object recall), suggesting that the observed reductions in cerebral activation 
may also underpin impaired performance in other cognitive domains.       
 
In more recent investigations activation studies have employed functional MRI (fMRI) 
instead of PET methodology; fMRI has the benefit of being entirely non-invasive as well as 
offering greater flexibility and availability as radioisotopes are not required. fMRI provides 
a measure of rCBF by utilising the paramagnetic properties of oxygenated haemoglobin to 
produce the blood-oxygen-level-dependent (BOLD) response which is tightly coupled with 
cellular glucose demand (Huettel, Song & McCarthy, 2009). In addition fMRI allows more 
refined spatial resolution that PET, although it is unable to provide information reflecting 
the functioning of discrete receptors (Logothetis, 2008).  
 
A study by Abrahams and others (2004) employed fMRI to investigate verbal fluency 
performance and confrontation naming in ALS in an effort to determine whether cerebral 
abnormalities were specific to executively demanding fluency tasks. Group comparisons in 
the modified letter fluency task revealed that ALS patients had significantly reduced BOLD 
responses (i.e. activation) in the middle and inferior frontal gyri as well as the anterior 
cingulate which may have been a reflection of the executive and attentional demands of the 
task (Frith, Friston, Liddle & Frackowiak, 1991). In addition, reduced activation was 
observed in parietal and temporal regions proposed to be involved in phonological 
processing and storage (Paulesu, Frith & Frackowiak, 1993). BOLD responses during the 
confrontation naming task revealed reduced activation in patients in inferior frontal gyrus 
(including Broca’s area) and regions corresponding to the ventral pathway involved in 
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object recognition (Mishkin & Ungerleider, 1983). Patient and control performance during 
scanning conditions was matched excluding the possibility that different BOLD responses 
were a reflection of varying ability between the groups. However, subsequent 
neuropsychological testing revealed group differences in letter fluency, confrontation 
naming, and short-term memory span suggesting that the observed pattern of cerebral 
dysfunction may underpin impaired performance in these tasks. Taken together, the findings 
of Abrahams et al. (2004) replicated previous investigations (e.g. Ludolph et al., 1992; 
Abrahams et al., 1996) into verbal fluency by implicating dysfunction in dorsolateral 
prefrontal cortex and anterior cingulate, although abnormalities also extended to parietal and 
temporal regions. In addition, the results indicated that cerebral abnormalities were also 
evident in confrontation naming implicating regions involved in language networks and 
further extending the heterogeneity of dysfunction in ALS.  
 
Functional MRI has also been used to investigate other cognitive domains in ALS. For 
example emotional processing and recognition has been investigated by Lulé et al (2007), 
and Palmieri et al., (2010), with both investigations revealing abnormal cortical activation 
patterns in tasks requiring emotional processing (see Table 2 for details). In contrast to 
studies reporting reduced activation during motor task performance, increased activation 
has been shown during a random hand movement task in a network of areas comprising 
sensorimotor cortex, inferior parietal lobule, and superior temporal gyrus (Stanton et al., 
2007). The increased activation observed in sensorimotor networks may represent processes 
of cortical plasticity in an attempt to compensate for dysfunction in primary motor regions 
(Schoenfeld et al., 2005). However, consistent with the results of earlier PET studies (Kew 
et al., 1993a, 1993b), ALS patients exhibited reduced activation in several prefrontal 
regions, potentially reflecting the executive demands of random generation. Cerebral 
66 
 
responses to executive and attentional processing have also been investigated by way of 
Stroop task paradigms (Goldstein et al., 2011). Inhibition of prepotent responses was 
investigated during Stroop colour-word interference and negative priming scanning 
conditions. Compared to controls, ALS patients displayed increased activation in several 
areas including left middle and superior temporal gyri, as well as left anterior cingulate 
during the interference condition. By contrast, reduced activation was evident in left 
precentral, cingulate, and medial frontal gyri during the negative priming condition. The 
authors proposed that the findings were indicative of altered inhibitory processing; although 
not significant, behavioural data revealed that patients had a tendency to find the Stroop 
interference more difficult than controls, and the authors concluded that increased activation 
in the observed areas may reflect additional processing required by ALS patients to maintain 
task performance. Alternatively the findings may suggest that cerebral abnormalities can 
occur before cognitive impairments are evident, and that the observed pattern of activation 
may reflect compensatory processing in the ALS group. 
 
Thus activation studies have provided neural correlates for observed cognitive deficits in 
ALS, with robust findings implicating dorsolateral and anterior cingulate dysfunction in 
verbal fluency impairements. However, PET and fMRI findings have suggested that 
cerebral dysfunction also encompasses more diffuse brain areas with functional changes 
particularly evident in thalamic, insular and parietal regions, as well as those involved in 
linguistic processing. These findings serve to show ALS as a multi-system disorder and 
demonstrate the heterogeneity that is present with patient groups. Although fMRI paradigms 
have proved useful in identifying changes in rCBF in response to cognitive tasks, caution 
must be applied when interpreting the results of such studies; rCBF measures do not provide 
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an explanation of underlying neural functioning which may be excitatory, inhibitory, or 
compensatory in nature (Logothetis et al., 2008).  
 
1.8.3 Structural studies 
1.8.3.1 Volumetric studies 
The first investigations of structural abnormalities in ALS patients were facilitated by 
computerised tomography (CT). Although compared to modern techniques CT provided 
fairly coarse information, some investigators were able to detect frontotemporal atrophy and 
significantly enlarged ventricles in patients with co-occurring ALS and dementia 
(Mitsuyama & Takayama, 1979). Subsequent studies in primarily non-demented ALS 
cohorts produced conflicting results; David and Gillham (1986) reported that over 50% of 
patients showed cortical atrophy (although measures were not quantified or correlated with 
neuropsychological impairments), whilst another study reported that CT abnormalities were 
rare and uncorrelated with cognitive performance (Poloni, Capitani, Mazzini & Ceroni, 
1986). Moreover, a study of 35 ALS patients (Gallassi et al., 1989) reported that although 
cognitive deficits were evident in a proportion of patients, there was no difference relative to 
controls in volumetric CT analyses. However, a longitudinal investigation revealed that 
atrophy developed in frontal and anterior temporal regions in the 20 out of 22 patients over 
the duration of the disease course (Kato, Hayashi & Yagishita, 1993). Interestingly, extra-
motor atrophy was observed before the development of atrophy in precentral and postcentral 
gyri, as well as further changes in the anterior cingulate and corpus callosum in over half of 
the patients. However, neuropsychological assessment was not conducted by this study, and 




In more recent years, the refinement of MRI technology and analysis techniques has 
facilitated the development of more sensitive imaging protocols which enable subtle 
cerebral changes to be detected. Some studies have applied MRI to investigate changes in 
specific regions of interest (ROI) as well as global cerebral abnormalities. Kiernan & 
Hudson (1994) used manual tracing to determine the surface areas of the precentral gyri and 
anterior frontal lobes in ALS and reported that although there were no significant 
differences compared to controls in grey matter (cortical) measurements, the surface area of 
the white matter (subcortical) underlying the frontal lobes was significantly reduced in the 
ALS group. A subsequent study employed similar techniques to investigate regional 
volumetric changes within the corpus callosum and reported that ALS patients had 
significant atrophy of the anterior portion of the frontal lobes (Yamauchi et al., 1995). 
Moreover, severe atrophy of the anterior fourth of the corpus callosum was evident in a 
subgroup of patients with behavioural abnormalities and those exhibiting cognitive 
impairment in the Mini Mental State Exam and verbal memory. In a large study, Frank et al. 
(1997) also obtained volumetric data from 74 ALS patients who were divided into 
subgroups by cluster analysis based on their cognitive performance in tests of letter fluency, 
WCST, visual attention (D2 test), and visual and verbal memory (recurring figures/words 
test). As a group, ALS patients had larger ventricles and lower parenchymal volumes than 
the control group, and furthermore those patients with cognitive impairment had 
significantly worse MRI parameters than those without, suggesting that cognitive 
dysfunction was a reflection of underlying cerebral atrophy.           
 
Rather than looking for atrophy and other cerebral changes on a case-by-case basis using 
manual tracing methods, statistical imaging packages have been developed to quantify and 
segment grey and white matter volumes into spatially normalised templates which can be 
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analysed to investigate group differences across the whole brain. Such techniques known as 
voxel based morphometry (VBM; Ashburner & Friston, 2000) have the advantage of being 
automated, and therefore can be performed relatively quickly and without human biases or 
errors. Each participant’s imaging data is normalised into three dimensional space and each 
point (voxel) within a template can be directly compared. However, accuracy is highly 
dependent upon the extent to which individual brains can be mapped onto standardised 
stereotactic templates – a process that is being continually refined but still remains 
contentious (Ashburner, 2007).  
 
VBM has been applied to the investigation of cerebral changes in ALS; the first study of 16 
patients (Ellis et al., 2001) revealed reduced grey matter volumes in superior, medial, and 
mid frontal gyri relative to controls. White matter changes were also reported but only in 
regions corresponding to the corticospinal tract (internal capsule and brainstem), and only in 
those patients with bulbar disease onset. By contrast, a subsequent study of 22 non-
demented ALS patients by Kassubek and others (2005) showed regional white matter 
reductions in corticospinal tract, corpus callosum, and frontal and occipital association 
fibres, accompanied by reduced grey matter density in primary motor areas and left medial 
frontal gyrus. Grosskreutz et al. (2006) revealed reduced grey matter volumes in motor 
regions (precentral gyrus and superior frontal gyrus), somatosensory regions (postcentral 
gyrus), as well as extra-motor regions (middle frontal gyrus and inferior parietal gyrus) in 
ALS patients compared to controls. Consistent with the Ellis et al. (2001), white matter 
changes were not found in this investigation. In a cohort of 25 mildly disabled ALS patients, 
Agosta and colleagues (2007) found that relative to controls, patients showed locally 
reduced grey matter density in right premotor cortex, left inferior frontal gyrus, and bilateral 
superior temporal gyri. Similar results have been reported by recent VBM studies, extending 
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findings to right inferior frontal gyrus and insula (Mezzapesa et al., 2007; Senda et al., 
2011), anterior cingulate (Filippini et al., 2010), and parahippocampal gyrus (Mezzapesa et 
al., 2007), further demonstrating multi-system involvement in the ALS disease process.  
 
Although VBM has proved useful in revealing extra-motor structural changes in ALS, few 
of the studies discussed above related their findings to cognitive performance, especially in 
non-demented patients. However, a study by Abrahams and colleagues (2005) demonstrated 
that patients with impaired fluency indices showed greater volumetric reductions than those 
with intact fluency performance.  VBM volumetric data from 11 fluency impaired ALS 
patients and 12 cognitively intact ALS patients were independently compared to the data of 
matched control participants. In contrast to others in the field (Ellis et al., 2001; Kassubek et 
al., 2005; Grosskreutz et al., 2006), the authors reported no significant differences between 
either ALS group and controls in grey matter volumes. However, fluency impaired ALS 
patients showed extensively reduced white matter volumes in regions corresponding to the 
corticospinal tract, as well as encompassing extensive frontotemporal association fibres and 
regions through which run several major white matter tracts – see Table 2 for details. 
Cognitively intact ALS patients also exhibited volumetric white matter reductions relative to 
controls but in a less extensive pattern suggesting that white matter changes may precede 
cognitive impairment. Neuropsychological assessment revealed that the fluency impaired 
patients also exhibited deficits in tests of executive functioning (category fluency) and 
memory (letter span and paired associates), the latter of which correlated with white matter 
clusters encompassing predominantly prefrontal and temporal association fibres, but also 
implicating occipital association fibres and the major white matter tracts connecting frontal 
regions to occipital and temporal regions. Thus, Abrahams et al. (2005) demonstrated 
extensive white matter involvement in ALS pathogenesis, particularly in patients with 
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cognitive impairment. Moreover, the pattern of widespread white matter atrophy in 
conjunction with preserved grey matter suggests that white matter degeneration may 
underpin the observed cognitive deficits in ALS. 
 
Other studies have also made direct correlations between structural change and cognitive 
impairment using VBM. Grossman et al. (2008) reported that 34 ALS patients (35% with 
cognitive impairments in fluency, trail making test and reverse digit span) showed diffuse 
cortical atrophy in dorsolateral and inferior prefrontal cortex, anterior temporal cortex, 
anterior cingulate, and occipital regions relative to controls. Performance in tests of object 
knowledge and action knowledge correlated with cortical volumes in bilateral dorsolateral 
and inferior frontal gyri suggesting that these regions may be crucial in implementing 
executive retrieval processes from semantic memory. Of note, greater impairments were 
observed in tests of action knowledge which correlated with cortical atrophy in motor and 
premotor areas indicating that conceptual information concerning verbs and actions may be 
specifically linked to motor networks.  Behavioural change was investigated in a study by 
Tsujimoto et al. (2011) who compared scores in the FrSBe before and after the diagnosis of 
ALS. The authors reported that ALS patients had significantly increased apathy scores in 
the FrSBe post-diagnosis, and that severity of apathy was correlated with multiple prefrontal 
regions (see Table 2). The authors proposed that their findings complemented those reported 
in studies of apathy in FTD (Zamboni, Huey, Krueger, Nichelli & Grafman, 2008), and may 
reflect “cognitive” apathy thought to be dependent on executive processing within 
dorsolateral prefrontal cortex and “affective” apathy thought to be dependent on 
orbitofrontal regions (Levy & Dubios, 2006).   
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Other studies have used VBM to investigate the proposed overlap between ALS and FTD. 
Chang et al. (2005) investigated grey and white matter changes in ALS patients compared to 
controls and those with ALS-FTD. Relative to controls, ALS patients had reduced grey 
matter volumes in motor regions, superior, middle, and inferior frontal gyri, in addition to 
superior temporal regions and posterior thalamus, however, no group differences in white 
matter volumes were observed. ALS-FTD patients exhibiting impairments in WCST, 
fluency and confrontation naming shared the same pattern of localised volume reductions as 
ALS patients, although atrophy was generally more extensive. An investigation by Murphy 
et al. (2007) investigated group differences between 11 cognitively and behaviourally intact 
patients and 11 patients who met criteria for FTLD or had evidence of cognitive or 
behavioural impairment. Concordant with Chang et al. (2005) significant group differences 
were reported between impaired ALS patients and controls in frontal and limbic structures, 
with findings extended to the parietal lobes (all lateralised to the right hemisphere), whilst 
intact ALS patients showed reduced temporal lobe volumes compared to controls. More 
recent studies have revealed a more detailed picture of the overlap between patients with 
ALS and those with FTD. Lillo and colleagues (2012) employed VBM to investigate grey 
matter atrophy in demographically matched ALS, ALS-FTD and bvFTD patients; the 
authors reported that relative to controls, ALS patients displayed volumetric reductions in 
motor regions and anterior cingulate, whilst ALS-FTD could be distinguished by additional 
temporal lobe involvement, and bvFTD patients could be identified by more extensive 
reductions in prefrontal regions. The findings demonstrated that atrophy in motor regions 
and anterior cingulate were shared by all three groups, providing support for the existence of 
a spectrum between the disorders. A subsequent study extended the findings of Lillo et al. 
(2012) by showing that only ALS patients with cognitive and behavioural impairments had 
cerebral atrophy beyond the brainstem (Mioshi et al., 2013). The authors reported that ALS 
patients’ with cognitive impairments in letter fluency, the Trail Making Test, or Hayling 
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test, or behavioural abnormalities as assessed by the Cambridge Behavioural Inventory, but 
who did not meet criteria for ALS-FTD, showed volumetric reductions in  motor and 
somatosensory regions as well as superior frontal gyrus and superior parietal gyrus. These 
findings are largely in support of previous investigations showing that cognitively impaired 
patients exhibit greater volumetric reductions than cognitively intact patients (e.g. Abrahams 
et al., 2005), although the findings of Mioshi et al. (2013) highlight the possibility that 
damage to grey matter structures may also be a factor. 
 
1.8.3.2 Cortical thickness studies 
Although VBM studies have dominated the investigation of cortical changes in ALS, 
recently developed neuroimaging packages have allowed the same T1-weighted MRI data 
used in VBM to produce cortical thickness maps. Cortical thickness procedures also rely on 
the segmentation of white and grey matter followed by the subsequent computation of 
thickness by measuring the distance between white matter and grey matter surfaces 
(vertexes); additional parameters of cortical surface area and volume may also be derived 
(Fischl & Dale, 2000). Group differences in cortical thickness between ALS and controls 
participants have been observed in primary motor areas of the precentral gyrus and 
postcentral gyrus, with the suggestion that cortical thickness parameters may be more 
sensitive to changes in the sensorimotor regions than surface area or volumetric data 
(Verstraete et al., 2012; Agosta et al., 2012). Moreover, the latter study detected reductions 
in cortical thickness in extensive cortical regions including prefrontal and ventral frontal 
cortices, cingulate gyrus, insula, superior and inferior temporal and parietal regions, and 
medial and lateral occipital areas, suggesting that this method may also be sensitive to subtle 
extra-motor changes in ALS. The association between cortical thickness and executive 
functioning was investigated in a recent study by Libon et al. (2012). The authors reported 
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that a proportion of ALS patients (9/41) exhibited impaired performance in the D-KEFS 
card sorting test, performance in which was correlated with letter fluency performance. 
Moreover, in a subgroup of patients (n = 20), age-corrected recognition performance in the 
card sorting test was correlated with cortical thinning in the left dorsolateral prefrontal 
cortex and left parietal cortex, suggesting that a left lateralised frontoparietal network 
underpinned impairment in this task.   
 
1.8.3.3 Diffusion tensor imaging (DTI) 
Studies employing volumetric techniques to investigate structural changes in ALS appeared 
to suggest that white matter pathology was by and large restricted to the corticospinal tract 
(e.g. Ellis et al., 2001; Grosskreutz et al., 2006). However, the findings of Abrahams et al. 
(2005) indicated that white matter changes were evident in extensive extra-motor areas, 
especially in patients with cognitive impairment. Moreover, subsequent histological studies 
have indicated a high degree of correspondence between TDP43 pathology in extra motor 
grey matter structures and the underlying local white matter further implicating the role of 
white matter in ALS pathogenesis (Geser et al., 2009). In contrast to the volumetric 
estimations provided by techniques such as VBM, diffusion tensor magnetic resonance 
imaging (DTI) allows the integrity and organisation of white matter structures to be 
investigated. DTI relies upon the diffusion properties of water molecules within neuronal 
axons; diffusion of water in white matter tracts is anisotropic, i.e. it moves more freely 
along the principal orientation of the axons, but not perpendicularly to them (Chenevert, 
Brunberg & Pipe, 1990). This allows 2 measures of axonal integrity to be derived: Mean 
diffusivity (D) corresponds to magnitude of water molecule diffusion in any direction - 
low D indicates good axon integrity as the myelin sheath restricts diffusion; fractional 
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anisotropy (FA) indicates the directional coherence of water molecule diffusion - high FA 
indicates good axon integrity as water movement is generally in the same direction. 
 
DTI data is typically processed and visualised in two ways; voxel by voxel analysis of 
whole brain white matter, or, the evaluation of specific white matter tracts. The first method 
has similarities to the methods employed by VBM analysis in that it relies upon the co-
registration of individual brain scans to a standardised template so that comparisons can be 
made across every point (voxel) in standard space. Such methods are useful for exploratory 
investigations as white matter changes can be visualised throughout the brain without the 
need for prior hypotheses. Tract Based Spatial Statistics (TBSS; Smith et al., 2006), for 
example, performs voxel by voxel comparisons within white matter skeletons created for 
each subject. However, as with all methods requiring co-registration to standard space, the 
quality of the data is dependent upon the accuracy of the spatial deformation and smoothing 
algorithms used in the registration process (Jones et al., 2005); TBSS, however, does not use 
spatial smoothing. By contrast, individual tracts can be segmented for each subject using 
tractography since large white matter fibre bundles are well defined anatomically and 
generally have a similar topology across cohorts. Such approaches are similar to region of 
interest (ROI) methods in that the specific structures under investigation are determined a 
priori, and thus promote hypothesis driven research.  Tractography methods rely upon the 
delineation of “seed points”, i.e. the origin of the white matter tract of interest; algorithms 
then trace the white matter structure and provide average DTI parameters for the entire tract 
(Vilanova, Zhang, Kindlmann & Laidlaw, 2006). In addition, ROI approaches can be 
adopted which investigate predefined regions within major tracts or subcortical white matter 
areas. Such approaches have been demonstrated to be sensitive to white matter degeneration 
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and cognitive change in healthy older adults (Shenkin et al., 2005), but have yet to be 
applied in ALS.    
 
It has long been recognised that degeneration of the corticospinal tract is a key component 
of ALS pathology (Smith, 1960; Turner, 2011), and DTI allows in vivo investigation of this 
structure. The majority of studies employing tractography and voxel based DTI analyses in 
ALS have confirmed presence of structural change in the corticospinal tract as indexed by 
reduced FA (e.g. Ellis et al., 1999; Abe et al., 2004; Sage, Peeters, Görner, Robberecht & 
Sunaert, 2007; Ciccarelli et al., 2006, 2009). Changes have been reported in various regions 
of the corticospinal tract including the cerebral peduncle, internal capsule and corona 
radiata, and a recent meta-analysis encompassing 143 patients (Li et al., 2012) revealed that 
the posterior limb of the internal capsule (PLIC) was the most sensitive region of the 
corticospinal tract for detecting white matter damage in ALS. Indeed, another recent study 
has suggested that integrity of the PLIC may have prognostic value (Menke et al., 2012). 
Although some studies have failed to show an association between corticospinal tract 
integrity as measured by DTI and clinical measures (e.g. Agosta et al., 2007), other studies 
have demonstrated correlations with disease severity (Ellis et al., 1999; Sage et al., 2007), 
rate of disease progression (Ciccarelli et al., 2006; Bastin et al., 2013) and 
electrophysiological measures of upper motor neuron degeneration (Sach et al., 2004). In 
addition, reduced structural integrity in the corpus callosum, and particularly the portion 
linking the motor cortices, has also been reported by many investigators (e.g.  Sach et al., 
2004; Sage et al., 2007; Agosta et al., 2007 Filippini et al., 2010; Verstraete et al., 2010; 
Zhang et al., 2011). Reduced FA in the splenium of the corpus callosum has been shown to 
correlate with clinical signs of upper motor neuron degeneration (Stanton et al., 2009). 
However, changes in this area are not consistently associated with disease severity or 
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duration (Bartels et al., 2008; Filippini et al., 2010) suggesting that the corpus callosum may 
be affected before the onset of clinical symptoms. The consistency of above findings and the 
correlation between corticospinal tract integrity and clinical and functional measures 
suggests that DTI techniques have the potential to be used as biomarkers of disease severity, 
although novel neuroimaging techniques such as whole-brain magnetic resonance 
spectroscopy (Stagg et al., 2013) and myelin imaging (Kolind et al., 2013) are also showing 
promise for this application. Such non-invasive clinical markers of ALS are crucial for 
differential diagnosis and also for monitoring disease progression and response to potential 
drug interventions (Turner, 2011). 
 
DTI investigations have also revealed reductions in structural integrity in extra-motor 
regions in ALS patients. Studies employing voxel-wise whole-brain analyses have reported 
significant differences between ALS patients and controls in multiple subcortical regions. 
For example, in group of 15 patients, Sach and colleagues (2004) reported reduced FA in 
the corpus callosum and right thalamus as well as in white matter adjacent to left inferior 
frontal and medial frontal gyri. Agosta et al. (2007) also reported reduced FA in the corpus 
callosum, however, D was more sensitive to extra-motor changes with local increases 
reported in white matter adjacent to right inferior frontal gyrus and superior temporal gyrus, 
bilateral middle temporal gyrus, as well as left lingual gyrus. In a study of 28 ALS patients 
Sage et al. (2007), reported reduced FA in multiple prefrontal regions including fibres 
adjacent to inferior and dorsolateral prefrontal cortex as well as orbitofrontal cortex. In 
addition, FA reductions were found in bilateral inferior parietal white matter, insula white 
matter and hippocampal formations, the latter two of which also had increased D. Such 
findings supported those of an earlier study which revealed extensive, predominantly 
frontotemporal, white matter abnormalities using VBM (Abrahams et al., 2005). The same 
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group (Sage et al., 2009) re-analysed their data using novel methods of voxel-wise analysis 
which overcome the limitations of co-registration and spatial smoothing incurred by 
traditional VBM-style techniques. In-house analysis software as well as TBSS produced by-
and-large the same findings as the original study with lower overall variance in the 
parameters, suggesting that imaging packages such as TBSS are more reliable in the 
detection of subtle white matter dysfunction. Support for these findings were provided by 
Ciccarelli et al. (2009) who showed extra-motor FA reductions in corpus callosum, right 
superior frontal gyrus, bilateral inferior and medial frontal gyrus and the bilateral post-
central gyrus (primary sensory cortex). Furthermore, a recent study which employed TBSS 
in conjunction with ROI analysis of diffusion data reported that both analyses revealed 
reduced structural integrity in corticospinal tract and corpus callosum in ALS patients 
(Prudlo et al., 2012). Moreover, the TBSS analysis revealed further FA reductions in 
inferior longitudinal fasciculus, superior longitudinal fasciculus, and cingulum, and integrity 
in these regions as well as motor regions correlated with ALSFRS-R scores. 
 
 Another investigation employing TBSS by Canu et al. (2011) which controlled for 
volumetric changes in a cohort of 23 ALS patients reported reduced white matter integrity in 
several frontotemporal regions compared to controls. Concordant with the findings of 
Agosta et al. (2007), the authors reported more changes in D with increases observed in 
left inferior frontal gyrus, insula, middle temporal gyrus, and supramarginal gyrus, as well 
as right temporal pole, putamen, angular gyrus, genu, and bilateral orbitofrontal white 
matter. By contrast, reduced FA was only reported in left inferior frontal white matter. Of 
note, Canu et al. (2011) did not report extra-motor white matter changes in VBM analyses 
indicating that diffusivity metrics are more sensitive to white matter pathology than 
volumetric data and suggesting that diffusivity abnormalities may precede atrophy. 
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Moreover, orbitofrontal D correlated with disease duration suggesting that white matter 
pathology may spread in an anterior direction as the disease progresses. Concordantly, a 
longitudinal study by Senda and colleagues (2011) reported that although white matter 
abnormalities were restricted to areas in close proximity to the corticospinal tract at 
baseline, at six month follow-up, FA reductions were also apparent in bilateral prefrontal 
regions. ALS patients in this study were also found to be impaired in the Frontal 
Assessment Battery although performance did not correlate with diffusivity metrics. 
However, Tsujimoto et al. (2011) did report correlations between white matter diffusivity 
metrics and behavioural changes: in a cohort of 21 patients, post-illness apathy scores (as 
assessed by the FrSBe) were correlated with reduced FA in white matter underlying 
predominantly right medial frontal gyrus, and increased D in white matter underlying 
predominantly anterior regions of the left superior frontal gyrus. These findings were 
concordant with grey matter atrophy observed in similar regions in the same patients 
suggesting that apathy in ALS was associated with the disruption of frontal lobe pathways.      
 
Other investigations employing voxel-wise analyses have provided evidence of white matter 
changes that support the proposed continuum between ALS and FTD. Lillo et al. (2012) 
performed TBSS analyses in patients with ALS, ALS-FTD, and bvFTD which revealed 
white matter commonalties and differences between the three groups. In comparison to the 
bvFTD group, ALS and ALS-FTD patients showed more damage in corticospinal tract and 
the temporal poles, whereas the bvFTD group showed more damage in anterior corpus 
callosum, forceps minor, and inferior longitudinal fasciculus. The same pattern was revealed 
in comparisons between ALS and ALS-FTD patients. However, analyses of regions 
common to all groups revealed white matter changes in portions of the corticospinal tract, 
inferior longitudinal fasciculus, and anterior corpus callosum indicative of shared pathology 
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in frontotemporal white matter. Other studies have shown white matter disruption in 
posterior and sensory areas – for example Stanton et al. (2009) reported that sporadic ALS 
patients had reduced FA compared to familial patients with SOD1 mutations in 
occipitotemporal association fibers and occipitopatietal white matter as well as corpus 
callosum and corona radiata. A subsequent study by Lule et al. (2010) demonstrated reduced 
white matter integrity in fibres projecting to extra-striate visual areas and primary and 
secondary auditory cortices (accompanied by abnormal visual and auditory processing 
during sensory fMRI tasks). However, ALS patients did not exhibit impairments at the 
behavioural level in either the visual or auditory sensory target detection tasks.  
 
Extra-motor changes have also been revealed in ALS patients by the application of 
tractography analyses to DTI data. In a large study of 46 non-demented ALS patients, Senda 
et al. (2009) reported reduced FA in frontal white matter, genu and splenium of the corpus 
callosum, as well as parietal and temporal lobe white matter, and posterior cingulum. Sato 
and others (2010) reported that a group of 15 ALS patients had significantly lower FA than 
controls in uncinate fasciculus, although group differences were not found in the apparent 
diffusivity coefficient. Concordantly, in a group of 20 mildly disabled ALS patients, Agosta 
et al. (2010) reported that in addition to corticospinal tract abnormalities, patients had 
increased axial diffusivity in right uncinate fasciculus relative to controls. The uncinate 
fasciculus connects the anterior portions of the temporal lobes to orbital and inferior gyri of 
the frontal lobes and lesions to this structure can result in naming deficits and impairment in 
the retrieval of memories (Lu et al., 2002; Diehl et al., 2008; Harvey, Wei, Ellmore, 
Hamilton & Schnur, 2013), problems that are often reported in ALS patients (Raaphorst et 
al., 2010). However, neither of the above studies administered neuropsychological 
assessment so structural changes in the uncinate fasciculus could not be related to cognitive 
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impairment. A recent study applied automated probabilistic neighbourhood tractography to 
the diffusivity data, which in addition to integrity parameters of FA and D, also allows 
tract topology or shape to be compared between individuals (Bastin et al., 2013). The 
authors reported reduced integrity (FA and D) in bilateral corticispinal tracts and cingulum 
(D) in 30 ALS patients compared to matched controls. In addition, tract topology was 
found to be significantly more altered in patients than controls in bilateral corticospinal 
tracts and the right uncinate fasciculus, providing further evidence of uncinate fasciculus 
abnormalities in ALS patients.  
 
The only study to report correlations between tractography and cognitive tests was an 
investigation of 16 ALS patients by Sarro et al. (2011). The authors administered 
neuropsychological tests of verbal and spatial memory (Rey’s word and figure tests), as well 
as attention and executive functioning (Trail Making Test, WCST, Stroop tests and letter 
and category fluency tests). Behavioural change was assessed by the Neuropsychiatric 
Inventory. Eleven patients (69%) were found to be impaired in at least one cognitive test 
although no group differences between patients and controls were reported. Two patients 
had evidence of executive impairment (ALSci) according to consensus criteria (Strong et al., 
2009), and a further patient met criteria for ALS with behavioural impairment (ALSbi). 
Tractography analyses revealed that compared with healthy controls, patients with ALS 
showed increased D and reduced FA of the corticospinal tract bilaterally as well as 
increased D of the corpus callosum, right cingulum, and bilateral superior longitudinal 
fasciculus and uncinate fasciculus. Correlations between diffusivity parameters and 
cognitive tests revealed several significant associations – see Table 2 for details. However, 
after correction for multiple comparisons were taken into account, only correlations between 
the Trail Making Test and FA in the corpus callosum, corticospinal tract, inferior fronto-
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occipital fasciculus, inferior longitudinal fasciculus, and right uncinate fasciculus remained 
significant. Moreover, the majority of the correlations were with Part A of the Trail Making 
Tests which is primarily a measure of psychomotor speed rather than high order cognitive 
functioning. The only region which correlated with Part B-A (assessing executive process of 
switching independent of motor speed) was left inferior fronto-occipital fasciculus (FA). 
Nevertheless, the findings of Sarro et al. (2011) suggest that motor independent executive 
functioning in ALS is related to the integrity of major white matter tracts connecting frontal 
regions to occipital and parietal regions. As such, they are consistent with lesion studies and 
functional imaging studies which suggest that executive functioning is dependent upon 
distributed regions throughout the frontal, parietal and temporal lobes (Alvarez & Emory, 
2006; Zakzanis, Mraz & Graham, 2005). Indeed, abnormalities in frontal, parietal, and 
temporal regions have also been reported in ALS studies employing volumetric structural 
imaging (Grosskreutz et al., 2006; Agosta et al., 2007), and functional imaging (Abrahams 
et al., 2004). Moreover, although the correlation between letter fluency and cingulum 
integrity did not survive correction for multiple comparisons, the relationship is consistent 
with other functional studies reporting reduced activation in anterior cingulate during 
fluency tasks (Kew et al., 1993b; Abrahams et al., 2004). However, it should be noted that 
motor slowing was not controlled for in the fluency task. In addition, a trend was present 
between immediate verbal recall performance and reduced FA in the fornix, a relationship 
that has been demonstrated in other neurodegenerative disorders such as Alzheimer’s 
disease (Sexton et al., 2010). 
 
1.8.4 Neuroimaging in ALS summary 
Neuroimaging studies in ALS have consistently implicated dysfunction of prefrontal and 
temporal regions in ALS. In addition activation studies, and to a lesser extent structural 
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studies, have demonstrated that disruption to frontotemporal regions is associated with 
cognitive impairment in a range of tests, predominantly those assessing executive 
functioning. However, cerebral dysfunction in posterior and parietal regions, as well as the 
white matter structures which connect them has also been reported. Such findings suggest 
that extra-motor changes in ALS may not be restricted to frontotemporal regions, but may 
also reflect more diffuse TDP-43 pathology which has been shown to affect brain structures 
globally in ALS (Geser et al., 2008, 2009). Although the findings of the neuroimaging 
studies discussed above suggest that extra-motor changes in ALS are not restricted to 
frontotemporal areas, the observed pattern of involvement may still be consistent with 
executive dysfunction as recent research has demonstrated the importance of distributed 
cortical networks, particularly frontoparietal, in the performance of executive tasks (Alvarez 
& Emory, 2006). More correlations between imaging parameters and appropriate 
neuropsychological testing are necessary to understand the link between cognitive 
impairment and disease pathogenesis in ALS. 
 
1.9 Multiple Sclerosis 
In addition to healthy control participants, a cohort of patients with Multiple Sclerosis (MS) 
was recruited as a comparative group for the main ALS investigation. MS is primarily a 
disease of cerebral and spinal white matter caused by pathological mechanisms of 
inflammation, demyelination, and axon degeneration (Compston & Coles, 2008). The most 
widely accepted theory proposes that MS begins as an inflammatory autoimmune disorder 
mediated by autoreactive inflammatory T-cells (Weiner, 2004), before progressing into a 
neurodegenerative disorder characterised by microglial activation (Compston & Coles, 
2008). Initial inflammatory lymphocytic pathology is focal and temporary resulting in 
clinical characteristics of acute dysfunction followed by periods of recovery (remission). 
84 
 
However, overtime microglial activation becomes chronic and widespread resulting in 
accumulative disabilities in coordination and balance, vision, bladder and bowel control, 
dysarthria and dysphasia, depression, and cognitive impairment (Noseworthy, Lucchinetti, 
Rodriguez & Weinshenker, 2000). Disease course is highly heterogeneous and MS patients 
can be grouped into 4 broad categories based on the progression of their clinical symptoms 
(Goldenberg, 2012): 
1. Relapsing-remitting (RR): The most common form of the disorder affecting 
approximately 85% of MS patients is characterised by acute flare-ups (relapses) followed by 
periods of recovery (remission) in which symptoms improve or diminish.  
2. Secondary progressive (SP): A progressive form of the disorder which affects a 
significant proportion of RR patients, although disease modifying treatments may delay 
development. Characterised by worsening symptoms in the absence of remission periods – 
in some MS patients symptom severity may reach a plateau.   
3. Primary progressive (PP): Less common affecting approximately 10% of patients and 
characterised by progressive worsening of symptoms from disease onset. Patients do not 
experience relapses or remissions although periods of symptomatic plateau are possible.  
4. Progressive-relapsing (PR): A rare form of the disorder affecting less than 5% of patients. 
Disease course is characterised by progressive worsening of symptoms from onset with 
additional intermittent flare-ups and without periods of remission. 
 
MS is far more common than ALS; indeed it is the most common neurological disease in 
young and middle-aged adults in Europe and the United States (Johnson, 2007). The 
incidence and prevalence of MS varies geographically with risk increasing with distance 
from the equator – high risk areas such as Europe, the northern United States, Canada, 
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south-east Australia and New Zealand typically report prevalence rates of over 100 per 
100,000, whilst the highest reported rate of 300 per 100,000 is in the Orkney Islands (Ebers, 
2008; Simpson, Blizzard, Otahal, Van der Mei & Taylor, 2011). MS affects more women 
than men, with an estimated female to male ratio of 2.3:1 (Alonso & Hernán, 2008) and 
peak onset age of 30 (although onset in women is approximately 5 years earlier). The 
aetiology of MS remains unknown however several genetic and environmental risk factors 
have been identified. Environmental factors include vaccinations and viral infections, 
latitude, UV exposure and vitamin D deficiency (Ascherio & Munger, 2007a, 2007b). 
Genetic risk factors include the presence of certain alleles of major histocompatability 
complex (MHC), interleukin-7 receptor (IL-7R), and apolipoprotein-E (APO-E), and it is 
likely that environmental and genetic risk factors play an additive role in disease 
susceptibility (Lincoln et al., 2005; Compston & Coles, 2008; Bahlo et al., 2009).   
 
Although ALS and MS are entirely separable entities, they do share some pathological and 
clinical similarities; both diseases commonly manifest with disruption to the motor 
symptoms although cognitive changes are common and can precede or occur in conjunction 
with movement problems (Feinstein, Kartsounis, Miller, Youl & Ron, 1992; Zipoli et al., 
2010; Abrahams et al., 2005a). The aetiology of the diseases is unknown but both appear to 
be multifactorial in nature and implicate dysfunction of cerebral white matter (Kuzelnigg et 
al., 2005; Geser, 2009). In addition, MS and ALS share pathogenic processes of 
inflammation, oxidative stress and mitochondrial dysfunction, with the suggestion that 
autoimmune dysfunction of vasoacive neuropeptides may be a common pathological 
pathway (Staines, 2008).  Moreover, both diseases present with considerable clinical and 
phenotypic heterogeneity. Thus it is of interest to compare the cognitive profile of MS and 




1.10 Cognition in MS 
A full review of cognitive impairment in MS is beyond the scope of this study, but the 
following section will provide a summary of the most prevalent findings. As is true for 
sensory and physical symptoms in MS, the presence of cognitive impairment is highly 
variable from patient to patient. Depending on the type of study (clinic-based or population-
based) and clinical characteristics of the patient cohorts (age, disease duration, MS subtype), 
the frequency of cognitive dysfunction in MS ranges between 40% and 65% (Rao, Leo, 
Bernardin & Unverzagt, 1991; Amato, Zipoli & Portaccio, 2006), with impairments 
observed in all subtypes of the disease (Foong et al., 2000; Rovaris et al., 2002). Cognitive 
impairments in MS can affect capacity to follow treatment and rehabilitation regimes, and 
impinge upon social interactions and activities of daily living, independently of physical 
disabilities (Amato et al., 1995).   
 
Some of the most commonly reported cognitive impairments in MS are in the domain of 
memory. Explicit and particularly episodic memory deficits appear to be most prevalent 
with a propensity towards impairments in delayed free recall and delayed recognition of 
verbal information (Grafman, Rao & Litvan, 1990; Grigsby, Ayarbe, Kravcisin & 
Busenbark, 1994; Staffen et al., 2002).  However, deficits have been consistently reported in 
immediate and delayed conditions of spatial and figural memory paradigms, as well as story 
recall, and paired associate learning (see Thornton & Raz, 1997 for a quantitative review). 
Early research postulated that retrieval deficits underpin poor memory performance in MS 
(Rao, Leo & Aubin-Faubert, 1989). However more recent studies have shown that MS 
patients take more trials to encode verbal information than controls, while subsequent recall 
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and recognition is unimpaired suggesting that poor memory performance may be a 
reflection of poor learning, encoding, and maintenance processes, rather than retrieval 
difficulties (DeLuca, Barbieri-Berger & Johnson, 1994).  On the other hand, recognition 
deficits have also been demonstrated in MS (Beatty et al., 1996) leading to the suggestion 
that memory impairment can be heterogeneous in MS and reflect disruption to different 
neural pathways (Benedict, Ramasamy, Munschauer, Weinstock-Guttman & Zivadinov, 
2009). By contrast, studies investigating implicit memory and priming have reported normal 
performance in MS patients (Grafman, Rao, Bernardin & Leo, 1991; Rao et al., 1993). 
Everyday memory deficits such as that for names, faces, and routes are more evident in 
patients with chronic progressive disease course than relapse-remitting patients (Calabrese 
et al., 2000), although deficits in prospective memory have been shown a mixed cohort of 
MS patients (Rendell, Jensen & Henry, 2007).  
 
Short-term and working memory can also be impaired in MS patients; Rao et al. (1993) 
reported the an exaggerated word-length effect in a group of MS patients that was 
independent of disease severity or duration suggesting specific deficit in phonological loop 
functioning. A subsequent quantitative review concluded that MS patients were impaired in 
verbal and spatial span measures, but higher effect sizes were found in working memory 
tasks with additional manipulation demands, namely the Brown-Peterson task and the 
PASAT (Thornton & Raz, 1997). MS patients with progressive forms of MS have exhibited 
deficits in forward and backward digit span although performance correlated with 
processing speed measures leading the authors to conclude that slowed central processing 
was the underlying problem (Grigsby, Ayarbe, Kravcisin & Busenbark, 1994). The 
relationship between working memory and processing speed has been further explored in a 
study by Lengenfelder et al. (2006). The authors demonstrated that MS patients could 
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perform a modified version of the PASAT with a 1-back manipulation to the same level as 
controls if they were allowed slower stimulus presentations suggesting that processing speed 
interacts with working memory ability. However, some patients were unable to perform the 
2-back manipulation regardless of the time limit imposed, suggesting that core working 
memory functioning was also compromised in a proportion of patients. 
 
One of the most well documented impairments in MS is that of slowed information-
processing speed, with some investigators proposing that slowed processing speed 
constitutes the most common deficit in MS (DeLuca, Chelune, Tulsky, Lengenfelder & 
Chiaravalloti, 2004). Processing speed has been shown to decline longitudinally in MS and 
be a predictor of overall cognitive decline (Bergendal, Fredrikson & Almkvist, 2007), with 
large scale studies demonstrating that secondary-progressive patients have a significantly 
higher prevalence of impairments than other subtypes (Fischer, 2001). Typically processing 
speed is assessed by the PASAT which is the cognitive component of the multiple sclerosis 
functional composite, a specifically designed outcome measure for assessing MS severity 
(Fischer, Rudick, Cutter & Reingold, 1999). Although the PASAT places demands on 
processing speed and has shown reasonable sensitivity (74%) and specificity (64%) to 
multiple sclerosis (Rosti, Hämäläinen, Koivisto & Hokkanen, 2007), as has been previously 
mentioned in relation to ALS research, the test also has a substantial working memory 
component and therefore deficits in this task do not necessarily represent a pure processing 
speed deficit. Other investigators have reported significant impairments in MS patients in 
tasks such as digit-symbol coding and symbol search (components the Wechsler Adult 
Intelligence Scales III processing speed index; Wechsler, 1997), as well as the Symbol Digit 
Modalities Test and choice reaction time paradigms (DeLuca et al., 2004; Hughes, Denney 
& Lynch, 2011). Although these tasks impose less demand on working memory and 
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therefore are better measures of processing speed, they typically rely on timed responses and 
thus results can be confounded by physical dysfunction and slowing.    
 
Further evidence for a processing speed deficit has been provided by studies investigating 
attentional processes. A detailed study by De Sonneville et al. (2002) employed multiple 
computer based reaction time tasks to investigate different attentional processing stages 
including target detection, divided attention, inhibition, focussed attention, sustained 
attention, flexibility, and motor pursuit. Compared to controls MS patients exhibited slower 
reaction times in all the tasks indicative of slowed processing in automatic and controlled 
processing stages. The authors also reported that MS patients exhibited a dramatic increase 
in reaction times in the more complex tasks of divided attention, sustained attention, and 
flexibility, indicative of impairment in controlled (i.e. cognitively demanding) processing 
speed. De Sonneville et al. (2002) showed that on average, MS patients were 40% slower 
than controls suggesting that reaction time paradigms were sensitive to MS and that slowed 
attentionally-demanding processing speed underpins cognitive dysfunction. However, 
accuracy was also impaired in the complex tasks but not in simple tasks such as target 
detection suggesting that MS patients experienced deficits in complex attentional tasks 
independent of slowed processing speed. Moreover, a subsequent study showed that while 
MS patients exhibited slowed reaction times in a test of basic tonic alertness, they did not 
show slowed reaction times in a divided attention task but did make significantly more 
errors than controls (Tinnefeld et al., 2005). These finding suggest that deficits in 
attentionally demanding tasks are independent of basic processing speed impairments. Of 
note, both of the above studies reported that patients with progressive disease course and 
more severe physical symptoms exhibited more marked deficits, particularly in complex 




Many of the studies discussed above investigating working memory, processing speed and 
attention in MS have employed methodology that incorporates a “speed versus accuracy 
confound”. The basis of this confound is that accuracy in performance generally decreases 
as the speed needed to process information increases (Pike, McFarland & Dalgleish, 1974). 
This confound makes it extremely difficult to attribute whether individuals with MS have 
specific problems in attention, working memory, or processing speed, or whether there is an 
interaction between these functions (Lengenfelder et al. 2006). Thus, there is a need to 
delineate the processes and design tasks that can investigate these processes independently. 
 
The reported deficits in divided and sustained attentive processing measures are consistent 
with disruption to proposed systems of executive and frontal lobe functioning (Baddeley, 
Logie, Bressi, Della Sala & Spinnler, 1986; Stuss et al., 1995 – see Chapter 3 Section 3.3 for 
model summaries).  Indeed, a significant proportion of MS patients present with 
impairments in tests of executive functioning, albeit less frequently than those in memory 
and processing speed. Population-based studies have shown that between 15 – 20% of MS 
patients exhibit impairments in executive functioning (Roa et al., 1991; Fischer, 2001), with 
a recent population-based study of 95 patients (including all disease subtypes) reporting that 
17% exhibited impairments in the D-KEFS battery (Drew, Tippett, Starkey & Isler, 2008). 
Deficits have been reported in a wide range of tests including letter fluency (Foong et al, 
1997; Henry & Beatty, 2006), category fluency (Foong et al., 1997; Henry & Beatty, 2006), 
Stroop interference (Foong et al., 1997; Drew et al., 2008), dual tasking (D’Esposito et al., 
1996), Wisconsin Card Sort Test (Parmenter et al., 2007), D-KEFS sorting test (Parmenter 
et al., 2007; Drew et al., 2008), and Tower of London-based paradigms (Foong et al., 1997). 
Some studies have suggested that some executive tasks are more sensitive to impairments in 
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MS patients; for example Henry and Beatty (2006) showed in a quantitative review that 
letter and category fluency tests were significantly more sensitive to executive dysfunction 
than the WCST. Concordantly Drew et al. (2008) demonstrated that fluency measures, and 
particularly switching fluency, along with Stroop interference were the most sensitive 
executive tests in MS. However, when the same authors attributed each test from their 
battery (D-KEFS) to one of the following executive domains; planning, inhibition, shifting, 
reasoning, and fluency, they reported that MS patients did not exhibit a higher proportion of 
impairment in any single executive domain. The interpretation of executive dysfunction in 
MS patients must be made with some caution as executive tests are particularly sensitive to 
the effects of depression (Arnett, Higginson & Randolph, 2001), the rates of which are 
elevated in MS (Arnett, Barwick & Beeney, 2008). Indeed, Parmenter et al. (2007) showed 
that group differences between patients and controls in the WCST were attenuated by 
depression scores, although differences in the D-KEFS sorting test remained significant. 
Moreover, some studies have reported that executive dysfunction is independent of physical 
disability (Foong et al., 1997), however others have reported correlations between executive 
impairments, although regression analyses demonstrated that the variance explained by 
physical disability was low (Drew et al., 2008). Some investigators have shown that 
executive deficits are worse in patients with a chronic progressive disease course (Henry & 
Beatty, 2006), whilst others have demonstrated that relapse-remitting patients perform as 
poorly as progressive subtypes in tests of executive functioning (Huijbregts et al., 2004). 
 
Thus, the cognitive profile of MS is characterised by heterogeneity – a significant 
proportion of patients will present with cognitive dysfunction with deficits most likely in 
tasks assessing delayed memory, attention, and working memory and speed of processing. 
Although executive impairments are a feature of MS, they are not as common as 
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impairments in other domains and are less likely to occur in isolation (Drew et al., 2008). 
However, as with neuropsychological assessment in ALS patients, verbal fluency tests 
appear to be particularly sensitive to cognitive impairment in MS which may reflect the 
demands imposed by fluency tasks on multiple cognitive processes (Henry & Beatty, 2006). 
Studies comparing the cognitive profile of MS to subcortical disorders such as Parkinson’s 
disease and Huntington’s disease, and cortical disorders such as Alzheimer’s disease have 
demonstrated that MS patients do not resemble any of these dementia syndromes (Beatty, 
Goodkin, Monson & Beatty, 1990). Indeed, cognitive impairments in MS have been 
associated with both white matter pathology and grey matter atrophy (Filippi et al., 2010), 
leading some investigators to postulate that MS is best described in terms of a “multiple 
disconnection syndrome” in which more than one cognitive domain can be interrupted 
(Calabrese & Penner, 2007; Dineen et al., 2009).  
 
1.11 Aims 
1.11.1 Aim 1 
The current study sought to investigate whether cognitive impairments in ALS and MS 
patients are characterised by slowed processing speed or deficits in executive functioning. 
 
1.11.2 Design – neuropsychological and experimental assessment  
A cross-sectional design was employed in which ALS patients, MS patients, and age and 
education matched healthy controls were recruited for cognitive assessment. Participants 
were administered several experimental tests that were specifically developed to be sensitive 
to executive dysfunction and processing speed in motor degenerative disorders: 
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Executive functioning  
 Dual Task: Participants were required to complete two cognitive tasks, first 
independently, and then at the same time.  
Processing speed  
 Visual Inspection Time (VIT): Participants were required to make a forced-choice 
decision about an abstract visual stimulus – the duration of the stimulus was 
manipulated to investigate processing speed. 
 Rapid Serial Letter Identification (RSLI): Participants were required to identify a 
target letter from a stream of distracter letters. The durations of the letter stimuli 
were manipulated to investigate processing speed.     
In addition to the experimental tasks, neuropsychological tests that have been shown to be 
sensitive to ALS cognitive impairment were included to assess the domains of executive 
functioning, language, working memory, and verbal memory. 
 
1.11.3 Justification of design, part 1 
Dual Task: Executive functioning was investigated by way of a dual task which required 
participants to perform two tasks concurrently. The only previous study of dual tasking in 
ALS patients utilised reaction time as the outcome measure (Schreiber et al., 2005) and 
previous investigations of dual tasking in MS have typically included a motor task as one of 
the component tasks (D’Esposito et al., 1996; Stoquart-Elsankari et al., 2010). Such studies 
have suggested that there is a correlation between dual task performance and processing 
speed measures, however the effect of processing speed (independent of motor functioning) 
on dual tasking has not been directly investigated.  The current study employed a dual task 
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which utilized a processing speed task and a working memory task as its sub-components, 
and had minimal demands on the motor system. Similar paradigms have been used to 
investigate dual task abilities across the lifespan (Cocchini, Logie, Della Sala, MacPherson 
& Baddeley, 2002; Anderson, Bucks, Bayliss & Della Sala, 2011), and allow processing 
speed and working memory to be investigated independently and under dual task conditions. 
 
VIT task: Processing speed is inherently difficult to measure in populations with motor 
dysfunction due to the reliance of most tasks on timed motor responses, or reaction times 
(e.g. Digit-Symbol Substitution Test, Wechsler, 1981; Digit-Digit task, Salthouse, 1994). 
Thus, the current investigation employed tasks that do not utilize reaction time as their 
output measure, and place minimal demands on the motor system. Inspection Time 
paradigms have been used  previously to investigate processing speed for abstract visual 
stimuli in cognitive ageing and Parkinson’s disease (Edmonds et al., 2008; Johnson et 
al.,2004), and can be measured in terms of accuracy instead of reaction time, making them 
appropriate for use in ALS and MS patients. 
 
RSLI task: Rapid Serial Visual Presentation (RSVP) paradigms have been consistently used 
as a measure of perceptual speed and to understand the temporal resolution of human vision 
under a variety of conditions (Schneider & Shiffrin, 1977; Broadbent & Broadbent, 1987). 
Processing speed for meaningful stimuli such as letter characters is well characterized and 
known to be faster than that of other stimuli such as faces (Nasanen, Ojanpaa, Tanskanen & 
Paallysaho, 2006). The current study adapted an RSVP paradigm to make the outcome 
measure accuracy rather than reaction time to investigate whether letter identification was 




Background Neuropsychological Testing: Impairments in tests of executive functioning are 
the most commonly reported cognitive deficit in ALS (Ringholz et al., 2005), therefore the 
current study employed two standardised tests of executive functioning (verbal fluency and 
card sorting) that have been shown by previous studies to be sensitive in this disorder (e.g. 
Abrahams et al., 2000; Abrahams et al., 1997). Language impairment in ALS (e.g. Taylor et 
al., 2012) may affect performance in the tests of executive functioning as both tasks have a 
linguistic component, especially verbal fluency. As such a confrontation naming task, 
sensitive to ALS (Abrahams et al., 2004), was employed to assess language by the current 
study. Working memory was assessed with Digit and Spatial span procedures; impairments 
in ALS have been demonstrated with Reverse Digit Span (Rakowicz & Hodges, 1998) as 
well as other tests (Serial Digit Learning Test - Hanagasi et al., 2002). Memory impairment 
is being increasingly recognised in ALS (Raaphorst et al., 2010), although it is still unclear 
whether it is secondary to an executive deficit. The current study employed the Logical 
Memory subtest of Wechsler Memory Scale III which has been shown by others to be 
sensitive to verbal memory deficits in ALS (e.g. Phukan et al., 2012) and allows distinctions 
to be made between encoding, retrieval, and recognition processes.  
 
1.11.4 Aim 2 
The current study also sought to elucidate the neural correlates of any observed cognitive 
impairments in ALS patients, and more specifically, to determine whether white matter 





1.11.5 Design – structural imaging 
The primary focus of the current investigation was white matter integrity as measured by 
diffusion tensor imaging (DTI). A hierarchical approach was adopted with regard to the 
complexity of the DTI techniques employed; a semi-automated Regions of Interest (ROI) 
protocol was employed initially which required minimal pre-processing and derived values 
from each subject’s native images. The second technique employed was Tract Based Spatial 
Statistics (TBSS) from the Oxford centre for Functional MRI of the Brain Software Library 
(FSL). TBSS is a fully automated whole-brain protocol which registers all subjects onto a 
standard template and makes group comparisons and correlations on the derived “average” 
image.  In addition to the DTI parameters, T1 data was used to perform volumetric whole-
brain analyses of grey matter. Each imaging parameter was correlated with scores on 
cognitive tasks in an effort to determine whether relationships exist between regional white 
matter integrity and performance in different cognitive tests. 
 
1.11.6 Justification of design, part 2 
Previous studies have highlighted several non-motor white matter regions which may 
underpin impairment in verbal fluency (Abrahams et al., 2005) and other cognitive 
functions (Sarro et al., 2011), suggesting that pathology in different white matter structures 
may affect different cognitive processes. However, correlations between structural imaging 
measures and cognitive data have rarely been undertaken in ALS, and have never been 
investigated in respect to processing speed and dual task paradigms. The current study 
aimed to address this issue by correlating cognitive performance in the ALS group with the 
parameters expressed by several brain imaging techniques. DTI allows inferences to be 
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made regarding the structural integrity of white matter by way of parameters which are 
functions of the flow of water within axons; fractional anisotrophy (FA) -  the coherence of 
water molecule movement, and mean diffusivity (D) -  the degree of water diffusion across 
axons. This methodology has been shown to be effective in identifying structural changes in 
motor and non-motor areas in ALS (Ciccarelli et al., 2009; Agosta et al., 2010; Canu et al., 
2011; Prudlo et al., 2012). The aim of the hierarchical approach was to deduce whether any 
of the methods had increased sensitivity to white matter pathology in ALS, as well as 
investigates the degree of consistency – and therefore robustness – within the different 
methodologies. Volumetric analyses of grey matter parameters were carried out to 
determine the extent to which grey matter changes corresponded to any observed white 
matter abnormalities.  
 
1.12 Hypotheses 
Different behavioural and structural predictions arise when considering whether cognitive 
impairments in ALS and MS are a manifestation of an underlying processing speed deficit, 
or executive dysfunction. As such, a strong inference approach was employed to develop the 
following differential hypotheses: 
If a core processing speed deficit is responsible for cognitive impairment it is predicted that, 
relative to healthy controls: 
1. Patients will exhibit impairments in the experimental processing speed measures. 
2. With regard to the dual tasks, patients will exhibit worse performance than controls 




3. ALS patients will show reduced structural integrity in diffuse white matter regions 
and tracts. 
4. Correlations will exist between processing speed tasks and diffuse white matter 
regions whereby poor performance is associated with reduced structural integrity. 
 
If executive dysfunction is responsible for cognitive impairment it is predicted that, relative 
to controls: 
1. Patients will exhibit impairments in background measures of executive functioning. 
2. With regard to the dual task, patients will exhibit comparable performance to 
controls in the Visual Inspection Time component under single task conditions, but 
show a disproportionate performance decrement under dual task conditions. 
3. ALS patients will show reduced structural integrity/volume in predominantly 
frontotemporal regions and tracts. 
4. Correlations will exist between tests of executive functioning and specific 









Chapter 2. Participant characteristics 
This chapter addresses participant recruitment and details the clinical and 
neuropsychological tests that were employed in the assessment of ALS, MS, and healthy 
control participants. In addition, comparative analyses of demographic data and standardised 
neuropsychological tests are presented for a) a two-way comparison between ALS patients 
and healthy controls, and b) a three-way comparison between a subset of ALS patients, MS 
patients, and healthy controls. 
 
2.1 Ethics 
The current study was reviewed by several NHS and university ethical committees. The 
application for the cognitive assessment of ALS and MS patients titled “Executive 
dysfunction or slowed-information-processing speed in motor disorders; a comparative 
study” gained a favourable opinion from the South East Scotland Research Ethics 
Committee (REC reference: 11/AL/0369). The magnetic resonance imaging of ALS patients 
was submitted as a substantial amendment to an on-going study with the following title; 
“The heterogeneity of cognitive impairment in Motor Neurone Disease” (REC reference: 
08/MRE00/50) which was given a favourable opinion by the Scotland A Research Ethics 
Committee. In addition, the cognitive assessment of healthy controls in university premises 
was reviewed and given favourable opinion by the University of Edinburgh PPLS Ethics 
Committee (Title: “Processing speed and dual task ability in younger and older adults”, 
reference number: 148-0910). For copies of the letters of favourable opinion and Participant 




2.2 Participant recruitment 
2.2.1 ALS patients 
Thirty people with Amyotrophic Lateral Sclerosis (26 sporadic, 4 familial) were recruited 
from regional ALS services at the following NHS sites; Western General Hospital, 
Edinburgh, Southern General Hospital, Glasgow, and Ninewells Hospital, Dundee. 
Prospective patients were identified by the site relevant consultant neurologist or ALS 
specialist nurse. An invitation letter was then sent which included a Participant Information 
Sheet – patients were then able to contact the study team directly to express an interest in 
participating. In an effort to exclude patients with potentially confounding conditions, and in 
accordance with the NHS ethics applications, prospective patients’ gave consent for their 
medical notes to be made available to the research team. All ALS patients met the following 
inclusion criteria: 
 Clinical and electrophysiological evidence of combined upper and lower motor 
neurone involvement. 
 Fulfilled the revised El Escorial criteria for clinically definite or probable ALS 
(Brooks, Miller, Swash, & Munsat, 2000).  
In addition, the following exclusion criteria were applied: 
 Mental or physical incapacity to give informed consent. 
 Severe disability which would prevent a participant from physically undertaking the 
tests. 
 History of and/or current illnesses which are known to affect cognitive functioning: 
1. Significant longstanding psychiatric illness, or alcohol/substance related 
disorders 
2. Significant trauma, e.g. stroke, head injury 
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3. Coexisting neurological condition e.g. Parkinson's Disease 
4. Participants with known and established ophthalmological disease (not 
optic neuritis) 
 High cardiovascular risk factors. 
 Forced Vital Capacity (FVC) of less than 70% of predicted value based on age and 
height (Rollings, 1984). 
 Participants older than 80 years and younger than 18 years of age. 
 
Unfortunately, one patient had to be excluded from the final analyses after cognitive 
assessment and evaluation of MRI data revealed that he met the inclusion criteria for 
probable Frontotemporal Dementia (Rascovsky et al., 2011). Of the remaining twenty-nine 
patients, nine patients had bulbar disease onset, eleven had upper limb onset, and nine had 
lower limb onset. Twenty-five of the patients had sporadic ALS whilst four patients had a 
familial history of probable ALS in a 1
st
 degree relative and were thus classified as familial 
cases. Detailed patient demographics are described later in section 2.4. 
 
2.2.2 MS patients 
Twenty-five MS patients were recruited from the Royal Infirmary of Edinburgh. 
Prospective patients were identified by a consultant neurologist or MS specialist nurse. An 
invitation letter was then sent to these patients which included a Participant Information 
Sheet containing details of the study – patients were then able to contact the study team 
directly to express an interest in participating. As with the ALS patients, prospective MS 
patients gave consent for their medical notes to be accessed by the study team. All MS 
patients met the following inclusion criteria: 
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 A diagnosis of MS based on revised MacDonald's criteria (Polman et al., 2005). 
 Capacity to give consent. 
The same exclusion criteria as for ALS patients were applied to MS patients (listed above). 
No MS patients had to be excluded from the study. Of the twenty-five MS patients, 8 were 
diagnosed as Relapsing-Remitting, 8 as Primary Progressive, and 9 as Secondary 
Progressive. Detailed patient demographics are described later in section 2.4 and Table 3.  
 
2.2.3 Healthy controls 
In total, thirty-eight healthy controls (HC) were recruited for the current study. Thirty-one 
were recruited from the University of Edinburgh Psychology department’s Volunteer 
Participant Panel, and a further seven were the spouses of participating patients. All control 
participants had normal hearing and normal or corrected to normal vision, and did not have 
any history of neurological problems, major medical or psychiatric illness, or learning 
disability. Several controls took medication to regulate blood pressure, but none were on 
any form of medication that could affect their cognitive performance. All control 
participants were tested at the university, and received 6 pounds per hour reimbursement for 
their time spent testing. Healthy controls were divided into two overlapping subgroups on 
the basis of matching age and education to the respective ALS and MS patient groups. Thus, 
thirty healthy controls were assigned to the ALS control group and twenty-five healthy 






2.3 Background and neuropsychological testing 
2.3.1 ALS specific assessment 
ALS Functional Rating Scale-Revised (ALSFRS-R; Cedarbaum et al., 1999)  
The ALSFRS-R was employed to assess disease progression and severity. It is a 
questionnaire comprising of 12 multiple-choice questions each assessing a different domain 
of daily functioning such as speech, ambulation, dressing and hygiene, and breathing. The 
separate domains allow the clinician to identify areas of specific weakness, while the total 
score reflects overall disease progression and severity. A measure of disease progression 
rate was also derived by the following formula: 
 
ALSFRS-R maximum score (48) – current ALSFRS-R score 
                      Disease duration in months 
 
 
Epworth Sleepiness Scale (ESS; Johns, 1991)  
The ESS was employed to measure the degree and impact of respiratory symptoms and 
daytime sleepiness. It is a simple multiple-choice questionnaire that assesses the likelihood 
of falling asleep under various everyday situations. All patients had scores within the 





2.3.2 MS specific assessment 
Expanded Disability Status Scale (EDSS; Kurtzke, 1983) and the Multiple Sclerosis Impact 
Scale 29 (MSIS29; Hobart, Lamping, Fitzpatrick, Riazi & Thompson, 2001) were employed 
to assess disease progression, severity and impact. 
 
2.3.3 Premorbid functioning 
Wechsler Test of Adult Reading (WTAR; Wechsler, 2001)  
The WTAR was employed as a measure of pre-morbid intelligence.  It correlates very 
highly with standard intelligence measures such as the Wechsler Adult Intelligence Scale – 
Revised (WAIS-R), and is comprised of a list of 50 irregularly pronounced words of 
increasing difficulty. Participants are instructed to read the words aloud, and the number of 
errors is recorded and converted into an Intelligence Quotient (IQ) score.   
 
2.3.4 Mood 
Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983)  
The HADS was employed to screen for anxiety and depression. It is a self-report assessment 
of mood and emotional state comprising of questions with multiple choice answers that are 
designed to be differentially sensitive to anxiety (HADS A score) and depression (HADS D 
score). However, in line with the procedure described in Abrahams et al. (1997, 2000),  the 
question “I feel as if I am slowed down” has exaggerated salience to ALS patients who 




2.3.5 Neuropsychological assessment  
Graded Naming Test (GNT; McKenna & Warrington, 1983) 
The GNT was employed as a test of confrontation naming and was included in the battery to 
assess word finding abilities which could potentially contribute to verbal fluency 
performance. The test has been shown to be sensitive to language impairment in ALS 
(Abrahams et al., 2004; Wicks et al., 2008), and comprises of 30 line drawings of 
uncommon words that increase in difficulty. Participants are asked to name the drawings, 
and the number of errors was recorded.  
 
Digit Span (adapted from the Wechsler Memory Scale III; Wechsler, 1997)  
An adapted version of The Digit Span subtest of the WMS III was employed to assess 
verbal working memory. Similar tasks have revealed impairments in ALS patients (Bartels 
et al., 2008; Hammer et al., 2011; Lillo et al., 2012). 
Forward Digit Span: Participants are read a sequence of digits and asked to immediately 
recall them.  
Reverse Digit Span: In this condition participants are again read a sequence of digits, 
however, they are required to recall the sequence in reverse order. This condition requires 
more manipulation of the to-be-recalled sequence and is therefore thought to be a better 
reflection of working memory ability.   
In both conditions the number of digits in each sequence is increased systematically until 
the participant can no longer recall the sequence accurately in 2 out of 3 attempts. All digit 
sequences were recorded previously and played back to participant via laptop speakers. In 




Spatial Span (adapted from the WMS III, Wechsler, 1997)  
An adapted version of the Spatial Span subtest of the WMS III was employed to assess 
spatial working memory. 
Forward Spatial Span: Participants are shown a random sequence of spatial locations on a 
board containing 10 raised blocks – they are asked to immediately recall the sequence by 
touching the blocks in the same order in which they were presented. 
Reverse Spatial Span: In this condition, participants are again shown a random sequence of 
spatial locations on the board, however, they are required to recall the sequence in reverse 
order. This condition requires more manipulation of the to-be-recalled sequence and is 
therefore thought to be a better reflection of working memory ability.   
In both conditions the number of spatial locations in each sequence is increased 
systematically until the participant can no longer recall the sequence accurately in 2 out of 3 
attempts. All spatial locations were presented at a rate of approx. 1 per second.  
 
Logical Memory (Wechsler Memory Scale III, Wechsler, 1999) 
The Logical Memory subtest of the WMS III was employed to assess immediate and 
delayed recall of verbal information and has been shown to be sensitive to memory 




Immediate recall condition: Participants are read a short story and instructed to retain as 
much information as possible for immediate recall. This stage is then repeated with a 
different short story. The number of correctly recalled items for both stories is recorded.  
Delayed recall condition: After a delay of approximately 25 minutes participants are asked 
to recall both stories again (they are made aware of this delayed condition). Again, the 
number of correctly recalled items for both stories is recorded.  
Delayed recognition condition: After the delayed condition, participants are asked a series 
of forced choice (yes or no) questions about each story and the number of correct answers is 
recorded. Correct responses in each condition for the two stories are combined and 
converted into scaled immediate, delayed, and recognition score. 
Retention: In addition to the standardised parameter of the logical memory task, the current 
study reported the proportion of information retained in delayed recall condition compared 
to the immediate recall condition. The proportion was expressed as a percentage using the 
following formula: 
Retention = Delayed Recall Score    x         100 
                    Immediate Recall Score 
 
Brixton Spatial Anticipation Test (Burgess & Shallice, 1997) 
The Brixton test was employed as a measure of executive functioning and assesses inductive 
reasoning, set-shifting ability and working memory. It has shown to be sensitive to left-
lateral frontal dysfunction (Reverberi et al., 2005), and a recent study has demonstrated that 
ALS patients can also show impairments in this measure (Taylor et al., 2012). The Brixton 
spatial anticipation test comprises a booklet in which each page shows an array of ten 
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circles, split into two rows of five. One circle in each page is coloured blue, and as the pages 
progress, the blue circle moves location in a logical pattern. The participant is shown a page 
and asked to predict where the blue circle will be on the subsequent page. Patterns are 
always evident in the test, however, the patterns change without warning, requiring 
participants to learn the new pattern quickly and adapt their predictions accordingly. Errors 
in predictions were tallied and converted into a scaled score.  
 
Sorting Test (Delis-Kaplan executive functions system; Delis, Kaplan & Kramer, 2001) 
The Sorting Test subtest of the D-KEFS was employed as a measure of concept-formation, 
modality-specific problem-solving (verbal/nonverbal), and the ability to explain sorting 
concepts abstractly. The Sorting Test has been shown to be sensitive to left frontal lesions 
(Fine et al., 2009), and has been shown to be sensitive to executive dysfunction in ALS and 
MS (Taylor et al., 2012; Parmenter et al., 2007). Participants are presented with 6 practice 
cards and instructed that the cards can be sorted into 2 groups of 3 based on a rule that will 
link the cards in each group. Rules can be based on verbal cues such as the meanings of the 
words written on the cards, or non-verbal cues such as the size and shape of the cards. An 
example of each is shown. Participants are then presented with 2 sets of different cards and 
asked to sort them in as many ways as possible. Each time a sort is made, participants are 
required to explain the rule. The number of correct sorts and rule explanations made is 
tallied for each set of cards and converted into a scaled score. In addition, participants are 
subsequently presented with cards already arranged into categories and asked to recognise 
the sorting rule – those which they previously produced themselves and any others they may 
have missed.  Three scores were recorded for the purpose of the current investigation; the 




Verbal Fluency (Abrahams et al., 1996; Abrahams et al., 2000) 
Spoken and written phonemic fluency tests were employed to assess intrinsic response 
generation, strategy formation and monitoring. Phonemic fluency tests have been shown to 
be highly sensitive to patients with frontal lobe damage (Baldo, Schwartz, Wilkins & 
Dronkers, 2006), and are the most sensitive test of cognitive dysfunction in ALS (Phukan et 
al., 2012).  
Spoken Letter Fluency Test: The spoken fluency task was adapted from Benton and de 
Hamsher’s (1983) Controlled Word Association Test (COWAT). Participants are instructed 
to generate as many words as possible beginning with a specified letter in a 60 second time 
period. Three conditions are employed with the letters “P”, “R”, and “W” used respectively. 
Words beginning with the given letters occur in different frequencies in the English 
language; words beginning with “P” have the highest frequency, those beginning with “R” 
have a lower frequency, and those with “W” have the lowest frequency. Thus, the respective 
letter conditions require increasing cognitive demand as the word frequencies decrease. In 
addition, a measure of total “PRW” output was calculated by adding the individual letter 
conditions together.  
Written Letter Fluency Test: The written fluency task was adapted from Thurstone and 
Thurstone’s (1962) written fluency test. Two conditions were employed in the written 
fluency test; in the first participants are instructed to write down as many words as possible 
beginning with the letter “S” in 5 minutes. In the second condition, participants are 
instructed to write down as many words as possible beginning with “C” in 4 minutes, 
however, the words produced had to contain only 4 letters. The “C4” condition is more 
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executively demanding as it requires highly constrained search conditions and imposes 
greater demands on inhibition.  
Fluency Procedure: In all fluency tasks, participants are instructed to avoid using people’s 
names, place names, or plurals of a previously generated word (e.g. “peach, peaches”), and 
to avoid producing different endings of the same root word (e.g. “pot, potted, potter, 
potting”). As such, any examples of these were marked as errors. Perseverations (using the 
same word twice) were also considered errors. The fluency tasks were scored in terms of the 
number of correct words generated for each condition. 
Fluency Index: Fluency tasks are essentially time based and involve a motor response 
(either spoken or written), and as such they will be affected by slowed motor functioning 
evident in ALS and MS. To control for this issue, the current study employed a Fluency 
Index (fi), as devised by Abrahams et al. (2000). Each fluency task employed a generation 
condition (as described above), and a motor control condition in which participants read 
aloud or copied the words they generated previously. This procedure provided a measure of 
the same motor responses required in the generation conditions, but without the cognitive 
requirements of each task. Thus, indices of the average time to think of a word could be 
calculated that were independent of motor functioning; fi’s were calculated as follows; 
 
Fluency Index (fi)   =   Total Generation Time – Control Copy/Read Time   




Errors (perseverations and any words which broke the fluency rules) were excluded from 
the fi calculations. Separate fi’s were calculated for each fluency condition as well as an 
average for all the letters combined. 
 
2.3.6 Statistical analyses 
The data were explored for normal distribution using histograms, boxplots and the Shapiro-
Wilk’s test of normality. In addition, all variables were checked for homogeneity of 
variance. Not all ALS and MS patients completed all of the tasks (see Tables 1 – 4 for exact 
participant numbers); some patients were unable to complete some tests due the inability to 
speak or to write, and others did not complete all tests due to fatigue or time pressures. One 
healthy control was unable to complete all the background neuropsychological tests due to 
time constraints. In addition, the DKEFS Sorting Test was added to the assessment battery 
midway through data collection and therefore data is only available in a subset of the ALS 
and Healthy control groups (see Table 3 for exact participant numbers).  
 
In the two-way analysis between ALS patients and healthy controls, comparative group 
analyses of demographic and cognitive data were performed using t-tests in normally 
distributed data and Mann-Whitney U tests in populations that were not normally 
distributed. Chi-Square tests were employed for categorical variables. In the ALS group, 
case analyses were also employed in which standardised scores (Z-scores) for individual 
ALS patients were derived from the mean and standard deviation of the healthy control 
group. In cases where statistical significance was marginally missed, measures of effect size 




In the three-way analysis between ALS patients, MS patients, and healthy controls, 
comparative group analyses were performed using one-way ANOVAs in normally 
distributed data and Kruskal-Wallis tests in populations that were not normally distributed. 
In parametric data planned post-hoc group comparisons with Tukey’s HSD or Games-
Howell corrections (for unequal variances) are reported for any variables in which there 
were significant group differences. In non-parametric data, Kruskal-Wallis post-hoc 
comparisons corrected for family wise errors are reported for any variables in which there 
was a significant group effect. Chi Square tests were employed for categorical variables. In 
cases where statistical significance was marginally missed, measures of effect size are 
provided by Cohen’s d. Associations between performance in neuropsychological tests and 
age were performed in the ALS group. Associations between performance in 
neuropsychological tests and mood were investigated in the MS patients. Spearman’s rho 
correlations were employed to investigate all associations as age and mood data were found 
to be non-parametric and covariate analyses were performed using Quade’s Rank ANCOVA 
(Quade, 1967). Quade’s Rank ANCOVA is a procedure where by the dependent variable 
and covariate of interest are first transformed by rank and then entered into a regression 
analysis. The unstandardized residual values of the regression are subsequently used in a 
standard one-way ANOVA. 
 
2.4 ALS patients versus healthy controls 
2.4.1 Demographic and mood data 
Participant’s demographic data are detailed in Table 3. There were no significant differences 
between groups in terms of age, gender, or premorbid IQ as assessed by the WTAR, 
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indicating that ALS patients and healthy controls were well matched.  In addition, there was 
no difference between groups in self-reported levels of anxiety and depression. The ALS 
cohort was relatively heterogeneous in terms of disease duration, severity, and onset site, 
suggesting that the sample was not skewed toward a certain phenotype of ALS.  
 
Table 3. Demographic data for ALS patients and healthy controls 
 n 
(ALS:HC) 




Age (years) 29:30 58.3 (28 – 79)  59.1 (34 – 79)  -0.264  0.793  
Gender (M:F) 29:30 16:13 17:13 0.013 (X²) 0.908 
WTAR IQ  27:30 104.0 (81 – 123)  108.4 (87 – 124)  -1.524 0.133  
HADS A  29:30 7 (0 – 19)  5.4 (0 – 14)  -1.112 (U) 0.266  
HADS D  29:30 3 (0 – 9)  3.1 (0 – 10)  0.016 (U) 0.988  
Disease Dur. 
(months)  
28 24 (5 – 88)  ---------------  ------------ --------- 
ALSFRS  28 38.6 (21 – 47)  ---------------  ------------ --------- 
FVC (% Pred) 29 103.9 (70.2 – 175.6) ---------------  ------------ --------- 
Mean values with ranges in parentheses are presented. Ratios are presented for number of patients 
versus controls in each task and for group gender breakdown. WTAR = Wechsler Test of Adult 
Reading, HADS A = Hospital Anxiety and Depression Scale - Anxiety, HADS D = Hospital Anxiety 
and Depression Scale – Depression, ALSFRS = Amyotrophic Lateral Sclerosis Functional Rating 
Scale, FVC = Forced Vital Capacity, M = male, F = female, Dur. = duration, Pred = predicted. 
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2.4.2 Neuropsychological data 
Group comparisons in the background neuropsychological tests are detailed in Table 4. ALS 
patients and controls performed comparably in terms of confrontation naming as assessed 
by the GNT. In terms of short-term memory and working memory, no significant 
differences were observed in the Spatial Span measures, however, ALS patients were 
impaired relative to healthy controls in both the forward and reverse measures of Digit 
Span. Moreover, ALS patients were impaired relative to controls in the Immediate, Delayed, 
Delayed Recognition, and Retention conditions of the Logical Memory task. In terms of 
executive functioning, ALS patient and controls performed comparably in the Brixton 
Spatial Anticipation Test, however, patients were impaired relative to controls in all 
conditions of the D-KEFS Sorting Test as well as the Spoken Letter Fluency Test (fi). ALS 
patients also appeared to perform worse than controls in the Written Letter Fluency Test (fi). 
However, despite a medium effect size, there was only a trend towards significance in these 
data. Therefore a breakdown of performance in each condition is provided in Table 5; 
although patients had longer fluency indices in both letter conditions, neither difference was 





Table 4. Background neuropsychological test data for ALS patients and healthy controls* 
 n 
(ALS:HC) 
ALS  HC t or U  P value  
Graded Naming Test 26:29 23.8 [4.1] 25.0 [3.4] 1.077 (U) 0.282 
Forward Spatial Span 27:30 5.7 [1.1] 5.5 [0.9] -0.615 (U)  0.539 
Reverse Spatial Span 27:30 4.9 [1.2]  4.7 [1.1] -0.391 (U) 0.696 
Forward Digit Span 27:29 6.8 [1.2] 7.4 [1.0] 2.078 (U) 0.038 
Reverse Digit Span 27:29 5.0 [1.0] 5.6 [1.2] 2.084 (U)  0.037 
Log. Memory Imm. 28:30 23.8 [6.7] 27.8 [7.9] -2.122  0.038 
Log. Memory Del. 28:30 18.9 [6.7] 24.7 [8.1] -2.964  0.004 
Log. Memory Rec. 29:30 24.8 [2.6] 26.3 [2.8] 2.181 (U) 0.029 
Log. Memory Ret. 28:30 78.7 [18.1] 87.2 [11.1] 2.172 (U) 0.030 
Brixton (Errors) 27:30 16.8 [7.8] 14.5 [7.4] -1.355 (U) 0.175 
Brixton (scaled) 27:30 5.7 [2.4] 6.5 [2.3] -1.309 (U) 0.190 
Sorting Test 
(no. of sorts) 
15:17 9.8 [1.7] 11.4 [1.8] -2.591 0.015 
Sorting Test 
(Recog) 
15:17 42.2 [9.6] 50.6 [7.9] -2.715 0.011 
Sorting Test  
(scaled score) 
15:17 12.1 [2.2] 13.8 [1.5] -2.671 0.012 
Spoken Letter Fluency 
Test (fi) 
28:30 4.5 [2.0] 3.2 [1.0] -2.894 (U) 0.004 
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Written Letter Fluency 
Test (fi) 
16:30 9.5 [4.6] 7.4 [3.8] -1.730 (U) 0.084 
(d= 0.50) 
Mean values with standard deviations in parentheses are presented. * Significant results are 
highlighted in bold. Ratios are presented for number of patients versus controls in each task. GNT = 
Graded Naming Test, Fwd = Forward, Rev. = Reverse, Log. = Logical, Imm. = Immediate recall, 
Del. = Delayed recall, Rec. = Recognition, Ret. = Retention, fi = fluency index, No. of sorts = 
number of correctly identified sorts in the DKEFS Sorting test, Recog = score in the recognition 
condition of the DKEFS Sorting test. 
 
Table 5. Letter condition performance in the Written Letter Fluency Test for ALS patients 
and healthy controls 
 n (ALS:HC) ALS  HC t or U  P value  
“S” condition  (fi) 16:30 4.7 [1.6] 4.0 [1.9] 1.397 0.169 
“C4” condition (fi) 16:30 14.3 [8.4] 10.9 [6.0] -1.626 (U) 0.104 
“S” = generation condition of words beginning with S, “C4” = generation condition with words 
beginning with C and containing exactly 4 letters, fi = fluency index. 
 
2.5 ALS case analyses 
Z-scores describing each ALS patients’ performance relative to the healthy control group 
mean were derived for each cognitive measure. According to the consensus criteria 
suggested by Strong et al. (2009), patients with cognitive impairment (ALSci) were 
classified as those exhibiting performance at or below the 5
th
 percentile of the control group 
mean in at least 2 tests sensitive to executive dysfunction. Tests employed by the current 
study meeting this criterion were the spoken and written letter fluency indices, D-KEFS 
sorting test, the Brixton Spatial Anticipation Test, and reverse digit span. In addition, based 
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on the method employed by Phukan et al. (2012), patients with cognitive impairments in 
non-executive domains were also identified. Patients with memory impairment were 
classified as those with z-scores at or below the 5
th
 percentile (≤ 1.65) of the control mean in 
at least 2 of the following measures; logical memory immediate recall, logical memory 
delayed recall, logical memory recognition, and logical memory retention. Patients with 
language impairment were classified as those with z-scores at or below the 5
th
 percentile of 
the control mean in the GNT.  Patients with non-executive impairments were identified as 
those with impairments in memory and/or language domains, in the absence of executive 
impairment. Case analyses revealed that 7 patients met the criteria for ALSci, whilst 4 met 
the criteria for memory impairment, and 4 met criteria for language impairment. The 
Spoken Letter Fluency Test was the most sensitive task with 8/29 patients meeting the 
criteria for impairment. Of the patients with memory and language impairments, 2 did not 
present with co-occurring executive dysfunction and could thus be classified as having non-
executive impairment.  Of these patients, one presented with memory impairment, and one 
with language impairment.    
 
2.6 ALS patients versus MS patients versus healthy controls 
2.6.1 Participants 
MS and healthy control participants are identical to those described previously in Section 
2.2.2, and 2.2.3 respectively. ALS patients were also the same as those described in 
previously (Section 2.2.1), except that the four oldest participants were excluded from the 
following analyses in an effort to match the groups as well as possible in terms of age whilst 




2.6.2 Demographic and mood data 
Details of participants’ age, intelligence, and mood are displayed in Table 6. Comparative 
analyses revealed significant group differences in age; H (2) = 13.50, p = 0.001. Post-hoc 
analyses showed that ALS patients were significantly older than MS patients (p =0 .001) but 
not healthy controls (p = 0.060, d = 0.59), and there was no difference between MS patients 
and healthy controls (p = 0.585). A Chi-Square analysis revealed that there was no 
difference in the gender split between the groups; X² (2) = 0.962, p = 0.618. No significant 
group differences in WTAR IQ were observed; F (2, 70) = 1.297, p = 0.280, indicating that 
the groups were well matched in terms of premorbid intelligence. Significant group 
differences were observed for the depression index of the HADS; H (2) = 6.05, p = 0.049. 
However post-hoc analyses corrected for multiple comparisons showed only a trend towards 
significance in comparisons between MS patients and healthy controls (p = 0.059, d = 0.70). 
There was no significant difference in HADS D scores between MS and ALS patients or 
between ALS patients and healthy controls. No significant group differences were observed 










Table 6. Demographic data for ALS patients, MS patients, and healthy controls 
 n 
(ALS:MS:HC) 
ALS MS HC 
Age 25:25:25 55.5 (28 – 67) 47.6 (36 – 61) 50.1 (34 – 62) 
Gender (M:F) 25:25:25 14:11 11:14 14:11 
WTAR IQ 23:25:25 102.7 (81 – 120) 101.8 (74 – 125) 106.8 (87 – 124) 
HADS A 25:25:25 7.6 (0 – 19) 6.9 (0 – 12) 5.6 (0 – 14) 
HADS D 25:25:25 3.3 (0 – 9) 5.4 (0 – 13) 3.0 (0 – 10) 
ALSFRS-R 25:0:0 38.4 (21 – 46)  ------------- ------------- 
FVC (% Pred) 25:0:0 97.5 (70.2 – 152.6) ------------- ------------- 
Disease Dur. 
(months)  
25:25:0 23.3 (5 – 88) 124.3 (24 – 336) ------------- 
EDSS  0:25:0 ------------- 5.3 (1 – 8) ------------- 
MSIS-29 0:25:0 ------------- 87.9 (40 – 132)  ------------- 
Mean values with ranges in parentheses are presented. M = male, F = female, WTAR = Wechsler 
Test of Adult Reading, HADS A = Hospital Anxiety and Depression Scale Anxiety score, HADS D = 
Hospital Anxiety and Depression Scale Depression score, ALSFRS = Amyotrophic Lateral Sclerosis 
Functional Rating Scale, FVC = Forced Vital Capacity, EDSS = Expanded Disability Status Scale, 







2.6.3 Neuropsychological data 
Group data for the background neuropsychological tests are detailed in Table 7. 
Comparative analyses revealed significant group differences in the GNT; H (2) = 6.500, p = 
0.039. Post-hoc analyses indicated that healthy controls had significantly higher scores than 
MS patients (p = 0.041) but not ALS patients, suggesting that only MS patients were 
impaired in confrontation naming. The comparison between ALS patients and MS patients 
was not significant.  
 
In terms of short-term memory and working memory, comparative analyses revealed 
significant group differences in Forward Digit Span; H (2) = 7.084, p = 0.029, as well as 
Reverse Digit Span; H (2) = 8.810, p = 0.012. Post-hoc analyses of Forward Digit Span 
showed only trends toward significance in comparisons between healthy controls and ALS 
patients (p = 0.076, d = 0.69) and MS patients (p = 0.056, d = 0.76) although effect sizes 
were medium-large in each case suggesting that the result may have been restricted by 
sample size. The comparison between ALS patients and MS patients was not significant. 
Post-hoc analyses of Reverse Digit Span indicated that healthy controls retained 
significantly more digits than ALS patients (p = 0.036) and MS patients (p = 0.028). Once 
again the comparison between ALS patients and MS patients was not significant. No 
significant group differences were found in Forward Spatial Span; H (2) = 4.417, p = 0.110, 
or Reverse Spatial Span; H (2) = 1.631, p = 0.442.  The results suggest that both ALS and 
MS patients showed the same pattern of selective impairment in Reverse Digit Span, with 




Impairments in both patient groups were also found in the Logical Memory Scales. 
Comparative analyses revealed significant group differences in the Immediate recall 
condition; H (2) = 9.050, p = 0.011, with post hoc analyses indicating that healthy controls 
recalled significantly more information than ALS patients p = (0.010) but not MS patients, 
suggesting that the ALS group had a selective impairment in immediate recall. The 
comparison between ALS patients and MS patients was not significant. Comparative 
analyses also revealed significant group differences in the Delayed recall condition; F (2, 
72) = 8.272, p = 0.001, with post-hoc analyses indicating that healthy controls recalled 
significantly more information than ALS patients (p = 0.001) and MS patients (p = 0.006), 
suggesting that both patient groups were impaired in this measure. The comparison between 
ALS and MS patients was not significant. A significant group effect was revealed in the 
Retention condition; H (2) = 8.745, p = 0.013, with post-hoc analyses indicating that healthy 
controls retained significantly more information than MS patients (p = 0.016), although only 
a trend was present between healthy controls and ALS patients (p = 0.076, d = 0.57), 
suggesting that MS patients may have had a selective retention deficit. The comparison 
between ALS and MS patients was not significant. Comparative analyses in the Recognition 
condition also revealed significant group differences; H (2) = 6.031, p = 0.049, however 
post-hoc analyses indicated that only the ALS group had significantly lower recognition 
scores than healthy controls (p = 0.045). Again the comparison between ALS and MS 
patients was not significant.      
 
In terms of executive functioning, no significant group differences were revealed in either 
the Brixton test scaled score; H (2) = 1.598, p = 0.450, or the number of errors made; H (2) 
= 1.685, p = 0.431. However, impairments in the patient groups were found in the D-KEFS 
sorting test. Significant group effects were revealed in terms of the number of sorts; F (2, 
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57) = 4.862, p = 0.011, with post-hoc comparisons indicating that healthy controls made 
significantly more sorts than ALS patients (p = 0.018) and MS patients (p = 0.041), 
although the comparison between ALS and MS patients was not significant. Similar 
significant group differences were found in the Recognition condition; F (2, 57) = 9.372, p = 
0.000, with post-hoc comparisons revealing that healthy controls had significantly higher 
recognition scores than ALS patients (p = 0.001) and MS patients (p = 0.003). Again, the 
comparison between ALS patients and MS patients was not significant. With regard to the 
Sorting Test scaled scores, comparative analyses revealed a significant group effect; F (2, 
57) = 4.743, p = 0.013, and post-hoc comparisons indicated that healthy controls had higher 
scores than MS patients (p = 0.012). Although only a trend was present between healthy 
controls and ALS patients (p = 0.099, d = 0.92), the large effect size observed suggested that 
this result may be due to a lack of statistical power. The comparison between ALS patients 
and MS patients was not significant. Finally, impairments in the patient groups were also 
observed in the fluency tests. Comparative analyses of the Spoken Letter Fluency Test (fi) 
revealed significant group effects; H (2) = 19.387, p = 0.000, with post-hoc comparisons 
indicating that healthy controls performed significantly better than ALS patients (p = 0.001) 
and MS patients (p = 0.000), although the comparison between ALS and MS patients was 
not significant. A significant group effect was also found in the Written Letter Fluency Test 
(fi); H (2) = 8.234, p = 0.016. However post-hoc comparisons indicated that only the MS 
group had significantly worse scores than healthy controls (p = 0.015). Again the 
comparison between ALS and MS patients was not significant. The results suggested that 
while both patient groups exhibited impaired letter fluency performance, only MS patients 










ALS  MS HC 
GNT 22:20:25 23.4 [4.2] 22.8 [3.6] 25.6 [2.5] 
For. Spatial Span 24:23:25 5.8 [1.2] 5.4 [0.9] 6.0 [1.1] 
Rev. Spatial Span 24:23:25 5.0 [1.2]  4.7 [0.9]  5.0 [1.1] 
For. Digit Span 23:25:25 6.8 [1.3] 6.8 [1.1] 7.6 [1.0] 
Rev. Digit Span 23:25:25 5.1 [1.0] 5.0 [1.3] 6.0 [1.4] 
Log Memory Imm. 24:24:25 23.8 [7.1] 26.1 [6.9] 30.2 [6.7] 
Log. Memory Del. 24:24:25 19.3 [7.0] 20.6 [8.0] 27.4 [7.5] 
Log. Memory Rec. 25:24:25 24.9 [2.6] 25.3 [3.2] 26.5 [2.7] 
Log. Memory Ret. 24:24:25 80.6 [18.7] 77.4 [20.0] 89.3 [10.9] 
Brixton (Errors) 23:23:25 16.1 [7.6] 13.0 [4.8] 14.9 [6.0] 
Brixton (scaled) 23:23:25 6.0 [2.4] 6.8 [1.7] 6.2 [1.9] 
Sorting Test 
(no. of sorts) 
13:25:20 9.8 [1.6] 10.2 [2.3] 11.8 [1.6] 
Sorting Test 
(Recog) 
13:25:20 41.9 [9.1] 44.8 [9.1] 53.4 [6.3] 
Sorting Test  
(scaled score) 




Fluency Test (fi) 
24:25:25 4.5 [2.1] 5.0 [2.3] 3.0 [0.9] 
Written Letter 
Fluency  Test (fi) 
14:14:25 9.5 [4.9] 11.1 [4.8] 6.9 [3.0] 
Mean values with standard deviations in parentheses are presented. Ratios are presented for number 
of patients versus controls in each task. GNT = Graded Naming Test, For. = forward, Rev. = reverse, 
Log. = Logical, Imm. = Immediate recall, Del. = Delayed recall, Rec. = Recognition, Ret. = 
Retention, fi = fluency index, No. of sorts = number of correctly identified sorts in the DKEFS 
Sorting test, Recog = score in the recognition condition of the DKEFS Sorting test. 
 
2.7 Correlations with age and depression 
Comparative analyses of age revealed that the average age of the ALS group was 
significantly higher than the MS group, although not healthy controls. Moreover, ALS 
patients had the largest age range of any of the participant groups indicating that any 
potential age effects would most likely exist within the ALS population. Thus, to further 
investigate the effect of age, correlational analyses were performed between age and all 
background variables in the ALS patient group.  Only significant correlations are reported. 
Age correlated significantly with GNT score; rho = 0.47, p = 0.029, Logical Memory 
Retention; rho = -0.42, p = 0.039, and the Sorting Test scaled score; rho = 0. 64, p = 0.019. 
The correlations suggested that while retention in the Logical Memory scales decreases with 
age, GNT performance Sorting Test performance increases with age in the ALS group. 
Therefore, the group effects in Logical Memory Retention, GNT, and Sorting Test scaled 




Quade’s Rank ANCOVA revealed significant group differences in Logical Memory 
Retention; F (2, 70) = 5.217, p = 0.008. Post-hoc comparisons indicated that MS patients 
had significantly lower scores than healthy controls (p = 0.006), however no significant 
differences were observed between ALS patients and healthy controls, or ALS and MS 
patients. The result suggested that the ALS group did not perform worse than the control 
group once age was accounted for. In terms of GNT performance, Quade’s Rank ANCOVA 
revealed significant group differences; F (2, 64) = 5.157, p = 0.008. Post-hoc comparisons 
showed that ALS patients named significantly fewer items than healthy controls (p = 0.009) 
but only a trend towards significance was observed between MS patients and healthy 
controls (p = 0.069, d = 0.90). There was no significant difference in GNT performance 
between ALS and MS patients. This result suggests that once age is accounted for ALS 
patients are in fact impaired relative to controls in the GNT whereas MS patients are not. 
However, it should be noted that a large effect size was present between MS patients and 
healthy controls in this data suggesting that group differences would have been significant 
in a slightly larger sample size. Finally, Quade’s Rank ANCOVA revealed significant group 
differences in the Sorting Test scaled scores; F (2, 55) = 3.891, p = 0.026. Post-hoc 
comparisons indicated that ALS patients had significantly lower scores than healthy controls 
(p = 0.039) whilst only a trend towards significance was present between MS patients and 
healthy controls (p = 0.072, d = 0.92) and there was no significant difference between ALS 
and MS patients. The results suggest that once age is accounted for ALS patients are 
impaired relative to controls in the terms of the Sorting Test scaled score. Although only a 
trend towards significance was observed between MS patients and controls, the presence of 




In addition, the significant effect of depression in the MS group was investigated by 
performing correlational analyses between HADS D scores and all background 
neuropsychological measures in the MS group. No significant relationships were found (see 
Appendix C for details), and as such no further covariate analyses were performed. 
 
2.8 ALS patients versus healthy controls summary  
Relative to the demographically matched healthy controls, ALS patients exhibited 
impairments in tests of executive functioning, working memory, and verbal memory. 
Deficits were observed in the Spoken Letter Fluency Test (fi) which is concordant with the 
majority of previous studies investigating cognition in ALS (e.g. Abrahams et al., 1997, 
2000, 2004; Ringholz et al., 2005; Taylor et al., 2012; Phukan et al., 2012), providing 
further evidence that fluency tests are among the most sensitive to cognitive impairment in 
ALS. Of note, ALS patients were unimpaired in the GNT suggesting that basic word 
retrieval difficulties may not have been the underlying cause of poor letter fluency 
performance. However, although patients had lower average scores than healthy controls in 
the Written Letter Fluency Test (fi), significant group differences were not found in this 
measure. This may have been due to the high proportion of ALS patients (n = 14) who were 
unable to complete the written task, thus lowering statistical power. Further evidence of 
executive dysfunction in the ALS group is provided by significant group differences in all 
measures of the D-KEFS Sorting Test (no. of sorts, recognition score, and scaled score). 
These findings are consistent with others reporting that a significant proportion of patients 
have impairments in this test of flexibility and concept formation (Libon et al., 2012; Taylor 
et al., 2012) and other similar tests such as the WCST (Abrahams et al., 1997; Lomen-




Evidence of working memory impairment was also exhibited by the ALS group as patient 
performance was significantly lower than that of controls in both forward and reverse digit 
span measures. Such findings have also been reported by other studies (Bartels et al., 2008), 
although not all (e.g. Ludolph et al., 1992; Jelsone-Swain et al., 2012) with deficits in 
reverse digit span reported more often (Rakowicz & Hodges, 1998; Hanagasi et al., 2002; 
Lillo et al., 2012). Although forward digit span deficits may be a better reflection of a short-
term memory/attentional impairment (Engle et al., 1999), the observed deficits in reverse 
digit span provide a more robust indication of working memory impairment in the ALS 
group. Of note, no impairment was exhibited in either forward or backward spatial span 
measures suggesting that these abilities may be dissociable in ALS patients. Spatial working 
memory has not been extensively investigated in ALS, but deficits in spatial span have been 
reported by some investigators in conjunction with abnormal ERP characteristics (Volpato 
et al., 2010; Hammer et al., 2011). 
 
The ALS patients also exhibited impairments in all measures of the Logical Memory scales 
with significant group differences between patients and controls evident in immediate, 
delayed, recognition, and retention conditions. Deficits in immediate and delayed conditions 
of story recall tests have been reported by some previous studies (Mantovan et al., 2003; 
Christidi et al., 2012) whereas other have reported unimpaired performance in both 
conditions (Newsom-Davis et al., 2001). ALS patients also exhibited deficits in the 
recognition condition and in the percentage of information recalled at delayed compared to 
immediate conditions (retention). Such findings suggest that memory impairment in ALS is 
not restricted to immediate recall conditions which are assumed to be a reflection of 
executive dysfunction (Lezak et al., 2004) and have been more commonly reported by 
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previous studies (Massman et al., 1996; Robinson et al., 2006).  As such, the logical 
memory deficits observed in the current investigation may indicate that memory impairment 
in ALS is not solely an encoding/retrieval problem, but may also be indicative of a failure to 
maintain memory traces (Christidi et al., 2012). Inconsistent findings within the literature in 
the domain of memory may reflect inherent heterogeneity of memory impairment in ALS as 
large scale studies indicate that between 11% and 14% of patients exhibit memory 
impairments (Taylor et al., 2012; Phukan et al., 2012).     
 
In terms of the case analyses, z-scores revealed that 9/29 (31%) ALS patients had cognitive 
impairment. This proportion is concordant with a recent population based study which 
reported that 35% of 160 incident ALS patients presented with cognitive impairment 
(Phukan et al., 2012). Executive dysfunction was the most common deficit with 7/29 (24%) 
patients exhibiting deficits in 2 or more tests sensitive to executive dysfunction, also 
concordant with the proportion reported by Phukan and colleagues (2012). Furthermore, 
4/29 (14%) of ALS patients exhibited evidence of either memory, or language impairment. 
The number of patients who exhibited memory or language impairment in the absence of 
executive impairment (i.e. non-executive impairment) was 2/29 (7%) which is lower than 
the proportion (14%) reported by Phukan et al. (2012). Thus, the ALS cohort in the current 
investigation appear to be a representative sample of patients as findings are largely 
consistent with those of previous large scale studies (e.g. Massman et al., 1996; Ringholz et 
al., 2005; Phukan et al., 2012; Elamin et al., 2013), with approximately 30% of patients 
showing evidence of cognitive impairment, predominantly in tests of executive functioning, 
with a smaller proportion exhibiting impairments in tests of language and memory. A recent 
study reported that language deficits in ALS were more common than executive dysfunction 
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(Taylor et al., 2012) which was not replicated by the current investigation – however, 
performance in this domain was not investigated as thoroughly as by Taylor and colleagues. 
 
2.9 ALS patients versus MS patients versus healthy controls summary 
In terms of ALS patient performance, the findings of the three-way analysis between ALS, 
MS, and healthy controls revealed largely the same pattern of impairment as the 2-way 
analysis between the whole ALS group and age-matched healthy controls. Although there 
were no significant differences between the ALS and MS groups themselves, there were a 
few instances in which ALS and MS performance differed relative to the control group. In 
measures of Forward Digit Span and Logical Memory Retention, the MS group performed 
worse than healthy controls but significant differences were not observed between the ALS 
group and healthy controls (although a trend towards significance was present in Forward 
Digit Span). Of these measures, Logical Memory Retention was found to correlate with age 
in the ALS group suggesting that the retention deficit observed in the two-way analysis may 
have been exacerbated by age. Nevertheless, ALS patients exhibited evidence of 
impairments in the same neuropsychological tests as described above suggesting that the 
effects are robust as they persist in analyses between younger patient and control cohorts.       
 
With regard to the MS group, compared to their age and education matched control group, 
patients were impaired in a number of the neuropsychological tests, displaying a similar 
pattern of impairment to that exhibited by ALS patients. In agreement with other 
investigators (Foong et al., 1997; Henry & Beatty, 2006), MS patients exhibited 
impairments in letter fluency indices. Significant group differences were found in spoken 
and written versions of the test (despite a relatively low number of patients completing the 
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written version) suggesting that these tasks are particularly sensitive to cognitive 
impairment in MS.  Further deficits in tests of executive functioning, namely the D-KEFS 
Sorting Test, were also observed in MS patients. There were significant group differences in 
terms of the number of sorts made and the recognition score consistent with the findings of 
other studies employing this test (Parmenter et al., 2007).    
 
MS patients also displayed deficits in working memory as evidenced by impaired 
performance relative to healthy controls in Reverse Digit Span. While post-hoc comparisons 
in Forward Digit Span were not significant, there was a strong trend toward significance 
suggesting that short-term memory capacity may also be effected in MS. Working memory 
impairment in MS is more commonly demonstrated by way of deficits in more demanding 
tasks such as the PASAT (Lengenfelder et al., 2006; Rosti et al., 2007), however, deficits in 
forward and reverse digit span procedures  have been reported by a quantitative review 
(Thornton & Raz, 1997) suggesting that these are robust and commonly exhibited 
impairments in MS cohorts. Moreover it has been suggested that span deficits appear to be 
particularly evident in patients with progressive forms of the disease (Grigsby et al., 1994).   
 
In addition, there was evidence of verbal memory impairment in the MS cohort with deficits 
observed in the Delayed and Retention conditions of the Logical Memory scales. Deficits in 
delayed recall have been particularly well documented in MS (Grafman, Rao & Litvan, 
1990; Staffen et al., 2002) although reports of impairment in immediate recall are also 
common (DeLuca et al., 1994; Thornton & Raz, 1997). The observation that the recognition 
component of the Logical Memory scale was not impaired is consistent with the finding of 
previous investigations of recognition memory in MS (Rao et al., 1993), although others 
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have reported recognition deficits in a proportion of patients (Beatty et al., 1996). Moreover, 
in contrast to other investigators (DeLuca et al., 1994) this finding suggests that 
retrieval/retention rather than encoding difficulties may underpin MS memory impairment 
in this cohort.   
 
 Finally, although there was initial evidence of a word retrieval deficit in MS patients, 
subsequent covariate analyses with age revealed that MS performance in the GNT was not 
statistically different from that of healthy controls (although a trend towards significance 
and a large effect size was observed). Language abilities such as simple word retrieval are 
regarded as generally intact in MS (Roa et al., 1991), however deficits in confrontation 
naming have been reported in relapsing-remitting and progressive MS patients (Friend et al., 
1999). Thus the cognitive profile of the MS cohort in the current study appears to be largely 
consistent with the findings of large-scale studies and quantitative reviews (Rao et al., 1991; 
Thornton & Raz, 1997; Drew et al., 2008), characterised by deficits in free recall, short-term 
memory, working memory and executive dysfunction.  
 
Although the ALS cohort was older than the healthy control participants in the 3-way 
analysis, the age difference between ALS and MS groups was not significant indicating that 
the two patients groups were relatively well matched. The analyses revealed that the 
cognitive profile of ALS and MS patients was very similar – relative to healthy controls 
deficits were exhibited in all of the same neuropsychological tests, with the exception of the 
GNT in which only the ALS group were impaired. However, some subtle within-test 
performance differences were observed. MS patients exhibited impairment in both the 
spoken and written fluency indices suggesting that they may be more sensitive to the written 
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measure than ALS patients, although previous investigations have shown ALS impairments 
in written letter fluency (Abrahams et al., 2000, 2004, 2005). Similarly, ALS and MS 
patients displayed impairments in different conditions of the Logical Memory scales; ALS 
patients had immediate and delayed recall as well as recognition deficits, whereas MS 
patients had only had delayed recall and retention deficits suggesting that while ALS 
memory may be a reflect difficulties in encoding, retention, or retrieval, MS deficits are 
more likely to reflect a problem with retention and/or retrieval.      
 
Thus, standardized neuropsychological assessment revealed a common pattern of executive 
dysfunction combined with impairments in working memory and verbal memory in ALS 
and MS patients. Although the ALS cognitive profile is typically associated with that of 
FTD, the current study has shown that similarities also exist with MS, a disorder 
characterised by white matter pathology. Such findings may further implicate the 











Chapter 3.  Development of experimental tasks and dual task ageing 
study 
This first aim of this chapter is to address the design of the experimental tasks employed by 
the current investigation, and the theories and models that informed them. The tasks 
developed for use in the current study focussed on processing speed and dual task ability, as 
well as the relationship between the two cognitive processes, with the aim of employing 
paradigms that were independent of motor impairment. Although dual tasking and 
processing speed have been investigated in ALS and MS (as discussed in Chapter 1, 
Sections 1.6.1.4 and 1.10), both abilities have been studied extensively in the cognitive 
ageing literature by way of a variety of techniques and paradigms, some of which are 
reviewed below. The second aim of this chapter was to test the functionality of a novel dual 
task paradigm in a pilot study, and subsequently investigate the effects of ageing in this 
experimental paradigm.  
 
3.1 Processing speed 
Processing speed refers to the maximum rate at which elementary cognitive operations can 
be achieved, assuming that faster processing is beneficial for subsequent cognitive 
operations (Salthouse, 1985). According to Kail and Salthouse (1994), the concept of 
processing speed encompasses several key characteristics: 
(a) The resource is limited in nature, and can be measured in terms of quantity or 
effectiveness, the ability of which increases up until maturity and then decreases 
across the adult years.  
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(b) The resource facilitates cognitive operations such that performance is improved 
when greater amounts of the resource are available. 
(c)The resource is not restricted to a small number of highly similar cognitive tasks, 
rather it is relevant to a broad range of cognitive operations. 
 
According to Salthouse (1996), the effect of processing speed on higher cognitive processes 
has been postulated to rely on two mechanisms; 
1. Time limited effect: asserts that if the amount of time taken to complete a low level 
process is too long, there will not be sufficient time to complete the next process in 
the hierarchy. Especially pertinent when there is a time limit to the goal-directed 
task. 
2. Simultaneity effect: asserts that if processing speed for a given function is slowed, 
the information may no longer be available or relevant when it is needed. Especially 
pertinent when information may be required for storage and processing, such as in 
working memory tasks. 
In addition, Salthouse (1996) asserted that any processing speed task must meet certain 
criteria: 
a) The task should be relatively simple so that performance is attributable to how 
quickly the task can be carried out, and is not affected by ability in other cognitive 
domains. 
b) However the task should not merely reflect simple sensory and motor responses or 
it may not represent a relevant cognitive process.  
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Tests that meet these criteria are those such as the DSST and perceptual speed tests, 
however, others such as the PASAT and Sternberg paradigm can be inferred to load too 
heavily on other cognitive processes such as working memory and mathematical ability. 
Computerised versions of perceptual speed tests are now commonly used as processing 
speed measures as they have the added advantage of allowing precise reaction times to be 
recorded for each trial, rather than a measure of the total time taken to complete the whole 
task, or the number of errors committed within a given time limit. For example, age effects 
have been reported by a study in which the DSST was modified into a computer based 
forced-choice reaction time task in which participants judged whether visually presented 
digit-symbol pairs matched those in a code table (Salthouse 1998). However, the main 
criticism of such tests, and one that is particularly pertinent to the current study, is their 
reliance on reaction times.  This is not only a potential confound in ageing populations in 
which reaction times are known to be slowed (Zacks & Zacks, 1993; Fozard, Vercruyssen, 
Reynolds, Hancock & Quilter, 1994), but also a major issue in the assessment of patient 
populations with inherent motor impairments. 
  
However, processing speed tests that are independent of motor functioning have been 
developed in the form of Inspection Time (IT) paradigms. IT paradigms are the only 
measures of mental speed that do not involve reaction times or high-order cognitive 
processes (Kranzler and Jensen, 1989). IT experiments typically involve the visual 
presentation of two lines of markedly different length (target), followed immediately by a 
backward mask to limit any additional processing from sensory traces. The participant is 
required to judge which line was longer (forced-choice, left or right). Inspection time is 
defined as the minimum target duration necessary for subjects to accurately identify the 
longer line. Thus, IT paradigms utilise forced-choice decision making, and the manipulation 
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of stimulus duration times, to allow the temporal limit at which information is available for 
processing to be elucidated. Indeed, IT tasks have been used to detect motor independent 
processing speed deficits in motor disorders such as Parkinson’s disease (Shipley, Deary, 
Tan, Christie & Starr, 2002; Johnson et al., 2004). Moreover, IT, like other processing speed 
measures has been shown to correlate with general cognitive abilities, particularly 
Performance IQ (Deary and Stough, 1996; Nettlebeck and Rabbit, 1992). As such, IT tasks 
are highly suitable for use in the current study as they meet the criterion proposed by 
Salthouse (1996) whist remaining independent of motor impairment. 
 
In addition to the investigation of processing speed for abstract visual stimuli via an IT 
paradigm, the current study sought to investigate processing speed for meaningful visual 
stimuli, and in particular, linguistic stimuli. Given that a proportion of ALS and MS patients 
have been shown to have language impairments (Bak & Hodges, 2001; Friend et al., 1999), 
and the reported association between verbal fluency performance and processing speed 
(Schaie 1989; Bryan, Lusczc & Crawford), the current study aimed to investigate whether 
processing speed for meaningful verbal information was differentially impaired in these 
patient groups. Rapid serial visual presentation (RSVP) tasks have been used in studies of 
perception and psychophysics to investigate the characteristics and temporal resolution of 
human visual processing (e.g. Schneider & Shiffrin, 1977). Processing speed for words and 
letters is relatively well characterised (James, James, Jobard, Wong & Gauthier, 2005), with 
words elucidating a more automatic and faster neural response than individual letters – the 
so called word superiority effect (Johnston & McClelland, 1974). Letter identification is a 
more controlled task, although processing is still significantly faster than that of more 
complex percepts such as faces; the temporal resolution of individual letter recognition has 
been reported at approx. 40ms in adults (Nasanen, Ojanpaa, Tanskanen & Paallysaho, 
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2006). Thus, letter identification appeared to be an appropriate method by which to 
investigate linguistic processing speed in ALS and MS. The current task was adapted from a 
standard RSVP paradigm to make accuracy the only outcome measure and allow the 
manipulation of stimulus duration times in an effort to make the task analogous to the VIT 
task.  
 
3.2 Processing speed and ageing 
It is generally accepted that processing speed becomes slower as people get older; a 
considerable number of studies have demonstrated age effects in different processing speed 
paradigms. Age effects have been reported in perceptual speed tasks which typically require 
participants to match or find a simple target stimulus from an array of distracter stimuli e.g. 
the Identical Pictures and Finding A’s tests from the ETS Kit of Factor-Referenced Tests 
(Ekstrom, French, Harman & Derman, 1976; Schaie, 1989) and the Visual Matching and 
Cross-Out tests from the Woodcock-Johnston Cognitive Ability Test (Kail & Salthouse, 
1994). Age effects are also reliably found in speeded tasks which require additional 
attentional demand and shifting between perceptual stimuli e.g. the Trail Making Test (Boll 
& Reitan; Kennedy, 1981) and Digit Symbol Substitution Test (DSST) from the Wechsler 
Adult Intelligence Scale – Revised (WAIS-R; Salthouse, 1992). Moreover, age effects have 
been reported in tasks which put an additional load on working memory such as the 
Sternberg paradigm (Anders & Fozard, 1973) and the Paced Auditory Serial Addition Test 
(PASAT; Crawford et al., 1998; Diehr et al., 2003). Furthermore, reductions in processing 
speed have been shown to have a wider impact in older adults. For example, IT tasks have 
been shown to be sensitive to the effects of cognitive decline in healthy ageing whereby 
individuals with reduced IT ability experience more difficulties in activities of daily living 
(Gregory, Calaghan, Nettelbeck & Wilson, 2009). Some researchers argue that slowed 
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processing speed accounts for the majority of age associated cognitive decline (e.g. 
Salthouse, 1996). Evidence for such theories comes from studies which show that 
processing speed performance is a significant predictor of performance in other high-order 
cognitive tasks. For example, older adults have been shown to have slower rehearsal times 
and articulation speeds for to-be-remembered words than younger adults (Bryan & Lusczc, 
1996); the authors reported that older participants were also slower than younger 
participants in the Digit Symbol Substitution Test (DSST), and that this relationship 
mediated word recall performance. Other studies have reported that processing speed 
mediates performance in high order tasks such as Raven’s Progressive Matrices (Fry & 
Hale, 1996) and verbal fluency (Schaie 1989; Bryan, Lusczc & Crawford, 1997).  
 
3.3 Models of executive functioning 
A comprehensive review of models of executive functioning is beyond the scope of this 
study, but summarised below are models which relate best to recent findings in ALS and 
which have been most influential in the design of the current investigation.  
 
Executive functions can and have been defined in numerous ways by different theorists. For 
example, executive functioning has been referred to as the highest order processes of human 
intelligence and includes the preparation and planning of actions as well as the monitoring 
and verification of those actions (Anderson, Jacobs, & Anderson, 2008). Others have 
suggested that they encompass the ability to solve novel problems, modify behaviour in 
light of new information, generate strategies, and sequence complex actions (Elliot, 2003). 
Some investigators have coined terms that encompass these wide-ranging functions such as 
the “Supervisory Attentional System” (Norman & Shallice, 1986), or the “Central 
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Executive” (Baddeley & Hitch, 1974). However, regardless of different definitions and 
concepts, there seems to be relative agreement that executive functions play a fundamental 
role in adaptive human behaviour.  
 
3.3.1 The multi-component model of working memory 
One of the most influential cognitive models of complex human behaviour was proposed by 
Baddeley and Hitch (1974) with the multi-component model of working memory. This 
model proposes that working memory, our ability to temporarily store, process, and 
manipulate information, is crucial to high-order human behaviour. Within the model there 
exists dissociable temporary storage systems for verbal (the phonological loop) and 
visuospatial (the visuospatial sketchpad) information, both of which are under the control of 
limited capacity coordinating system (the central executive). An additional component, the 
episodic buffer, which enables coding of information from multiple sensory domains and 
provides a link to episodic memory, was more recently added to the model (Baddeley, 
2000). The multi-component model is based on the fundamental principle that the temporary 
storage of perceptual information is limited capacity in nature, and as such tasks which draw 
on this capacity will have a detrimental effect on the ability to complete another task 
simultaneously. For example, Baddeley and Hitch (1974) demonstrated that holding a string 
of digits in mind whilst concurrently reading a prose passage reduced performance in the 
recall of the digits and comprehension of the text suggesting that there was a limited 
capacity system for the storage and processing of verbal information. Similar results were 
found for the visuospatial domain in that simultaneous performance of two tasks requiring 
visual or spatial processing resulted in interference in the performance of both tasks (e.g. 
Logie et al., 1990). However, the crucial finding from this set of experiments was that when 
two tasks from separate domains are performed simultaneously, performance remains good 
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in both tasks suggesting that the verbal and visuospatial components of working memory are 
dissociable. However, although performance under these conditions was good, it was not as 
good as performance when completing the tasks in isolation, which suggested that there 
must be a common resource which has the ability to coordinate and control the functioning 
of the two sensory stores, i.e. the central executive.  
 
A significant amount of research has led to further fractionation of the phonological loop 
and visuospatial sketchpad and these constructs are now relatively well characterised (see 
Repovs & Baddeley, 2006 for a review). By contrast, the central executive has received far 
less attention. The first inroads into the functions of the central executive were made with 
the aid of Norman and Shallice’s (1986) Supervisory Attentional System which proposed 
that while many basic human behaviours are governed by environmental cues and occur 
automatically, novel situations and goal oriented behaviour requires controlled processing 
which is attentionally demanding. Thus, control of attention has been adopted as the main 
function of the central executive, and various experiments have been devised to investigate 
the nature of these attentional processes. Selective (or focussed) attention has been 
investigated by assessing the effects of random generation on other executively demanding 
tasks. Random generation tasks require focussed attention to ensure that number or letter 
sequences are not repeated and inhibit stereotyped responses (Baddeley, 1998). Such tasks 
when performed concurrently have been found to disrupt syllogistic reasoning (Gilhooly, 
Logie, Wetherick & Wynn, 1993), mental arithmetic (Logie, Gilhooly & Wynn, 1994) and 
chess (Robbins et al., 1996). Crucially, concurrent random generation tasks were shown to 
disrupt performance more than other concurrent tasks designed to disrupt the sensory 
storage systems (subvocal rehearsal or finger tapping), suggesting that focussed attention 




The ability to switch attention between relevant tasks has also been postulated to be a 
function of the central executive although the evidence is less clear cut. Switching tasks 
such as those which require participants to switch between simple addition and subtraction 
have been shown to be disrupted by executively demanding tasks such as alternatively 
saying the days of the week and months of the year or random generation (Baddeley, 
Chincotta & Adlam, 2001). However, the same study also revealed that performance in an 
arithmetic switching task was disrupted to the same extent, and more specifically, by 
articulatory suppression, suggesting that the phonological loop may play a bigger role in 
task-switching than the central executive. These results were replicated and extended to 
show that concurrent tapping did not have an effect on arithmetic switching suggesting that 
the visuospatial sketchpad was not involved in task-switching (Saeki & Saito, 2004). 
Moreover, an additional finding of the above studies, as well as another investigation 
(Emerson & Miyake, 2003), was to demonstrate that articulatory suppression only affected 
task performance in the absence of external switching cues, suggesting the phonological 
loop may place a crucial role in maintenance of the switching programme by preventing 
decay whereas the central executive is implicated in the execution of task switching (Repovs 
& Baddeley, 2006).    
 
Another proposed capacity of the central executive is divided attention – the ability to split 
attentional resources so that multiple tasks may be completed simultaneously. This process 
is described in more detail in the following section and so shall not be discussed here - 
suffice to say that neuropsychological evidence has demonstrated that patients with 
Alzheimer’s disease present with a specific deficit in the coordination of two tasks despite 
normal performance when either task is performed in isolation (Baddeley, Logie, Bressi, 
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Della Sala & Spinnler, 1986). Thus although the multi-component model of working 
memory has not provided a comprehensive characterisation of executive functioning as it 
has for the phonological loop and visuospatial sketchpad, it has produced clear evidence for 
the role of attentional control, and most importantly provided a mechanism by which to 
assess executive functioning, namely the dual task paradigm (Della Sala, Baddeley, 
Papagno & Spinnler, 1995). 
 
3.3.2 Anterior attentional functions 
The previously mentioned Supervisory Attentional System (Norman & Shallice, 1986) has 
also provided the basis for more advanced theories of executive functioning. Drawing on 
data from patients with frontal lobe lesions, Stuss, Shallice, Alexander and Picton (1995) 
suggested that the SAS could be fractionated and that attentional processes could be 
differentiated as sustaining, concentrating, sharing, suppressing, switching, preparing, and 
setting. In addition, Stuss et al. (2005) postulated that each attentional process could be 
realised by multiple underlying mechanisms. For example, sustaining attention refers to the 
ability to remain vigilant to events that occur with relative infrequency, and thus requires 
mechanisms such as monitoring of the events, re-energising of the original response criteria, 
and inhibition of other irrelevant processes. This process is hypothesised to be a function of 
right prefrontal cortex as evidenced by patients with right frontal lesions who exhibited poor 
performance on a vigilance test at slow presentation rates but normal performance at fast 
presentation rate (Wilkins, Shallice & McCarthy, 1987). Moreover, patients with right 
anterior lesions have been shown to be impaired on simple continuous performance tests but 




By contrast, concentrating attention is postulated to be required in highly demanding tasks 
and instances where rapid responses are necessary. This process is dependent upon 
mechanisms of energising to enable multiple responses to be prepared as well as inhibition 
to ensure the appropriate response is activated at the right time. A potential anatomical locus 
for this process is cited as the anterior cingulate cortex as evidenced by functional imaging 
studies in which the anterior cingulate has been shown to be activated by high demand 
conditions such as Stroop interference as opposed to low demand conditions (Bench et al., 
1993; Pardo, Pardo, Janner & Raichle, 1990).  
 
Sharing attention in the Stuss et al. (1995) model is similar to the concept of divided 
attention defined by the multi-component model of working memory except that it extends 
to instances when two or more tasks are carried out simultaneously. As with concentrating 
attention, sharing attention requires energising mechanisms as two sets of responses must be 
active at once, and additionally requires monitoring mechanisms to ensure that a balance is 
maintained between the active response sets.  Evidence for frontal lobe involvement in 
sharing attention has come from patients with frontal lobe lesions and behavioural 
dysexecutive syndrome who exhibited dual task impairments (Baddeley et al., 1997), 
suggesting a role for orbitofrontal cortex, and functional imaging studies which have 
implicated anterior cingulate cortex (Fletcher et al., 1995).  
 
Suppressing attention is required in instances where response sets are automatically 
activated when they are inappropriate to the goal oriented task, an example of which would 
be Stroop interference. This process is reliant upon a rule detecting mechanism (so called 
“if-then logic”) and inhibition of the inappropriate response. Stroop tasks have been shown 
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to be sensitive to patients with dorsolateral lesions whilst those with orbitofrontal damage 
perform normally (Richer, Décary, Lapierre & Rouleau, 1993; Stuss, Benson, Kaplan, Weir 
& Della Sala, 1981) suggesting that suppressing attention may be dissociable to specific 
areas in the frontal lobes. Other potential anatomical loci include the medial prefrontal 
regions as evidenced by patients who exhibit utilization behaviour and grasp reflex which 
may reflect an inability to inhibit responses (Shallice, Burgess, Schon & Baxter, 1989). 
 
Switching attention as defined by Stuss et al. (1995) is required when a shift is required 
from one concept or response to another within a task. It is reliant upon an energising 
mechanism to activate the to-be-switched-to response as well as subtle inhibitory responses 
so that the initial response is still ready to be deployed if it is required. Evidence for 
anatomical localisation has been provided by lesion studies employing the WCST which 
have implicated the bilateral dorsolateral prefrontal cortex (Milner, 1963), although it is 
recognised that the WCST is not a “pure” test of switching, and more recent studies have 
shown that patients with lesions to non-frontal areas can also exhibit WCST impairment 
(Mukhopadhyay et al., 2008). 
 
Preparatory attention is required when a response must be carried out at a future time point. 
According to Stuss et al. (1995) this process relies on mechanisms of submaximal activation 
so that the response can be efficiently energised when triggered by the critical stimulus. The 
time frame for preparatory attention is in the region of milliseconds to seconds and is most 
readily applicable to simple reaction time paradigms for which preparatory responses are 
critical. Patients with Parkinson’s disease, and especially those with frontal involvement, 
have shown slowed reaction times in simple reaction time paradigms whereas choice 
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reaction times are unimpaired (Goodrich, Henderson & Kennard, 1989; Harrison, Goodrich, 
Kennard & Henderson, 1993) which suggests that there is a specific deficit when the 
response parameters are known and can be prepared for. Similar findings have been reported 
in patients with bilateral dorsolateral lesions (Alivisatos & Milner, 1989) implicating this 
area in preparatory attention.  
 
The final component in the Stuss et al. (1995) model of anterior attentional functions is 
setting attention which is defined as selecting the most appropriate response-set over 
extended periods, and is particularly relevant when multiple response sets have been 
recently activated. Monitoring and evaluation mechanisms are required to ensure that the 
appropriate response is activated for the current demands of the task. Patients with traumatic 
brain injury have been shown to have highly variable performance over time which may 
reflect impairment in setting attention (Stuss, Pogue, Buckle & Bondar, 1994; Stuss et al., 
1989), although by nature these patients have diffuse atrophy which may include frontal 
lobe pathology, but nevertheless makes predicting potential anatomical loci problematic.  
 
The anterior attentional model has been influential in the investigation of executive 
functioning as it has fractionated an all-encompassing construct of attentional control into 
discrete and well defined processes that can be subjected to more stringent investigation. In 
addition, unlike the multi-component model of working memory, the anterior attentional 
model has combined cognitive theory with lesion studies and evidence from functional 
imaging to provide a theory of complex behaviour that has an anatomical grounding, 
ultimately lending itself to investigation via a variety of techniques. However, other 
investigators (Miyake et al., 2000; Repovs & Baddeley, 2006) have warned of the dangers 
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of assuming that cognitive functions map onto cortical locations in a one-to-one nature 
when there is a greater likelihood that networks of brain regions are responsible for 
executive processes. Indeed, more recent studies employing neuroimaging and lesion 
techniques alike have started to come to the consensus that executive functions are not 
solely dependent on the frontal lobe (see Jurado & Rosselli, 2007 for a review), although 
few theorists have doubted that the prefrontal cortex plays a fundamental role in executive 
control.   
 
3.4.3 Statistical models of executive functioning 
One of the main debates within the field is whether executive functioning is achieved by a 
single underlying ability (i.e. unitary), or whether executive functioning can only be 
achieved by a number of dissociable, albeit related processes (non-unitary). Unitary theories 
have been developed as a result of data which show that performance in many tests of 
executive functioning are highly correlated with a factor of general intelligence, or g (e.g. 
Duncan et al., 1996). However, neuropsychological studies of patients with lesions to 
different parts of the brain have provided evidence to suggest that different executive 
processes are localised to specific regions of the frontal lobes (e.g. Burgess & Shallice, 
1994; Stuss et al., 1995). The question of unitary versus non-unitary was addressed by 
Miyake and colleagues (2000) in a study which utilised latent variable analysis in a large 
cohort of healthy individuals to investigate the independence of three of the most commonly 
postulated executive functions, namely shifting, updating, and inhibition. This was achieved 
by developing and employing 9 tasks; 3 of which were specifically designed to isolate 
switching processes, 3 were designed to isolate updating processes, and 3 were designed to 
isolate inhibition processes. In addition, 5 complex tasks commonly used to assess executive 
functioning were also administered, namely the Wisconsin Card Sort Test, the Tower of 
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Hanoi, Random Number Generation, Operation Span, and a Dual Task. The authors 
reported that the 9 tests designed to tap specific processes showed convergent and 
discriminant validity as significant correlations were present between tasks in the same 
domain (e.g. shifting), but only small correlations were revealed between tasks designed to 
assess different domains. Several statistical models were subsequently developed to 
investigate which would explain data from all the tests with the greatest accuracy. The first 
was a full 3 factor model of shifting, updating, and inhibition each containing 3 of the 9 tests 
as described above. The second was a single factor model which assumed that all 9 tests 
were equally related to a unitary executive construct. In addition, several 2 factor models 
containing combinations of shifting updating and inhibition were created to assess whether 
any 2 of the factors overlapped. Miyake et al. (2000) reported that the data were best 
explained by the 3 factor model suggesting that shifting, updating, and inhibition were 
independent processes. Moreover, although correlations between the 3 factors were 
moderate, none of the confidence intervals contained a 1.0 correlation indicating that the 
factors were related but dissociable. Finally, the authors also carried out Structural Equation 
Modelling on the 5 complex tasks of executive functioning to see which of the 3 factors 
contributed most to performance in these tasks. It was reported that shifting contributed to 
the WCST, inhibition to Tower of Hanoi, inhibition and updating to Random Number 
Generation, and updating to Operation span. By contrast, none of the 3 factors contributed 
significantly to performance on the Dual Task suggesting that this type of task may 
represent a different type of executive process. 
 
The findings of Miyake et al. (2000) were replicated in a group of older adults by Fisk and 
Sharp (2004). They reported the same dissociations between commonly used measures of 
executive functioning which appeared to load on the same underlying factors of shifting, 
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updating and inhibition as proposed by Miyake et al. (2000). However, Fisk and Sharp 
(2004) also reported an additional factor which determined performance on verbal fluency 
tests, suggesting that these tests may tap into a separate executive function that is associated 
with access to long-term memory. Moreover, this factor was the only one which was shown 
to be independent of age-related decline in processing speed. Thus, the approach to 
investigating executive functioning adopted by Miyake et al., (2000) and Fisk & Sharp 
(2004) has demonstrated the importance of using multiple tests to assess a purported 
executive process. It is only by examining the combined data from multiple tests that 
inferences can be made regarding the underlying functions, although the validity of the 
findings is still dependent upon the success of the underlying tasks in tapping into the target 
executive processes. Moreover, these studies have highlighted the importance of testing the 
construct validity of commonly used tasks of executive functioning.   
  
3.4 Dual tasking 
 The ability to perform two tasks concurrently is highly valuable in everyday life, humans 
routinely engage is dual task like behaviours whether it be driving and talking or listening 
while note-taking. Much of the research into dual tasking has stemmed from the model of 
working memory proposed by Baddeley and Hitch (1974). It has been postulated that dual 
tasking is a function of the “central executive”, a cognitive construct which allows the 
coordination of visual and auditory sensory “slave” systems (Della Sala, Baddeley, Papagno 
& Spinnler 1995; Baddeley, 2000, Engle, 2002). However, it has also been argued that 
slowed processing speed can affect dual task performance because of the added processing 
stages required to carry out two tasks instead of one (Somberg & Salthouse, 1982; 
Salthouse, Fristoe, Lineweaver & Coon, 1995). A typical dual task format requires 
participants to perform two cognitive tasks, initially separately in the single task condition. 
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Participants are subsequently required to perform the same two tasks concurrently – the dual 
task condition. Any decrease in performance in either task between single task and dual task 
conditions can then be calculated and represented as dual task cost – that is the cost 
associated with performing two tasks concurrently.  
 
3.5 Dual tasking, aging, and dementia 
Dual tasking ability has been investigated in several patient populations, and it has been 
proposed that a specific dual task deficit exists in Alzheimer’s disease (Logie, Cocchini, 
Della Sala & Baddeley, 2004), although other degenerative disorders such as Multiple 
Sclerosis and Parkinson’s disease have shown dual task decrements when one of the 
concurrent tasks is a motor task (e.g. walking and talking in MS; Hamilton et al., 2009, 
tracking and digit span in PD; Dalrymple-Alford, Kalders, Jones & Watson, 1994). The only 
study investigating dual tasking in ALS also reported a deficit (Schreiber et al., 2005), 
however, the outcome measure in this case was reaction time and so may have been a 
manifestation of motor impairment rather than a dual task deficit per se. Indeed, 
methodological issues in dual task paradigms are contentious, and appear to underlie much 
of the debate in the literature concerning whether dual task performance decreases across 
the lifespan. Many studies have suggested that although there may be a small speed or 
accuracy cost associated with performing two tasks concurrently, in general, healthy young 
adults are able to perform relatively well in both tasks (Cocchini, Logie, Della Sala, & 
MacPherson, 2002; Della Sala, Foley, Beschin, Allerhand, & Logie, 2010), provided the 
constituent tasks do not involve the same sensory input. However, in terms of healthy 
ageing, the literature is less consistent with some authors reporting a disproportionate dual 
task decrement in older adults, whereas others report that older adults perform comparably 
with their younger counterparts (Baron & Mattila, 1989; Batsakes & Fisk, 2000; c.f. Logie 
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et al., 2004; MacPherson, Della Sala, Logie and Wilcock, 2007; Anderson, Bucks, Bayliss 
& Della Sala, 2011).  
 
The inconsistencies in the dual tasking literature have resulted in the development of several 
theories to explain the observed effects (or lack thereof). For example, Task-Switching 
models propose that concurrent tasks may be processed in parallel, however only one task 
can have access to the response-selection mechanism. The prediction of such a model is that 
dual task conditions will delay the onset of the secondary task until the primary task is near 
completion (Pashler, 1994). This should be especially prevalent when tasks are performed at 
short Stimulus Onset Asynchronies (SOAs,) as the need for the processing resource will 
inherently overlap to a greater extent. Studies manipulating the delay (SOA) between the 
primary and secondary tasks have reported age-effects (Allen, Smith, Vires-Collins & 
Sperry 1998) suggesting that older adults may experience a time-sharing impairment, an 
effect that seems to be magnified when the response to both tasks is in the same sensory 
modality (Hartley & Little, 1999). In related studies, it has been suggested that older adults 
are more cautious and show a lack of flexibility when switching attentional resources in 
dual task paradigms (Korteling 1991; Batsakes and Fisk, 2000), although this was not 
reproduced by other studies (Salthouse, Rogan & Prill, 1984; Crosseley & Hiscock, 1992). 
 
Capacity-Sharing models propose that there is a limited processing resource available for 
any given task, so that when a secondary task is concurrently presented, some of that 
resource must be directed away from the primary task and hence responding is slowed or 
hindered (e.g. Kahneman, 1973). This model predicts worse performance as task complexity 
increases, as each constituent task will demand more of the limited processing resource. It 
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has been assumed that age effects reported in dual tasking are a result of a decline in 
resource capacity (Hartley & Little, 1999). Indeed, several studies have shown that 
increasing the complexity of the constituent tasks results in a greater age effect (Wright, 
1981; Lorsbach & Simpson, 1988), however, a meta-analysis reported that age-related 
decline in dual tasking was independent of task complexity (Verhaegen, Steitz, Sliwinski & 
Cerella, 2003). Moreover, Salthouse and Somberg (1982) demonstrated that controlling 
single task difficulty by titrating the tasks to individual ability level attenuated any age 
effect in dual task conditions. However, the authors argued that dual task decrements may 
be due to a decrease in older adults’ speed of processing in single tasks rather than a decline 
in processing capacity. Thus, when single task ability is controlled for, dual task decrement 
may be substantially less than expected although a subsequent study suggested that this was 
not the case for more complex tasks (Salthouse et al., 1984). Furthermore, it has been 
asserted that the combined cost of the two component tasks under dual task conditions is a 
better representation of dual task cost as it controls for strategic prioritizing of one task over 
the other (Salthouse et al., 1995).  
 
Single task titration has also been adopted in studies which have used dual task paradigms to 
investigate the models of working memory. Such studies have shown that if single tasks are 
titrated, healthy adults have the ability to perform simultaneous verbal and visuospatial 
working memory tasks (Cocchini, Logie, Della Sala, MacPherson & Baddeley, 2002), with 
relatively small dual task costs. The authors suggest that this is indicative of domain-
specific working memory systems encompassing discrete storage and processing resources. 
Moreover, it has been suggested that the coordination of these independent resources is a 
function of the central executive, and that the modest dual task cost observed in the data 
may reflect the additional demand placed upon this system under dual task conditions (Duff 
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& Logie, 2001; Cocchini et al., 2002). Further evidence for executive control in dual task 
paradigms has been produced by studies into Alzheimer’s disease (AD). It has been shown 
that AD patients have a specific deficit in dual tasking, even when both component tasks are 
set below individuals’ titrated ability level suggesting that there is a specific problem with 
task coordination rather than overall load of the tasks (Logie et al., 2004). This claim was 
strengthened by data which showed that AD patients’ dual task performance was not 
differentially worse than controls when demand was increased in one of the tasks suggesting 
that overall cognitive load was not the causal factor in the observed dual task deficit.  
 
An interesting problem can be derived from the findings of dual task sensitivity in AD 
which is characterised by episodic memory impairment and medial temporal lobe atrophy in 
the early stages before progressing to predominant bilateral parietal, temporal and limbic 
atrophy (Perry & Hodges, 2010; Sebastian-Gascon & Hernandez-Gill, 2010). However, dual 
tasking is assumed to be a function of the central executive or SAS, disruption of which is 
normally associated with lesions to frontal areas (Baddeley et al., 1997). Some functional 
imaging studies have shown that dual task performance is associated with specific areas of 
the frontal lobes; for example, dorsolateral and prefrontal cortex and anterior cingulate show 
increased activity during dual task conditions for tasks which predominantly activate 
posterior regions when performed in isolation (D’Esposito et al., 1995), whereas a meta-
analysis suggested that dual task manipulations are most frequently associated with right 
inferior prefrontal cortex (Wager & Smith, 2003). By contrast, some investigations have 
shown that dual tasks simply impose higher processing demands on cortical areas already 
involved in the component single tasks, i.e. no additional areas are recruited under dual task 
conditions (Adcock et al., 2000; Klingberg, 1998), and others have shown that dual tasks 
can be completed in the absence of any prefrontal involvement when dual task costs are low 
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(Smith et al., 2001). Results of this nature would suggest that dual tasking is achieved by the 
communication between brain networks and suggest that executive functioning may be an 
emergent property of this interplay between regions (Collette & Van der Linden, 2002). 
This theory lends itself well to the findings in Alzheimer’s disease, as dual task deficits and 
other executive impairments can be explained in terms of a disconnection syndrome that 
disrupts effective communication between disparate brain regions (Delbeuck, Van der 
Linden & Collette, 2003).  
 
Dual tasking has been investigated using a variety of component tasks such as; visual search 
and auditory detection (Broadbent & Heron, 1962), digit span and verbal reasoning (Wright, 
1981), tone detection and sequential digit keying (Somberg & Salthouse, 1982), pursuit 
tracking and forced-choice tone identification (McDowd, 1986), rotary pursuit and choice 
reaction time (Ponds, Brouwer & van Wolffelaar, 1988), and dot location and tone 
discrimination (Allen et al., 1998). However, working memory tasks (e.g. Digit Span) are 
amongst the most commonly used in dual task paradigms (Baddeley & Hitch; 1976; 
McDowell, Whyte & D’Esposito, 1997; Baddeley, Della Sala, Papagno & Spinnler, 1997; 
Logie et al., 2004), along with a secondary task from a different sensory domain (e.g. 
Spatial Span, Cocchini et al., 2002; Macpherson, Della Sala, Logie & Wilcock, 2007) or a 
simple perceptuomotor task (e.g. Tracking; Baddeley et al., 1991; Della Sala et al., 1995). 
As such, a common dual task scenario is to test working memory and psychomotor speed 
concurrently. The use of secondary motor and reaction time tasks may explain some of the 
inconsistencies in the dual task and ageing literature; it is well documented that movement 
times and reaction times are affected by ageing (Brian and Luszcz, 1996; Salthouse, 1996; 
Salthouse, 1998), and an age effects are evident in dual task paradigms which employ 
concurrent motor tasks (Ponds, Brouwer & van Wolffelaar, 1988). Certainly, the use of such 
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paradigms would not be suitable for the current study given the motor impairments that 
characterise both disorders.  
 
The current study aimed to investigate the effect of attention and processing speed on 
executive functioning in ALS and MS by investigating both processes within a dual task 
paradigm. Digit Recall was chosen as the attentional measure in the current study as it is 
considered a measure of short-term memory or attention and has minimal motor demands. 
Visual Inspection Time (VIT as described previously) was chosen as the processing speed 
measure as it impinges upon the visuospatial domain and thus, according to multi-
component model of working memory, should not cause any interference with processing of 
the auditory Digit Recall task. As described previously, the VIT task has the added 
advantage of assessing processing speed, independently of motor speed. However, 
stereotypical dual task paradigms are still likely to put high demands on response selection 
and initiation as behavioural responses are made in parallel and thus can result in 
interference, especially in populations with motor difficulties. For this reason a “preload” 
methodology (as described in Cocchini et al, 2002) was utilised. The preload dual task 
procedure has three stages; first participants attend to and encode the primary memory task 
(in this case Digit Recall), then complete the secondary task of choice (in this case VIT), 
and finally recall the information from the primary task. Using a preload paradigm over 
comes the problem of response interference as responses are required in a serial manner. 
Nevertheless, cognitive demand must remain concurrent to allow information from the 
primary task to be maintained during performance of the secondary task so that is available 





3.6.1 Experimental Task 1 – Visual Inspection Time (VIT)  
In this task (adapted from Edmonds et al., 2008), participants were required to make a 
forced choice decision regarding an abstract visual stimulus presented briefly on a computer 
screen. Participants were first presented with a fixation cross on the middle of the screen 
(1000ms duration). An interstitial stimulus interval (ISI) of 800ms preceded the target 
stimulus; a simple geometric figure with a clearly elongated “tail” on either the left or right 
side. The target stimulus was then replaced by a mask (500ms duration) which obscured 
which side of the tail figure was longer. Finally participants were presented with a cue to 
“respond” – they were required to indicate whether they saw a longer tail on the right or left 
side of the stimulus figure. Responses could be made manually by using specially designed 
buttons applied to the keyboard, or verbally. Only response accuracy was recorded. An ISI 
of 1000ms preceded the start of each trial. Before the test procedure, all participants were 
given 9 practice trials of gradually increasing difficulty (3 x 400ms target stimuli, 3 x 150ms 
target stimuli, 3 x 68ms target stimuli) in which they were given feedback (with the word 
“correct” or “incorrect” presented for 1500ms) after each trial. During the test procedure, 
participants did not receive feedback, and the duration time of the stimulus was manipulated 
in a fixed pseudorandom order at durations of 150ms, 125ms, 102ms, 85ms, 68ms, 51ms, 
34ms, and 17ms, requiring faster processing to respond accurately. A total of 80 trials were 
completed (10 at each stimulus duration), thus the maximum number of errors possible was 
80. The target stimulus was an inverted u-shape that was 25 mm across the top, 50 mm on 
the long leg and 25 mm on the short leg. The mask was a similar shape, but larger than the 
stimulus, and included an irregular array of vertical lines in order to cover the long and short 
stimulus lines completely. The mask was 25 mm across the top, both legs were 55 mm long 
and each leg was 14 mm wide at the widest point. The VIT task was presented on a laptop 
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with a screen refresh rate of 17ms and participants viewed the display at 45cm from the 
screen. A schematic of the VIT task procedure is displayed in Figure 1. 
 
Figure 1. Schematic of VIT task 
 
 
3.6.2 Experimental task 2 – Rapid Serial Letter Identification (RSLI)  
In this task (adapted from Hoffman, 1978) participants were presented initially with a 
fixation cross (1000ms duration), followed by an ISI of 200ms and then the rapid 
presentation of the stimuli; a sequence of six consecutive letters. Five of the letters within 
the stream were black, and one, the target, was red. There were no ISI’s between any of the 
letters in a sequence. After the letter stream, an ISI of 350ms preceded a cue to “respond” 
and participants were required to identify the target letter verbally. The target letter was 
presented randomly in positions 2, 3, 4, or 5 and could be any letter of the alphabet 
excluding “O” or “I”. An ISI of 1000ms preceded the following trial. Before the test 
procedure, all participants were given 10 practice trials of gradually increasing difficulty (2 
x 800msstimuli, 2 x 400ms stimuli, 2 x 200ms stimuli, 2 x 85ms stimuli, 2 x 68ms stimuli) 
in which they were given feedback (with the word “correct” or “incorrect”, presented for 
1500ms) after each trial. Processing speed was investigated by manipulating the duration of 
the presentation of the letter stimuli in any one sequence; duration time was manipulated in 
 
 
Fixation (1000ms) Target (duration manipulated) Mask (500ms) Response 
ISI (1000ms) ISI (800ms) 
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a fixed pseudorandom order and letters could be displayed for 150ms, 125ms, 102ms, 85ms, 
68ms, 51ms, 34ms, or 17ms. There were 40 trials in total (5 at each duration), thus the 
maximum number of errors possible was 40. All letters within any one trial had the same 
duration time. Letter size was approximately 10mm by 10mm (bold Arial font size 18).The 
RSLI task was presented on a laptop with a screen refresh rate of 17ms and participants 
viewed the display at approximately 45cm from the screen. A schematic of the RSLI task is 
displayed in Figure 2. 
 
Figure 2. Schematic of the RSLI task 
 
 
3.6.3 Dual task ageing study 
Before the dual task developed by the current investigation was employed in the patient 
cohorts, a preliminary study was administered in healthy adults.  A similar paradigm to the 
one employed in the current study has been used to investigate dual tasking in ageing 
(Anderson et al, 2011) which showed no disproportionate age-effects in dual task cost. 
However, the authors did not have a middle-aged group in their study. As the patients in the 
current investigation were likely to be aged between 25 and 80, it was anticipated that the 




was set up to investigate dual task performance in the newly developed paradigm in three 
age groups (young, middle, and older) to investigate whether there could be a 
disproportionate dual task cost in patients or controls of a certain age. As the dual task 
paradigm employed a novel procedure, a pilot study was conducted in healthy young adults, 
the results of which informed the final procedure described below. A full description of the 
pilot study is presented in Appendix D. 
 
3.6.3.1 Participants 
Participants were recruited either through the University of Edinburgh’s volunteer 
participant panel or through friends and families of the researchers. Cognitive assessment of 
healthy controls in university premises was reviewed and given favourable opinion by the 
University of Edinburgh PPLS Ethics Committee (Title: “Processing speed and dual task 
ability in younger and older adults”, reference number: 148-0910). Twenty-five participants 
were recruited for each of the following age groups: Young = 18 – 35, Middle = 36 – 64, 
and Older = 65 – 85.  
 
3.6.3.2 Background measures 
Wechsler Test of Adult Reading (WTAR; Wechsler, 2001)  
The WTAR was employed as a measure of pre-morbid intelligence.  The number of errors 





3.6.3.3 Experimental task 3 – dual task  
Executive functioning was investigated by way of a dual task paradigm which employed 
VIT as one of the tasks, and delayed digit span as the other. A similar paradigm has been 
used to investigate dual task ability, without the confounds of reaction time based tasks, in 
children and older adults (Anderson et al., 2011). The dual task employed a preload 
paradigm (Cocchini et al., 2002) as typical concurrent dual task paradigms are likely to put 
high demands on response selection and initiation and thus result in interference, especially 
in populations with motor difficulties. All participants completed the dual task procedure in 
the same order as follows: 
 
 1. Baseline Delayed Digit Recall (DDR) level 
An individual’s baseline DDR level was determined by presenting them with increasing 
sequences of numbers to recall until maximum capacity was established. All participants 
started with trials containing a sequence of two digits, and were given three trials at each 
sequence length. Participants were presented with digits aurally at a rate of one per second, 
and asked to recall them after a fifteen second delay. If 2 out of 3 trials were completed 
accurately then the number of digits per sequence was increased incrementally, one digit at 
a time. Baseline DDR level was taken as the maximum number of digits recalled accurately 
in at least 2 out of 3 trials. 
 
2. Baseline Visual Inspection Time (VIT) level 
Participants completed VIT trials of decreasing stimulus duration until their own maximum 
level of ability was established.  Before the test procedure, all participants were given 9 
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practice trials of gradually increasing difficulty (3 x 400ms, 3 x 150ms, 3 x 68ms) in which 
they were given feedback (“correct” or “incorrect”) after each trial. During the titration 
procedure the VIT stimuli were presented at increasingly shorter durations (150ms, 125ms, 
102ms, 85ms, 68ms, 51ms, 34ms, and 17ms). Six VIT trials were presented at each stimulus 
duration – if participants responded accurately to at least five, they moved on to the next 
shortest duration. The stimulus duration time at which participants failed to reach the 
accuracy criterion (5 out of 6 trials correct) was taken as their baseline VIT level.  
 
3. Delayed Digit Recall single task 
Participants completed the DDR single task with sequences that had one less digit than their 
baseline DDR level – for example if baseline level was found to be 7 digits, they would be 
presented with sequences of 6 digits. This procedure was adopted as the results of a pilot 
study in young adults indicated that performing the dual task at maximum ability was overly 
difficult. Digit sequences were presented, and a 15 second delay preceded a cue to recall. 
Each participant completed a total of 8 trials. The number of digits correctly recalled from 
each sequence was added up across all trials, and this was represented as a percentage of the 
total number of digits presented to give the DDR single task performance as follows: 
 
DDR % correct = Number of digits recalled correctly     x   100 





4. VIT single task 
Participants completed the VIT single task with durations one step slower their baseline VIT 
level – for example if baseline level was found to be 17ms, they would be presented with 
trials of 35ms. This procedure was adopted as the results of a pilot study in young adults 
indicated that performing the dual task at the maximum ability was overly difficult. 
Participants were presented with 8 blocks of VIT trials, each block lasting 15 seconds and 
containing as many trials as would fit in that period. The number of accurate responses 
produced was taken as a measure of performance and represented as a percentage of the 
total number of trials to give the VIT single task performance as follows. 
 
VIT % correct = Number of VIT trials correct    x   100 
     Total VIT trials completed 
 
5. Preload Dual Task (Delayed Digit Recall interleaved with VIT trials) 
A schematic of the preload dual task procedure is presented in Figure 3. During any one 
trial, participants were presented with digit sequences, followed immediately by 15 seconds 
of VIT trials (digit sequence length and VIT durations were the same as in the single tasks). 
A cue was then presented to prompt recall of the digit sequence. Participants completed 8 
trials so that the total number of digit items and VIT items completed was equivalent to that 
of the single tasks. Performance in each task was measured in the same way as described in 
the single task conditions above to give DDR and VIT percentage correct scores under dual 
task conditions. A measure of dual task cost was then produced by calculating the 
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percentage change in performance between the single task conditions and dual task 
conditions as follows: 
 
Dual Task Cost (% change) = Dual task % correct – Single-task % correct        x   100 
                                                                     Single task % correct  
 
The average cost of the two component tasks under dual task conditions is a better 
representation of dual task cost as it controls for strategic prioritizing of one task over the 
other (Salthouse et al., 1995).  Thus average scores were also produced for dual task cost as 
follows:  
 
Average % change = DDR % change + VIT % change  
           2 
 






The cognitive data were explored for normal distribution using histograms, boxplots and the 
Shapiro-Wilk’s test of normality. In addition, all variables were checked for homogeneity of 
variance. Group differences were explored by one-way ANOVA’s. Planned post-hoc group 
comparisons with Tukey’s HSD or Games-Howell corrections (for unequal variances) are 
reported for any variables in which there were significant group differences. 
 
3.7 Dual task ageing study results 
Demographic data for the participants are displayed in Table 8. A significant difference was 
found in the Years of Education between groups; F (2, 72) = 5.179, p = 0.008. Planned post-
hoc comparisons revealed that the difference between Young and Middle participants was 
not significant, although Older participants had significantly fewer years of education than 
the Middle participants (p = 0.025), but not Young participants. However, there was no 
significant group differences in terms of the WTAR scores; F (2, 72) = 2.003, p = 0.142, 
suggesting that in fact the groups were well matched in terms of intelligence. 
 
Table 8. Ageing study group demographics 
 Young Middle Older 
Year of Educ. 16.2 (1.3) 17.3 (3.0) 14.7 (3.6) 
WTAR IQ 109.6 (12.1) 107.4 (10.3) 113.4 (9.7) 
Mean values with standard deviations in parentheses are presented. WTAR = Wechsler Test of Adult 




Participants’ baseline level of performance in the component tasks are displayed in Table 9. 
There were no significant group differences in the DDR level; F (2, 72) = 0.748, p = 0.477, 
suggesting that the ability to maintain digit sequences in mind was equal across the age 
groups. However, a significant group difference was revealed in the VIT level; F (2, 72) = 
21.284, p = 0.000. Planned comparisons revealed that Older participants were significantly 
slower than Middle participants (p = 0.001) and Young participants (p = 0.000), and in 
addition, Middle participants were significantly slower than Young participants (p = 0.018) 
indicative of a linear decrease in processing speed with age. 
 
Table 9. Ageing study baseline task performance levels 
 Young Middle Older 
DDR Level (digits) 5.8 (1.1) 5.4 (1.1) 5.6 (1.3) 
VIT Level (ms) 54.4 (15.5) 70.3 (19.9) 91.3 (23.9) 
Mean values with standard deviations in parentheses are presented. DDR = Delayed Digit Recall, 
VIT = Visual Inspection Time, ms = milliseconds. 
 
Participant performance in the single-task and dual task conditions is displayed in Table 10. 
There was no significant difference between the groups in terms of DDR single task 
performance; F (2, 72) = 1.401, p = 0.253. However, there was a significant group 
difference in VIT single task performance; F (2, 72) = 5.285, p = 0.007. Planned 
comparisons revealed that Older participants performed significantly worse than the Middle 
(p = 0.013) and Young (p = 0.023) participants, although there was no difference between 




Table 10. Ageing study single task and dual task performance; percentage correct scores 
 Young Middle Older 
DDR Single 97.5 (3.9) 98.1 (4.2) 96.1 (4.7) 
VIT Single 95.0 (5.3) 95.3 (3.5) 91.4 (5.4) 
DDR Dual 94.4 (7.4) 93.7 (9.7) 89.0 (7.0) 
VIT Dual 89.3 (9.4) 84.5 (12.6) 83.1 (7.2) 
Mean values with standard deviations in parentheses are presented. DDR = Delayed Digit Recall, 
VIT = Visual Inspection Time 
 
Details of the dual task costs incurred by the groups are presented in Table 11. The mean 
percentage change scores demonstrate that all groups experienced a modest drop in 
performance under dual task conditions. However, no significant group differences in dual 
task cost were observed in DDR; F (2, 72) = 1.578, p = 0.213, VIT; F (2, 72) = 1.739, p = 
0.183, or in the Average Dual Task Cost across both tasks; F (2, 72) = 2.066, p = 0.134. 
This result indicated that although group differences were observed in performance in the 
single-task condition, the relative drop in performance between single and dual task 








Table 11. Ageing study dual task cost; percentage change scores 
 Young Middle Older 
DDR cost 3.2 (7.7) 4.5 (9.6) 7.3 (7.5) 
VIT cost 6.1 (7.0) 11.3 (13.2) 8.9 (8.1) 
Average cost 4.7 (6.3) 7.9 (7.9) 8.1 (5.7) 
Mean values with standard deviations in parentheses are presented. DDR = Delayed Digit Recall, 
VIT = Visual Inspection Time 
 
3.8 Dual task ageing study summary 
The ageing study revealed that all participants experienced a dual task cost associated with 
completing the component tasks in the dual task condition compared to the single task 
conditions. However, there was no disproportionate drop in performance in either the 
middle-aged or older adults compared to the younger adults. As such, this study is 
consistent with the findings of others employing preload dual task methodology (Cocchini 
et al., 2002; MacPherson et al., 2007) and concurrent dual task methodologies (Logie et al., 
2004; Anderson et al., 2011) in suggesting that there is not an age-effect in dual tasking 
when performance in the component single-task are titrated. This is a beneficial finding for 
the application of the dual task procedure in degenerative disorders as age effects are 
unlikely to be a factor in any observed differences between patient and control groups. In 
addition, the fact that participants were able to perform a processing speed task, at or close 
to their maximum ability, concurrently with another task without suffering from a 
substantial performance decrement suggests that processing speed tasks do not interfere 




Chapter 4. Experimental tasks; ALS patients versus healthy controls 
The following chapter investigated the performance of ALS patients compared to healthy 
controls in the three experimental tasks described previously in Chapter 3, namely the VIT 
and RSLI tasks which assessed processing speed, and the dual task which assessed 
executive functioning.  
 
4.1 Participants 
ALS and matched healthy control participants were the same as described in Chapter 2 




The VIT and RSLI processing speed tasks were administered as described in Chapter 3 
(Sections 3.6.1 and 3.6.2 respectively). The dual task procedure was also the same as that 
described in Chapter 3 (Section 3.6.3.3). The same study protocol was employed in all 
participants whereby the dual task was performed near the start of the testing session, 
followed immediately by the RSLI task and then shortly by the VIT task (see Protocol, 
Appendix E). Experimental tests were performed near the beginning of the testing sessions 





4.3 Statistical analyses 
The data were explored for normal distribution using histograms, boxplots and the Shapiro-
Wilk’s test of normality. In addition, all variables were checked for homogeneity of 
variance. Not all ALS patients completed the VIT and RSLI tasks (see Table 12 for exact 
participant numbers); some patients were unable to complete some tests due to fatigue or 
time pressures. Comparative group analyses were performed using t-tests in normally 
distributed data and Mann-Whitney U tests in populations that were not normally 
distributed. In the ALS group, case analyses were also employed in which standardised 
scores (Z-scores) for individual ALS patients were derived from the mean and standard 
deviation of the healthy control group – individuals with scores that fell below 2 standard 
deviations of the control group mean were considered to be impaired. Correlational analyses 
in the ALS group were performed between experimental and standardized 




4.4.1 Processing speed 
Details of participant’s performance in the processing speed tasks are shown in Table 12. 
An examination of the group means shows that ALS patients and controls performed 
comparably in the VIT task and the RSLI task; indeed no significant differences were 
observed between the groups in terms of the amount of errors made on either task. The 
results indicate that ALS patients did not exhibit slowed processing speed in the 
identification of either abstract or meaningful visual information. Calculation of Z-scores in 
the ALS group revealed that only 1 patient had a score that fell below 2 standard deviations 
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of the control group mean in the VIT, and the same result was observed in the RSLI task. 
Different individuals were impaired in the respective tasks.     
 
Table 12. Processing speed data for ALS patients and healthy controls 
 n (ALS:HC) ALS  HC  t or U p value  
VIT (errors) 25:29 13.5 [8.0]  
(0 – 38) 
12.9 [7.6] 
(4 – 37) 
-0.565 (U) 0.572 
RSLI (errors) 28:30 16.4 [3.9] 
(9 – 24) 
15.8 [3.1] 
(9 – 24) 
0.648 0.520 
Mean values with [standard deviations] and (ranges) in parentheses are presented. Ratios are 
presented for number of patients versus controls in each task. VIT = Visual Inspection Time (max. 
errors = 80), RSLI = Rapid Serial Letter Identification (max. errors = 40). 
 
4.4.2 Dual task 
Details of participant performance in the baseline DDR and VIT levels are displayed in 
Table 13. Comparative analyses revealed that ALS patients and controls performed 
comparably in baseline levels in both the DDR and VIT tasks, suggesting that the ability to 
maintain digit sequences in mind and the speed at which visual information could be 
processed was equal to healthy controls. Z-scores in the ALS group revealed that no patients 
were impaired in the DDR baseline task, whilst only one patient met this criterion in the 





Table 13. Baseline task performance levels for ALS patients and healthy controls 
 n (ALS:HC) ALS  HC  U p value  
DDR baseline (digits)   29:30 5.5 [1.1] 
(4 – 8) 
5.8 [1.0] 
(4 – 7) 
1.187  0.235 
VIT baseline (ms) 29:30 60.9 [23.9] 
(34 – 150) 
62.3 [18.6] 
(34 – 102) 
0.679  0.497 
Mean values with [standard deviations] and (ranges) in parentheses are presented. Ratios are 
presented for number of patients versus controls in each task. VIT = Visual Inspection 
Time, DDR = Delayed Digit Recall, ms = milliseconds. 
 
Participant performance in the single-task and dual task conditions is displayed in Table 14. 
The means show that ALS patients and healthy controls performed similarly under single 
task conditions whereas under dual task conditions ALS patients were less accurate than 
controls. Indeed, comparative analyses revealed that there was no significant difference 
between the groups in terms of DDR single-task performance (U = -0.78, p = 0.433) or VIT 








Table 14. Single and dual task performance: percentage correct for ALS patients and 
healthy controls 
 n (ALS:HC) ALS  HC  
DDR Single  29:30 97.2 [4.7] 
(83 - 100) 
96.4 [4.6] 
(88 – 100) 
VIT Single  29:30 89.4 [10.8] 
(56 - 100) 
90.8 [9.3] 
(59 – 100) 
DDR Dual 29:30 91.7 [10.2] 
(73 – 100) 
94.0 [6.7] 
(73 – 100) 
VIT Dual 29:30 81.8 [13.3] 
(56 – 100) 
87.6 [10.3] 
(63 - 100) 
Mean values with [standard deviations] and (ranges) in parentheses are presented. Ratios are 
presented for number of patients versus controls in each task. VIT = Visual Inspection Time, DDR = 
Delayed Digit Recall.  
 
Percentage change scores are a more accurate reflection of the cost associated with 
performing two tasks concurrently than percentage correct scores. An examination of the 
mean percentage change scores (displayed in Table 15 below) indicates that ALS patients 
experienced greater Dual Task Costs than healthy control participants in both the DDR and 
VIT tasks, however, these differences did not reach statistical significance. Crucially, 
comparative analyses of the Average Dual Task Cost revealed significant differences 
between ALS patients and healthy controls suggesting that ALS patients did exhibit 
impaired dual task performance. Indeed, the mean percentage change scores show that 
patients exhibited a drop in performance from single to dual task that was more than twice 
that of controls. Z-scores in the ALS group indicated that 9 patients were impaired in terms 
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of DDR Dual Task Cost, with 1 further patient showing impairment in VIT Dual Task Cost. 
In terms of the Average Dual Task Cost, Z-scores revealed that 3 patients met the criteria 
for impaired performance. 
 
Table 15. Dual Task Cost: percentage change for ALS patients and healthy controls* 
 n 
(ALS:HC) 
ALS  HC  t or U p value  
DDR Dual Task Cost 29:30 5.6 [10.5] 
(-21 – 25) 
2.5 [5.3] 




VIT Dual Task Cost 29:30 8.3 [11.4] 
(-15 – 32) 
2.6 [14.5] 
(-40 – 36) 
1.661 0.102 
Average Dual Task Cost  29:30 6.9 [7.2] 
(-5 – 22) 
2.5 [7.7] 
(-20 – 17) 
2.240 0.029 
Mean values with [standard deviations] and (ranges) in parentheses are presented. * Significant 
results are highlighted in bold. Ratios are presented for number of patients versus controls in each 
task. VIT = Visual Inspection Time, DDR = Delayed Digit Recall.  
 
4.4.3 Correlations with standardised neuropsychological tests 
Associations between performance in each experimental task (VIT errors, RSLI errors, and 
Average Dual Task Cost) and the standardised neuropsychological tests employed in 
Chapter 2 were performed; no significant correlations were observed for any experimental 
measure. In addition, there were no significant correlations between any of the experimental 





ALS performance in the experimental tests showed a clear dissociation between intact 
performance in the processing speed tasks, and impaired performance in the executively 
demanding dual task. The ALS group showed no evidence of impairment in either the VIT 
or RSLI task, in fact performance in both tasks was almost identical to that of healthy 
controls, suggesting that processing speed for visually presented information was normal. 
Inspection time tasks have been shown to be sensitive to slowed processing speed in healthy 
ageing (Gregory et al., 2009) and subcortical dementias such Parkinson’s disease (Johnson 
et al., 2004) with the suggestion that impaired inspection time ability is a reflection of 
slowed processing speed in early or low-level cognitive functions. The RSLI task was 
employed as an extension of the inspection time paradigm to investigate processing speed 
for meaningful verbal information. Both tests assessed processing speed by manipulating 
stimulus duration, and as such account for motor disability with untimed responses. The 
results of the current investigation suggest that reports of slowed reaction times in tasks of 
visuoperceptual speed such as digit cancellation and visual search tasks (Gallassi et al., 
1985; Chari et al., 1996) may not be a reflection of slowed processing speed in ALS, but 
rather may simply reflect a compromised motor system as such paradigms place 
considerable demand on the motor (hand) functions. Similarly, previous reports of 
impairments in traditional tests of processing speed such as the SDMT (Massman et al., 
1996; Messapesa et al., 2007), TMT (Hanagasi et al., 2002; Witgert et al., 2010), and 
PASAT (Moretti et al., 2002) are unlikely to reflect a slowing of cognitive processing in 
ALS. Instead, poor performance in these tasks is more likely to be a manifestation of 
impairments in executive processes such as working memory, and the ability to shift or 
divide attention, which have also been implicated in these complex tasks (Robertson et al., 
1996; Bate et al., 2001; Sanchez-Cubillo et al., 2009). Thus, the current findings suggest 
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that studies which report deficits in psychomotor speed (see Raaphorst et al., 2010 meta-
analysis) are most likely a reflection of motor impairment rather than cognitive slowing, and 
that ALS patients are able to process simple visual information at a normal rate. Processing 
speed, when isolated from motor functioning and other high-order processes, is not impaired 
in ALS patients and does not contribute to other observed cognitive impairments. 
 
In contrast, ALS patients exhibited a selective deficit in dual task performance; the accuracy 
cost incurred by performing two tasks concurrently was more than twice as high in patients 
compared to healthy controls. The component tasks were matched to each participant’s 
baseline level so that a dual task effect could not be the result of single task difficulty 
(Anderson et al., 2011). No group differences were found in terms of the baseline levels on 
either the DDR or VIT task indicating that ALS patients were able to perform as well as 
healthy controls; this was confirmed by similar accuracy scores achieved by both groups in 
single task conditions. Thus, the dual task decrement exhibited by patients is likely to be a 
reflection of a specific impairment in the ability to co-ordinate cognitive resources 
appropriately between the two tasks, and reflect dysfunction of the central executive. Dual 
task impairments are observed in Alzheimer’s Disease (Logie et al., 2004; MacPherson et 
al., 2007) and have also been reported to a lesser extent in FTD (Perry & Hodges, 2000; 
Sebastian & Hernandez-Gill, 2010) and in a previous study of ALS based on reaction time 
measures (Schreiber et al., 2005). The current investigation employed a preload 
methodology to minimise motor demands (Cocchini et al., 2002), and constituent tasks for 
which accuracy was the outcome measure, and as such is the first demonstration of a dual 
task impairment in ALS that it independent of single task difficulty, processing speed, and 
motor functioning.  
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Chapter 5. Experimental tasks; ALS patients versus MS patient versus 
healthy controls 
Chapter 5 investigates experimental task performance in a slightly smaller subgroup of ALS 
patients (n =25) compared to that of MS patients and healthy controls. In this way, direct 
comparisons can be made between the ALS and MS groups to determine whether or not 
they exhibit a similar cognitive profile. 
 
5.1 Participants 
MS patients and the matched healthy control participants were the same as those described 
in Chapter 2 (Section 2.2.2 and Section 2.2.3 respectively), and ALS patients were the same 
as those described in Section 2.6.1 The group demographic are identical to those described 
in the 3-way analysis of background neuropsychological assessment in Chapter 2 (Section 
2.6.2). As a summary: significant group differences were found between age (ALS patients 
were significantly older than healthy controls), and HADS D score (MS patients displayed a 
trend towards significantly higher HADS D scores than healthy controls).  
 
5.2 Methodology 
The VIT and RSLI processing speed tasks were administered as described in Chapter 3 
(Sections 3.6.1 and 3.6.2 respectively). The dual task procedure was also the same as that 
described in Chapter 3 (Section 3.6.3.3). The same study protocol was employed in all 
participants whereby the dual task was performed near the start of the testing session, 
followed immediately by the RSLI task and then shortly by the VIT task (see Protocol, 
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Appendix E). Experimental tests were performed near the beginning of the testing sessions 
to maximise data collection in the event of participant fatigue.  
 
5.3 Statistical analyses 
The data were explored for normal distribution using histograms, boxplots and the Shapiro-
Wilk’s test of normality. In addition, all variables were checked for homogeneity of 
variance. Not all ALS patients completed the VIT and RSLI tasks (see Table 16 for exact 
participant numbers); some patients were unable to complete some tests due to fatigue or 
time pressures. Comparative group analyses were performed using one-way ANOVAs in 
normally distributed data and Kruskal-Wallis tests in populations that were not normally 
distributed. In parametric data planned post-hoc group comparisons with Tukey’s HSD or 
Games-Howell corrections (for unequal variances) are reported for any variables in which 
there were significant group differences. In non-parametric data, Kruskal-Wallis post-hoc 
comparisons corrected for family wise errors are reported for any variables in which there 
was a significant group effect. In cases where statistical significance was marginally missed, 
measures of effect size are provided by Cohen’s d. In the ALS and MS groups, case 
analyses were also employed in which standardised scores (Z-scores) for individual ALS 
and MS patients were derived from the mean and standard deviation of the healthy control 
group – individuals with scores that fell below 2 standard deviations of the control group 
mean were considered to be impaired. Associations between performance in experimental 
tests and age were performed in the ALS group. Associations between performance in 
experimental tests and mood were investigated in the MS group. Spearman’s rho 
correlations were employed to investigate all associations as age and mood data were found 
to be non-parametric and covariate analyses were performed using Quade’s Rank ANCOVA 
(Quade, 1967). Quade’s Rank ANCOVA is a procedure whereby the dependent variable and 
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covariate of interest are first transformed by rank and then entered into a regression analysis. 
The unstandardized residual values of the regression are subsequently used in a standard 
one-way ANOVA. In addition, correlational analyses in the ALS and MS groups were 
performed between experimental and standardized neuropsychological tests with Pearson’s 
r in parametric variables and Spearman’s rho in non-parametric variables. 
 
5.4 Results 
5.4.1 Processing speed 
Details of the number of errors made by each group in the VIT and RSLI experimental 
processing speed tasks are displayed in Table 16. The mean scores show that MS patients 
made the most errors in both tests, and comparative analyses revealed significant group 
differences in the RSLI task; F (2, 71) = 8.354, p = 0.001, but not in the VIT task; H (2) = 
1.292, p = 0.524. Post-hoc analyses in the RSLI task showed that MS patients made 
significantly more errors than healthy controls (p = 0.007) and ALS patients (p = 0.016), but 
there was no difference between ALS patients and healthy controls. The results suggest that 
MS patients exhibited slowed processing speed for meaningful visual information. Z score 
analyses revealed that 4 ALS patients and 4 MS patients had scores below 2 standard 
deviation of the control group mean in the VIT task. In the RSLI task, z-scores indicated 
that 1 ALS patient and 10 MS patients met the criterion for impaired performance. 





Table 16. Processing speed performance: errors for ALS patients, MS patients, and healthy 
controls 
 n (ALS:MS:HC) ALS MS HC  
VIT (errors) 21:23:25 12.5 [6.8] 
(0 – 27) 
14.9 [9.5] 
(5 – 50) 
11.6 [4.0] 
(5 – 21) 
RSLI (errors) 25:24:25 16.2 [4.0] 
(9 – 24) 
21.1 [7.2] 
(7 – 36) 
16.0 [2.6] 
(10 – 22) 
Mean values with [standard deviations] and (ranges) in parentheses are presented. Ratios are 
presented for number of patients versus controls in each task. VIT = Visual Inspection Time (max. 
errors = 80), RSLI = Rapid Serial Letter Identification (max. errors = 40). 
 
5.4.2 Dual task  
Details of participant performance in the baseline DDR and VIT levels are displayed in 
Table 17. Comparative analyses revealed significant group differences in baseline DDR 
performance; H (2) = 6.831, p = 0.033. Post-hoc analyses showed that the MS group 
retained significantly fewer digits than the healthy control group (p = 0.045). However no 
significant differences were observed between the ALS group and the MS group, or the 
ALS group and healthy controls. With regard to baseline VIT performance, although the 
mean scores show that the MS group performed more poorly than the healthy control group 
and the ALS group, these differences just failed to reach significance; H (2) = 5.683, p = 
0.058. Unplanned post-hoc comparisons were carried out between the MS group and 
healthy control group and revealed a significant group effect; H (1) = 4.438, p = 0.035, 
however the result was no longer significant after correction for family wise error (p = 
0.105, d = 0.63). The results replicate the findings demonstrated in Chapter 4 (section 4.4.2) 
179 
 
by showing that ALS patients and healthy controls performed comparably in the baseline 
component tasks. By contrast, MS patients showed evidence of impaired performance in 
DDR baseline level, and although not significant after family wise error correction, also had 
lower scores in the VIT baseline level.  Z-scores in the patient group revealed that 5 ALS 
patients and 5 MS patients met the criteria for impairment in the DDR baseline level 
performance. In terms of the VIT baseline performance, z-scores indicated that 1 ALS 
patient and 3 MS patients were impaired relative to controls in this measure. 
 
Table 17. Baseline task performance levels for ALS patients, MS patients, and healthy 
controls 
 n (ALS:MS:HC) ALS  MS HC  
DDR baseline (digits)    25:25:25 5.4 [1.1] 
(4 – 8) 
5.3 [1.2] 
(3 – 8) 
6.0 [0.9] 
(4 – 7) 
VIT baseline (ms) 25:25:25 59.7 [24.6] 
(34 – 150) 
71.5 [26.1] 
(34 – 150) 
57.8 [16.3] 
(34 – 102) 
Mean values with [standard deviations] and (ranges) in parentheses are presented. Ratios are 
presented for number of patients versus controls in each task. VIT = Visual Inspection Time, DDR = 
Delayed Digit Recall, ms = milliseconds. 
 
Participants’ performance under single and dual task conditions are displayed in Table 18. 
Comparative analyses revealed no group differences in terms of single task performance in 
the DDR task; H (2) = 1.518, p = 0.468, or the VIT task; H (2) = 2.698, p = 0.259. The 
results indicate that the patient groups were able to perform comparably to healthy controls 
under single task conditions. 
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Table 18. Single and dual task performance: percentage correct for ALS patients, MS 
patients, and healthy controls 
 n (ALS:MS:HC) ALS  MS HC  
DDR Single  25:25:25 97.0 [5.0] 
(83 – 100) 
95.3 [6.1] 
(83 – 100) 
96.2 [4.5] 
(88 – 100) 
VIT Single  25:25:25 90.5 [10.4] 
(56 – 100) 
89.6 [10.1] 
(53 – 100) 
93.4 [6.7] 
(79 – 100) 
DDR Dual 25:25:25 91.9 [10.1] 
(73 – 100) 
90.8 [11.1] 
(63 – 100) 
96.5 [4.4] 
(88 – 100) 
VIT Dual 25:25:25 83.7 [12.9] 
(56 – 100) 
81.7 [14.7] 
(48 – 100) 
90.5 [8.5] 
(64 – 100) 
Mean values with [standard deviations] and (ranges) in parentheses are presented. Ratios are 
presented for number of patients versus controls in each task. VIT = Visual Inspection Time, DDR = 
Delayed Digit Recall  
 
Mean percentage change scores (Dual Task Cost) for the participant groups are displayed in 
Table 19 and show that the ALS and MS groups experienced substantially greater Dual 
Task Costs than the healthy control group in both component tasks. Comparative analyses 
revealed significant group differences in DDR Dual Task Cost; H (2) = 6.914, p = 0.032. 
Post-hoc group comparisons revealed trends towards significance suggesting that the 
healthy control group exhibited smaller Dual Task Costs than the ALS group (p =  0.058, d 
= 0.69) and the MS group (p = 0.082, d = 0.74), but there was no difference between the 
ALS group and MS group. Group differences in VIT Dual Task Cost scores were not 
statistically significant; H (2) = 3.900, p = 0.142. However, the Average Dual Task Cost 
was significantly different between groups; F (2, 74) = 5.419, p = 0.006. Post-hoc group 
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comparisons indicated that the healthy control group exhibited a significantly smaller Dual 
Task Cost than the ALS group (p = 0.026) and the MS group (p = 0.010) whilst there was no 
difference in performance between the ALS group and MS group. The results suggest that 
both patient groups exhibited impaired dual task performance relative to controls. In terms 
of individual patient performance, z-scores in the patients groups indicated that 9 ALS 
patients and 7 MS patients showed impaired performance in terms of DDR Dual Task Cost, 
whereas 2 ALS patients and 3 MS patients showed impaired performance in terms of the 
VIT Dual Task Cost. Z-scores for the Average Dual Task Cost revealed that 5 ALS patients 
and 8 MS patients exhibited impairments in the overall measure of dual task performance.  
  
Table 19. Dual Task Cost: percentage change for ALS patients, MS patients, and healthy 
controls 
 n (ALS:MS:HC) ALS  MS HC  
DDR Dual Task Cost 25:25:25 5.2 [10.2] 
(-21 – 22) 
4.8 [8.5] 
(-8 – 25) 
-0.4 [5.1] 
(-14 – 10) 
VIT Dual Task Cost 25:25:25 7.2 [11.7] 
(-15 – 32) 
9.0 [11.5] 
(-10 – 32) 
2.6 [11.6] 
(-23 – 36) 
Average Dual Task Cost  25:25:25 6.2 [6.7] 
(-5 – 21) 
6.9 [7.8] 
(-7 – 21) 
1.1 [5.8] 
(-14 – 16) 
Mean values with [standard deviations] and (ranges) in parentheses are presented. Ratios are 
presented for number of patients versus controls in each task. VIT = Visual Inspection Time, DDR = 





5.4.3 Correlations with age and depression 
The ageing study (Chapter 3, Section 3.6.3) demonstrated that the dual task paradigm 
employed by the current investigation was unaffected by age. However, processing speed 
measures have been consistently shown to be sensitive to ageing (e.g. Salthouse, 1996). 
Comparative analyses of age (Chapter 2, Section 2.6.2) revealed that the average age of the 
ALS group was significantly higher than the MS group, although not healthy controls. 
Moreover, ALS patients had the largest age range of any of the participant groups indicating 
that any potential age effects would most likely exist within the ALS population. Thus, to 
further investigate the effect of age, correlational analyses were performed between age and 
all background variables in the ALS patient group. No significant correlations were found 
between age and any of the experimental measures and as such no covariate analyses were 
performed.  
 
The effect of depression in the MS group was investigated in all experimental variables; a 
significant correlation was observed between HADS D score and RSLI errors; rho = 0.59, p 
= 0.002. Thus, the investigation of group effects in this measure was subjected to covariate 
analyses with depression. Quade’s Rank ANCOVA revealed significant group differences in 
the RSLI task; F (2, 71) = 4.562, p = 0.014. Post-hoc comparisons showed that MS patients 
made significantly more errors than healthy controls (p = 0.027) and ALS patients (p = 
0.029), but there was no difference between ALS patients and healthy controls. The result 
indicates that the observed impairment exhibited by MS patients in the RSLI task remained 





5.4.4 Correlations with standardized neuropsychological tests 
Associations between performance in each experimental task (VIT errors, RSLI errors, and 
Average Dual Task Cost) and the standardised neuropsychological tests employed in 
Chapter 2 were performed. In the ALS group no significant correlations were observed for 
any experimental measure. In addition, there were no correlations between any of the 
experimental tasks. However, in the MS group several significant correlations were 
revealed. Average Dual Task Cost correlated with performance in all conditions of the 
Logical Memory scales: Immediate recall; rho = -0.44, p = 0.031, Delayed recall; r = -0.59, 
p = 0.003, Retention; rho = -0.42, p = 0.041, and delayed Recognition; rho = -0.55, p = 
0.006. In addition, Average Dual Task Cost correlated with performance in the RSLI task; r 
= 0.46, p = 0.023. There were no significant associations between the VIT task or RSLI task 
and any standardized neuropsychological tests. 
 
5.5 Summary 
The three-way group comparison in the experimental tasks revealed some interesting 
differences between ALS patients and MS patients. Relative to healthy control participants, 
the subgroup of 25 ALS patients exhibited the same pattern of intact processing speed and 
impaired dual task performance as that reported and discussed in Chapter 4. Such findings 
suggest that this pattern of selective dual task impairment in the absence of slowed 
processing speed is a robust finding in ALS, even when patients are compared to a younger 
control group. Moreover, correlational analyses between age and the experimental measures 





Patients with MS made more errors in the VIT task than ALS patients and healthy controls, 
however, the difference was not significant. The standard deviation of the MS group in the 
VIT task indicates that performance was more variable than that of ALS patients and 
healthy control participants, and further evidence for this is provided by the difference 
between MS patients and healthy controls in the baseline VIT level within the dual task 
paradigm. In terms of the RSLI task, MS patients made significantly more errors than both 
healthy controls and ALS patients suggesting that the MS group exhibited impaired 
processing speed for meaningful visual stimuli. Although scores in self-reported depression 
in MS correlated with performance in this task, covariate analyses demonstrated that 
controlling for depression did not attenuate the group differences. Processing speed deficits 
have been postulated by some investigators to be the most common impairment in MS 
(DeLuca et al., 2004; Rosti et al., 2007) and the results of the current study provide further 
evidence of such impairment. However, unlike commonly used tests of processing speed 
such as the PASAT, the RSLI task employed by the current investigation minimises 
demands on working memory and thus the observed impairment in this task is a more valid 
indication that MS patients can experience slowed processing speed independent of working 
memory abilities. In addition, the RSLI task utilised the manipulation of stimuli duration 
and was therefore independent of the motor dysfunction confounds that are inherent to other 
tasks such as symbol search and choice reaction time tests which previous studies have 
employed to demonstrate processing speed deficits in MS (DeLuca et al., 2004; Hughes, 
Denney & Lynch, 2011). Nevertheless, the RSLI task imposes greater attentional demands 
than the VIT task as it requires the identification of a specific letter as opposed to a simple 
choice between left and right. These additional processing demands may be the difference 
between normal and slowed processing speed in MS and suggest that MS patients may be 




The MS group exhibited a dual task deficit as evidenced by significantly greater Dual Task 
Cost than the matched healthy control group. Although MS patients’ baseline performance 
in the DDR and VIT task was worse than that of healthy control participants, performance 
in both tasks under single task conditions was comparable to that of healthy controls. This 
finding demonstrates the importance of matching baseline task performance to each 
individual’s ability, and moreover suggests that the dual task deficit was specific to the 
demands incurred when completing two tasks concurrently. Therefore, although MS 
patients displayed evidence of slowed processing speed in the RSLI task, the fact that they 
were able to complete the VIT task under single task conditions comparably to the control 
group suggests that the observed dual task deficit is independent of the observed processing 
speed impairment. As such, the findings of the current study are consistent with others 
reporting greater impairments in attentionally demanding tasks that are independent of basic 
processing speed ability as assessed by reaction times (DeSonneville et al., 2002; Tinnefeld 
et al., 2005). Moreover, the current findings are concordant with others reporting dual task 
impairments in MS patients (D’Esposito et al., 1996; Comi et al., 1999), and extend these 
findings to a paradigm that is independent of motor functioning.  
 
The comparison between ALS and MS patients in the dual task revealed essentially similar 
performance once single task abilities were taken into account. Both patient groups 
performed comparably to controls, and each other, under single tasks conditions, but 
showed impairment under dual task conditions as evidenced by significant differences in 
Average Dual Task Cost. The only clear difference in performance between ALS and MS 
patients in the experimental tasks was observed in the RSLI task in which MS patients 
showed significantly worse performance than both healthy controls and ALS patients. Such 
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a result indicates that although both patient groups show a pattern of intact basic processing 
speed (as evidenced by VIT task performance), combined with impaired executive 
functioning (as evidenced by dual task performance), MS patients may be more susceptible 
to lower levels of attentional demand required by the RSLI task which may suggest that 


















Chapter 6. Structural imaging in ALS patients versus healthy controls 
The following chapter primarily concerns the investigation of white matter integrity in ALS 
patients compared to that of matched healthy control participants by way of diffusion tensor 
magnetic resonance imaging (DTI). The basic principles of DTI and previous studies 
employing this technique in the investigation of cerebral changes in ALS have been 
discussed in Chapter 1 (Section 1.8.3.3). The current study employed region-of-interest 
(ROI) and voxel-based methods, specifically Tract-based Spatial Statistics (TBSS), to 
investigate diffusion data in ALS patients and healthy controls. In addition, volumetric 
analyses of grey matter structure obtained from high-resolution three dimensional T1-
weighted scans were carried out using voxel-based morphometry (VBM) to determine the 




ALS and matched healthy control participants were the same as described in Chapter 2 
(Sections 2.2.1 and 2.2.3), and group demographics are the same as reported in Section 2.4. 
Imaging data was collected for all 29 ALS patients and 30 healthy control participants 
unless otherwise stated. All MRI scans were completed within 4 weeks of the 







6.2.1 MRI acquisition  
All MRI data were acquired using a GE Signa Horizon HDxt 1.5 T clinical scanner (General 
Electric, Milwaukee, WI, USA) equipped with a self-shielding gradient set (33 mT/m 
maximum gradient strength) and manufacturer supplied 8-channel phased-array head coil. 
The diffusion MRI protocol consisted of 7 T2-weighted (b ~ 0 s/mm
2
) and sets of diffusion-
weighted (b = 1000 s/mm
2
) whole brain single-shot spin-echo echo-planar imaging (EPI) 
volumes acquired with diffusion encoding gradients applied in 64 non-collinear directions 
(Jones et al., 2002). The acquisition parameters were: field-of-view 256  256 mm; imaging 
matrix 128  128; and 72  2 mm thick contiguous axial slice locations giving 2 mm 
isotropic voxels. The repetition and echo times for the single-shot spin-echo EPI sequence 
were 16.5 s and 98.3 ms respectively. The whole protocol took approximately 20 minutes.  
 
6.2.2 DTI preprocessing 
Diffusion MRI data were converted from DICOM (http://dicom.nema.org) to NIfTI-1 
(http://nifti.nimh.nih.gov/nifti-1) format, and pre-processed with FSL tools 
(http://www.fmrib.ox.ac.uk/fsl) in order to extract the brain, eliminate bulk patient motion 
and eddy current-induced artefacts, and estimate the water diffusion tensor parameters mean 






6.2.3 Regions of Interest white matter analysis  
ROI analysis was performed using ‘in-house’ software written in MATLAB (The 
MathWorks, Natick, MA, USA) which allowed multiple small square ROIs to be placed on 
the T2-weighted EPI volumes and then overlaid on the co-registered mean diffusivity (D) 
and fractional anisotropy (FA) maps either by hand or automatically using locations defined 
in Montreal Neurological Institute (MNI; http://www.bic.mni.mcgill.ca) standard space. In 
the latter, the software allows the user to interactively move ROIs if standard to native space 
registration errors cause white matter ROIs to be placed over cerebrospinal fluid (CSF) or 
grey matter structures. Thus, the ROI analysis was semi-automated, and specifically 
designed to be as reproducible as possible by defining the central ROI coordinates in MNI 
space and transferring them to native space. This allowed the initial positioning of each ROI 
to be the same for every individual. This approach provides a sensible method for measuring 
the integrity of a range of small to medium sized white matter structures, a number of 
which, such as the corona radiata, white matter underlying the prefrontal gyri and temporal 
and occipital gyri, cannot easily be identified using tractography.  
 
The procedure for obtaining D and FA values for each ROI was as follows. First, MNI 
coordinates were defined in standard space for each ROI using the ICBM-DTI-81 white 
matter atlas (Oishi et al., 2011). Typically, between 6 and 12 square ROIs were defined for 
each white matter structure in axial view, sizes of which were 3  3  1 voxels, or 2 x 2 x 1 
voxels depending on the white matter region. Several ROIs were used for each white matter 
region in order to reduce the effects of differences in individual ROI placement. Next, the 
coordinates were mapped from standard to native space using the affine transformation 
matrices derived by registering each subject’s T2-weighted EPI volume to MNI standard 
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space. The placement of the ROIs in individual images was then checked manually to 
ensure minimal contribution of grey matter and CSF signal to the D and FA 
measurements. An example of typical ROI placements is presented in Figure 4. To ensure 
unbiased measurements of D and FA, all ROI were defined on the T2-weighted EPI 
volumes (Bozzali & Cherubini, 2007) blind to each subjects’ clinical status. Values for D 
and FA were then obtained for each square ROI and averaged to give mean values for each 
white matter structure-of-interest. Finally, blinded to the original ROI selection, an 
assessment of intra-rater reliability of ROI placement was also performed by repeating the 
above analysis in 10 subjects (5 patients and 5 controls) chosen at random from the study 
cohort. 
 
Figure 4. Examples of standard space white matter ROIs; association fibres in middle 





Based on previous studies, a set of white matter structures that are potentially affected in 
ALS were chosen for investigation (Abrahams et al., 2005; Sarro et al., 2011). These 
included major white matter fibre bundles of the anterior thalamic radiation, uncinate 
fasciculus, superior longitudinal fasciculus, inferior longitudinal fasciculus, corticospinal 
tract, as well as the genu and splenium of corpus callosum. Also measured were the anterior 
cingulum, as well as the cingulum and ventral cingulum bundle connected to the 
hippocampus. White matter underlying sub-regions of prefrontal cortex were investigated; 
a) superior frontal gyrus white matter (near cortical area BA10), b) middle frontal gyrus 
white matter (near cortical area BA9/46), and c) inferior frontal gyrus white matter (near 
cortical area BA44/45). In addition, white matter within the corona radiata (superior and 
posterior regions), anterior corona radiata, superior parietal lobule, and temporal gyri 
(superior, middle and inferior) were also measured. Finally, areas that were not expected to 
be implicated in ALS were included, namely the optic radiation and white matter within 
occipital gyri.  
 
6.2.4 Corpus callosum segmentation  
As abnormalities in corpus callosum structural integrity have been shown to be a consistent 
feature of cerebral pathology in ALS (Yamauchi et al., 1995; Filippini et al., 2010), the 
corpus callosum was extracted at midline using an automatic segmentation tool. The method 
takes the FA and principal eigenvector volumes and registers them to the JHU-ICBM 2 mm 
FA template (Johns Hopkins University, Baltimore, MD, USA; http://cmrm.med.jhmi.edu) 
using affine registration to ensure the midline is in the centre of the x-axis. The midline 
corpus callosum is then identified by applying a threshold between 0.2 and 0.4 to the FA 
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volume, and identifying those voxels whose principal eigenvectors have a predominantly 
left-right orientation (red) from the red/green/blue principal eigenvector colour map. The 
resulting segmentation mask (see Figure 5) is then applied to the D and FA volumes to 
provide average values for these water diffusion biomarkers in this structure-of-interest. 
Segmentation was unsuccessful in 6 ALS patients and 3 healthy controls so comparative 
analyses were conducted in 23 and 27 participants respectively.  
 
Figure 5. Example of corpus callosum segmentation 
 
 
6.2.5 Statistical analyses; ROI and corpus callosum segmentation 
White matter ROI and corpus callosum segmentation data was explored for normality using 
Shapiro-Wilk tests and histograms, while comparative analyses were conducted with 
univariate analysis of variance with age entered as a covariate (ANCOVA; Agosta et al., 
2010). Multiple comparisons were controlled for by applying a false discovery rate 
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algorithm to the data (Pike, 2011; Sarro et al., 2011). Associations between performance in 
cognitive tests and white matter ROI data was investigated in the patient group only using 
Pearson’s r correlations. Correlations were only performed between regions/tracts and 
cognitive tests in which there were significant group differences. As such the reported p 
values are one-tailed.  
 
6.2.6 Tract based spatial statistics white matter analysis 
TBSS, part of the FSL image analysis platform (Smith, 2004), was used to perform a 
skeleton-based analysis of white matter FA and D data (Smith, 2006). Non-linear co-
registration was performed using FNIRT to align the FA volumes of each individual 
participant to the MNI standard space of the FMRIB58_FA template (Anderson, Jenkinson 
& Smith, 2007a, 2007b) which uses a b-spline representation of the registration warp field 
(Rueckert 1999). The resulting FA volumes were then visually checked for any registration 
errors. After image registration, these FA maps were averaged to produce a group mean FA 
volume. Next, the mean FA volume was thinned to create a mean FA skeleton which 
represents the centres of all tracts common to the group. Each participant's aligned FA data 
was then projected onto this skeleton to create a 4 dimensional FA volume. The process was 
then repeated for D data using the same non-linear registration parameters and projection 
vectors used to create the original mean FA skeleton, to produce a 4 dimensional D 






6.2.7 Statistical analyses; TBSS  
The 4 dimensional skeletonized FA and D volumes were statistically tested via a voxel-
wise general linear model (GLM) design matrix. Significant clusters were formed by 
employing the threshold-free cluster enhancement (TFCE) method (Smith & Nichols, 
2009). The TFCE method is a cluster-based thresholding method which does not require the 
setting of an arbitrary cluster forming threshold, instead it takes a raw statistics image and 
produces an output image in which the voxel-wise values represent the amount of cluster-
like local spatial support. The TFCE image is then turned into voxel-wise p-values via 
permutation testing. Permutation testing was performed using the program Randomise, part 
of FSL, which uses Monte Carlo permutation testing to generate 5000 random permutations 
and provides a solution to the multiple testing problem (Nichols and Holmes, 2007). Group 
comparisons between ALS patients and healthy controls were performed for the conditions 
‘voxel FA/D for controls > voxel FA/D for ALS patients’, and the converse statement 
‘voxel FA/D for ALS patients > voxel FA/D for controls’. Clusters reported have 
significance at p ≤ 0.05, corrected for multiple comparisons via family-wise error 
correction. For the ALS patients, correlational analyses were also performed between 
FA/D maps and neuropsychological and experimental tests in which significant group 
differences were exhibited. Inter-subject voxel-wise correlations were performed between 
skeletonised voxel FA/D values and demeaned neuropsychological/experimental tests 
scores, while treating age as a covariate of no interest. Again, the output was thresholded 
using the TFCE method and corrected for multiple comparisons family-wise error (p ≤ 
0.05). Significant skeleton voxels were overlaid onto the mean FA template to allow 




6.2.8 Voxel based morphometry grey matter analysis 
VBM was conducted on the three dimensional T1-weighted scans acquired during the same 
examination as the DTI protocol using FSL-VBM (Douaud et al., 2007, 
http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLVBM), an optimised VBM protocol (Good et al., 
2001). These volume scans were acquired in the coronal plane with: field-of-view 256  256 
mm; imaging matrix 192  192 (zero filled to 256  256); 160  1.3 mm thick contiguous 
slice locations giving 1  1  1.3 mm isotropic voxels; and repetition, echo and inversion 
times 10, 4 and 500 ms respectively. All scans were visually checked and 1 ALS patient was 
subsequently removed from the analysis due to motion artefacts; thus VBM group 
comparisons are between 28 patients and 30 healthy controls. 
 
Preprocessing of these volumes included conversion from DICOM to NIfTI-1 format, affine 
registration to an axial T2*-weighted gradient echo volume (voxel resolution 1  1  2 mm) 
acquired during the imaging protocol, and brain extraction using a brain mask created from 
the T2*-weighted gradient echo volume. Grey matter volumes were then identified using 
FSL’s Automated Segmentation Tool (FAST). Each participant’s grey matter volume was 
registered to the MNI 152 standard space using non-linear registration (Andersson et al., 
2007b). The resulting images were averaged and flipped along the x-axis to create a left-
right symmetric, study-specific grey matter template. Subsequently, all native grey matter 
partial volume maps were then non-linearly registered to the study-specific template via 
non-linear b-spline representation of the registration warp and "modulated" to correct for 
local expansion (or contraction) due to the non-linear component of the spatial 
transformation. The modulated grey matter images were then smoothed with an isotropic 




6.2.9 Statistical analyses; VBM 
Voxel-wise general linear modelling was applied using the same TFCE method and 
permutation-based non-parametric testing, correcting for multiple comparisons across space, 
as described for the TBSS analyses above (Section 6.2.6). In addition, several ROI masks 
were created using Harvard-Oxford post-mortem templates available in FSL to investigate 
grey matter volumes in regions which corresponded to white matter changes revealed by the 
white matter ROI analysis. The derived ROI templates were subjected to the same TFCE 
and permutation based statistical testing as described previously. Correlational analyses in 
ALS patients were subsequently performed between VBM ROIs and cognitive data using 
the same methods as described previously in section 6.2.6. 
 
6.3 Results 
6.3.1 ROI reproducibility 
The intra-rater reliability analysis indicated excellent reproducibility of ROI measurements 









/s) and 0.012 (mean of measurements 0.411), 
respectively. This yielded coefficients of variation of 2.94 % for D (range 0.6% for 
cingulum to 6.1% for genu) and 2.85% for FA (range 0.5% for superior longitudinal 
fasciculus to 4.4% for frontal white matter), which compares well with values for other 





6.3.2 ROI comparative between group analyses 
White matter ROI analyses are displayed in Table 20. An investigation of the means shows 
that ALS patients had poorer structural integrity parameters (i.e. lower FA and higher D) 
than healthy controls in almost all ROIs with the exception of posterior areas such as the 
occipital gyrus white matter and optic radiation. Significant group differences were found in 
the following frontal tracts; the anterior cingulate (FA and D), anterior thalamic radiation 
(FA and D), and uncinate fasciculus (D). In addition, group differences in white matter 
integrity were observed in the following prefrontal regions; superior frontal gyrus white 
matter (FA and D), inferior frontal gyrus white matter (FA and D), middle frontal gyrus 
white matter (FA), and anterior corona radiata (FA and D). Large differences were 
observed in the corticospinal tract (FA and D). Further significant differences were also 
found in temporal areas; the hippocampal (ventral) portion of the cingulum (D), temporal 
gyri white matter (FA), as well as in the inferior longitudinal fasciculus (FA) and corona 
radiata (FA). Investigation of white matter integrity in posterior brain regions (occipital gyri 









Table 20. White matter ROI means and comparative analyses between ALS patients and 
controls* 
 ALS  HC  F(1, 56) p value  FDR adj. 
Ant. Cingulum FA 











Ant. Thal. Rad. FA 











SFG white matter FA 











IFG white matter FA 











MFG white matter FA 











Ant. Corona Radiata FA 
Ant.CoronaRadiata D† 
0.27 [0.038]  
805 [77] 
0.30 [0.035] 



















Uncinate Fas. FA 

























Ventral Cingulum FA 













0.53 [0.039]  
651 [37] 
0.57 [0.036] 







Inferior Long. Fas. FA 











Superior Long. Fas. FA 











SPL white matter FA 























TG white matter FA 











Corona Radiata FA 











OG white matter FA 











Optic Radiation FA 











Mean values with standard deviations in parentheses are presented. * Significant results are 
highlighted in bold. † values x 10⁻ ⁶  mm2/s, Ant. = Anterior, SFG = Superior Frontal Gyrus, IFG = 
Inferior Frontal Gyrus, MFG = Middle Frontal Gyrus, Long. = Longitudinal, Fas. = Fasciculus, SPL 
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= Superior Parietal Lobule, TG = Temporal Gyri, OG = Occipital Gyri, FA = Fractional Anisotrophy, 
D = Mean Diffusivity.  FDR adj = p values after adjustment for False Discovery Rate.  
 
6.3.3 Corpus callosum segmentation 
ANCOVA’s revealed a significant difference in FA values between patients (Mean = 0.56, 
SD = 0.046) and controls (Mean = 0.59, SD = 0.043); F (1, 47) = 6.120, p = 0.017, as well 




/s) and controls (Mean = 




/s); F (1, 47) = 4.045, p = 0.050.   
 
6.3.4 ROI correlates 
Correlational analyses were performed between cognitive measures in which ALS patients 
exhibited evidence of impairment (see sections 2.4 and 4.4.2) and white matter ROIs in 
which significant group differences were observed. Correlational analyses were also 
performed between corpus callosum segmentation parameters and cognitive measures. 
Correlations between white matter ROIs and performance in the D-KEFS Sorting Test were 
not performed due to the low number of ALS participants who were administered this 
measure. Only significant correlations are reported below. Associations between white 
matter ROIs and background and experimental cognitive tests are displayed in Table 21 and 






Table 21. Significant ROI correlations with background neuropsychological and 
experimental tests 
 ROI Parameter Pearson’s  r p value  
(1-tailed) 
Spoken Letter  
Fluency Test (fi)  
Corticospinal Tract FA 





Reverse Digit Span 
 
Ventral Cingulum D 





Log. Memory Imm. Inferior Longitudinal Fas. FA 0.58 0.001 
Log. Memory Del. 
Log. Memory Recog. 
Inferior Longitudinal Fas. FA 





Average Dual Task Cost Middle Frontal Gyrus WM FA -0.44 0.008 
ROI = Region of Interest, fi = fluency index, Log. = Logical, Imm. = immediate recall condition, Del. 
= delayed recall condition, Recog. = delayed recognition condition, Fas. = Fasciculus, FA = 




Figure 6. Significant correlations between performance on cognitive tests and white matter 
ROIs in ALS patients 
MNI coordinates: a) Right [x 22, y –18, z 12], Left [x –22, y –18, z 12]; b) Right [x 24, y -22, z -22], 
Left [x –24, y -24, z -22]; c) Right [x 30, y 9, z -11], Left [x –27, y 9, z -11]; d) Right [x 44, y -30, z -
10], Left [x –43, y -30, z -10]; e) Right [x 32, y 39, z 17], Left [x –31, y 39, z 17]. MNI = Montreal 
Neurological Institute coordinates, FA = Fractional Anisotrophy, D = Mean Diffusivity. 
 
With regard to the background tests, fluency indices (fi) in the Spoken Letter Fluency Test 
correlated with FA in the corticospinal tract and corpus callosum whereby longer thinking 
times indicative of poorer performance were associated with lower FA and hence poorer 
structural integrity in both regions. The relationship between fluency performance and 
structural integrity in the corticospinal tract and corpus callosum is presented in Figures 7 




Figure 7. Association between Spoken Letter Fluency Test performance (fluency index) and 









Performance in Reverse Digit Span correlated with D in the ventral cingulum and uncinate 
fasciculus (see Figures 9 and 10 respectively) whereby lower span performance was 





















Performance in three measures of Logical Memory performance (Immediate Recall, 
Delayed Recall, and Delayed Recognition) all correlated with FA in the inferior longitudinal 
fasciculus whereby poorer recall and recognition scores were associated with lower FA. 





Figure 11. Association between Logical Memory Immediate Recall performance and 










Figure 12. Association between Logical Memory Delayed Recall performance and inferior 










Figure 13. Association between Logical Memory Delayed Recall performance and inferior 
longitudinal fasciculus integrity 
 
 
In terms of the experimental tasks, Average Dual Task Cost correlated with FA in white 
matter underlying the medial frontal gyri whereby higher percentage change between single 
and dual task conditions was associated with lower structural integrity. The relationship 





Figure 14. Association between Average Dual Task Cost performance and middle frontal 
gyrus white matter integrity 
 
 
6.3.5 ROI relationship with clinical variables 
Comparative analyses were employed to investigate the effect of onset site (Bulbar vs. 
Limb) in all white matter regions/tracts; there were no significant group differences in any 
of the measures. Furthermore, Forced Vital Capacity predicted percentage values were not 
significantly associated with FA or D in any white matter regions. In addition, correlations 
were investigated between significantly different ROIs and disease parameters of severity 
(ALSFRS-R), duration and progression rate. Finally, correlational analyses were performed 
between corpus callosum segmentation parameters and the above disease parameters. 
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Significant correlations between white matter ROIs and disease parameters are displayed in 
Table 22. Disease duration and disease severity as measured by the ALSFRS-R did not 
correlate with any ROIs, however the index of disease progression rate correlated with 
corona radiata FA and a further strong trend was observed with FA of the corticospinal tract. 
Both associations indicated that faster disease progression rate was associated with lower 
FA and hence poorer integrity in regions implicating the major motor pathways. The 
relationship between progression rate and FA in the corona radiata and corticospinal tract is 
displayed in Figures 15 and 16 respectively. 
  
Table 22. ROI correlations with disease parameters 
 ROI  Pearson’s  r p value  
(1-tailed) 
Progression Rate Corona Radiata FA 





ROI – Region of Interest, ALSFRS-R = Amyotrophic Lateral Sclerosis Functional Rating Scale – 





















Figure 16. Association between disease progression rate and corticospinal tract integrity 
 
 
6.3.6 TBSS group analyses 
Voxel-wise group comparisons of ALS patients’ and healthy controls’ mean FA maps 
revealed two large significantly different clusters for the condition control FA > patient FA. 
Cluster 1 contained 13094 voxels with the highest intensity voxel located in the motor 
segment of the corpus callosum (Figure 17a); p = 0.004. Cluster 2 contained 207 voxels 
with the highest intensity voxel located in the corticospinal tract (Figure 17b); p = 0.048. No 




Figure 17. Group analysis of skeletal voxel FA showing location of highest intensity voxel 
within cluster 1 (a) and cluster 2 (b)  
Panel a (top) = cluster 1, panel b (bottom) = cluster 2. FA cluster based thresholding (TFCE) 
corrected for multiple comparisons, p ≤ 0.05 shown in red-yellow. Background: greyscale mean FA 
map for all participants. Crosshairs indicate highest intensity voxel; anatomical location given in 
MNI coordinates. 
 
As can be seen in Figure 18, and Figure 19a, cluster 1 included large portions of the central 
and anterior corpus callosum, and extended dorsally to involve white matter underlying 
bilateral precentral gyri, and anteriorly into superior frontal gyrus white matter and anterior 
corona radiata. The cluster also extended ventrally from the corpus callosum with clear 
involvement of the corticospinal tract, and furthermore into right hemispheric temporal 
regions implicating the inferior longitudinal, inferior fronto-occipital, and uncinate 
fasciculus, as well as ventral (hippocampal) cingulum and superior temporal lobe white 
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matter. By contrast, as shown in Figure 19b, cluster 2 was localised to the corticospinal 
tract.     
 
Figure 18. Group analysis of skeletal voxel FA showing extent of cluster 1 
FA cluster based thresholding (TFCE) corrected for multiple comparisons, p ≤ 0.05 shown in red-





Figure 19. Three-dimensional rendering of FA cluster 1 (a) and cluster 2 (b)     
Panel a (left) = cluster 1, panel b (right) = cluster 2. FA cluster based thresholding (TFCE) corrected 
for multiple comparisons, p ≤ 0.05 shown in red. Background: standard MNI T1 1mm template. 
 
Voxel-wise group comparisons of ALS patients’ and healthy controls’ mean D maps 
revealed two large significantly different clusters for the condition patient D > control D. 
Cluster 1 contained 22385 voxels with the highest intensity voxel located in the left 
posterior limb of the internal capsule (PLIC) corresponding to the corticospinal tract (Figure 
20a); p = 0.008. Cluster 2 was small containing only 23 voxels with the highest intensity 
voxel located in the right splenim (Figure 20b); p = 0.05. No significant differences were 








Figure 20. Group analysis of skeletal voxel D showing location of highest intensity voxel 
within cluster 1 (a) and cluster 2 (b)  
Panel a (top) = cluster 1, panel b (bottom) = cluster 2. D cluster based thresholding (TFCE) 
corrected for multiple comparisons, p ≤ 0.05 shown in blue-light blue. Background: greyscale mean 
FA map for all participants. Crosshairs indicate highest intensity voxel; anatomical location given in 
MNI coordinates. 
 
As can be seen in Figure 21 and Figure 22a and b, cluster 1 comprised large portions of the 
corpus callosum including bilateral genu and left splenium, and extended dorsally to involve 
white matter underlying bilateral precentral gyri and superior corona radiata. In addition, the 
cluster extended anteriorly into bilateral inferior, middle and superior frontal gyrus white 
matter as well as anterior corona radiata. The cluster also extended ventrally from the corpus 
callosum with clear involvement of the corticospinal tract, and further into right hemispheric 
temporal regions implicating the inferior longitudinal, inferior fronto-occipital and uncinate 
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fasciculus, as well as ventral (hippocampal) cingulum. By contrast, as shown in Figure 22c, 
cluster 2 was localised to the right splenium.     
 
Figure 21. Group analysis of skeletal voxel D showing extent of cluster 1 
D cluster based thresholding (TFCE) corrected for multiple comparisons, p ≤ 0.05 shown in blue-





Figure 22. Three-dimensional rendering of D cluster 1 (a and b) and cluster 2 (c)      
Panels a and b (left and middle) = cluster 1, panel c (right) = cluster 2. D cluster based thresholding 
(TFCE) corrected for multiple comparisons, p ≤ 0.05 shown in blue. Background: standard MNI T1 
1mm template. 
 
6.3.7 TBSS correlates 
Correlational analyses between patient performance in cognitive tests and FA and D maps 
revealed a significant association between fluency indices (fi) in the Spoken Letter Fluency 
Test and FA values. When the cluster threshold was set at p = 0.05, a single large cluster 
was revealed containing 32891 voxels with the highest intensity voxel located in the 
corticopsinal tract (Figure 23a); p = 0.006. Figure 23 (a, b, and c) shows that the cluster 
extended dorsally from lower portions of the corticopsinal tracts through the thalamic 
nuclear complex and internal and external capsules, and into central and anterior portions of 
the corpus callosum, as well as involving white matter underlying the postcentral and 
precentral gyri. Moreover, the cluster extended anteriorly to involve bilateral inferior, 
middle and superior frontal gyri white matter, and into temporal regions implicating right 
inferior longitudinal fasciculus and inferior fronto-occipital fasciculus, as well as bilateral 




Figure 23. Skeletal FA voxels correlated with ALS patient letter fluency indices at p = 0.05. 
Location of highest intensity voxel (a), and extent of cluster (b and c)   
Panel a (top) = highest intensity voxel, panel b (middle) = temporal aspect of cluster, panel c 
(bottom) = anterior aspect of cluster. FA cluster based thresholding (TFCE) corrected for multiple 
comparisons, p ≤ 0.05, corrected for effects of age, shown in yellow. Background: greyscale mean 
FA map for all participants. Crosshairs indicate highest intensity voxel; anatomical location given in 
MNI coordinates. 
 
To identify the white matter regions most associated with fluency index scores, the cluster 
threshold was subsequently set at p = 0.001 which revealed 2 significant clusters.  Cluster 1 
contained 1385 voxels with the highest intensity voxel located in the anterior portion of the 
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corpus callosum (Figure 24a); p = 0.008. Cluster 2 contained 456 voxels with the highest 
intensity voxel located in the left corticospinal tract (Figure 24b); p =0.006.  
 
Figure 24. Skeletal FA voxels correlated with ALS patient letter fluency indices at p = 0.01. 
Location of highest intensity voxel in cluster 1 (a), and cluster 2 (b) 
Panel a (top) = cluster 1, panel b (bottom) = cluster 2. FA cluster based thresholding (TFCE) 
corrected for multiple comparisons, p ≤ 0.05, corrected for effects of age, shown in red-yellow. 
Background: greyscale mean FA map for all participants. Crosshairs indicate highest intensity voxel; 
anatomical location given in MNI coordinates. 
 
Figure 24a and Figure 25a show that cluster 1 was localised to anterior and central portions 
of the corpus callosum while cluster 2 was localised to bilateral corticospinal tracts (Figures 
24b and 25b). No further correlations were found between any cognitive tests and voxel FA 




Figure 25. Three-dimensional rendering of FA cluster 1 (a) and cluster 2 (b) correlation with 
letter fluency indices      
Panel a (left) = cluster 1, panel b (right) = cluster 2. FA cluster based thresholding (TFCE) corrected 
for multiple comparisons, p ≤ 0.05, corrected for effects of age, shown in red. Background: standard 
MNI T1 1mm template. 
 
6.3.8 VBM grey matter between group analyses 
Whole brain voxel-wise group comparisons of ALS patients’ and healthy controls’ 
volumetric data failed to show significant group differences for either the control volume > 
patient volume condition or patient volume > control volume condition. Based on areas 
showing significant group differences in the white matter ROI analysis, the following VBM 
ROI templates were created and tested for group effects; frontal pole, medial frontal gyrus, 
inferior frontal gyrus, motor region (pre-central and post-central gyri), cingulate gyrus and 




Voxel-wise group comparisons in the motor ROI revealed two large significantly different 
clusters for the condition control volume > patient volume. Cluster 1 contained 122 voxels 
with the highest intensity voxel located in right pre-central/post-central junction (Figure 
26a); p = 0.009. Cluster 2 was small containing 29 voxels with the highest intensity voxel 
also located in right pre-central/post-central junction (Figure 26b); p = 0.024. No significant 
differences were found in the patient volume > control volume condition. 
 
Figure 26. Group analysis of voxel volumes in motor ROI showing location of highest 
intensity voxel within cluster 1 (a) and cluster 2 (b) 
Panel a (top) = cluster 1, panel b (bottom) = cluster 2. FA cluster based thresholding (TFCE) 
corrected for multiple comparisons, p ≤ 0.05, corrected for effects of age, shown in red. Background: 
standard MNI T1 2mm template. Crosshairs indicate highest intensity voxel; anatomical location 




Figures 26 and 27 show that both cluster 1 and cluster 2 were localised to the junction 
between the right pre-central and post-central gyri, with the larger cluster occupying a more 
lateral aspect.  
 
Figure 27. Three-dimensional rendering of VBM analysis in motor region showing cluster 1 
(a) and cluster 2 (b)      
Panel a (left) = cluster 1, panel b (right) = cluster 2. VBM cluster based thresholding (TFCE) 
corrected for multiple comparisons, p ≤ 0.05, corrected for effects of age, shown in red. Background: 
standard MNI T1 1mm template. 
 
Voxel-wise group comparisons in the inferior frontal gyrus ROI revealed two large 
significantly different clusters for the condition control volume > patient volume. Cluster 1 
was small containing 22 voxels with the highest intensity voxel located in right inferior 
frontal gyrus (Figure 28a); p = 0.025. Cluster 2 was very small containing 10 voxels with 
the highest intensity voxel also located in right inferior frontal gyrus (Figure 28b); p = 





Figure 28. Group analysis of voxel volumes in inferior frontal gyrus ROI showing location of 
highest intensity voxel within cluster 1 (a) and cluster 2 (b) 
Panel a (top) = cluster 1, panel b (bottom) = cluster 2. FA Cluster based thresholding (TFCE) 
corrected for multiple comparisons, p ≤ 0.05, corrected for effects of age, shown in red. Background: 
standard MNI T1 2mm template. Crosshairs indicate highest intensity voxel; anatomical location 
given in MNI coordinates. 
 
Figures 28 and 29 show that both cluster 1 and cluster 2 were localised to the right inferior 







Figure 29. Three-dimensional rendering of VBM analysis in inferior frontal gyrus showing 
cluster 1 (a) and cluster 2 (b)      
Panel a (left) = cluster 1, panel b (right) = cluster 2. VBM cluster based thresholding (TFCE) 
corrected for multiple comparisons, p ≤ 0.05, corrected for effects of age, shown in red. Background: 
standard MNI T1 1mm template. 
 
No significant group differences were found in any of the other VBM ROI analyses. No 
significant correlations were found between patient whole-brain or ROI voxel volumes and 
performance in cognitive tests. 
 
6.4 Summary 
The white matter ROI analyses revealed extensive changes in structural integrity in ALS 
patients relative to healthy controls. The ALS patient group showed increased D and 
reduced FA in anterior corona radiata and in white matter underlying superior, middle, and 
inferior frontal gyri, as well as in white matter underlying temporal gyri. In addition, 
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changes were evident in the anterior thalamic radiation which connects the thalamus to areas 
of the prefrontal cortex, as well as in the anterior and ventral portions of the cingulum, 
which connects subcallosal regions to the frontal lobes and hippocampus respectively. The 
observed pattern of impoverished integrity in prefrontal associative fibres and cingulum, 
with preserved integrity in parietal and posterior regions is largely consistent with a 
previous study showing volumetric white matter reductions in similar regions using less 
refined automated volumetric estimations (Abrahams et al., 2005). In agreement with other 
studies (Abrahams et al., 2005; Agosta et al., 2007; Sarro et al., 2011), reduced structural 
integrity was observed in the corpus callosum which has been suggested to be one of the 
most consistent MRI findings in ALS (Filippini et al., 2010). Substantial changes were 
observed in the corticospinal tracts, indicative of upper motor neuron pathology which has 
been consistently shown in previous DTI investigations (Abe et al., 2004; Ciccarelli et al., 
2006; Agosta et al., 2010). Moreover, ALS patients have reduced FA in the corona radiata 
which projects primarily to motor regions of the cortex providing further evidence of upper 
motor neuron pathology. Reduced white matter integrity was also found in ROI sampling of 
the uncinate fasciculus which connects the temporal lobes and amygdala to orbitofrontal and 
inferior regions of the prefrontal lobes, a result which is consistent with other studies in 
ALS (Sato et al., 2010; Agosta et al., 2010) and FTD (Matsuo et al., 2008). Concordant with 
a recent DTI investigation (Sarro et al., 2011), ALS patients showed reduced structural 
integrity in the inferior longitudinal fasciculus, one of the long association bundles 
connecting the temporal and occipital lobes.  
 
The pattern of results revealed in the TBSS analysis was largely consistent with those 
revealed by the ROI analysis. Analysis of voxel FA and D values showed that ALS 
patients had reduced structural integrity relative to healthy controls in motor regions 
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corresponding to the corticospinal tracts and white matter underlying the pre-central and 
post-central gyri which corresponds to the corona radiata region in the ROI analysis. 
Reduced white matter integrity was also found in the corpus callosum; notably in the FA 
analysis this was restricted to central and anterior portions whereas the D analysis revealed 
changes throughout the corpus callosum including the genu and splenium. Such findings are 
consistent with a multitude of studies employing VBM style analysis of diffusion data (e.g. 
Sach et al., 2004; Agosta et al., 2007) as well as those employing TBSS (e.g. Ciccarelli et 
al., 2009; Prudlo et al., 2012). Moreover, the fact that the highest intensity voxel in the D 
analysis was located in the PLIC lends further support to the meta-analysis of Li et al. 
(2012) who showed that the PLIC was the most sensitive region of the corticospinal tract for 
detecting white matter damage in ALS. Consistent with the ROI investigation, changes in 
ALS patients were observed in prefrontal regions; reduced FA was found in superior frontal 
gyrus and anterior corona radiata, and in the D analysis changes were extended to the 
inferior and middle frontal gyri. These findings are concordant with previous investigations 
employing TBSS, particularly those of Sage et al. (2009) and Ciccarelli et al. (2009) who 
reported reduced FA in multiple prefrontal regions including white matter fibres underlying 
superior, inferior, and dorsolateral prefrontal cortex as well as the hippocampal formations. 
White matter integrity reductions were also revealed in several temporal regions in the 
TBSS analyses, with changes predominantly located in the right hemisphere. Significant 
group differences were observed in FA and D clusters implicating major white matter 
tracts of the inferior longitudinal fasciculus, inferior fronto-occipital fasciculus, and uncinate 
fasciculus in addition to association fibres underlying superior temporal gyrus. Previous 
investigations employing both TBSS and tractography techniques have reported similar 
involvement of major longitudinal tracts (Sarro et al., 2011; Prudlo et al., 2012). Finally, in 
agreement with the ROI analysis and previous investigations (Sage et al., 2009; Senda et al., 
2011), reduced structural integrity was observed in ventral/posterior cingulum, although 
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corresponding changes in anterior portions were not observed. Of note, there was a distinct 
lack of FA or D changes in both the ROI and TBSS analyses in posterior regions (posterior 
parietal or occipital regions).  
 
The TBSS analysis employed in the current investigation may suggest that D is more 
sensitive to white matter changes in ALS than FA; the D analysis involved more 
significant voxels than the FA analysis in the major clusters (22385 vs 13094) and 
encompassed more regions. Other investigators (Agosta et al., 2007; Canu et al., 2011) have 
also found D to be more sensitive to prefrontal white matter changes, although Sage et al. 
(2007, 2009) reported more changes in FA. However, although D may be the more 
sensitive diffusion parameter, more correlations (in ROI and TBSS analyses) were observed 
between cognitive measures/disease parameters and FA suggesting that FA changes may be 
more relevant to functional changes in ALS.  
 
In terms of correlations between MRI parameters and cognitive performance in ALS, the 
white matter ROI analysis appeared to be the most sensitive measure. Average Dual Task 
Cost scores correlated with FA values in middle frontal gyrus white matter, whereby poorer 
performance was associated with lower white matter integrity. The middle frontal gyrus (or 
dorsolateral prefrontal cortex) is thought to be highly influential in the regulation of 
executive processes such as strategy formation, set-shifting and working memory (Stuss, 
2002; Royall et al., 2002) and was previously identified as a site of dysfunction in ALS in 
functional imaging (Abrahams et al. 1996; 2004). The neural correlates of dual tasking are 
hotly debated (Erickson et al., 2005), however the white matter region identified by the 
current study correspond wells to the prefrontal areas that were suggested to reflect central 
230 
 
executive activity in functional imaging studies of dual tasking in healthy adults 
(D’Esposito et al., 1995).  Moreover, subsequent functional imaging studies have 
demonstrated the importance of the bilateral frontal gyri (including the dorsolateral 
prefrontal cortex) in managing and coordinating response selection and interference 
(MacDonald et al., 2000; Wager & Smith, 2003), and it is possible that the white matter 
findings presented in this study underpin dysfunction in these processes. It has also been 
suggested that executive functioning is best understood in terms of interactions between 
networks of regions (Collette & Van der Linden, 2002), and that dual tasks impose higher 
processing demands on cortical areas already involved in the component single tasks. Thus, 
it is also possible that the correlation with white matter underlying dorsolateral prefrontal 
cortex may be a reflection of the high demands on working memory that are required to 
maintain performance on the DDR task whilst completing a concurrent task.  
 
Of particular interest is the finding that performance in the dual task was associated with 
different white matter pathways than the commonly reported letter fluency deficits. Scores 
in the Spoken Letter Fluency Test (fi) were associated with low FA in the corpus callosum 
in the ALS cohort. A previous study has implicated volumetric reductions in anterior 
portions of the corpus callosum amongst other prefrontal and temporal regions in ALS 
patients with impaired letter fluency (Abrahams et al., 2005); the results of the current study 
further builds on these findings to demonstrate a direct correlation between fluency 
performance and structural integrity of the corpus callosum. Further support for the 
importance of corpus callosum integrity to ALS cognition is provided by Sarro and 
colleagues (2011) who reported correlations between corpus callosum FA and performance 
in another test of executive functioning, namely the Trail Making Task. Moreover, an early 
structural investigation by Yamauchi and others (1995) suggested that pathology in the 
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anterior portion of corpus callosum was associated with cognitive and behavioural changes. 
Although the methods employed by our corpus callosum segmentation analysis were unable 
to differentiate between discrete portions of the corpus callosum, trends in the ROI analysis 
toward low FA in the genu, but not splenium, may indicate the presence of an anterior 
gradient of corpus callosum involvement as postulated by others (Filippini et al., 2010). 
Indeed, the TBSS analysis of FA indicated greater involvement of anterior corpus callosum, 
and subsequent correlational analyses revealed significant association between this region 
and performance in the Spoken Letter Fluency Test (fi). Such consistency between the ROI 
and TBSS analyses suggests that the relationship between corpus callosum integrity and 
letter fluency performance is robust. Furthermore, the observed correlation between letter 
fluency performance and corticospinal tract integrity in both the ROI and TBSS analyses 
suggests that fluency performance may be sensitive to disease severity. This may be related 
to the propensity for patients with bulbar onset to show more upper motor neuron 
degeneration, as well as being more likely to exhibit cognitive impairment (Abrahams et al., 
1997). However, some longitudinal studies have suggested that cognitive impairment occurs 
early in the disease and does not progress at the same rate as motor dysfunction (Schreiber 
et al., 2005). Nevertheless, the fact that letter fluency was the only cognitive measure to 
correlate with ROI and TBSS analyses, with the same regions implicated by both 
techniques, is further evidence that fluency impairments are one of the core deficits that 
characterize cognitive change in ALS. Thus, performance in these two tests of executive 
functioning appears to be underpinned by different white matter pathways; letter fluency 
appears to be sensitive to changes in the corpus callosum and particularly regions linking 
the prefrontal cortices, whereas dual tasking seems to be sensitive to white matter disruption 




In addition to correlations with tests of executive functioning, a correlation was observed 
between patient performance on the Reverse Digit Span task and increased D in the 
hippocampal portion of the cingulum, as well as in uncinate fasciculus. The hippocampal 
portion of the cingulum is traditionally associated with episodic and long-term memory 
(Köhler et al., 1998), indeed it has been shown to correlate with cognitive functioning in 
Alzheimer’s disease (Nakata et al., 2009). Increasingly however, the hippocampus has been 
shown to have a role in working memory paradigms (Ranganath & D’Esposito, 2002), and 
together with the posterior cingulate has been associated with tasks assessing multiple 
cognitive domains suggesting that it may be a crucial structure in complex cognitive 
circuitry (Kantarci et al., 2011). Moreover, neuropathological studies in ALS patients with 
and without dementia have shown abnormalities in the hippocampus (Okamoto et al., 1991; 
Takeda et al., 2009). Reduced integrity in uncinate fasciulus has commonly been associated 
with memory impairment and naming deficits in other disorders such schizophrenia and 
epilepsy (Kubicki et al., 2002; Diehl et al., 2008; Papgno et al., 2011). However, a recent 
study by Tartaglia and colleagues (2012) in FTD patients revealed that uncinate fasciculus 
integrity was associated with the number of errors made in a modified version of the Trail 
Making Task which places considerable demands on working memory (Sanchez-Cubillo et 
al., 2009) and the results of the current study may reflect a similar association in ALS 
patients.  
 
In the present study, correlations were also observed between impairment in the Logical 
Memory scales and inferior longitudinal fasciculus integrity. Memory dysfunction in ALS 
has been previously highlighted (Raaphorst et al. 2010), although typically related to 
secondary executive retrieval dysfunction. Here correlations were observed in the patient 
sample not only in measures of immediate memory, but also in retention and recognition, 
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and as such are unlikely to be explained through an executive dysfunction alone. This 
suggests a primary memory deficit in some ALS patients that is associated with disruption 
to a major white matter pathway connecting temporal regions to posterior cortical regions. 
Although changes in the inferior longitudinal fasciculus have been reported in a previous 
investigation into ALS (Sarro et al., 2011), performance in a test of executive functioning 
(Trail Making Task) not memory was associated with integrity in this tract. Thus, although 
the functional significance of the inferior longitudinal fasciculus remains unclear, there is 
evidence that this tract is related to cognitive change in ALS, and further investigation of 
this relationship should be considered by future studies. 
 
In addition to association with cognitive measures, the white matter ROI analyses also 
revealed a significant correlation between corona radiata integrity and rate of disease 
progression, as well as a strong trend between corticospinal tract integrity and rate of 
disease progression. Similar findings have been reported by other investigators assessing 
white matter integrity with a variety of diffusion imaging techniques (Ciccarelli et al., 2006; 
Agosta et al., 2010; Bastin et al., 2013). Of interest, and as has been the case in other studies 
(e.g. Agosta et al., 2007), disease severity as measured by the ALSFRS was not associated 
with corticospinal tract or corona radiata integrity suggesting that this measure is not as 
robust as disease progression indices which take into account functional severity and disease 
duration.  Despite these inconsistencies, the correlation between motor tract integrity and 
clinical and functional/cognitive measures suggests that DTI techniques have the potential 




In comparison to the ROI and TBSS analyses of diffusion data, the VBM analyses of T1-
weighted images showed considerably less evidence of cortical involvement. Indeed, only 
when ROI masks were applied to the VBM analyses were volumetric reductions in ALS 
patients revealed in right hemispheric motor cortex and inferior frontal gyrus. Nevertheless, 
previous investigations employing VBM have also reported cortical atrophy in motor cortex 
and inferior frontal gyrus amongst others regions (Ellis et al., 2001; Kassubek et al., 2005; 
Mezzapesa et al., 2007; Agosta et al., 2007). The volumetric reductions revealed by the 
VBM analysis in current study are also concordant with functional imaging studies in ALS 
which have shown decreased blood-oxygen response in inferior frontal gyrus (Brodmann 
Area 44) in response to fluency tasks (Abrahams et al. 2004). Furthermore, this region has 
been noted as a site of pathological focus in patients with ALS-Aphasia syndrome (Bak et 
al. 2001). The VBM findings in the current study suggest that grey matter analyses may not 
be as sensitive to cerebral changes in ALS as white matter investigations with DTI – indeed 
a similar pattern of results has been found in previous investigations (Abrahams et al., 2005; 
Canu et al., 2011). Thus, the relative propensity of white matter changes may suggest that 
white matter pathology is the core deficit underlying cognitive change in ALS and may 









Chapter 7. Discussion 
The current study aimed to investigate whether cognitive impairments observed in ALS 
patients are characterised by slowed processing speed or executive dysfunction. Moreover, 
the inclusion of an MS patient group facilitated a comparison between the cognitive profiles 
exhibited in ALS and MS.   In addition, we sought to elucidate whether integrity of specific 
white matter structures was associated with any observed cognitive deficits in the ALS 
patient cohort.  
 
7.1 Summary of findings 
7.1.2 Patient performance in background neuropsychological assessment 
Cognitive domains of executive functioning, short-term memory, working memory, verbal 
memory, and language were assessed by a range of neuropsychological tests as described in 
Chapter 2.  The two-way analysis between the ALS patients and matched healthy controls 
revealed that ALS patients exhibited impaired performance in tests of short-term memory 
(Forward Digit Span), working memory (Reverse Digit Span), verbal memory (Logical 
Memory scales), and executive functioning (Spoken Letter Fluency Test fi and D-KEFS 
Sorting Test), whilst confrontation naming (GNT) performance remained intact. Analysis of 
individual patient z-scores showed that 7/29 ALS patients presented with impairments in at 
least two tests of executive functioning, compared to 2/29 patients who presented with 
impairments in the Logical Memory scales or GNT in the absence of executive dysfunction.  
 
The pattern of impairment exhibited by the current ALS cohort is largely consistent with the 
findings of other large scale studies (e.g. Ringholz et al., 2005; Phukan et al., 2012; Elamin 
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et al., 2013) in that approximately 30% of patients showed evidence of cognitive 
impairment, predominantly in tests of executive functioning, with a smaller proportion 
exhibiting impairments in tests of language and memory. However, other studies have 
suggested that impairments in domains of language (Taylor et al., 2012) and verbal memory 
(Raaphorst et al., 2010) may be at least as common as those observed in executive 
functioning. Although the data from the current investigation do not fully support these 
findings, the current study did not set out to address all aspects of cognitive functioning in 
ALS, and as such the domains of language and memory were not comprehensively assessed. 
Nevertheless, there was some evidence to suggest that cognitive impairment in ALS is not 
restricted to executive dysfunction. Not only did some patients present with memory or 
language impairments in the absence of executive dysfunction, the pattern of logical 
memory performance exhibited by the ALS group revealed poor performance in delayed 
recall and retention conditions which may reflect an underlying consolidation problem 
(Christidi et al., 2012). Moreover, the finding that patients recalled significantly less digits 
than controls in forward as well as backward versions of the Digit Span tasks may suggest 
that ALS patients experience reduced short-term memory capacity in addition to reduced 
working memory capacity (Conway et al., 2005).  
 
In terms of ALS performance, the three-way analysis between ALS patients, MS patients, 
and healthy controls revealed essentially the same pattern of results – a subgroup of 25 ALS 
patients showed impairments in working memory, verbal memory, executive functioning 
and confrontation naming relative to a group of healthy controls that were matched to the 
MS patient cohort. Although, some of the group differences observed in the two-way 
analysis failed to reach significance, namely in Forward Digit Span and Logical Memory 
Retention, trends towards significance were observed in Forward Digit Span suggesting that 
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the group differences were still present but may have been masked by the additional 
statistical constraints associated with having fewer participants and performing post-hoc 
pairwise comparisons. The most interesting difference between the two-way and three-way 
analyses was in confrontation naming. Whilst in the two-way analysis ALS patients 
appeared unimpaired in the GNT, in the three-way analysis age was found to be correlated 
positively with GNT performance and a subsequent covariate analysis controlling for the 
effects of age suggested that in fact ALS patients were impaired in the GNT. Such a finding 
further demonstrates that cognitive deficits are not restricted to executive functioning in 
ALS, and highlights the importance of controlling for positive age correlations in linguistic 
assessments. 
 
In terms of MS performance in the background neuropsychological assessments, the MS 
cohort showed a similar pattern to that exhibited by ALS patients with the same 
impairments evident in verbal memory (Logical Memory scales), executive functioning 
(Spoken Letter Fluency Test and D-KEFS Sorting Test), working memory (Reverse Digit 
Span), as well as a trend towards impairment in short-term memory (Forward Digit Span). 
However, some differences between the two patient groups were observed; MS patients 
exhibited additional impairment in the Written Letter Fluency Test, whereas ALS patients 
presented with impairment in confrontation naming (GNT) that was not observed in the MS 
patients (although a trend was present). The observed impairment in the GNT suggests that 
ALS patients may have difficulties with basic word retrieval processes, a deficit which may 
in turn contribute towards poor performance in the letter fluency tests. Confrontation 
naming deficits have been shown before in ALS cohorts (e.g. Wicks et al., 2008), but 
detailed investigations into verbal fluency performance in ALS have shown that letter 
fluency deficits occur independently of confrontation naming performance ( Abrahams et 
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al., 2000), suggesting that fluency impairments are more likely to reflect executive 
dysfunction than basic word retrieval problems. Nevertheless, the result of the current 
investigation highlights the presence of language impairment in ALS which should be taken 
into account when interpreting performance in other cognitive tests. 
 
In addition, a breakdown of performance in the Logical Memory scales showed that while 
ALS patients exhibited difficulties in immediate recall, delayed recall and delayed 
recognition, MS patients exhibited impairments in the delayed recall and retention 
conditions but not immediate recall or delayed recognition. Such a pattern suggests that 
although ALS patients may experience consolidation difficulties (as evidenced by retention 
deficits in the two-way analysis), performance in the Logical Memory scales may also have 
been affected by encoding and/or retrieval deficits reflecting an underlying executive 
dysfunction (Mantovan et al., 2003; Lezak et al., 2004). The pattern of performance 
exhibited by MS patients suggests that verbal memory deficits in MS are more likely to 
reflect problems with retrieval of information from long term memory. Thus, although the 
cognitive profiles of ALS and MS appear strikingly similar, there are some subtle 
differences in performance that may reflect disruption to different underlying cognitive 
processes. Overall, with regard to the neuropsychological tests employed by the current 
investigation, the cognitive profile of ALS and MS patients is consistent with predominant 
executive dysfunction, with further deficits extending to verbal memory in both patient 






7.1.2 Patient performance in the experimental tasks 
The experimental tasks were developed to assess processing speed and executive 
functioning, as well as any potential interaction between these functions, independent of 
motor abilities. This was achieved by developing two processing speed tasks, the VIT task 
and RSLI task, as well as a dual task paradigm which employed VIT as one component task 
and Delayed Digit Span as the other. As described in Chapter 3, before the dual task was 
administered in patient populations, an ageing study was carried out. The ageing study 
revealed that although VIT performance decreased as a function of age, when individual 
abilities were calibrated, subsequent dual task performance was unaffected by age as has 
been reported by previous investigations employing similar paradigms (Cocchini et al., 
2002; Logie et al., 2004; Anderson et al., 2011).  
 
In terms of patient performance in the experimental tasks, two-way analyses between the 
ALS group and matched healthy controls revealed that ALS patients performed almost 
identically to the control group in both processing speed tasks. Such a result suggested that 
ALS patients did not exhibit slowed processing of abstract visual information (VIT task) or 
meaningful visual stimuli (RSLI task). By contrast, the ALS group did show a selective 
impairment in dual tasking as evidenced by significantly higher Average Dual Task Cost 
scores than the control group. This effect was revealed despite ALS patients performing 
comparably to healthy controls in baseline task levels and under single task conditions. 
These findings not only indicate that ALS patients exhibited a motor independent dual 
tasking deficit, but also show that this impairment was independent of processing speed 




The three-way comparison between ALS patients, MS patients, and healthy controls 
revealed the same pattern of results in terms of ALS performance as that of the two-way 
analysis conducted in the full ALS group; ALS patients displayed normal performance in 
both processing speed tasks whilst exhibiting a selective deficit in Average Dual Task Cost. 
MS patients also exhibited significantly higher Average Dual Task Cost scores than the 
control group alongside normal performance under single task conditions, indicative of a 
selective dual task deficit. However, within the dual task paradigm, MS patients did show 
some evidence of processing speed impairment as the group exhibited a trend towards 
significantly slower baseline VIT level than healthy controls. Further evidence of slowed 
processing speed in MS patients was revealed by significant group differences in the 
experimental RSLI task. MS participants made significantly more errors in this task than 
both ALS patients and healthy controls suggesting that the speed at which they could 
identify meaningful visual stimuli was slowed. However, with respect to the dual task 
paradigm, the VIT level was calibrated to each individual’s ability suggesting that the 
observed deficit in dual tasking was independent of processing speed impairment. Of note, 
MS patients were not impaired in the VIT processing speed task despite showing a trend 
towards slower baseline VIT level within the dual task paradigm.  
 
As far as we are aware, this is the first study to demonstrate a dual task impairment in ALS 
patients that is independent of motor functioning. The only previous investigation of dual 
tasking in ALS was conducted by Schreiber et al. (2005) and employed the divided attention 
subtest of the Test of Attentional Performance (TAP; Zimmermann & Fimm, 2002), a 
paradigm in which participants are required to respond to simultaneously presented auditory 
and visual cues. Outcome measures were reaction times and the number of omitted 
responses. The authors reported that reaction times in the ALS group were slower than 
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normative data suggesting the presence of impairment in divided attention. However, not 
only did this task utilize reaction time data that is susceptible to the confounds of motor 
dysfunction in ALS, the component tasks were not calibrated for individual performance 
making it difficult to determine whether any difficulties experienced in the dual task 
condition are a result of overall task load or to a specific impairment in divided attention 
(Baddeley et al., 1991).  
 
By contrast, previous investigations into cognitive functioning in MS have set out with the 
specific aim of investigating dual tasking within the multiple-component model of working 
memory. D’Esposito et al. (1996) employed a dual task paradigm in which performance in a 
line judgement task was assessed in single task conditions and under dual task conditions. 
The line judgement task was in a multiple choice format to allow participants to point to, or 
verbally identify their responses thereby minimising motor demands. In addition, three 
secondary tasks designed to impose sequentially greater demands on the central executive; 
finger tapping, humming of a pre-learned tune, and alphabet recital.  Under single task 
conditions, the authors reported that MS patients performed comparably to controls in all 
the tasks with the exception of finger tapping, presumably due to motor dysfunction. 
However, MS patients exhibited a decrement in the line judgement task when it was 
performed concurrently with humming or alphabet recital. The authors concluded that this 
finding was indicative of a selective dual task deficit reflecting impairment in the 
coordinating function of the central executive component of working memory.  
 
Thus, the result of dual task paradigm employed by the current investigation lends support 
to the findings of D’Esposito et al. (1996) by showing a selective dual task deficit in MS, 
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and in addition extends these findings to ALS patients. Moreover, the findings of the current 
investigation provide stronger evidence of an independent dual task deficit than previous 
studies in ALS or MS as the component tasks employed were not affected by motor 
dysfunction, and were performed under more stringent conditions in which difficulty levels 
were tailored to each individual’s ability. As such, we could be confident that the same 
cognitive demand was placed on all participants such that the observed performance 
decrements observed in dual task conditions were likely to reflect a specific problem with 
the coordination of concurrent tasks.      
 
7.1.3 Structural imaging in ALS 
As described in Chapter 6, diffusion tensor and volumetric MRI analyses were carried out in 
the ALS cohort to investigate structural changes in cerebral white and grey matter 
respectively. DTI data was analysed by way of an in-house Region-of-Interest (ROI) 
approach, and Tract Based Spatial Statistics (TBSS), an automated whole brain white matter 
analysis package. In addition an in-house automatic segmentation tool was employed to 
investigate corpus callosum integrity. Volumetric T1-weighted data was analysed using 
Voxel Based Morphometry (VBM).  
  
The ROI white matter analyses revealed reduced structural integrity in ALS patients in 
predominantly frontotemporal structures including white matter underlying the major frontal 
and temporal gyri as well as anterior and ventral portions of the cingulum. Further changes 
were revealed in white matter tracts corresponding to motor functioning (corticospinal 
tracts), and those linking cortical and subcortical structures (anterior thalamic radiation). 
Changes were also observed in longitudinal tracts connecting disparate cortical regions; 
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reduced integrity was revealed in the uncinate fasciculus which connects the temporal lobes 
and amygdala to inferior aspects of the prefrontal lobes, and inferior longitudinal fasciculus 
which connects the temporal and occipital lobes. In addition, the corpus callosum analysis 
revealed significantly reduced integrity in this structure in ALS patients compared to 
healthy controls. Voxel wise analysis of diffusion data (TBSS) revealed a very similar 
pattern of results with group comparisons in fractional anisotropy (FA) and mean diffusivity 
(D) showing a consistent pattern of reduced integrity in ALS patients in sub-gyral white 
matter in extensive bilateral prefrontal regions, predominantly right temporal regions, and 
regions corresponding to motor functioning. Moreover, the TBSS analyses highlighted the 
involvement of major white matter structures of the corticospinal tracts, corpus callosum, 
hippocampal portion of the cingulum, uncinate fasciculus, inferior longitudinal fasciculus, 
and occipito-frontal fasciculus. Of note, there was a distinct lack of FA or D changes in 
both the ROI and TBSS analyses in posterior regions (posterior parietal or occipital 
regions). Moreover, there were no regions in which white matter integrity as indexed by 
water diffusion parameters was enhanced in ALS patients compared to healthy controls. 
 
The findings of the current investigation are largely consistent with previous studies of 
white matter integrity in ALS employing a variety of techniques from volumetric white 
matter analysis (Abrahams et al., 2005), VBM style analysis of DTI data (Sage et al., 2004; 
Agosta et al., 2007), tractography (Sarro et al., 2011;), and TBSS (Ciccarelli et al., 2009; 
Prudlo et al., 2012). The majority of changes reported in the above studies highlight the 
involvement of predominantly frontotemporal regions although it should be recognised that 
longitudinal tracts such as the inferior and superior longitudinal fasciculus connecting 
frontal and temporal regions to posterior regions are also commonly implicated (e.g. 
Abrahams et al., 2005; Sarro et al., 2011). Moreover, the degree of consistency between the 
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ROI and TBSS analyses suggests that the changes observed in the current investigation are 
robust, and that DTI data is sensitive to structural pathology in ALS. In contrast to the 
extensive changes revealed in white matter structures, VBM analysis of T1-weighted data 
revealed only small and localised volumetric reductions in right hemispheric motor cortex 
and inferior frontal gyrus. Nevertheless, atrophy in this region has been reported in 
numerous previous studies (e.g. Kassubek et al., 2005; Agosta et al., 2007; Agosta et al., 
2012), as well as being implicated in functional abnormalities in verbal fluency 
performance, one of the most commonly observed cognitive impairments in ALS (e.g. 
Abrahams et al. 2004). 
 
The imaging parameters described above were subjected to correlational analyses with 
performance in the cognitive tests described in Chapter 2 and Chapter 4. Correlations with 
structural imaging parameters were only performed for those tests (neuropsychological or 
experimental) which revealed significant group differences between ALS patients and 
healthy controls. As discussed in detail in Chapter 6 (Section 6.4), several correlations were 
observed between white matter ROIs and performance in cognitive tests; Average Dual 
Task Cost correlated with FA values in middle frontal gyrus white matter, performance in 
the Spoken Letter Fluency Test correlated with FA in the corpus callosum and corticospinal 
tracts, Reverse Digit Span performance correlated with D in hippocampal portion of the 
cingulum and uncinate fasciculus, and performance in the Logical Memory scales correlated 
with FA in the inferior longitudinal fasciculus. Compared to the ROI analyses, correlations 
between cognitive performance in ALS and water molecule diffusion parameters in the 
TBSS analyses were more limited – as in the ROI analyses, significant correlations between 
FA and performance in the Spoken Letter Fluency Test were revealed, but diffusion 





7.2.1 Executive functioning, processing speed, and attention in motor disorders 
The dual task deficits observed in the current patient cohorts can be interpreted in terms of 
the multiple-component model of working memory (Baddeley & Hitch, 1974; Baddeley, 
2000). In the terms of this model, the component tasks of Delayed Digit Span (DDR) and 
Visual Inspection Time (VIT) would have placed demands on the Phonological Loop and 
Visuospatial Sketchpad respectively. The component tasks in isolation were unlikely to tax 
the Central Executive component of the multiple-component model due to their limited 
processing demands; the DDR task simply required the maintenance of a sequence of digits 
so that they were available for recall after a 15 second delay, and the VIT task required very 
basic forced-choice perceptual processing. The ALS and MS patient groups were able to 
perform comparably to the control groups in both of the component tasks at their own 
predetermined maximum ability level. Thus, the dual task deficit observed in ALS and MS 
patients is likely to reflect a specific difficulty in the ability to perform these tasks 
concurrently. Investigation of dual tasking in healthy adults has demonstrated that dual task 
costs are low even when two working memory tasks (one verbal, one visuospatial) are 
performed concurrently, provided the single tasks are tailored to individual ability level 
(Cocchini et al., 2002). Results of this nature suggest that the domain specific sensory slave 
systems are able to independently perform additional processing functions required by 
working memory tasks, not just (temporarily) store sensory information. A further 
consequence of this finding is to suggest that the central role of the central executive in dual 
task paradigms is the coordination of the slave systems, and that dual task decrements 
observed in the current study may reflect a specific deficit in this attentional ability (Duff & 
Logie, 2001; Cocchini et al., 2002). Such an interpretation of the dual task impairment 
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observed in ALS and MS patients is also consistent with a deficit in “sharing attention”, one 
of the proposed components of Norman and Shallice’s (1986) Supervisory Attentional 
System defined by Stuss et al. (1995).  According to this account the patient groups in the 
current study may have deficits in energising and monitoring mechanisms required to ensure 
that a balance is maintained between the active response sets of two tasks. 
 
However, other researchers have proposed dual task decrements may be a result of slowed 
processing rather than a decline in attentional capacity (e.g. Salthouse & Somberg, 1982). 
The paradigm employed in the current investigation addressed this possibility by including a 
processing speed task as one of the component tasks (VIT task). According to Salthouse 
(1996), slowed processing may cause dual task interference due to the Simultaneity Effect 
which asserts that if processing speed for a given function is slowed then the information 
may no longer be available or relevant when it is needed. In this case slowed processing in 
either of the component tasks may result in there being insufficient time to complete the 
other task effectively, i.e. before the memory trace decays in Delayed Digit Recall, or before 
the stimulus disappears in the VIT task. As demonstrated in Chapter 3, younger, middle, and 
older adults exhibited differences in processing speed with the expected relationship of 
slowed perceptual encoding occurring with increasing age. Despite this, all age groups were 
able to perform the dual task to the same ability when individual differences in processing 
speed were calibrated suggesting that there is no effect of ageing on dual task ability when 
individual differences in task performance are calibrated. In addition, participants were able 
to perform a processing speed task, at or close to their maximum ability, concurrently with 
another task without suffering from a substantial performance decrement. This finding 
suggests that processing speed is unlikely to be a crucial component of executive 
coordination as it has no detrimental effect on dual task ability in healthy adults. Thus it is 
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hypothesised that dual task impairments observed in the patient cohorts reflect an executive 
dysfunction that is independent of any individual differences in processing speed. Further 
evidence for this claim is provided by the finding that performance in the experimental VIT 
processing speed task did not correlate with Dual Task Cost in the ALS or MS groups 
suggesting that performance in these tasks was not related. 
 
The results of the current investigation also go against the interpretation of dual task 
impairment in MS offered by D’Esposito et al. (1996). The authors proposed that the 
functioning of the central executive may rely upon processing speed as dual task decrement 
scores correlated with PASAT performance in MS patients. It was reasoned that as PASAT 
performance has traditionally been related to speed of information processing (Gronwall, 
1977), one could draw the conclusion that processing speed is also crucial component of the 
coordinating function of the central executive. However, the results of the current 
investigation show that MS patients are not impaired in a well validated test of perceptual 
processing speed (the VIT task), and more over, the observed dual task deficit occurred 
independently of processing speed ability in this task suggesting that in fact processing 
speed is not a contributing factor in executive control (at least within the dual task).  Of 
note, this explanation of dual task performance seems particularly unlikely to be relevant to 
ALS patients as performance in both processing speed measures (VIT task and RSLI task) 
was comparable to that of healthy controls. 
 
However, MS patients did exhibit impairments in the RSLI processing speed tasks 
suggesting that executive dysfunction may not account for all cognitive deficits observed in 
this patient population. The observed pattern of a selective impairment in the RSLI 
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processing speed task may be explained by the demands imposed by the respective tasks. 
The VIT task requires the identification of abstract visual stimuli for which there are only 2 
choices, therefore it is essentially a simple forced-choice decision task. By contrast, the 
RSLI task requires the identification of a specific letter, and therefore imposes greater 
attentional demands as there are multiple potential responses. In addition, there are more 
distracter stimuli (forward and backward masking) in the RSLI task whereas the VIT task 
only employs a single backward mask. Thus, the RSLI task may require a further element of 
inhibitory control as responses to letters other than the target must be suppressed. Further 
support for this possibility is provided by the correlation between performance in RSLI task 
and Average Dual Task Cost in MS patients suggesting that an underlying attentional deficit 
may underpin performance on both tasks. The fact that ALS patients were unimpaired in the 
RSLI task suggests that the task is not as executively demanding as tasks requiring abstract 
thought such as letter fluency or sorting tasks. However, good performance in the RSLI task 
may still require some element of attentional control and MS patients may be more 
vulnerable to attentional deficits than ALS patients as evidenced by the greater number 
patients who exhibited impairment in the dual task (8 MS versus 5 ALS).  Moreover, such 
an attentional impairment in MS would certainly explain the commonly reported deficits in 
tasks such as the PASAT (Fischer, Rudick, Cutter & Reingold, 1999) and Symbol Digit 
Modalities Test (DeLuca et al., 2004), which although purportedly assess processing speed, 
undoubtedly require an element of attentional control to keep track of changing task-
relevant information and inhibit irrelevant previous responses. Indeed, some investigators 
have suggested that tasks such as the PASAT are better described in terms of “information 
processing efficiency” which is defined as involving working memory capacity in addition 




In addition to the dual task impairments discussed above, other cognitive deficits observed 
in the current patient cohorts can also be interpreted in terms of the multiple-component 
model of working memory. For example the significant group differences (trend in MS 
patients) observed in Forward Digit Span may reflect disruption of the Phonological Loop 
which is responsible for maintaining verbal information. The Phonological Loop is 
comprised of two systems, the phonological store which holds memory traces for a few 
seconds, and articulatory rehearsal which refreshes the contents of the phonological store 
through subvocal speech (Baddeley, 1986). Although the current study did not investigate 
Phonological Loop functioning, a previous investigation reported that ALS patients 
exhibited the normal Word Length Effect and Phonological Similarity Effect suggesting that 
articulatory rehearsal and phonological storage processes are intact (Abrahams et al., 2000).  
Thus, the impairments in Forward and Reverse Digit Span exhibited by ALS patients in the 
current study may reflect impaired attentional capacity. More specifically, deficits in 
Reverse Digit Span may be indicative of reduced working memory capacity as additional 
attentional resources are required to reverse the order of the digits whilst maintaining the 
original sequence in mind. Moreover, such “high-order” processes of attentional control are 
also assumed to be crucial for performance in novel or goal directed behaviour such as those 
assessed by the Spoken Letter Fluency Test and the D-KEFS Sorting Test (Stuss et al., 
1995; Baddeley, 1996; Abrahams et al, 2000; Gilbert & Burgess, 2008; Fine et al., 2010).  
 
7.2.2 Sensitivity of letter fluency to cognitive impairment in ALS 
The current investigation serves to highlight the sensitivity of letter fluency tests to extra-
motor dysfunction in ALS. Not only was the Spoken Letter Fluency Test (fi) the most 
sensitive measure for detecting cognitive impairment in ALS, it was also the only cognitive 
measure to correlate with both ROI and TBSS white matter analyses. The sensitivity of 
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letter fluency to cognitive and cerebral changes in ALS may be a reflection of the unique 
demands imposed by the task. Letter fluency tests remain one of the most commonly used  
tests of executive functioning (Baldo et al., 2001), and performance is thought to be 
dependent upon discrete executive processes including; initiation, strategy formation, 
sustained attention, set-shifting, working memory and inhibition (Troyer et al., 1997; 
Azuma, 2004; Abrahams et al., 2000; Rende et al., 2002). However, a factor analysis by 
Fisk and Sharp (2004) revealed that letter fluency tests were not related to performance in 
tests requiring updating, inhibition, or shifting, and proposed that letter fluency tests may 
reflect a specific executive ability, namely the efficiency of access to long-term (lexical) 
memory. Such a process may be interpreted as a function of the ‘episodic buffer’ which has 
been proposed to facilitate the transfer of information between working memory and long-
term memory (Baddeley, 2000). Moreover, we have demonstrated that ALS patients exhibit 
impairments in basic linguistic retrieval (confrontation naming), and retrieval from long-
term memory (Logical Memory scales). Thus, deficits in letter fluency in ALS may arise 
due to impairment in any one, or combination of, executive, linguistic, or retrieval 
processes.  
 
7.2.3 Distinct white matter structures correlate with cognitive performance in ALS 
The integrity of different white matter regions and pathways were related to performance in 
different cognitive tests. Letter fluency and reverse digit span performance were each 
associated with two anatomically distinct white matter structures, and in both cases, the 
associated areas were not restricted to prefrontal regions. Such results suggest that 
performance in executive tasks in ALS is likely dependent on the integrity of pathways 
connecting distributed brain regions. Indeed the concept that performance in tasks assessing 
executive functioning is dependent upon distributed brain networks has been suggested by 
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recent reviews of neuropsychological and neuroimaging studies (e.g. Collette & Van der 
Linden, 2002; Alvarez & Emory, 2006; Jurado & Roselli, 2007). For example, although 
letter fluency tasks are sensitive to frontal lobe lesions, and particularly to left dorsolateral 
and inferior frontal lesions (Stuss et al., 1998; Baldo, Schwartz, Wilkins & Dronkers, 2006; 
Robinson et al., 2012), patients with non-frontal lesions have been shown to perform as 
badly as those with frontal lesions (Perret, 1974; Pendleton et al., 1982). Similarly, although 
there is a propensity for frontal lobe activation during fluency tasks (Frith et al., 1995; 
Abrahams et al., 2004; Katzev, Tüscher, Hennig, Weiller & Kaller, 2013), other regions 
such as the thalamus, parietal lobes and temporal lobes are also commonly implicated 
(Paulesu et al., 1997; Birn et al., 2009). Thus, letter fluency tasks, although sensitive to 
frontal lobe damage, may not be specific to focal frontal lesions because executive 
functioning requires coordination of diffuse anatomical and functional cerebral regions. 
Furthermore, cognitive theorists have also postulated that performance of complex systems 
such as working memory is less likely to be dependent upon a single anatomical locus, and 
more likely to be an emergent property of several connected regions (Repovs & Baddeley, 
2006).  
 
By contrast, poor dual task performance was associated with low integrity in a specific 
region of prefrontal white matter (that underlying middle frontal gyrus or dorsolateral 
prefrontal cortex), which may suggest that this region plays a specific role in the 
coordination and division of attention. Indeed, some functional imaging studies have 
highlighted the importance of this region in dual task performance (D’Esposito et al., 1995; 
Bunge et al., 2002), and neuropsychological studies have shown dual task impairment in the 
patients with frontal lobe lesions and dysexecutive behaviour (Baddeley et al., 1997), 
although deficits are also exhibited in patients characterised by temporal lobe involvement 
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(e.g. Alzheimer’s disease; Logie et al., 2004). While some investigators have postulated that 
specific areas of the prefrontal lobes are crucial for managing and coordinating response 
selection and interference (MacDonald et al., 2000; Wager & Smith, 2003),  others have 
suggested that dual task performance may dependent upon distributed networks (Collette & 
Van der Linden, 2002). However, the fact that dual task performance did not correlate with 
any of the same regions associated with performance in letter fluency or reverse digit span is 
further evidence to suggest that the processes underpinning these tasks may be functionally 
distinct. 
 
Moreover, performance in the domain of verbal memory was associated with integrity in 
another discrete white matter pathway as evidenced by the correlation between Logical 
Memory and the inferior longitudinal fasciculus. The inferior longitudinal fasciculus 
connects anterior temporal regions to the occipital lobes and recent studies have implicated 
this structure in semantic memory (Vigneau et al., 2006) and language comprehension 
(Wong, Chandrasekaran, Garibaldi & Wong, 2011) although its functional significance 
remains controversial (see Dick & Tremblay, 2012 for a review). Moreover integrity of the 
inferior longitudinal fasciculus has been shown to correlate with cognitive functioning in 
ALS, albeit to a test of executive functioning, not memory (Sarro et al., 2011). Verbal 
memory deficits have been consistently reported in ALS (Raaphorst et al., 2010), and in the 
current investigation performance in Immediate recall, Delayed recall, and Recognition 
conditions all correlated with inferior longitudinal fasciculus integrity suggesting that the 
observed relationship is a reflection of a primary memory deficit in ALS patients. Thus, 
although the functional significance of the inferior longitudinal fasciculus remains unclear, 
there is now evidence that this tract is involved ALS as well as FTD pathology (Whitwell et 




7.2.4 Cognitive change as a marker of underlying white matter pathology 
Although both DTI analyses produced consistent results in terms of identifying structures in 
which ALS patients had reduced structural integrity, the ROI data was more sensitive to 
relationships between white matter integrity and performance in cognitive tests. ROI 
techniques may be more sensitive to correlations with small sub-gyral regions as, unlike in 
TBSS, native images do not have to be registered to standard templates. However, other 
correlations with major tracts (e.g. uncinate fasciculus and inferior longitudinal fasciculus) 
were observed in the ROI but not TBSS analyses suggesting that this may not be the only 
reason. Another possibility is that the ROI methodology was less statistically conservative; 
multiple comparison corrections were not applied to correlational analyses as only those 
cognitive tests and cerebral regions in which there were significant group differences were 
investigated. By contrast TBSS applies strict multiple comparison corrections as 
correlations are investigated in a voxel-wise manner for whole brain white matter. Thus, 
ROI or semi-automated ROI techniques employed by the current investigation may be more 
sensitive to correlations between cognitive performance and structural integrity in small 
patient populations. 
 
Nevertheless the ROI and TBSS analyses showed a very good degree of consistency; the 
regions most strongly associated with letter fluency performance in the TBSS analysis were 
the same as those revealed by correlations with ROI data, namely the corpus callosum and 
corticospinal tracts, indicative of a robust effect. Moreover, the anatomical localisation 
afforded by the TBSS analysis revealed that reduced integrity in the anterior portion of the 
corpus callosum was associated with poor letter fluency performance. As such, the results of 
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the current investigation suggest that poor fluency performance in ALS may reflect the 
disruption of pathways between right and left prefrontal areas, as has been suggested by 
other studies in ALS (e.g. Yamauchi et al., 1995; Filippini et al., 2010), as well as FTD 
(Matsuo et al., 2008). One possible interpretation of these findings is that fluency deficits 
may be a sensitive marker of white matter changes in areas that occur frequently and early 
in ALS, i.e. the corticospinal tract and corpus callosum. By contrast, dual task impairments 
may be more sensitive to the disruption of more specific prefrontal pathways that affect a 
smaller subset of ALS patients, and may be a reflection of pathological spread from central 
areas to more anterior and dorsolateral cerebral areas. Indeed, the corpus callosum has been 
implicated as a key structure in the mechanism of pathological spread (Eisen, 2009), and 
thus we may expect callosal abnormalities and verbal fluency deficits to precede anterior 
and dorsolateral involvement and the associated dual task impairment. However, of the three 
patients who exhibited impaired performance in the dual task (z-score ≤ 2) only one also 
exhibited impairment in letter fluency. Moreover, as discussed previously (Chapter4, 
Section 4.4.3) dual-task and letter fluency performance were not correlated, suggesting that 
impairments in executive functions are dissociable in ALS patients. Further support for this 
proposal is provided by research which postulates that executive functions are dissociable at 
a behavioural and neuroanatomical level (Goldman-Rakic, 1995; Jurado & Roselli, 2007), 
and particularly by studies which suggest that verbal fluency and dual tasking do not share 
the same cognitive processes, making them less likely to rely on the same neural pathways 
(Miyake et al., 2000). 
 
7.2.5 Implications for pathological mechanisms in ALS 
As discussed above, the relationships between DTI parameters and performance in cognitive 
tests suggest that the integrity of white matter structures can be related to functional changes 
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in ALS. Moreover, white matter integrity in motor regions (corticospinal tract and corona 
radiata) was associated with an index of disease progression indicating that DTI parameters 
are also related to clinical disease parameters. However, the question remains as to why 
changes in grey matter volumes are not observed to the same extent as the changes revealed 
by the assessment of white matter integrity. One possibility lies in the fundamental 
difference between DTI and volumetric MRI data. The diffusivity metrics of FA and D 
provide an estimate of white matter integrity, whereas volumetric analyses evaluate cortical 
structures in terms of absolute volume. Therefore, DTI analyses may be sensitive to small 
changes in integrity which are too subtle to cause detectable changes in volume. A related 
point concerns the heterogeneous nature of cognitive impairment in ALS; approximately 
30% patients in the current investigation presented with cognitive impairment in standard 
neuropsychological tests, and as such any volumetric changes present in this relatively small 
proportion of patients may be lost in whole group analyses – this may explain why the VBM 
analysis revealed volumetric reductions in primary motor regions as such changes are likely 
to affect a significant proportion of patients. An upshot of this point is to suggest that the 
volumetric reductions observed in right inferior frontal gyrus are an important feature of 
ALS cortical pathology as reductions in this region are seemingly as robust as those 
observed in motor regions. A final point to consider is the possibility that diffusion 
abnormalities in white matter may precede cortical atrophy (i.e. volumetric loss) which may 
occur downstream as a result of more considerable reductions in axonal integrity. As such, 
the findings of the current investigation appear to be consistent with the “dying-back” 
hypothesis of ALS pathogenesis which proposes that disease processes begin in the 
neuromuscular junction and are spread via axonal transport before eventually disrupting the 
functioning of the upstream neuronal cell (Chou & Norris, 1992 Fischer et al., 2004). 
However, the degree of cortical involvement revealed by the DTI analyses may be better 
explained by the notion of focality and contiguous spread recently proposed by Ravits and 
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La Spada (2009). According to this model, pathology can occur at any level of the motor 
system (upper or lower motor neurons) before spreading to contiguous regions via 
transneuronal signalling. Of note, Ravits and La Spada (2009) postulate that disease spread 
in the upper motor neurons is likely to occur in a medial-to-lateral direction which 
implicates major inter-hemispheric structures such as the corpus callosum which have been 
suggested to be crucial in the spread of motor and extra-motor pathology in ALS (Eisen, 
2009, Filippini et al., 2010). 
     
Indeed, the pattern of cerebral involvement revealed in the current investigation, as well as 
those of other studies is concordant with cerebral pathology in ALS. A recent pathological 
study investigating the presence and severity of TDP-43 proteinopathy (Geser et al., 2008) 
reported that although a degree of pathology was found in all sampled cortical and 
subcortical regions, there were marked differences in terms of the percentage of cases 
exhibiting pathology in different cerebral regions. Within motor, sensory, and regions 
through which run the corticospinal tract, TDP-43 abnormalities were found in nearly 100% 
of cases, with high proportions also found in thalamus and subcortical regions involved in 
motor control (e.g. substantia nigra and cerebellum). In terms of non-motor regions, TDP-43 
proteinopathy was reported in cingulate gray matter in approximately 70 % of cases, 
followed by approximately 60% of cases in midfrontal grey matter, and between 35 – 40% 
of cases in temporal, hippocampal, and parietal regions. By contrast, only 11% of cases 
showed TDP-43 pathology in occipital lobe. The pathology gradient observed in this study 
is broadly consistent with the propensity of changes revealed by the neuroimaging studies 
described previously, although it should be noted that the Geser et al. (2008) study did 
include several patients with ALS-FTD. Of particular interest, TDP-43 pathology was more 
common in grey matter than the corresponding white matter structures. Such findings 
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provide further evidence to suggest that DTI analyses have considerably greater sensitivity 
to pathology in ALS than volumetric analyses, although the possibility remains that DTI 
metrics are sensitive to pathological changes other than those caused by TDP-43 
proteinopathy.  
 
Another implication of the correspondence between the structural imaging findings and 
those of pathological studies is to provide further evidence of a link between ALS and FTD. 
TDP-43 pathology is not only a hallmark of ALS, it is also the main proteinopathy in cases 
of frontotemporal lobar degeneration with ubiquinated inclusions (FTLD-U; Geser et al., 
2009). According to the TDP-43 clinico-pathological spectrum proposed by Geser et al. 
(2009), ALS and FTLD exist on opposite ends of a continuum with predominant 
involvement of the spinal cord at one end, and predominant involvement of cortical areas at 
the other – cases of ALS with cognitive impairment and ALS-FTD fall somewhere in the 
middle of the spectrum. Thus, structural MRI, and particularly DTI data from the current 
study lend support to the postulated continuum between classical ALS and FTD (Lomen-
Hoerth et al., 2003; Abrahams et al., 2004; Murphy et al., 2007; Sage et al., 2007; Raaphorst 
et al., 2010), as it highlights a preponderance for frontotemporal white matter pathology 
which may play a crucial role in the multi-system involvement observed in this disorder. 
Moreover, both DTI analyses implicated the involvement of the inferior longitudinal 
fasciculus and the uncinate fasciculus which have been shown to be preferentially involved 
in FTD (Whitwell et al., 2010). However, further investigations are needed in which 
neuroimaging and pathological techniques are combined within the same patient cohort to 
allow the relationship between ALS, cognitive impairment, and TDP-43 pathology to be 




The extent of white matter changes revealed in the current investigation, as well as the 
observed associations between integrity and cognitive performance suggests that white 
matter pathology may be the core mechanism underlying functional changes in ALS. 
Cortical disconnection has been proposed as a mechanism to account for the cognitive 
impairments observed in other neurodegenerative disorders characterised by white matter 
pathology such as MS (Dineen et al., 2009), as well as subcortical dementias (Huntingdon’s 
disease; Rosas et al., 2010) and Alzheimers disease (Delbeuck et al., 2003). It is 
hypothesised that pathological processes resulting in intrinsic damage to white matter 
structures prevent the communication and coordination of discrete cerebral regions, thus 
disrupting functional networks. For example, in Alzheimer’s disease, convergent evidence 
has emerged from pathological and DTI investigations to suggest that white matter 
pathology results in isolation of the hippocampi which may cause the profound memory 
dysfunction that characterises this disorder (Delbeuck et al., 2003). In terms of ALS, one 
may expect executive functions to be particularly vulnerable to this kind of pathological 
process as they are likely to rely upon complex functional networks spread across disparate 
brain areas. Moreover, comparative analyses between ALS and FTD patients show that 
while there are only small regions in which FTD patients have worse white matter integrity 
than ALS patients (corpus callosum and inferior longitudinal fasciculus), there are large 
(frontotemporal) areas in which FTD patients display greater grey matter atrophy (Lillo et 
al., 2012). Thus, cortical disconnection as a function of white matter pathology may explain 
the more subtle cognitive impairments observed in ALS, whereas the more profound 






7.2.6 Implications for disease management and patient care 
The current investigation has demonstrated that patients with ALS and MS can exhibit 
impairments in verbal memory, working memory, and executive functioning. Moreover, 
other studies investigating ALS have shown that deficits in domains of language, behaviour, 
mood, and social cognition (see Goldstein and Abrahams, 2013 for a review). Although 
cognitive deficits do not always manifest in either disorder, there is now consistent evidence 
to show that a significant proportion of ALS and MS patients will develop problems of this 
nature (Rovaris et al., 2002; Ringholz et al., 2005; Amato et al., 2006; Phukan et al., 2012; 
Elamin et al., 2013). Cognitive assessment is relatively common place in MS clinical 
management by way of specifically designed tools such as the Brief Repeatable Battery of 
Neuropsychological Tests (BRB-N; Rao, 1990) and the Screening Examination for 
Cognitive Impairment (SEFCI; Beatty et al., 1995), both of which have been shown to 
provide good sensitivity and specificity to MS cognitive impairment (Sartori & Edan, 2006). 
However, cognitive assessment and screening is not common place in ALS clinical 
management as appropriate and validated measures are not currently readily available – at  
present the screening assessments suggested for use in ALS either have not been specifically 
designed for ALS populations (e.g. the Penn State screen exam; Flaherty-Craig, Brothers, 
Dearman, Eslinger & Simmons, 2009), do not adequately control for motor dysfunction 
(Gordon et al., 2007), or are limited to assessing only one cognitive domain (ALS-Cognitive 
Behavioural Screen; Wooley et al., 2010). Thus, the first challenge is to develop a cognitive 
screen that is both sensitive to the heterogeneity of cognitive impairment in ALS and 
independent of motor and bulbar dysfunction.   
 
In terms of disease management and patient care, even relatively subtle impairments, 
especially in executive functioning, can dramatically affect an individual’s ability to make 
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decisions and form effective plans and strategies to deal with new situations. Deficits of this 
nature may hinder adherence to interventions and result in problems learning to perfrom 
new tasks such as those required for gastrostomy or ventilation purposes (Olney et al., 
2005). In cases where more severe impairments are present such as those exhibited by 
patients with ALS-FTD, individuals may be unable to make decisions regarding their 
finances and their future, which may ultimately lead to the need for capacity assessment 
(Goldstein & Abrahams, 2013). Similarly, in addition to the considerable challenges 
associated with declining motor/bulbar functioning, impairments in memory and language 
are likely to affect an individual’s ability to communicate effectively and function 
independently (Abrahams, 2013). Therefore, the accurate identification of cognitive deficits 
is crucial to empower clinicians to employ appropriate interventions and make provisions to 
educate carers in an effort to ensure that quality of life is maximised for both patients and 
their families.     
 
7.3 Limitations and future directions 
The current investigation was not without limitations. In terms of patient sampling, the ALS 
cohort were a prevalent rather than incident sample and as a result included a small number 
of patients (n = 2) with disease duration of over five years, although patients with significant 
respiratory dysfunction were excluded. However, large population studies of cognitive 
impairment in ALS using incidence sampling methods have shown similar rates of 
impairment as those from prevalent samples. They have also revealed a more heterogeneous 
presentation not only of executive dysfunction but including changes in language and 
memory (Phukan et al. 2012, Goldstein & Abrahams, 2013) which is consistent with the 
findings of the current investigation. It should also be noted that the MS group comprised 
patients with relapse-remitting, primary progressive, and secondary progressive disease 
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course subtypes. Although cognitive impairment is recognised in all disease subtypes 
(Foong et al., 2000; Rovaris et al., 2002; DeSonneville et al., 2002), several studies have 
shown that patients with progressive forms of the disorder are more likely to experience 
deficits in memory (Calabrese et al., 2000; Gaudino, Chiaravalloti, DeLuca, & Diamond, 
2001), executive functioning and attention (Huijbregts et al., 2004, 2006), and processing 
speed (DeSonneville et al., 2002). As such, the inclusion of relapse-remitting patients in the 
current study may have resulted in greater cognitive heterogeneity within the current sample 
and therefore a lower likelihood of detecting cognitive impairment in some of the 
neuropsychological and experimental tasks. On the other hand, the potential for variation 
within the MS group may provide greater relevance for comparison with an ALS population 
in which cognitive heterogeneity is well established.    
 
In addition, we were unable to match the subgroup of 25 ALS patients, MS patients, and 
healthy controls in terms of age in the three-way comparisons. However, effects of age were 
investigated and controlled for by covariate analyses and the general consistency between 
the findings of the two-way and three-way comparisons in both background and 
experimental tests suggest that age differences were not a major factor. With regard to task 
design, the processing speed measures were analysed in terms of the number of errors made, 
a method which proved successful in showing that ALS patients performed comparably to 
controls in both tasks while MS patients exhibited a selective deficit in RSLI task. However, 
it would have been of interest to investigate the qualitative nature of processing speed 
performance as well – for example did MS patients make more errors purely in the faster 
trials, or were errors dispersed more randomly? Such a design may have provided more of 
an indication as to whether impaired task performance was due to attentional deficits or 
slowed processing speed. Furthermore, although direct comparisons were made between 
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ALS and MS patients in terms of cognitive performance, we were unable to attain structural 
imaging data in the MS cohort and therefore we were unable to determine whether the two 
groups also shared similarities in terms of white and grey matter pathology. Given, the 
relatively similar cognitive profiles exhibited by the ALS and MS cohorts, such a 
comparison may have provided additional insights as to whether the neural correlates of 
cognitive impairment are also shared. 
 
The current investigation has provided further evidence to show that ALS is a complex 
multi-system disorder with a considerable degree of heterogeneity in clinical and cognitive 
impairment. As such, it would be advantageous for future investigations to recruit relatively 
large cohorts (e.g. n = 100) so that patients can be divided into subgroups based on whether 
or not they exhibit cognitive impairment. In this way comparisons of structural data may be 
able to elucidate the specific cerebral changes associated with those patients who exhibit 
impairments and those who do not. Although recent studies (Phukan et al., 2012; Elamin et 
al., 2013) have included large samples and identified cognitive subtypes, future studies 
should investigate multiple aspects of the disease including clinical features, cognition, 
structural imaging, and pathological examinations, within the same cohort. Only in this way 
can direct associations be made regarding the complex interactions between functional and 
pathological processes. Moreover, longitudinal studies are needed to investigate whether 
extra-motor structural changes in ALS, and the associated cognitive deficits, are stable or 
whether they represent another component of disease spread and pathogenesis. Finally, the 
current investigation has made an attempt to investigate cognition in ALS in terms of 
current cognitive models of human behaviour, and subsequent studies should also consider 
this approach instead of relying purely upon clinical assessment tools which are more 




In conclusion, the current investigation has shown that processing speed is not impaired in 
ALS, and is unlikely to be related to observed impairments in tests of executive functioning. 
By contrast, there is more evidence of a processing speed deficit in MS, although the extent 
to which it is a reflection of a low-level attentional deficit remains to be seen. In addition, 
both patient groups exhibited impairments in dual tasking that were independent of 
processing speed and motor dysfunction. Executive dysfunction and particularly deficits in 
letter fluency remain the most common impairment in ALS, and may reflect the spread of 
disease pathology into prefrontal white matter structures. Moreover, there is evidence that 
impairments in different executive functions are related to the integrity of distinct prefrontal 
white matter tracts. However, further deficits in tests of language and memory suggest that 
cognitive impairment in ALS may not be restricted to executive functioning, particularly in 
the light of the observed correlation between verbal memory performance and white matter 
structures in temporal regions. Finally, DTI techniques are sensitive to cerebral changes in 
ALS and reflect damage to white matter structures and the disruption of cortical connections 
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Appendix B – Participant Information Sheets and Consent Forms 
 
SFC BRAIN IMAGING RESEARCH CENTRE 
Clinical Neurosciences 
SCHOOL OF MOLECULAR AND CLINICAL MEDICINE 
The University of Edinburgh 
Western General Hospital 
Crewe Road 
Edinburgh EH4 2XU 
Tel: 0131 537 2664 
Fax: 0131 537 2661 
Email Lewis Pettit : L.D.Pettit@sms.ed.ac.uk 
Email Dr Bastin: Mark.Bastin@ed.ac.uk  
Email Dr Abrahams: s.abrahams@ed.ac.uk 
Direct Line to Dr Abrahams: 0131 650 3339 
 
 
PATIENT INFORMATION SHEET 
 
MAGNETIC RESONANCE IMAGING OF PATIENTS WITH MOTOR 
NEURONE DISEASE 
 
Research Project: The heterogeneity of Cognitive Impairment in MND: Brain Imaging.  
Principal Investigators: Dr. Sharon Abrahams, Lewis Pettit and Dr Mark Bastin 
 
Thank you for your interest in this important work.  
Medical researchers need to know more about how different regions of the brain may be 
related to the changes in thinking and behaviour that are present in some people with MND. 
In this study, we will use Magnetic Resonance Imaging (MRI) to collect images of 
brain. This imaging data will be used with the data collected from previous interviews 






MRI uses a combination of powerful magnets and radio waves to create very high quality 
pictures of particular parts of the body without using X-rays. Although MRI techniques are 
already very well developed for taking pictures of the brain, less is known about how the 
structure of the brain is altered during illness. This Centre’s scanner is dedicated to finding 
out more about these important questions. 
 
If you agree to join the study, we will check that it is perfectly safe for you to be scanned. 
Although MRI is normally a very safe method of taking pictures, we do not scan people 
who have a heart pacemaker or who have had surgery involving the insertion of metal clips 
into the brain, or people who have metal fragments in their eyes, perhaps as a result of their 
job. Neither will we scan you if there is a chance that you might be pregnant. On the other 
hand, the metals used in operations such as hip replacements are very rarely a reason not to 
undergo scanning. The Radiographers will check if you are in any doubt. 
 
When you come to the Centre for your scan, a changing cubicle will be provided. You will 
be asked to place any metal objects, such as keys, watches, coins and credit cards, in a 
locker. Please do not wear any make-up or talc, and be prepared to remove contact lenses if 
you use them.  
 
You will be asked to lie on the scanner bed for up to an hour. While you are in the 
scanner, a series of pictures of your brain will be taken. The scanner makes quite loud 
noises while it operates. For your comfort, you will be provided with ear-plugs or 
headphones, and it may be possible to play music into the Scanner Room if you wish. If at 
any stage shortly before or during your scan, you become worried, or wish to ask a question, 
you will be able to speak to one of the Radiographers, who will use an intercom to keep in 
touch with you. 
 
Of course you do not have to take part in this study, and you may withdraw 
from it at any time. Please also be aware that this is non-therapeutic research 
from which you cannot expect to derive any direct benefit, and that 
participating or not participating in the study will not affect the treatment you 
would normally receive.  Please note that we are required by a medical ethics 
committee to send a routine report of the scan to your Doctor. 
 
All pictures that are taken within the Centre are entirely confidential, in the same way as all 
other medical records are. Pictures gathered from the scanner are stored and processed using 
computers and, after the study is completed, will be copied onto a permanent record which 




Further information on magnetic resonance imaging is available, if you 
require it, from Mr. David Summers, Consultant Neuroradiologist, 
Clinical Neurosciences, Western General Hospital, Edinburgh (Tel: 
0131 537 2022). He is not involved in this study, and so will be able to 
give you independent advice. Otherwise, the one of the Radiographers will be happy to try 
to answer any other questions that you might have. They can be contacted at the address 
shown at the top of the front of this information sheet. 
 
The University has in place a policy that provides an indemnity against legal 
liability (and includes a no fault compensation section) for accidental injury to any 
research subject arising out of participation in a clinical trial. 
 
Finally, you will be fully reimbursed for your travelling to the Brain Imaging 
Centre for this study.  
 
Once again, many thanks. 
 
 
Dr Sharon Abrahams 
Senior Lecturer in Human Cognitive Neuroscience 
s.abrahams@ed.ac.uk 















SFC BRAIN IMAGING RESEARCH  
CENTRE FOR SCOTLAND 
& DEPARTMENT OF PSYCHOLOGY 
 
 
PATIENT CONSENT FORM 
 
Research Project: The Heterogeneity of Cognitive Impairment in MND: Brain Imaging. 
 
Principal Investigators: Dr. Sharon Abrahams and Dr Mark Bastin 
 
 I have read the Information Sheet that has been provided to me, and this Consent Form, 
and have been given the opportunity to ask questions about them. I am satisfied that I 
have all the information that I need to provide informed consent. 
 
 I understand that my General Practitioner (GP) will be informed of my participation in 
this study, and know that he/she will be provided with a routine clinical report. 
 
 I know of no reason why I should not undergo Magnetic Resonance Imaging or take 
part in the study. 
 
 I know that I am under no obligation to take part in the study and I can withdraw at 
any time. 
 
 I understand that that is non-therapeutic research from which I cannot expect to 
derive any direct benefit. 
 
 I understand that participating or not participating in the study will not affect the 
treatment that I would normally receive. 
 
 I understand and agree that medical images obtained during my scan will be stored and 
processed using computers and, after the study is completed, that these may be copied 




 I understand and agree that information gathered during my scan may be shared with 
other medical and scientific researchers, subject to strict laws and University of 
Edinburgh policies intended to safeguard my privacy. 
 
 I agree to participate in the study. 
 








Witnessed by (signature) 



























Both copies of this form must be brought to the Centre on the day of scanning. The pink 
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SCHOOL OF MOLECULAR AND CLINICAL MEDICINE 
The University of Edinburgh 
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Crewe Road 
Edinburgh EH4 2XU 
Tel: 0131 537 2664 
Fax: 0131 537 2661 
Email Lewis Pettit : L.D.Pettit@sms.ed.ac.uk 
Email Dr Bastin: Mark.Bastin@ed.ac.uk  
Email Dr Abrahams: s.abrahams@ed.ac.uk 





MAGNETIC RESONANCE IMAGING  
 
Research Project: The heterogeneity of Cognitive Impairment in Motor Neurone Disease: 
Brain Imaging.  
Principal Investigators: Dr. Sharon Abrahams, Lewis Pettit and Dr Mark Bastin. 
 
Thank you for your interest in this important work.  
Medical researchers need to know more about how different regions of the brain may be 
related to the changes in thinking and behaviour that are present in some people with Motor 
Neurone Disease. To do this we also need to collect information from healthy people as a 
comparative group. In this study, we will use Magnetic Resonance Imaging (MRI) to 
collect images of brain. This imaging data will be used with the data collected from 






MRI uses a combination of powerful magnets and radio waves to create very high quality 
pictures of particular parts of the body without using X-rays. Although MRI techniques are 
already very well developed for taking pictures of the brain, less is known about how the 
structure of the brain is altered during illness. This Centre’s scanner is dedicated to finding 
out more about these important questions. 
 
If you agree to join the study, we will check that it is perfectly safe for you to be scanned. 
Although MRI is normally a very safe method of taking pictures, we do not scan people 
who have a heart pacemaker or who have had surgery involving the insertion of metal clips 
into the brain, or people who have metal fragments in their eyes, perhaps as a result of their 
job. Neither will we scan you if there is a chance that you might be pregnant. On the other 
hand, the metals used in operations such as hip replacements are very rarely a reason not to 
undergo scanning. The Radiographers will check if you are in any doubt. 
 
When you come to the Centre for your scan, a changing cubicle will be provided. You will 
be asked to place any metal objects, such as keys, watches, coins and credit cards, in a 
locker. Please do not wear any make-up or talc, and be prepared to remove contact lenses if 
you use them.  
 
You will be asked to lie on the scanner bed for up to an hour. While you are in the 
scanner, a series of pictures of your brain will be taken. The scanner makes quite loud 
noises while it operates. For your comfort, you will be provided with ear-plugs or 
headphones, and it may be possible to play music into the Scanner Room if you wish. If at 
any stage shortly before or during your scan, you become worried, or wish to ask a question, 
you will be able to speak to one of the Radiographers, who will use an intercom to keep in 
touch with you. 
 
Of course you do not have to take part in this study, and you may withdraw 
from it at any time. Please also be aware that this is non-therapeutic research 
from which you cannot expect to derive any direct benefit, and that 
participating or not participating in the study will not affect the treatment you 
would normally receive.  Please note that we are required by a medical ethics 
committee to send a routine report of the scan to your Doctor. 
 
All pictures that are taken within the Centre are entirely confidential, in the same way as all 
other medical records are. Pictures gathered from the scanner are stored and processed using 
computers and, after the study is completed, will be copied onto a permanent record which 




Further information on magnetic resonance imaging is available, if you 
require it, from Mr. David Summers, Consultant Neuroradiologist, 
Clinical Neurosciences, Western General Hospital, Edinburgh (Tel: 
0131 537 2022). He is not involved in this study, and so will be able to 
give you independent advice. Otherwise, the one of the Radiographers will be happy to try 
to answer any other questions that you might have. They can be contacted at the address 
shown at the top of the front of this information sheet. 
 
The University has in place a policy that provides an indemnity against legal 
liability (and includes a no fault compensation section) for accidental injury to any 
research subject arising out of participation in a clinical trial. 
 
Finally, you will be fully reimbursed for your travelling to the Brain Imaging 
Centre for this study.  
 




Dr Sharon Abrahams 
Senior Lecturer in Human Cognitive Neuroscience 
s.abrahams@ed.ac.uk 














SFC BRAIN IMAGING RESEARCH  
CENTRE FOR SCOTLAND 
& DEPARTMENT OF PSYCHOLOGY 
 
VOLUNTEER CONSENT FORM 
 
Research Project: The Heterogeneity of Cognitive Impairment in MND: Brain Imaging. 
 
Principal Investigator: Dr. Sharon Abrahams and Dr Mark Bastin 
 
 I have read the Information Sheet that has been provided to me, and this Consent Form, 
and have been given the opportunity to ask questions about them. I am satisfied that I 
have all the information that I need to provide informed consent. 
 
 I understand that my General Practitioner (GP) will be informed of my participation in 
this study, and know that he/she will be provided with a routine clinical report. 
 
 I know of no reason why I should not undergo Magnetic Resonance Imaging or take 
part in the study. 
 
 I know that I am under no obligation to take part in the study and I can withdraw at 
any time. 
 
 I understand that that is non-therapeutic research from which I cannot expect to 
derive any direct benefit. 
 
 I understand that participating or not participating in the study will not affect the 
treatment that I would normally receive. 
 
 I understand and agree that medical images obtained during my scan will be stored and 
processed using computers and, after the study is completed, that these may be copied 
onto a permanent record which might be studied again at a later time.  
 
 I understand and agree that information gathered during my scan may be shared with 
other medical and scientific researchers, subject to strict laws and University of 




 I agree to participate in the study. 
 









Witnessed by (signature) 
 
 
























Both copies of this form must be brought to the Centre on the day of scanning. The pink 


































Participant Information Sheet for Patients 
 
Study title: “Thinking and behaviour in movement disorders; a 
comparative study”. 
 
You are being invited to take part in a research study.  Before you decide it 
is important for you to understand why the research is being done and what 
it will involve.  Please take time to read the following information carefully 
and discuss it with others if you wish.  Ask us if there is anything that is not 
clear or if you would like more information.  Take time to decide whether or 
not you wish to take part.  
 
What is the purpose of the study? 
 
The current study investigates processes of thinking in motor disorders and 
uses some measures which focus on how we pay attention to information 
and the ability to perform two tasks at once.  
 
Why have I been chosen? 
 
We will be seeing 40 people with motor neuron disease (MND), 40 people 
with Parkinson’s disease (PD), and 40 people with multiple sclerosis (MS). 
We will also be seeing a total of 40 healthy control participants. 
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part.  If you do decide to take 
part you will be given this information sheet to keep and be asked to sign a 
consent form. If you decide to take part you are still free to withdraw at any 
time and without giving a reason.  A decision to withdraw at any time, or a 
decision not to take part, will not affect the standard of care you receive, now 
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or in the future. If you wish to discuss the study with somebody else who is 
informed but independent from the research team, please contact Dr Rob 
McIntosh; Department of Psychology, PPLS, University of Edinburgh, 7 




What will happen to me if I take part? 
 
The study will consist of an interview during which you will undertake a 
series of simple tasks, some of which will take place on a computer. Please 
feel free to say no at this stage if you do not wish to participate any further. 
You are under no obligation to participate.  
 
The interview will last for approx. 2.5 hours. You can take as many breaks 
as you want and the study can be split across two separate days if you like. 
The interview can take place at your home at a time of your convenience, or 
at the Department of Psychology, University of Edinburgh, 7 George Square, 
if you prefer. Your travelling expenses will be reimbursed if you decide to 
come to the University of Edinburgh to take part in the study. 
 
If you wish, your G.P will be informed of your participation in this research. 
 
 
What do I have to do? 
 
You will not have to come off medication or undergo any invasive procedure 
whatsoever. Most tests are in the form of computer games and puzzles. 
Some of these tests assess how quickly your brain can do things, some of 
them test your memory, and some of them test your ability to problem solve 
and perform two tasks at the same time. The tests have been designed 
specifically to accommodate for movement problems. If you are unable to 
move your hands we will assist you in completing the tasks. If you are 
unable to speak we may skip certain tests that rely on spoken answers. 
Some of the tests may be filmed to help with data analysis.  
 
What are the possible disadvantages and risks of taking part? 
 
We do not anticipate any health risks from taking part in this study. If you 
feel distressed at any time during the interview it is important that you let the 
interviewer know straight away. If you feel distressed after the interview, 
please contact Dr. Sharon Abrahams 0131 650 3339 (project leader).  
 
What are the possible benefits of taking part? 
 
There will be no direct benefit to you by taking part, and your individual 
results will not be revealed to you. However, if you wish, we will send you a 
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summary of the study’s findings. It is hoped that this research will improve 
our knowledge relating to motor disorders and may influence care practices 
in the future. 
 
What if something goes wrong? 
 
Whilst we do not anticipate any adverse effects from taking part in this study, 
if you are harmed by taking part in this research project, there are no special 
compensation arrangements. If you are harmed due to someone’s 
negligence, then you may have grounds for a legal action but you may have 
to pay for it. Regardless of this, if you wish to complain, or have any 
concerns about any aspect of the way you have been approached or treated 
during the course of this study, the normal National Health Service 
complaints mechanisms should be available to you. 
 
Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the course of the 
research will be kept strictly confidential. The research team will enquire 
about your educational history to check for any previous or existing problems 
that could affect the results of the study. Only members of the research team 
and the clinical team at your hospital will have access to your medical 
records and notes. The research team will check your medical notes for any 
prior or existing problems that may affect the results of the study. Any 
information about you which leaves the hospital will have your name and 
address removed so that you cannot be recognised from it. You will be 
allocated an anonymous ID code during testing which will be used in place 
of your name in our testing materials, computers or on any future 
publications. 
 
In the unlikely event that you have given informed consent, but lose the 
ability to give consent during the study, the information we have already 
collected about you will be retained and used in the research. As stated 
earlier, all personal information will be kept strictly confidential.   
 
What will happen to the results of the research study? 
 
The results of the research will be published in appropriate peer-reviewed 
scientific journals for distribution to other healthcare professionals. Talks and 
presentations may be made at academic and clinical meetings and 









Who is organising the research? 
 
The study is being organised by Dr. Sharon Abrahams and Lewis Pettit from 
the University of Edinburgh, in collaboration with neurology centers at the 
Western General Hospital (Edinburgh), and the Royal Infirmary of 
Edinburgh.  
 
Who has reviewed the study? 
 




Contact for Further Information 
 
If you wish to ask anything further then please contact Lewis Pettit via the 
address below or on 0131 650 3423 (Lewis.D.Pettit@sms.ed.ac.uk) or            
Dr Sharon Abrahams 0131 650 3339 (s.abrahams@ed.ac.uk). 
 
Lewis Pettit and Dr Sharon Abrahams 
Department of Psychology, PPLS , 7 George Square 
Edinburgh, EH8 9JZ    
 
Thank you for reading this information sheet. You will be given a copy to 
keep. If you have understood the contents of this sheet and wish to take 
part, please complete the consent sheet on the next page. If you have any 



















Title of Project: “Thinking and behaviour in movement disorders; a 
comparative study”  
 
Name of Researchers:  Dr. Sharon Abrahams & Lewis Pettit 
 
 
Please tick box 
 
 I confirm that I have read and understand the information sheet (July 
2011, version 2) for the above study and have had the opportunity to ask 
questions. 
 I understand that I will be filmed/recorded for data analysis purposes. 
 I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected. 
 I understand that sections of any of my medical notes may be looked 
at by responsible individuals from (name of hospital) (location) or by 
members of the research team.  I give permission for these individuals to 
have access to my records. 
 Please tick if you would like your G.P. to be informed of your 
participation in this research. 
 Please tick if you would like to receive a summary of the findings 





Name of Patient Signature  Date  
 
_________________________ ____________________   _____________ 





















Participant Information Sheet for Healthy Volunteers 
 
 
Study title: “Thinking and behaviour in movement disorders; a 
comparative study”. 
 
You are being invited to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it 
will involve.  Please take time to read the following information carefully and 
discuss it with others if you wish.  Ask us if there is anything that is not clear 
or if you would like more information.  Take time to decide whether or not 
you wish to take part.  
 
What is the purpose of the study? 
 
The current study investigates processes of thinking in motor disorders and 
uses some measures which focus on processes of attention and your ability 
to perform two tasks at once.  
 
Why have I been chosen? 
 
We will be seeing a total of 40 healthy control participants. We will also be 
seeing 40 people with motor neuron disease (MND), 40 people with 
Parkinson’s disease (PD), and 40 people with multiple sclerosis (MS). 
  
Do I have to take part? 
 
It is up to you to decide whether or not to take part.  If you do decide to take 
part you will be given this information sheet to keep and be asked to sign a 
consent form. If you decide to take part you are still free to withdraw at any 
time and without giving a reason.  A decision to withdraw at any time, or a 
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decision not to take part, will not affect the standard of care you receive, now 
or in the future. If you wish to discuss the study with somebody else who is 
informed but independent from the research team, please contact Dr Rob 
McIntosh; Department of Psychology, PPLS, University of Edinburgh, 7 




What will happen to me if I take part? 
 
The study will consist of an interview during which you will undertake a 
series of simple tasks, some of which will take place on a computer. Please 
feel free to say no at this stage if you do not wish to participate any further. 
You are under no obligation to participate.  
 
The interview will last for 2.5 hours. The interview will take place at the 
Department of Psychology, University of Edinburgh, 7 George Square. You 
will be paid £6 an hour as a reimbursement for your time. 
 
If you wish, your G.P will be informed of your participation in this research. In 
addition, in the unlikely event that the study identifies any medical problems, 
your G.P will be informed of your participation in this research and advised 
as necessary. 
 
What do I have to do? 
 
You will not have to take medication or undergo any invasive procedure 
whatsoever. Most tests are in the forms of computer games and puzzles. 
Some of these tests assess how quickly your brain can do things, some of 
them test your memory, and some of them test your ability to problem solve 
and perform two tasks at the same time. Some of the tests may be filmed to 
help with data analysis.  
 
 
What are the possible disadvantages and risks of taking part? 
 
We do not anticipate any health risks from taking part in this study. If you 
feel distressed at any time during the interview it is important that you let the 
interviewer know straight away. If you feel distressed after the interview, 
please contact Dr. Sharon Abrahams 0131 650 3339 (project leader).  
 
What are the possible benefits of taking part? 
 
There will be no direct benefit to you by taking part, and your individual 
results will not be revealed to you. However, if you wish, we will send you a 
summary of the study’s findings. It is hoped that this research will improve 
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our knowledge relating to motor disorders and may influence care practices 
in the future. 
 
What if something goes wrong? 
 
Whilst we do not anticipate any adverse effects from taking part in this study, 
if you are harmed by taking part in this research project, there are no special 
compensation arrangements. If you are harmed due to someone’s 
negligence, then you may have grounds for a legal action but you may have 
to pay for it.  Regardless of this, if you wish to complain, or have any 
concerns about any aspect of the way you have been approached or treated 
during the course of this study, the normal National Health Service 
complaints mechanisms should be available to you. 
 
 
Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the course of the 
research will be kept strictly confidential. Only people from the research 
team will see your information. You will be allocated an anonymous ID code 
during testing which will be used in place of your name in our testing 
materials, computers or on any future publications. 
 
What will happen to the results of the research study? 
 
The results of the research will be published in appropriate peer-reviewed 
scientific journals for distribution to other healthcare professionals. Talks and 
presentations may be made at academic and clinical meetings and 
conferences. In all cases, your name and personal details will not be 
identified. 
 
Who is organising the research? 
 
The study is being organised by Dr. Sharon Abrahams and Lewis Pettit from 
the University of Edinburgh, in collaboration with neurology centers at the 
Western General Hospital (Edinburgh) and the Royal Infirmary of Edinburgh. 
 
Who has reviewed the study? 
 
This study has been reviewed by the South East Scotland Research Ethics 
Committee. 
 
Contact for Further Information 
 
If you wish to ask anything further then please contact Lewis Pettit via the 
address below or on 0131 650 3423 (Lewis.D.Pettit@sms.ed.ac.uk) or            




Lewis Pettit and Dr Sharon Abrahams 
Department of Psychology, PPLS , 7 George Square 
Edinburgh, EH8 9JZ    
 
Thank you for reading this information sheet. You will be given a copy to 
keep. If you have understood the contents of this sheet and wish to take 
part, please complete the consent sheet on the next page. If you have any 




























Title of Project: “Thinking and behaviour in movement disorders; a 
comparative study”  
 
Name of Researchers:  Dr. Sharon Abrahams & Lewis Pettit 
 
 
Please tick box 
 
 I confirm that I have read and understand the information sheet 
(July 2011, version 2) for the above study and have had the 
opportunity to ask questions. 
 I understand that I will be filmed/recorded for data analysis 
purposes. 
 I understand that my participation is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my 
medical care or legal rights being affected. 
 Please tick if you would like your G.P. to be informed of your 
participation in this research. 
 Please tick if you would like to receive a summary of the 
findings 






Name of Volunteer Signature  Date  
 
_________________________ ____________________  
 _____________ 




Appendix C – Relationship between depression and cognition in MS 
 
Table 23. HADS depression correlations with background neuropsychological testing 
Test Correlation coefficient (rho) p value 
GNT -0.31 0.182 
Spatial Span Fwd -0.03 0.910 
Spatial Span Rev -0.25 0.259 
Digit Span Fwd 0.17 0.428 
Digit Span Rev 0.27 0.191 
Log. Memory Imm. -0.05 0.817 
Log.Memory Del. -0.13 0.551 
Log. Memory Rec. -0.24 0.267 
Log. Memory Ret. -0.20 0.341 
Brixton (Errors) -0.13 0.551 
Brixton (scaled) 0.08 0.718 
Sorting Test (no. of sorts) -0.17 0.415 
Sorting Test (Recog) -0.08 0.701 
Sorting Test (scaled score) -0.25 0.227 
Spoken letter fluency (fi) -0.21 0.306 
Written letter fluency (fi) -0.20 0.495 
GNT = Graded Naming Test, Fwd = Forward, Rev. = Reverse, Log. = Logical, Imm. = Immediate 
recall, Del. = Delayed recall, Rec. = Recognition, Ret. = Retention, fi = fluency index, No. of sorts = 
number of correctly identified sorts in the DKEFS Sorting test, Recog = score in the recognition 
condition of the DKEFS Sorting test. 
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Appendix D – Dual task pilot study 
 
Participants 
In total fifteen healthy young adults (8 males, and 7 females, mean age = 23.3, range = 21 – 
30, mean WTAR score = 110.6, range = 96 – 122) were recruited from the university’s 
Volunteer Participant Panel. Seven participants were administered the dual-task using each 
individual’s maximum level of performance in the component tasks. A subsequent eight 
participants were administered an updated version of the task in which the component tasks 
were administered at a level one increment below their maximum level (level -1). 
Participants who undertook this version of the dual task went on to form part of the young 
participant group in the ageing study. 
 
Procedure 
The procedure for the pilot study was identical to that of the ageing study (described in 
Chapter 3, Section 3.6.3.4), except that the first seven participants were administered the 
component tasks at their maximum ability level in single and dual task conditions. 
 
Results 
Percentage change scores revealed that dual-task costs were relatively high when 
individuals’ were administered component tasks at their maximum level.  The average dual-
task cost was 5.6% (SD = 7.4) and the range was large (min = -1.9%, max = 18.8%) 
suggesting that performance was highly variable. For this reason, the dual-task methodology 
was updated so that component tasks (in both single-task and dual-task conditions) were 
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administered at a level one below an individual’s maximum ability. The updated dual-task 
methodology was subsequently piloted on a further eight healthy young adults, and revealed 
a smaller average dual-task cost of 3.6% (SD = 4.0), with a more conservative range (min = 
-0.3%, max = 12.5%) suggesting that performance under these conditions was more stable 
and predictable. Indeed, the small dual-task costs observed in the updated dual-task 
methodology are consistent with those produced by other studies employing similar 
“preload” methodology (Cocchini et al., 2002; MacPherson et al., 2004). Thus, the updated 
of version of the dual task paradigm was employed in all subsequent investigations. Full 
details of the dual-task pilot study are displayed in Table 24. 
 
Table 24. Dual task performance in healthy young participants, means [SD] are presented 
 Max. level (n = 7) Level -1 (n = 8) 
Baseline DDR level (digits) 6.7 [1.0] 6.3 [0.7] 
Baseline VIT level (ms) 38.9 [8.3] 53.1 [10.9] 
DDR Single % correct 95.6 [4.2] 97.8 [3.6] 
VIT Single % correct 94.6 [5.5] 95.1 [3.9] 
DDR Dual % correct 95.1 [5.8] 94.9 [5.6] 
VIT Dual % correct 84.9 [13.3] 91.1[6.8] 
DDR Dual Task Cost (% change) 0.5 [6.2] 2.7 [5.5] 
VIT Dual Task Cost (% change) 10.6 [10.6] 4.3 [4.2] 
Average Dual Task Cost (% change) 5.6 [7.4] 3.6 [4.0] 















Order Test Duration Notes Score 
1 WATR 5 mins   
2 Dual Task 30 mins Inc. VIT and DS 
titrations 
 
3 Letter RSVP 15 mins Spin laptop screen  
4 HADS 5 mins   
5 Card Sort 15 mins   
6 VIT 15 mins   
7 Written Verbal Fluency 10 mins S for 5 mins, C4 for 4 
mins 
 
8 Spoken Verbal Fluency 5 mins P,R,W  
9 wVF control  10 mins   
10 sVF control 5 mins   
  *BREAK*   
11 Logical Memory  10 mins Immediate Recall  
12 Brixton 10 mins   
13 Corsi Block 10 mins Forward  
14 Corsi Block  10 mins Reverse  
15 Logical Memory 10 mins Delayed 
recall/recognition 
 
16 GNT 5 mins   
17 Digit Span 5 mins Forward  
18 Digit Span 5 mins Reverse  
19 Force Respiration 5 mins ALS only  
20 ALSFRS 10 mins ALS only  
21 Sleep Apnoea Scale 10 mins ALS only  
